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ABSTRACT 
Sleep is a critical modulator for daytime functioning, health and wellbeing and has a 
pivotal role in motor memory consolidation. It is for these reasons that sleep is a 
potentially important part of stroke care. However, this idea is severely under 
researched. It is necessary to explore sleep behaviour in stroke patients and the 
importance of healthy sleep for recovery and neurorehabilitation. More specifically, 
investigate the extent to which sleep may be a key modulator for motor 
neurorehabilitation success. It is the central aim of this thesis to contribute to the 
understanding of the sleep behaviour and daytime functioning in patients with 
chronic physical deficits after stroke and to explore the potential role of sleep for 
neurorehabilitation. Furthermore, this is the first known study to monitor sleep 
behaviour during a motor neurorehabilitation trial and assess outcome within this 
context. The research aimed to: 1) make a substantial contribution to the under 
researched field of post stroke sleep, 2) address some of the limitations imposed on 
previous studies, 3) focus on a specific cohort, 4) examine sleep in the context of a 
neurorehabilitation programme. The patient cohort employed in this research 
comprised chronic stroke patients (>'12 months) with upper limb hemiparesis. It was 
found that sleep and daytime functioning disturbances were prevalent in 
approximately one third of patients. Interestingly, patients were not generally aware 
of the severity of their daytime functioning deficits. Sleep and daytime functioning 
were mildly related to motor recovery and neurorehabilitation. In conclusion, sleep 
clearly has a role in stroke patient quality of life, recovery and neurorehabilitation 
outcome, however further research using alternative assessments of sleep are 
necessary. The findings of this thesis have implications for post stroke management 
including increasing medical knowledge and adjustments in rehabilitation protocols 
that favour sleep. 
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CHAPTER 1: Theoretical Perspective 
Chapter 1 Overview 
Stroke is one of the leading causes of disability, associated with a range of acute and 
long term somatic, behavioural, cognitive and motor consequences. Treatment 
intends to alleviate and manage these characteristics of the stroke sequelae through 
pharamacological, psychological and rehabilitative interventions. These treatments 
primarily focus on waking behaviour and consequently neglect sleep. It is well 
documented in the literature that sleep is a critical mediator of wellbeing, daytime 
functioning and learning. Therefore, healthy sleep may be highly important for stroke 
treatment provisions. More research into the potentially crucial role of sleep in stroke 
recovery and management is essential for recovering patients. 
The objective of Chapter 1 is to present the theoretical perspective from which the 
research for this thesis evolved (Figure 1.1). 
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Figure 1.1. The framework for the theoretical perspective of this thesis, as described 
in this chapter. Grey ovals represent each section of this chapter and the white boxes 
describe theory/evidence presented within these sections. 
Firstly, the clinical definition and epistemology of stroke is described followed by the 
endured consequences and a summary of current treatments available to manage the 
condition. Secondly, a paradigm shift in the approach to stroke treatment is proposed 
and the field of sleep is introduced. The physiology of sleep is explained as well as 
how it is measured and the disorders of sleep. The third section of this chapter 
continues to discuss sleep with regard its overall function for the body, brain and 
quality of life. The fourth section proposes the importance of sleep for recovering 
stroke patients and presents the overall working model for this thesis. The final 
section describes the development of the research design for the four studies carried 
out for this thesis. 
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1.1 Stroke Epidemiology, Consequences and Treatment 
Stroke is a form of cardiovascular disease that manifests itself as an acquired brain 
injury. It presents a multitude of acute and chronic consequences that severely impact 
the quality of life of patients. Current service provisions offer a range of rehabilitative 
treatments to support acute stroke however there are fewer regimes in place for 
chronic suffers. Further research is required to generate a greater understanding of the 
stroke sequelae and improve levels of care for both short and long term 
consequences. 
1.1.1 What Is A Stroke? 
Clinical Definition 
A stroke is characterised by the rapid deterioration of neurological function as a result 
of interrupted blood supply to the brain, lasting more than 24 hours (World Health 
Organisation, 1998). Blood supply to the brain can be affected by either a blockage or 
haemorrhage which immediately initiates focal neuronal damage (Lipton, 1999; 
Sugawara et al., 2004). This impacts those functions controlled by the affected brain 
regions. Motor control, language and comprehension, vision and cognitive function 
are typically impaired by stroke (American Heart Association, 2009). However, 
severe strokes within critical brain areas, such as the midbrain and brain stem, may 
result in coma or death. A stroke event begins as an acute medical emergency 
requiring immediate medical attention and, depending on the extent of the damage, 
may cause long-term disability in patients. 
Types of Stroke 
There are two main types of stoke: ischemic and haemorrhagic (Caplan, 2005, p. 10). 
Ischemic stroke accounts for 67-80% of all stroke events (Feigin, Lawes, Bennett, & 
Anderson, 2003; Leoo, Lindgren, Petersson, & von Arbin, 2008). This form of stroke 
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is caused by a blockage that restricts blood flow to a specific area of the brain, known 
as an infarct (Aminoff, Simon, & Greenberg, 2005, p. 290). Blockages may occur as a 
result of a thromobus or collection of debris such as plaques, fat, air or cancerous 
cells. Infarcts may originate from within the brain or a result of travelling debris from 
another part of the body, known as an embolism. Haemorrhagic strokes occur when a 
blood vessel in the brain ruptures. A bleeding blood vessel can no longer carry blood 
to its target tissue, therefore causes cell damage, similarly to ischemia. Haemorrhagic 
strokes may also occur due to a burst aneurysm. Accumulating blood not only 
increases intracranial pressure but irritates brain tissue causing cell damage (Caplan, 
2005, p. 13). 
A transient ischemic attack (TIA) is a less severe form of stroke. A TIA is defined as 
"a brief episode of neurologic dysfunction caused by focal brain or retinal ischemia, 
with clinical symptoms typically lasting less than one hour, and without evidence of 
acute infarction" (Albers et al., 2002, p. 1713-1716). Blood supply is interrupted from 
a few minutes up to 24 hours, however, full recovery is achieved post event 
(Aminoff, Simon and Davis, 2005, p. 286). A TIA is sometimes considered a warning 
for a stroke. Eight to fifteen percent of people who experience a TIA, have a stroke 
within a year (Hankey & 1996; Lovett et al., 2003; Weimar et al., 2009). 
Incidence 
Stroke affects approximately 100,000 people per year in England and Wales, and 
30,000 of those people suffer further strokes (Department of Health, 2001). Although 
risk increases with age, 10,000 sufferers are under 55 years old and 1,000 of those 
persons are under 30 (Office of National Statistics UK, 1998). Stroke mortality has 
declined in recent years (Bonita, Stewart, & Beaglehole, 1990; Feigin, Lawes, 
Bennett, Barker-Collo, & Parag, 2009; Sarti, Rastenyte, Cepaitis, & Tuomilehto, 
2000). Therefore, an increasing amount of people are surviving and living with the 
consequences (Bonita, Beaglehole, & Asplund, 1994; Elneihoum, Goransson, Falke, 
& Janzon, 1998). 
27 
Causes and Risk Factors 
For some patients, strokes have a clear cause, e. g. as a result of vascular injury after 
an accident or due to complications during brain surgery (Gerlach et al., 2002; Norris, 
Beletsky, Nadareishvili, & Consortium, 2000; Wong et al., 2000), however the cause 
of some strokes are not identified. Several patients have an increased vulnerability to 
stroke due to several well known risk factors. This includes demographical risks such 
as increasing age and being male (Gafarov, Gromova, Gagulin, & Pilipenko, 2005; 
Goldstein et al., 2008). Presence of congenital heart diseases, such as arrhythmia, 
diseases of the blood and atrial fibrillation, are associated with stroke (American 
Heart Association, 2001). Chronic conditions including diabetes mellitus, high 
cholesterol and hypertension, are also associated with stroke (American Heart 
Association, 2001; Goldstein et al., 2008; Leoo et al., 2008). Unhealthy lifestyle such 
as obesity, smoking and high levels of stress are also prominent risk factors (Office of 
Population Censuses and Statistics UK, 1995; Gafarov et al., 2005). A link has been 
identified between a stroke event and existence of sleep breathing disorders 
(described in Section 1.2.4), even when controlling for other stroke risks such as 
smoking and obesity (Bradley & Floras, 2009; Drager, Bortolotto, Krieger, & 
Lorenzi-Filho, 2009; Portela, Fumado, Garcia, & Borrego, 2009; Spriggs et al., 
1992b; Yaggi et al., 2005). Successful treatment of sleep breathing disorders using 
Continuous Positive Airway Pressure (CPAP) is associated with a reduced risk of 
cardiovascular disease, including stroke (Drager, Bortolotto, Figueiredo, Krieger, & 
Lorenzi, 2007; Marin, Carrizo, Vicente, & Agusti, 2005). Also regarding sleep, those 
who sleep more than eight hours a night and have excessive daytime sleepiness are 
more likely to experience a stroke (Qureshi, Giles, Croft, & Bliwise, 1997). 
Stroke In The Wider Context of Acquired Brain Injury and Chronicity 
Within the stroke literature, patient samples normally include only those who have 
experienced a brain injury of a vascular origin. In the wider context of brain injury, 
some studies use mixed samples of both stroke and patients with traumatic brain 
injury (TBI). TBI refers to acquired brain damage caused by an external force, e. g. 
automobile accident (Maas, Stocchetti, & Bullock, 2008). Only patients who 
28 
experienced stroke (excluding TIA) were included for the research carried out for this 
thesis. 
The stages of injury, as defined by time since injury, or chronicity, is subject to 
different interpretations in literature (Sullivan, 2007). Some studies refer to 
chronicities less than six months as acute stroke, whereas some studies define acute 
as less than three months. Some researchers describe the three to six month post brain 
injury phase as sub acute. To confuse this issue further, several studies report that 
patients at three to six months post injury have reached a plateau in their recovery and 
are therefore considered chronic (Sullivan, 2007). However, the long term 
consequences of stroke, both physical and psychological, are unlikely to remain 
stable until 12 months after injury (Donnan, Bladin, Berkovic, Longley, & Saling, 
1991; Duncan, Goldstein, Matchar, Divine, & Feussner, 1992; Horgan, O'Regan, 
Cunningham, & Finn, 2009; Jorgensen et al., 1995; Kotila, Waltimo, Niemi, 
Laaksonen, & Lempinen, 1984; Lesniak, Bak, Czepiel, Seniow, & Czlonkowska, 
2008; MacHale, O'Rourke, Wardlaw, & Dennis, 1998; Rasquin, Lodder, & Verhey, 
2005). Based on this evidence, this thesis will use the term acute to refer to patients 
with chronicities of less than 12 months, whereas chronic will describe those beyond 
this time. Those at 12 months post stroke and beyond are more likely to be in a 
chronic state regarding their recovery levels, and critically, are stable in terms of their 
psychological adjustment to the disease. 
1.1.2 Pathouenesis 
Blood supply to the brain is vital for maintaining normal brain function and to sustain 
life. Restricted blood supply or haemorrhaging within the brain facilitates a complex 
cascade of cellular, structural and behavioural alterations. 
Brain Blood Supply 
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Brain metabolism is an energy consuming process (aerobic) that requires a constant 
supply of oxygen and glucose carried by the blood (Amonoff, Simon and Davis, 
2005, p. 289). Cerebral blood flow (CBF) is the main homeostatic factor for 
maintaining adequate oxygen and is tightly regulated to meet metabolic demands 
(Walters, 1998). CBF also serves a purpose to remove waste products such as free 
radicals that are harmful to cells. Furthermore, CBF is important for maintaining 
intracranial pressure levels (Walters, 1998). 
Blood is supplied to the brain via two main pairs of arteries: the common carotid and 
vertebral (Figure 1.2; The Internet Stroke Centre, 1998-1999). The carotid divides 
into two major terminal branches, known as the internal and external carotid arteries. 
The external carotid artery supplies blood to the face and scalp whereas the internal 
carotid supplies blood to most of the brain. The vertebral artery carries blood to parts 
of the cerebrum, cerebellum and brain stem. The common carotid and vertebral both 
feed into the circle of willis located at the base of the brain (Aminoff, Simon and 
Davis, 2005, p288). The circle of willis supplies blood to discrete brain regions via 
the anterior, middle and posterior cerebral arteries. Interruption of blood flow 
deprives neurons of energy, and, unless normal blood flow is promptly restored, leads 
to cell death (Aminoff, Simon and Davis, 2005, p286-290). Too much blood as a 
result of haemorrhage can raise intracranial pressure which can compress and damage 
delicate brain tissue. Lack of blood, also known as ischemia, causes cell damage. 
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Figure 1.2. Reproduced from The Stroke Internet Center (1998-1999). 
Stroke In Evolution 
Figure 1.3 presents the biological cascade at stroke onset which may last from 
minutes to hours (Aminoff, Simon and Davis, p. 289; Pulsinelli, 1992). Disruption of 
the energy supply to cells causes depolarisation. Cell membrane permeability 
becomes increased, leading to an inability to maintain potential. This results in a 
neurotransmitter imbalance, most notably an increase in glutamate. An abundance of 
glutamate stimulates an influx of sodium or calcium that causes cells to swell and 
break down (mitochondria injury). Furthermore, increased sodium and calcium lead 
to the activation harmful enzymes and release of reactive free radicals. Haemorrhagic 
strokes generate toxic by-products which may also release free radicals (Thanvi, 
Treadwell, & Robinson, 2008). Additionally, continuing haemorrhagic strokes 
facilitate an accumulation of fluid; blood or endema. This results in cell swelling and 
an increase in intracranial pressure (Rincon & Mayer, 2008). Continuation of this 
cascade eventually leads to cell damage or death, causing a focal deterioration in 
neural function. A fully completed stroke event is defined by "the presence of 
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residual deficits, and this can include those that are stable or improving" (Aminoff, 
Simon and Davis, p. 287). 
The Stroke Cascade 
CeNular 
sweYing 
Mitochondral Free-radical Enzyme 
injury generation activation 
Cell Damage/Death 
Figure 1.3. Adapted from Aminoff, Simon and Davis (2005) p. 289. 
The longer the time since stroke onset, the greater the severity of injury (Hacke et at., 
2004; Hacke, Kaste, Skyhoj Olsen, Orgogozo, & Bogousslavsky, 2000; Ringleb, 
Schellinger, Schranz, & Hacke, 2002). Cell damage may occur at three levels 
(Aminoff, Simon and Davis, p. 288): 1) preferential loss whereby only certain 
neuronal populations are affected, 2) further selective damage but more severe 
however some parts of the cell are preserved, e. g. glial (support cells), which have the 
capacity to regenerate as part of recovery (Butefisch, 2006; Cramer & Bastings, 
2000) and, 3) permanent ischemia as a result of gross cell damage (Aminoff, Simon 
and Davis, p. 288). 
32 
Stroke produces focal symptoms that correlate with the area of the brain tissue 
affected by the ischemia or haemorrhage (Davis, 2005). Strokes within the cerebral 
cortex are associated with aphasia, apraxia, visual deficits, memory difficulties, 
hemineglect and confusion. Damage to the cortex may also produce muscle weakness 
in limbs and face, numbness, poor coordination and poor sensation. Cerebellum and 
brain stem strokes are associated with motor and sensory loss, nystagmus, amnesia, 
altered senses, ocular weakness, decreased reflexes, balance problems, altered 
breathing and heart rate, poor control of the tongue. Increased intracranial pressure as 
a result of stroke can cause vomiting, headache and eventually loss of consciousness 
(Aminoff, Simon and Davis, p. 315). 
Early recognition and treatment is critical to minimise the extent of brain damage. 
Treatment windows beyond three to six hours after onset are less favourable for 
stroke outcome (Hacke et al., 2004; Hacke et al., 2000; Ringleb et al., 2002). 
Pharmacological treatments are commonly applied to reduced blockages (The 
National Institute of Neurological Disorders and Stroke, 1995). For example, 
anticoagulant medications are used to thin the blood in the event of a clot (Lip & 
Edwards, 2006). For haemorrhagic stroke, neurosurgery is required to contain 
bleeding (Rincon & Mayer, 2008). Only 10% of stroke survivors achieve a full 
recovery, 25% have minor impairments, 40% have moderate to server impairment, 
10% require long-term care and 15% die shortly after stroke (National Stroke 
Association, 2009). 
1.1.2 Consequences of Stoke 
Survivors of stroke endure a multitude of somatic, behavioural, psychological, 
cognitive and motor movement consequences. Deficits in these areas considerably 
affect the quality of life of suffers and their families (de Haan, Limburg, Van der 
Meulen, Jacobs, & Aaronson, 1995; Duncan, 1997; Gokkaya, Aras, & Cakci, 2005; 
Hop, Rinkel, Algra, & van Gijn, 1998). 
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Somatic 
Stroke is associated with various comorbid medical conditions including pain, 
seizures, hypertension, incontinence and vision problems. These medical ailments are 
most prominent within the acute phase of stroke however some somatic concerns 
become chronic (Sisson, 1995). 
Post stroke pain may include headaches as well musculoskeletal, joint and 
neuropathic pain (Gamble, Barberan, Bowsher, & Tyrrell, 2000; Kong, Woon, & 
Yang, 2004; Widar, Ek, & Ahlstrom, 2004). Long term pain interferes with activities 
of daily living, quality of life, mood and sleep (Iolascon, Gimigliano, & Gimigliano, 
2006; Widar et al., 2004). Pain also adversely affects motor rehabilitation processes 
as patients struggle with physical endurance (Griffin, 1986; Roy, Sands, Hill, 
Harrison, & Marshall, 1995). Successful post stroke pain treatment is associated with 
better functioning and quality of life (Zorowitz, Smout, Gassaway, & Horn, 2005). 
Increased stroke severity is associated with a high risk of seizures (Reith, Jorgensen, 
Nakayama, Raaschou, & Olsen, 1997). Eight to twelve percent of stroke survivors 
experience seizures and a small proportion may develop epilepsy (Bentes, Pimentel, 
& Ferro, 2001; Bladin et al., 2000). While seizures can be controlled with medication, 
patients still experience difficulties (Strine et al., 2005). Epilepsy is associated with 
increased psychological stress and cognitive deficits (Moore & Baker, 2002; 
Motamedi & Meador, 2003). Furthermore, the side effects of anti-epileptic 
medication can cause severe drowsiness (Hoeppner, Garron, & Cartwright, 1984; 
Legros & Bazil, 2003). 
Hypertension is not only a risk factor of stroke (Lewington, Clarke, Qizilbash, Peto, 
& Collins, 2002) but is also a consequence (Carlberg, Asplund, & Hagg, 1990). Post 
stroke psychological stresses (Carlberg et al., 1990; Morfis, Schwartz, Poulos, & 
Howes, 1997) and increased sympathetic activity within the nervous system (Naredi 
et al., 2000) can cause high blood pressure. This is normally controlled with 
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medication which also reduces risk of further strokes (Cook et al., 2007; Rashid, 
Leonardi-Bee, & Bath, 2003). Hypertension and blood pressure variability have been 
mildly associated with poorer stroke outcome (Ahmed & Wahlgren, 2001; Potter et 
al., 2009) however this may also be related to initial stroke severity. 
Weakened bladder and bowel control is commonly reported in acute and to a lesser 
degree, chronic stroke (Barrett, 2002). Incontinence may be directly related to brain 
damage to the neural pathways that control the bladder, pudendal nerve and pelvic 
floor muscle (Sakakibara, Hattori, Yasuda, & Yamanishi, 1996). In addition, 
incontinence can be caused by cognitive deficits or is a side effect of medication 
(Gelber, Good, Laven, & Verhulst, 1993). The social consequences and 
inconvenience of incontinence is severely disturbing for patients (Brittain, 2001; 
Burney, Senapati, Desai, Choudhary, & Badlani, 1996). Incontinence reflects the 
severity of the stroke and is associated with poorer recovery (Brittain, 2001) and 
rehabilitation outcome (Ween, Alexander, D'Esposito, & Roberts, 1996). 
In the acute phase of stroke, the visual system is affected in 92% of patients (Rowe, 
2009). More specifically, 8.4% of patients have eye movement difficulties, 46.1% 
have visual field impairments, 25.1% have low vision and 20.5% have perception 
problems (Rowe, 2009). Peripheral field loss may persist in chronic patients (Cassidy, 
Bruce, & Gray, 2001). Some patients even report hallucinations as a directly related 
to brain damage after stroke, rather than presence of psychoses (Ashwin & 
Tsaloumas, 2007). Problematic vision is associated with poorer functioning on 
activities that require vision (Gall, Lucklum, Sabel, & Franke, 2008; Jones & 
Shinton, 2006; Rowe, 2009) and may impede rehabilitative treatment (Johansen, 
White, & Waraisch, 2003). 
Behavioural 
Nocturnal sleep disturbance and poor daytime functioning, such as increased 
sleepiness and fatigue, are common co-morbidities of acute stroke (Annoni, Staub, 
Bogousslavsky, & Brioschi, 2008; Bassetti, 2005a; Bassetti & Valko, 2006). 
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Maladaptive sleep/wake behaviour may be caused by a multitude of factors including 
the physical and psychological consequences of stroke (Schepers, Visser-Meily, 
Ketelaar, & Lindeman, 2006; Van Zandvoort, Kappelle, Algra, & De Haan, 1998) or 
as a direct result of brain damage per se (Ingles, Eskes, & Phillips, 1999; van der 
Werf, van den Brock, Anten, & Bleijenberg, 2001), particularly disruptions to those 
mechanisms involved in sleep regulation and arousal (Bassetti & Valko, 2006; Evans, 
2002). Poor sleep and daytime functioning evolves into a chronic condition in 25- 
67% of patients (Cadilhac et al., 2005; Campos et al., 2005; Masel, Scheibel, 
Kimbark, & Kuna, 2001'; Palomaki et al., 2003; Schuiling, Rinkel, Walchenbach, & 
de Weerd, 2005; Sterr, Herron, Dijk, & Ellis, 2008; Van Zandvoort et al., 1998; 
Worthington & Melia, 2006'). Post stroke sleep and daytime functioning difficulties 
not only impact quality of life of patients (Schuiling et al., 2005) but have 
implications for recovery outcome (Choi-Kwon, Han, Kwon, & Kim, 2005; Glader, 
Stegmayr, & Asplund, 2002; Ingles et al., 1999; Naess, Nyland, Thomassen, Aarseth, 
& Myhr, 2005) and adversely affect participation in rehabilitation (Barker-Collo, 
Feigin, & Dudley, 2007; Morley, Jackson, & Mead, 2005; Terzoudi et al., 2009; 
Worthington & Melia, 2006). 
Psychological Disturbance 
Stroke is associated with a wide range of psychological disturbances, which may have 
psychiatric connotations (Carota & Bogousslavsky, 2002), as defined by the Fourth 
revision of Diagnostic and Statistical Manual of Mental Disorders (DSM-IV; 1994) 
or 10th revision of International Classification of Diseases (ICD-10; 1992). Such 
disturbances stem from a complex array of etiologies including lesion characteristics, 
functional impairment, cognitive difficulties, medications, support, resources and 
ability to cope (Carota & Bogousslavsky, 2002). Depression and anxiety are among 
the most commonly experienced psychological difficulties after stroke (Clarke & 
Currie, 2009). 
1 Mixed stroke and TBI sample. 
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The DSM-IV identifies major and minor post stroke depression. Major depression is 
characterised by a presence of depressed mood, apathy, mania, or a mixture of these 
features for two weeks. In addition, patients must experience four other symptoms for 
including a significant changes in appetite or weight, sleep difficulties, daytime 
tiredness, psychomotor agitation, feelings of worthlessness or guilt, loss of 
concentration, and recurrent suicidal ideation. Patients diagnosed with minor 
depression typically have a depressed mood or loss of interest with at least two but 
fewer than four symptoms of major depression. It is important to note that studies 
examining post stroke depression do not necessarily utilise the DSM-IV 
conceptualisation (Whyte & Mulsant, 2002). 
Within the first few weeks after stroke, 6-27% of patients fulfil DSM criteria for 
major depression (Whyte & Mulsant, 2002) and approximately 30-50% experience 
minor depression (Paolucci, 2008; Robinson, 1997). Acute depression may evolve 
into a chronic condition, with 19-29% of patients having major depression (Astrom, 
Adolfsson, & Asplund, 1993a; Robinson, Bolduc, & Price, 1987; Whyte & Mulsant, 
2002) and 30-40% with minor depression (Robinson et al., 1987). Depression is a 
strong predictor of poorer quality of life after stroke (Jonkman, de Weerd, & Vrijens, 
1998; Kim, Warren, Madill, & Hadley, 1999; Neau et al., 1998) and has been linked 
to increased morbidity and mortality (Morris, Raphael, & Robinson, 1992; Morris, 
Robinson, Andrzejewski, Samuels, & Price, 1993). Post stroke depression is 
associated with poorer long term functional outcome (Herrmann, Black, Lawrence, 
Szekely, & Szalai, 1998; Pohjasvaara, Vataja, Leppavuori, Kaste, & Erkinjuntti, 
2001; Sisson, 1995), cognitive impairment (Kauhanen et al., 1999), daytime 
sleepiness and fatigue (Ingles et al., 1999; LaChapelle & Finlayson, 1998; Naess et 
al., 2005; Van Zandvoort et al., 1998), worse rehabilitation outcome (Gillen, Tennen, 
McKee, Gernert-Dott, & Affleck, 2001; Paolucci et al., 2001) and impacts ability to 
return to work in younger survivors (Neau et al., 1998). 
Anxiety describes a psychological state involving a summation of cognitive, somatic, 
emotional, and behavioural components which create feelings of uneasiness, distress, 
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catastrophic thinking and heightened physiological arousal (Davidson & Neale, 2001, 
p. 127). Although anxiety is a normal reaction to a stressful situation, persistent or 
non-specific anxiety may evolve into a chronic condition, i. e. Generalised Anxiety 
Disorder (GAD). The DSM-IV categorizes post stroke GAD as "anxiety disorder due 
to stroke, with generalized anxiety". More specifically, GAD is accompanied with 
restlessness, decreased energy, difficulty in concentration, irritability, muscle tension, 
and sleep disturbance (DSM-IV, 1994). 
Approximately 24-28% of patients will develop acute GAD (Astrom, 1996; Castillo, 
Starkstein, Fedoroff, Price, & Robinson, 1993; Leppavuori, Pohjasvaara, Vataja, 
Kaste, & Erkinjuntti, 2003), however, this becomes chronic in 20.6% (Astrom, 1996; 
Leppavuori et al., 2003; Sharpe et al., 1990). Fourteen percent of patients experience 
mild anxiety symptoms but do not fulfil DSM-IV criteria (Castillo et al., 1993). 
Moreover, 74% of GAD suffers will also experience depression (Castillo et al., 
1993). The existence of post stroke anxiety substantially has negative implications for 
health, social life, functional recovery and rehabilitation (Astrom, 1996; Leppavuori 
et al., 2003; Shimoda & Robinson, 1998; Visser-Meily, van Heugten, Post, Schepers, 
& Lindeman, 2005). 
Stroke is also associated with psychological conditions other than depression and 
anxiety. Eleven to twenty-one percent of patients report apathy (Santa et at., 2008; 
Starkstein, Fedoroff, Price, Leiguarda, & Robinson, 1993), a condition characterised 
by lack of emotion, interest, motivation or concern. Apathy can exist independently 
of depression (Marin & Wilkosz, 2005; Starkstein et at., 1993) and is associated with 
increased daytime naps (Muller, Czymmek, Thone-Otto, & Von Cramon, 2006), 
fatigue (Sisson, 1998) and reduced work capacity (Bassetti, Mathis, Gugger, Lovblad, 
& Hess, 1996). It has also been attributed to poorer functional outcome and may 
hinder rehabilitation participation (Santa et at., 2008; Starkstein et at., 1993). Fifteen 
to 25% of patients experience emotionalism within the first six months of stroke, 
(MacHale et al., 1998) which describes sudden or easily provoked episodes of crying 
or laughing precipitated by seemingly minor stimuli. These symptoms usually decline 
38 
within the first year of stroke (MacHale et at., 1998). Emotionalism has been linked 
to poorer motor dysfunction (Kim & Choi-Kwon, 2000) and severely impairs social 
contact (Allman, Hope, & Fairburn, 1992). A small of number of patients may 
develop post stroke psychotic disorder (Chemerinski & Robinson, 2000). This 
disorder reflects the severity of stroke and is associated with greater mortality 
(Almeida & Xiao, 2007). 
Cognitive Disruption 
The brain damage sustained after stroke usually disrupts cognitive functioning. Focal 
damage may lead to selective cognitive deficits whereas diffuse neural dysfunction 
may produce global impairments such as a reduction in processing speed, memory 
and executive functioning difficulties, e. g. planning and problem solving (de Haan, 
Nys, & Van Zandvoort, 2006; Mori, Sadoshima, Ibayashi, Lino, & Fujishima, 1994). 
Seventy-eight percent of patients may be impaired on one or more cognitive domain 
(Lesniak et at., 2008), most notably attention, language, short-term memory and 
executive functioning (Lesniak et al., 2008). Left stroke is associated with language 
and comprehension difficulties, affecting 38% of acute patients and 18% of chronic 
patients (Pedersen, Jorgensen, Nakayama, Raaschou, & Olsen, 1995). Deficits in 
cognitive functioning can improve, particularly within the first six months (Lesniak et 
al., 2008; Rasquin et al., 2005; Siccoli & Bassetti, 2008). Overall, poorer cognitive 
functioning after stroke is associated with lower quality of life (Kwa, Limburg, & de 
Haan, 1996; Paolucci et al., 1998), poorer social functioning (Hommel, Trabucco- 
Miguel, Naegele, Gonnet, & Jaillard, 2009; McDowd, Filion, Pohl, Richards, & 
Stiers, 2003), functional ability (McDowd et al., 2003; Sisson, 1995; Van Zandvoort 
et al., 1998) and response to rehabilitation (Galski, Bruno, Zorowitz, & Walker, 1993; 
Mokier, Sandstrom, Griffin, Farris, & Jones, 2000; Sandra Zinn et at., 2004). 
Motor Deficit 
Hemiplegia describes full paralysis of one side of the body whereas hemiparesis 
refers to partial paralysis (Schmahmann, Ko, & MacMore, 2004). Paralysis affects the 
side of the body that is contralateral to the lesion, where damage affects motor areas 
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of the brain including the corticospinal tract (Jang, 2009; Schaechter, Perdue, & 
Wang, 2008). Patients experience problems with balance, walking and functioning of 
the affected limbs. Activities of daily living such as cooking, eating, personal care, 
attending work and social activities are challenging tasks in stroke patients. 
Moreover, degree of motor loss was reported as the single biggest predictor of overall 
physical recovery and independence (Lincoln et al., 1989). Thirty-three percent of 
survivors to rely on 24 hour care and 71% are unable to work primarily due to motor 
function incapacity (American Heart Association, 2009). 
1.1.3 Treatment Options for Post-Stroke Management 
The consequences of stroke are managed through coordinated intervention. Recovery 
can occur spontaneously and as a result of multifaceted support including 
pharmacological, psychological, cognitive and motor neurorehabilitative 
interventions. Motor neurorehabilitation is by and large, the primary focus of post 
stroke treatment as successful outcome enables greater independence of the patient, 
therefore lower care requirement (Laidler, 2000, p. 83). 
Pharmacological, Psychological and Cognitive Interventions 
Stroke survivors are normally prescribed life long medications, such as 
anticoagulants, antiplatelets and blood pressure reducing drugs to reduce the likely 
hood of further strokes (Aminoff, Simon and Davis, 2005, p. 308-312; PROGRESS 
Collaborative Group, 2001). Other medications may be applied to manage co-morbid 
conditions including anti-epileptic drugs (Ryvlin, Montavont, & Nighoghossian, 
2006) and pain control (Kumar, Kalita, Kumar, & Misra, 2009; Zorowitz et al., 
2005). Furthermore, sleep medication is sometimes prescribed to patients suffering 
from sleeping difficulties (Palomaki et al., 2003). Approximately twenty percent of 
stroke patients remain on sleep medications at three to four months after stroke 
(Palomaki et at., 2003). 
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Post stroke depression is normally treated with anti-depressant medication (Clarke & 
Currie, 2009; Paolucci et al., 2001). Emotionalism also responds well to 
antidepressants (Robinson, 1997). Anti-depressants are commonly prescribed to 
patients to help them cope and psychologically adjust to the consequences of stoke 
(Paolucci, 2008). Alternative non-pharmacological therapies are also beneficial for 
patients (Paolucci, 2008). For example, counselling and cognitive behavioural 
therapy have shown high efficacy for post stroke depression and anxiety (Clark, 
Rubenach, & Winsor, 2003; Kendall et al., 2007; Kneebone & Dunmore, 2000; 
Thompson, 2000). 
Cognitive impairment can be treated with a range of cognitive training therapies 
including cognitive exercises, computer-assisted training, communication skill 
training and physical exercise (Jordan, 2000; Pyun et al., 2009). Speech and language 
therapy is also beneficial for those with communication difficulties (Bhogal, Teasell, 
& Speechley, 2003; Marshall, 2000). 
Motor Neurorehabilitation 
Motor neurorehabilitation is a vital part of post-stroke treatment to enable the patient 
regain previously lost motor skills. After stroke, the brain holds the capacity to regain 
some lost motor functions via neuroplasticity, i. e. the ability to adapt and reorganise 
in response to injury (Matthews, Johansen-Berg, & Reddy, 2004; Mulder & 
Hochstenbach, 2001; Platz, Kim, Engel, Kieselbach, & Mauritz, 2002). 
After the stroke event, tissue damage to the motor areas, including the pre-motor 
cortex, the primary motor cortex and the supplementary motor area (SMA), results in 
impairment or even cessation of motor function (Lukacs, Vecsei, & Beniczky, 2008). 
The neuroplastic properties of the brain allow some motor skills to be, at least in part, 
regained (Carey, Abbott, Egan, Bernhardt, & Donnan, 2005; Mark Hallett, 2001; 
Matthews et al., 2004; Platz et al., 2002). Neuroplasticity involves the interaction of 
neural and behavioural inputs which enable the brain to reorganise and adapt. As 
neural pathways have a larger region of anatomical connectivity than their usual 
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territory of functional influence, the brain can remap itself to reinstate some motor 
ability after stroke (Butefisch, 2006; Cramer & Bastings, 2000). Neuroplasticity is 
facilitated in three ways: 1) through self organisation, i. e. spontaneous recovery, 2) 
exercise, i. e. treatment induced recovery and 3) lack of input which may lead to 
shrinkage of a specific neural net therefore reduce functionality (Hallett, 2001; Nudo, 
2006). Early neuroplasticity mechanisms originate from emerging activity of latent 
synapses whereas changes over longer periods of time involve cell regeneration and 
recruitment of connections from other areas (Chen, Cohen, & Hallett, 2002; Jang, 
2007). Re-learning motor skills intensifies connectivity between neurons and the co- 
activation of connected cells causes modifications in demand upon these areas 
(Hallett, 2001; Kopp et al., 1999; Sunderland & Tuke, 2005). This process allows the 
brain to form alternative motor pathways which ultimately leads to an increase of 
motor movement in patients with hemiparesis. The behavioural demands of motor 
neurorehabilitation, including skill, strength and endurance, facilitate structural and 
functional reorganisation of the motor system (Adkins, Boychuk, Remple, & Kleim, 
2006). 
The majority of UK neurorehabilitative service provisions use neurodevelopmental 
treatments (NDTs), most typically, Bobath approaches (Davidson & Waters, 2000; 
Lennon & Ashburn, 2000). Such treatments aim to reduce muscle spasticity by 
focusing on normal patterns of movement and adaptation to the environment and to 
gain a better range and quality of functional skills. NDT approaches introduce 
physiotherapeutic strategies and exercises early after injury. However NDTs alone, 
are largely ineffective due to the lack of emphasis on task orientated motor learning 
(Langhammer & Stanghelle, 2000) and focus on compensatory strategies rather than 
restitution of motor function (Duncan, 1997). One form of treatment uses alternative 
strategies that are specifically based on to the theory of motor learning and 
neuroplasticity, i. e. `Constraint-Induced Movement Therapy' (CIT; Taub et al., 
1993). CIT aims to maximise use of the paretic limbs and mass practice of newly 
learned skills. Extensive clinical trials reveal high efficacy of CIT over other forms of 
motor neurorehabilitation (Wolf et al., 2006). 
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Current Issues In Stroke Medical Care and Management 
Although existing rehabilitation strategies are of some benefit for patients, current 
treatment options and rehabilitation strategies are deemed unsatisfactory (Rodgers & 
Thomson, 2008; Wilkinson et al., 1997). Increased independence, motor and 
cognitive performance are typically found between discharge from acute care and one 
year however levels begin to plateau, or even decline, between three to five years 
(Leonard, Miller, Griffiths, McClatchie, & Wherry, 1998). Many survivors remain 
chronically disabled, require full time care, cannot work and have a reduced quality 
of life as promotion of long term functional recovery remains largely ignored 
(Murray, Ashworth, Forster, & Young, 2003; Neau et al., 1998; Wolf, 1997). Despite 
the large burden of stroke, substantially less is spent on stroke research than that of 
heart disease and cancer (Rothwell, 2001). Therefore, it is highly necessary to 
research and explore other strategies to improve current treatment and long term care 
protocols and consider alternative avenues which may influence the post-stroke 
recovery process. Recent evidence suggests that one such avenue is the field of sleep. 
--* Proposed Paradigm Shift In Stroke Medical Care, Management and 
Neurorehabilitation 
Evidence within the field of sleep has highlighted a new direction in the approach to 
post-stroke treatment, including medical care, management and motor 
neurorehabilitative strategies. It is well established that the consequences of stroke 
including somatic complaints, behavioural changes, cognitive deficits, and 
psychological disturbance are all influenced by sleep (Bassetti & Aldrich, 1999; 
Bassetti & Valko, 2006; Bassetti & Aldrich, 2001; Gamble et al., 2000; Kong et al., 
2004; Schepers et al., 2006; Siengsukon & Boyd, 2008a, 2009a; Siengsukon & Boyd, 
2008b; Van Zandvoort et al., 1998; Widar et al., 2004). With particular relevance to 
neurorehabilitation, several studies have revealed compelling evidence that supports 
the role of sleep for consolidation of motor learning (Siengsukon & Boyd, 2009b), 
and more specifically, neuroplasticitic processes in response to motor learning 
(Hoffman & McNaughton, 2002; Walker & Stickgold, 2006). Although, there is 
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strong theoretical reason to predict a relationship between the consequences of stroke 
and sleep, the evidence-base for research and support provisions for patients is 
primarily focused on daytime behaviour, and largely neglects sleep. The central 
argument within this thesis is that sleep may be a critical element to the post stroke 
sequelae with regard to quality of life, recovery and treatment efficacy. Therefore, a 
paradigm shift in the direction of sleep in the context of stroke will have great 
implications, not only within care provisions, but future research and rehabilitation 
related fields. 
The next section of this chapter aims to introduce the field of sleep, including neural 
mechanisms, how sleep is measured, sleep disorders and the function of sleep. The 
remaining sections of this chapter aim to merge the fields of stroke and sleep 
literature and introduce the thesis concept. 
1.2 What is sleep? 
"Sleep is a reversible behavioural state of perceptual disengagement from and 
unresponsiveness to the environment" (Carskadon & Dement, 2005, p. 13) 
characterised by changes in behavioural and physiological processes that are distinct 
from waking behaviour. Sleep is manifested in mammalian and, to some extent, non- 
mammalian species (Siegel, 2008). However, scientists have only recently begun to 
understand the overall function of sleep. Sleep is by no means a passive state, it is an 
active process involving several brain mechanisms, including the forebrain, mid-brain 
and brainstem (Hirshkowitz, Moore, & Minhoto, 1997; Jones, 2005). 
The sleep process has distinct physiological biomarkers that define a sleep period, 
sleep architecture and sleep/wake regulation. These processes can be measured via 
several methods including objective techniques and by examining an individuals 
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perception of sleep. Persons with poor sleep may exhibit a sleep disorder which 
impairs daytime functioning and requires medical attention. 
1.2.1 Physiological Biomarkers of Sleep-Wake Function 
Sleep is easily recognisable in humans based on behavioural observations which 
include closed eyes, postural recumbrance, and a heightened threshold for responding 
to external stimuli (Carskadon & Dement, 2005, p. 13). However, it is the 
physiological mechanisms behind sleep that truly defines the process. Transition to 
and from wakefulness, as well as the sleep period per se, is accompanied by a 
complex array of brain activity alterations. 
Neurological Correlates of Sleep 
Electroencephalography (EEG) is the main form of neurophysiological measurement 
used to describe the distinct characteristics of sleep (the method is described in 
Section 1.2.3). Standard criteria for defining sleep and sleep stages are based on 
characteristics within the sleep EEG (Carskadon & Rechtschaffen, 2005, p. 1362- 
1368). Additional physiological signals are also used to define sleep including eye 
movement (electrooculogram; EOG) and muscle movement (electromyogram; EMG). 
Respiratory function, oxygen saturation and heart rate (electrocardiogram; ECG) may 
also be measured but are not typically part of the criteria for defining sleep. Global 
patterns of simultaneous synchronisation and disruption (desynchronisation) of EEG 
rhythms not only identify sleep/wake states, but sleep architecture (Steriade, 
McCormick, & Sejnowski, 1993). 
EEG measures brain activity which oscillates at varying frequencies. With regard to 
sleep/wake function, frequencies are conventionally subdivided into four main bands: 
beta (13-30 Hz), alpha (12-8 Hz), theta (4-7 Hz) and delta (1-3 Hz). Sleep 
architecture comprises two states: non-rapid eye movement (NREM) and rapid eye 
movement (REM). Non-REM and REM alternate throughout the night as part of the 
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normal sleep cycle (Figure 1.4; Carskadon & Dement, 2005; Hirshkowitz et al., 
1997). Non-rapid eye movement (NREM) sleep comprises four stages, individually 
characterised by a set of criteria (Carskadon & Dement, 2005; Hirshkowitz et al., 
1997). Stage 1 contains rolling eye movements, an increased presence of 
synchronised theta, slower heart rate, and a lower arousal threshold. Stage 2 consists 
largely of theta with regular bursts of spindles (12-14 Hz) and k-complexes (a high 
voltage peak). Stages 3 and 4 are deeper aspects of the sleep cycle, characterised by 
synchronised slow waves within the delta range, collectively known as slow wave 
sleep (SWS). During SWS, heart, breathing and metabolic rate is slower. 
REM is sometimes referred to as `paradoxical sleep' as the EEG rhythm becomes 
mixed in frequency, generally faster, and desynchronized as observed during 
wakefulness (Siegel, 2005). Similarly to wake, heart and breathing rates are increased 
as well as blood flow to the brain (Geyer & Dillard, 2005, p. 77). However unlike 
wake, REM sleep comprises muscle atonia, saccadic eye motion and is associated 
with dreaming. Peripheral muscle activity is disabled so that the active brain state 
does not influence bodily behaviour. This is coordinated by the release of 
neurotransmitters, glycine and gamma-aminobutyric acid (GABA) which inhibit 
motor neurons (Chase & Morales, 2005). 
Although NREM and REM alternate in approximately 90 minute cycles, the make up 
of these cycles changes across the night where a greater proportion of SWS occurs 
during the first third of the night and REM predominantly occurs within the final 
third of the night (Figure 1.4; Carskadon & Rechtschaffen, 2005). The typically 
reported optimum sleep duration is eights hours (Van Dongen, Maislin, Mullington, 
& Dinges, 2003) however this largely varies between individuals due to circadian 
timing (Wyatt, Ritz-De Cecco, Czeisler, & Dijk, 1999), lifestyle (Groeger, Zijlstra, & 
Dijk, 2004; Krueger & Friedman, 2009), presence of a sleep disorder (Vaughn, Neill, 
& D'Cruz, 2005) and ill health (Ferrie et al., 2007). 
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The Sleep Histogram 
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Figure 1.4. The Sleep Histogram, based on Carskadon and Rechtschaffen (2005). 
Diagram of one night of sleep shows sleep stages across time. 
Neural Mechanisms Behind Neurological Correlates 
Several regions within the forebrain, mid-brain and brainstem are simultaneously 
involved in sleep/wake activity (Hirshkowitz et al., 1997; Jones, 2005). Damage to 
these areas is likely to result in abnormal sleep and wakefulness regulation (Evans, 
2002). More specifically, key neuronal populations and pathways (Figure 1.5) have 
been identified as mechanisms for co-ordinating sleep transition from wakefulness 
and vice versa (Jones, 2005; Nofzinger, 2005). Neural projections from the brain stem 
to the thalamus, hypothalamus and basal forebrain facilitate sleep (Figure 1.5). 
Additional pathways from the mid-brain directly to the hippocampus and cortex are 
also involved in this process (Figure 1.5). 
Sleep promoting systems act antagonistically with wake promoting systems forming a 
`sleep switch' which results in stable wakefulness and sleep (Saper, Chou, & 
Scammell, 2001). Mutual inhibition between the arousal and sleep promoting 
chemical messengers result in switching processes that define discrete wake and sleep 
1 
2 
3 
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states (Saper, Scammell, & Lu, 2005). Sleep antagonists include those mechanisms 
within the recticular activating system which are important for controlling arousal 
levels (Culebras, 1999, p. 38). The recticular activating system is network of neurons 
within the brain stem up towards the upper border of mid brain. Ascending 
projections from the reticular activating system are involved in the modulation of 
arousal (Jones, 2005). The activated reticular formation arouses the cerebral cortex 
via two routes: dorsal route which projects to nonspecific thalamic nuclei and 
cerebral cortex; and the ventral route which projects to the hypothalamus, basal 
forebrain, eventually reaches the cerebral cortex and hippocampus (Figure 1.5). 
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Neural Mechanisms of Sleep 
Figure 1.5. Adapted from Jones (2005, p. 137 and 139). The diagram shows the main 
brain areas involves in sleep/wake regulation; in addition to the cortex, thalamus, 
cerebrum, midbrain, caudate, suprachiasmatic nucleus (SC), hypothalamus, basal 
forebrain, pons and medulla. The faint lines show the pathways for projection of 
neurons to other structures associated with wake and sleep promoting systems. 
1.2.2 Sleep/Wake Regulation 
The amount, timing and quality of sleep are combined effects of two processes: 1) the 
homeostatic sleep debt and, 2) the circadian rhythm phase The haemostat is 
determined by prior sleep and waking. It aims to balance the sleep/wake schedule by 
driving sleep need in response to prolonged wakefulness (Borbely & Acherman, 
2005). Circadian rhythm is pertained to a biological clock which is in approximation 
with the 24-hour clock and is independent of prior sleep or wakefulness (Borbely & 
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Acherman, 2005). Homeostatic drive and circadian rhythm are integrated which form 
an overall model for the sleep-wake cycle, known as the `Two Process Model' 
(Figure 1.6; Borberly, 1982). An essential determinant of these systems is the 
influence of social factors which is not included in the model (Dijk & Franken, 2005, 
p. 421). 
Two Process Model 
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Figure 1.6. Two Process Model. Adapted from Borbely and Acherman (2005). As S 
(homeostatic sleep drive) increases, the need for sleep increases during wakefulness 
and then declines during sleep. C describes the circadian rhythm cycle (measured by 
body temperature). The greatest point of sleep propensity occurs during the trough of 
body temperature and when S is at its peak. 
The Homeostatic Drive 
The homeostatic drive reflects pressure for sleep, similar to that of hunger and thirst. 
These motivational states direct behavioural systems to perform actions which reduce 
this drive. Prolonged wakefulness reliably induces sleep, and failure to obtain at least 
a core amount (sleep deprivation) leads to impaired function. As well as regulating 
sleep/wake cycles, homeostatic mechanisms also regulate sleep stages. Amount of 
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slow wave sleep corresponds to amount of hours of wakefulness previously, 
independent of circadian phase (Dijk, Brunner, Beersma, & Borbely, 1990). This may 
explain why the majority of slow wave sleep occurs at the beginning of the night and 
exhibits an immediate rebound after sleep deprivation (Borbely and Acherman, 2005, 
p. 407-408). 
Circadian Rhythm 
Circadian rhythm is an endogenous biological timing system that oscillates over 
approximately a 24 hour period (Czeisler, Buxton, & Khalsa, 2005). Hormonal 
output, core body temperature, rest and activity, sleep and wakefulness, and cellular 
process are mediated by the circadian timing system (Campbell, 2000). The circadian 
component of sleep enables behavioural states to adapt to day and night. The 
mechanism that maintains the circadian clock for sleep is located within the 
suprachiasmatic nucleus (SCN) of the hypothalamus (Zlomanczuk & Schwartz, 
1999). The SCN has its own internal momentum and acts as a central convergence 
point for both the sleep agonists and the sleep antagonists. The SCN is made up of a 
cluster of neurons which receive both photic cues from the retinal ganglion cells and 
nonphotic information from hormones and neurotransmitters (Culebras, 1999, p. 46- 
48). The SCN facilitates regularity in the sleep wake cycle pertaining to the 24 hour 
clock, however can be entrained by exogenous factors (Campbell, 2000), e. g. when 
adjusting to a different time zone. 
1.2.3 Measuring Sleep 
Sleep, as well as wake, can be assessed using objective and subjective techniques. 
The gold standard objective technique for measuring sleep is polysomnography 
(PSG). Actigraphy is an alternative objective assessment of sleep which uses a less 
intrusive technique compared to PSG. However, actigraphy is limited to measuring 
behavioural measures and cannot measure sleep architecture. Subjective measures of 
sleep are typically in the form of sleep diaries and questionnaires. Criteria derived 
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from these methods can be used to characterise sleep behaviour, define a sleep 
disorder or indicate general sleep and daytime functioning disturbance. 
PSG 
PSG involves measuring physiological signals by means of electrode sensors that 
record the EEG, EOG, EMG, respiratory function, oxygen saturation and ECG. Some 
researchers use a variety of physiological signals whereas others measure EEG only. 
PSG is typically recorded in a purpose built laboratory however recent developments 
have simplified this technique to be used in participant homes. The PSG technique 
requires four main processes: 1) electrode placement, 2) data recording, 3) 
observation and processing and 4) offline pre-processing and quantitative analysis. 
Electrode sensors are applied to predefined sites on the scalp (EEG) and on the body 
for the remaining signals. The electrodes are plugged into a receiving device that 
record sleep behaviour and amplifies the signal for technician viewing and analysis. 
PSG traces are viewed on a computer monitor in real time. Figure 1.7 provides an 
example of a waking EEG trace. 
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Figure 1.7. Waking EEG traces for 33 channels across a 10 second segment of 
recording drawn from data used for Chapter 5 of this thesis. Each trace represents the 
recording of a particular electrode. The EEG presents mixed, dysynchronised 
frequencies which defines wake. The black arrow shows an eye blink event. 
The EEG trace can be used to detect clinical abnormalities after brain injury 
(Finnigan, Walsh, Rose, & Chalk, 2007; Lukashevich et al., 1999; Sainio, Stenberg, 
Keskimaki, Muuronen, & Kaste, 1983). It also enables of sleep propensity to be 
performed such as the Multiple Sleep Latency Test (MSLT; Carskadon, 1994, p962- 
96,1994) or Maintenance of Wakefulness Test (MWT; (Miltner, Carskadon, & 
Hirshkowitz, 2005; Mitler, Gujavarty, & Browman, 1982,2005, p. 1420). 
In order to derive sleep behaviour parameters and determine feature of sleep 
architecture including proportions of sleep stages, off line analyses is required. 
Offline analysis allows the study of the frequency composition within the EEG. 
Frequency can also be used to determine level of arousal during wakefulness. More 
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specifically, daytime sleepiness can be detected by the EEG increased sleepiness is 
associated greater presence of theta waves (Gillberg, Kecklund, & Akerstedt, 1994; 
Marzano et al., 2007; Torsvall & Akerstedt, 1988). 
The PSG technique holds several disadvantages. In particular, it is an expensive and 
lengthy procedure, and imposes great intrusion on natural sleep behaviour (Reynolds 
et al., 1992; Richards, O'Sullivan, & Phillips, 2000). Critics therefore argue that the 
methodological rigor of PSG comes at the expense of ecological validity (Reynolds et 
al., 1992; Richards et al., 2000). Alternative modes of monitoring sleep have been 
designed to address these issues, e. g. actigraphy. 
Actigraphy 
Actigraphy is considered a favourable objective method for measuring sleep in 
situations where PSG is not feasible and can be applied to a range of research 
protocols (Ancoli-Israel et al., 2003). Furthermore, actigraphy also provides an 
estimate of daytime functioning through the identification of naps. This is done by 
calculating sleep/wake states of an individual based on their activity every 24 hours 
as monitored by a wrist worn device (Figure 1.8). 
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Figure 1.8. Actiwatch Mini ®' (CamNtech Ltd., © 2009). Various actigraphy devices 
have been developed and the device name is specific to the manufacturer. 
The device contains a piezo-electric accelerometer which produces an electrical 
signal when distorted. The corresponding voltage is then converted into an activity 
count using an algorithm set by the manufacture. Activity counts are an integration of 
the amount and duration of movement. Sensitivity of this algorithm can be adjusted 
by the researcher. This information is downloaded telemetrically and stored on a 
computer. Actigraphy software packages are able to derive behavioural sleep 
parameters from the raw activity data. This is done by examining the data in terms of 
pre-set epoch lengths, e. g. one minute. The software determines if each epoch is sleep 
or wake by either utilising an algorithm that detects the number of zero crossings (i. e. 
the number of times the activity count is zero) or the number of counts above a set 
threshold. These algorithms are limited to calculating sleep/wake distinctions and 
cannot determine sleep stages. The software allows the extraction of sleep parameters 
including bed time, get up time, wake time, time in bed, sleep duration, sleep onset 
latency, sleep efficiency, night time awakening frequency and duration. Furthermore, 
daytime napping parameters can also be calculated by actigraphy. 
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A significant benefit of actigraphy is that it enables quantification of sleep/wake 
cycles over days, weeks and months under natural conditions. Actigraphy is 
increasingly recognised as a valid measure of long term sleep behaviour (Ancoli- 
Israel et al., 2003; Littner et al., 2003; Sadeh & Acebo, 2002). The technique has 
shown good concordance with PSG measures in healthy (Cole, Kripke, Gruen, 
Mullaney, & Gillin, 1992; Sadeh, Hauri, Kripke, & Lavie, 1995) and clinical samples 
including those disordered sleep (Jean-Louis et al., 1996; Kushida et al., 2001; 
Lichstein et al., 2006). 
Sleep Diaries 
Sleep diaries involve the collection of subjective sleep variables, such as bed time, 
sleep duration, number of night awakenings, for a specified number of days. Sleep 
diaries may also request daytime functioning information such as number of naps, 
level of sleepiness and caffeine intake. Sleep diaries rely on self inspection and 
therefore provide an account of the subjective perception of sleep rather than a direct 
measure. In this respect, it is considered less accurate than objective methods, 
particularly regarding those parameters that rely on night awakening reports 
(Fontaine, 1989; Kushida et al., 2001; Means, Edinger, Glenn, & Fins, 2003; 
Vanable, Aikens, Tadimeti, Caruana-Montaldo, & Mendelson, 2000). Sleep diaries 
are vulnerable to under or overestimation of sleep parameters (Fontaine, 1989; 
Kushida et al., 2001) and lack of compliance (Stone, Shiffman, Schwartz, Broderick, 
& Hufford, 2002). However, sleep diaries contribute clinically useful information by 
providing important insights into the perception of sleep behaviour (Chesson et al., 
2000) as well as serving a complimentary function to other objective methods (Sadeh 
& Acebo, 2002). 
Questionnaires 
Similarly to sleep diaries, questionnaires capture the subjective perspective of how an 
individual rates their sleep in retrospect. One time questionnaires are commonly used 
as they are relatively simple and quick to administer, measure a range of sleep and 
daytime functioning behaviour and are easily applied to a range of cohorts including 
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those with sleep disorders, chronically ill, brain injured and psychiatric patients. 
Retrospective questionnaires may be used to determine habitual sleep traits, such as 
the Pittsburgh Sleep Quality Index (PSQI). This measure is sensitive to identifying 
good or poor quality sleep and is useful for highlighting those persons likely to 
experience a sleep disorder (Buysse et al., 2008; Buysse, Reynolds, Monk, Berman, 
& Kupfer, 1989). Questionnaires may also be used to capture daytime functioning at 
a particular point in time (e. g. current level of sleepiness). A commonly used 
assessment of daytime sleepiness is the Karolinska Sleepiness Scale (KSS; Akerstedt 
& Gillberg, 1990). This form of assessment is short and can be used over several 
intervals during the day (Akerstedt & Gillberg, 1990; Kosuke Kaida, Torbjörn 
Akerstedt, Göran Kecklund, Nilsson, & John Axelsson, 2007). Moreover, this method 
is cheap, does not require specialist equipment or sophisticated data processing. 
However, the results of subjective assessments should be interpreted with caution due 
to possible inaccuracies for several reasons as a result of experimenter bias and poor 
introspection of personal behaviour (Elsenbruch, Harnish, & Orr, 1999; Harvey, 
Stinson, Whitaker, Moskovitz, & Virk, 2008; Robert & Zadra, 2008). 
1.2.4 Disorders of Sleep and Daytime Functioning 
Sleeping difficulties are common in the general population (Anderson & Horne, 
2006; Groeger et al., 2004) and may occur as a result of ill health, psychological 
disturbance, lifestyle, environmental cues, and for some, the causes may remain 
unknown (Basner, Muller, Elmenhorst, Kluge, & Griefahn, 2008; Foley, Ancoli- 
Israel, Britz, & Walsh, 2004; Groeger et al., 2004; Ohayon, 2005; Parish, 2009; 
Pressman, Gollomp, Benz, & Peterson, 2000). Although sleep problems are often 
transient, they can evolve into a severe and chronic disorder. Sleep disorders can 
occur as a primary condition or are secondary to ill health. Clinical diagnoses of sleep 
disorders typically apply criteria provided by the International Classification of Sleep 
Disorders (ICSDI; American Acamdemy of Sleep Medicine, 2001) or Diagnostic and 
Statistical Manual of Mental Disorders (DSM-IV, 1994). The ICSD classifies sleep 
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disorders into: 1) dyssomnias, 2) parasomnias and 3) sleep disorders associated with 
mental, neurologic and other medical disorders. A range of pharmacological and non- 
pharmacological treatments have been implemented in sleep medicine to alleviate 
such disorders. 
Dyssomnias 
Dyssomnias describe those sleep disorders where the main symptom is related to 
initiating or maintaining sleep or excessive daytime sleepiness. Such disorders 
include insomnia, sleep disordered breathing (e. g. sleep apnoea), periodic limb 
movement disorder (PLMD), restless leg syndrome (RLS), circadian rhythm disorder, 
narcolepsy and hypersomnia. 
Insomnia refers to a complaint of insufficient or non-restorative sleep as a result of 
difficulty getting to sleep or problems staying asleep for at least one month with 
marked impairment on functioning (ICSD, 2001). Insomnia affects approximately 
30% of the population (Roth, 2007). Sleep disordered breathing refers to abnormal 
respiratory function during sleep such as frequent snoring and apnoeas. Sleep apnoeas 
is a syndrome characterised by recurrent episodes of partial or complete obstruction 
of the upper airway during sleep, result in oxygen desaturation which causes frequent 
arousals from sleep. The prevalence of sleep apnoea ranges from 2-19% in the 
general population (Duran, Esnaola, Rubio, & Iztueta, 2001; Young et al., 1993) 
whereas snoring occurrence is higher (35%; Duran et al., 2001). PLMD sufferers 
experience unintentionally initiated movements in one or both legs frequently 
throughout the night, more than 15 times an hour (ICSD, 2001). These movements 
are substantial enough to cause an awakening and severely disrupt sleep (Hornyak, 
Feige, Riemann, & Voderholzer, 2006). PLMD affects approximately 8% of the 
general population (Scofield, Roth, & Drake, 2008). RLS describes abnormal 
sensations in the legs with an increasing urge to move, particularly during times of 
rest such as lying in bed (Allen et al., 2003). The symptoms of RLS prolong sleep 
onset and lower quality of sleep (Hornyak, Feige, Voderholzer, Philipsen, & 
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Riemann, 2007). RLS affects approximately 7-10% of the general population (Allen 
et al., 2005; Phillips et al., 2000). 
Dyssomnias may also be manifested during wakefulness. The most severe of these 
disorders is invariably narcolepsy. Persons with narcolepsy experience frequent 
`sleep attacks' during the day, characterised by a rapid onset of REM sleep (Overeem, 
Mignot, van Dijk, & Lammers, 2001). Narcolepsy is one of the least common 
dyssomnias, affecting 0.05% of the general population (Ohayon, Priest, Zulley, 
Smirne, & Paiva, 2002). A more commonly experienced wakefulness syndrome is 
hypersomnia which is a disorder of excessive sleepiness and increased sleep needs. 
Parasomnias 
Parasomnia refers to those sleep disorders which intrude on the normal sleep/wake 
cycle, characterised by arousals and abnormal sleep stage transition. Parasomnias 
include sleep walking, sleep talking, nightmares, snoring and sleep paralysis (ICSD). 
Parasomnias are particularly distressing for sufferers and their partners. These 
problems occur commonly in children (Petit, Touchette, Tremblay, Boivin, & 
Montplaisir, 2007) and up to approximately 4% of adults exhibit some form of 
parasomnia (Ohayon, Guilleminault, & Priest, 1999). 
Sleep Disorders Associated with Medical, Mental and Neurologic Disorders 
Some of the above sleep disorders develop as a result of a medical condition, mental 
health disorder or abnormal neurological function (e. g. after brain damage). 
Symptoms of medical conditions including pain, fever, increased bed rest and general 
ill health are associated with increased sleep disturbance (Dogan, Ertekin, & Dogan, 
2005; Katz & McHorney, 1998; Lautenbacher, Kundermann, & Krieg, 2006; Widar 
et al., 2004). Mental health are also strongly associated with disturbed sleep including 
schizophrenia, depression, anxiety and post traumatic stress disorder (Green, 2003; 
Hofstetter, Lysaker, & Mayeda, 2005; McCall, Reboussin, & Cohen, 2000; Ware & 
Morin, 2000; Wirz-Justice, Haug, & Cajochen, 2001). Given that the mechanisms 
driving sleep and arousal are located in the brain, it is not surprising that neurological 
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disease; such as dementia, Parkinsonism, epilepsy, and acquired brain injury; such as 
stroke and TBI, are associated with sleep/wake disturbance (Bassetti & Valko, 2006; 
Foley et al., 2004; Happe, 2003; Happe et at., 2005; Vitiello & Borson, 2001). Post- 
traumatic hypersomnia refers to excessive sleepiness after a traumatic event, 
including brain injury (ICSD, 2005). 
Treatment of Sleep Disorders 
Recent advances in sleep medicine have drastically improved treatment options for 
those with sleep disorders, including pharmacological and non-pharmacological 
interventions. For insomnia related problems, pharmacological treatments, also 
referred to as hypnotics, typically involve medications which act on 
neurotransmitters, normally GABA, in order to initiate sleep (Dundar et al., 2004; 
Mendelson, 2005). Medications may also be prescribed to achieve the opposite for 
disorders of excessive sleepiness where arousal promoting mechanisms are driven by 
stimulants (Boutrel & Koob, 2004). Parasomnias can be treated by medication 
(Schenck & Mahowald, 1996) and some approaches use psychological techniques if 
the origins are believed to have stemmed from anxiety (Hauri, Silber, & Boeve, 
2007). Sleep disordered breathing can be treated medications that act on the neural 
mechanisms that control respiratory function (Hedner, Grote, & Zou, 2008) however 
devices to aid breathing (e. g. Continuous Positive Airway Pressure; CPAP) are used 
to reduce frequency of respiratory malfunction (Gay, Weaver, Loube, & Iber, 2006). 
Studies have shown that modifying behaviour to accommodate healthy sleep hygiene 
can largely improve sleep disorders (Edinger & Wohlgemuth, 1999; Espie, 1993; 
Stepanski & Wyatt, 2003). 
1.3 Function of Sleep 
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Sleep is an active process that subserves daytime functioning and performance, 
memory consolidation as well as being a critical mediator of health and wellbeing. In 
order to understand the importance of sleep for these functions, experiments have 
examined sleep loss under laboratory based sleep deprivation conditions or sleep 
disturbance in the natural environment. 
1.3.1 Maintaining Daytime Functioning and Cognitive Performance 
Daytime Functioning 
Sleepiness describes an increased need to sleep and is typically experienced after 
prolonged wakefulness. Experimental paradigms involving total or partial sleep 
deprivation have shown increased objective sleepiness in the waking EEG (Akerstedt 
& Gillberg, 1990; Franzen, Siegle, & Buysse, 2008; Ikegami et al., 2009; Marzano et 
al., 2007; Strijkstra, Beersma, Drayer, Halbesma, & Daan, 2003; Torsvall & 
Akerstedt, 1987,1988) as well as subjective reports of sleepiness (Franzen, Siegle et 
al., 2008). Furthermore, increased sleepiness is experienced as a result of sleep loss in 
naturalistic settings including those who endure shift work (Drake, Roehrs, 
Richardson, Walsh, & Roth, 2004; Gold et al., 1992; Harma, Sallinen, Ranta, 
Mutanen, & Muller, 2002; Papp et al., 2004; Torsvall & Akerstedt, 1987) and those 
that live in environments that are not conductive to sleep, e. g. near airports (Basner et 
al., 2008). Sleepiness may also be caused by poor health (Kapur et al., 2002; Parish, 
2009) and brain injury (Bassetti & Valko, 2006). Increased sleepiness has 
repercussions for mood (Dinges et al., 1997; Ikegami et al., 2009), cognitive 
performance (filcher & Huffcutt, 1996) and social activity (Drake et al., 2004; Papp 
et al., 2004). Importantly, the presence of excessive sleepiness is extremely dangerous 
for everyday tasks. For example, driving whilst sleep deprived has been likened to 
driving under the influence of alcohol (Powell et al., 2001). Therefore efforts to 
minimise sleepiness is essential for daytime functioning as well as reducing risk of 
injury from accidents (Dinges, 1995; Gold et al., 1992; Kaida, Akerstedt, Kecklund, 
Nilsson, & Axelsson, 2007). 
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Fatigue is another dimension of poorer daytime functioning, which shares some 
overlap with sleepiness, despite being a distinct entity (Hossain et al., 2005; 
Mahowald & Mahowald, 2000). Fatigue is clinically defined as "a reversible decrease 
or loss of abilities associated with a heightened sensation of physical or mental strain, 
even without conspicuous effort, an overwhelming feeling of exhaustion, which leads 
to inability or difficulty to sustain even routine activities and which are commonly 
expressed verbally or a loss of drive" (Staub & Bogousslavsky, 2001). Sleepiness and 
fatigue are often poorly defined in the literature and used interchangeably (Hossain et 
al., 2005; Mahowald & Mahowald, 2000; Pigeon, Sateia, & Ferguson, 2003). Like 
sleepiness, fatigue is associated with poor sleep at night (Chervin, 2000; Hossain et 
al., 2005; Lichstein, Means, Noe, & Aguillard, 1997) and sleep deprivation 
(Akerstedt & Gillberg, 1990; Akerstedt et al., 2004; Franzen, Siegle et al., 2008; 
Ikegami et al., 2009; Marzano et al., 2007). Severe fatigue is a disease itself, known 
as chronic fatigue syndrome., but fatigue is also a commonly reported symptoms of 
poor health (Akerstedt et al., 2004; Pawlikowska et al., 1994) and after brain injury 
(Choi-Kwon et at., 2005; Ingles et al., 1999; Park et al., 2009; Schepers et al., 2006; 
Valko, Bassetti, Bloch, Held, & Baumann, 2008; van der Werf et al., 2001; Van 
Zandvoort et al., 1998). Similarly to sleepiness, fatigue can occur despite sleeping 
well at night (Nijrolder, van der Windt, & van der Horst, 2008). 
Cognitive Performance 
Meta-analyses have shown that sleep deprivation, even partial, impairs cognitive 
performance (Pitcher, Ginter, & Sadowsky, 1997; Samkoff & Jacques, 1991). 
Reaction time, correct responses and attention to tasks under laboratory conditions 
are affected by both short and long term sleep deprivation (Dinges et at., 1997; 
Ikegami et al., 2009; Van Dongen et al., 2003). Furthermore, sleep loss under natural 
conditions, such as shift work, working to deadlines and sleep disorders are 
associated with decrements in cognitive functioning (Durmer & Dinges, 2005; 
Kobbeltvedt, Brun, & Laberg, 2005; Robbins & Gottlieb, 1990). 
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Cognitive functioning is impaired after sleep loss due to the reduced capacity of the 
brain to perform cognitive tasks. Neuroimaging studies have shown brain 
deactivation, or low level activity, in response to sleep loss (Thomas et al., 2000; 
Thomas et al., 2003). Recent evidence has shown that particular brain regions are 
affected by sleep deprivation which selectively impairs facets of cognitive function 
(Drummond & Brown, 2001; Drummond et al., 1999; Harrison & Horne, 1998; 
Thomas et al., 2000; Thomas et al., 2003). For example, sleep loss particularly affects 
the frontal lobe with repercussions for executive functioning, such as problem solving 
and decision making (Harrison & Horne, 1999; Killgore et al., 2007; McKenna, 
Dicjinson, Orff, & Drummond, 2007). 
1.3.2 Memory Consolidation 
Recent behavioural and neural evidence has shown that a period of sleep is linked to 
stabilisation of a memory or enhancement of skill, i. e. consolidation. More 
specifically, neural processes during sleep may selectively enhance learning (Cohen, 
Pascual-Leone, Press, & Robertson, 2005; Fischer, Hallschmid, Eisner, & Born, 
2002; Gaab, Paetzold, Becker, Walker, & Schlaug, 2004; Karni, Tanne, Rubenstein, 
Askenasy, & Sagi, 1994; Kuriyama, Stickgold, & Walker, 2004; Robertson, Press, & 
Pascual-Leone, 2005; Wagner, Gais, Haider, Verleger, & Born, 2004; Walker, 
Brakefield, Hobson, & Stickgold, 2003a; Walker, Brakefield, Morgan, Hobson, & 
Stickgold, 2002a). This discovery has been described as a "renaissance in sleep 
research" (Walker & Stickgold, 2006). The modulatory processes of sleep for 
learning is commonly referred to as offline learning or sleep dependent consolidation 
(Robertson, Pascual-Leone, & Miall, 2004). Memories are encoded during wake and 
then enhanced by sleep (Walker et al., 2003a) via "dynamic stabilisation through 
reactivation of the corresponding neuronal assemblies which cannot be done during 
wake due to incoming stimuli with waking behaviour" (Krueger & Obal, 1993, cited 
in Maquet, Smith, & Stickgold, 2003, p. 2). As learning new skills is an important part 
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of neurorehabilitation after stroke, this theory holds particular relevance for this 
thesis. 
Types of Learning and Memory 
Experiments have investigated the two major dimensions of memory; declarative and 
non-declarative (Gabrieli, 1998; Figure 1.9). Declarative memories comprise the 
knowledge of facts (semantic) and events (episodic). Semantic and episodic 
memories are usually explicitly acquired, i. e. with awareness (Tulving, 1972, p. 10). 
Non-declarative memories refer to a learned skill involving motor function such as 
walking, riding a bike and playing a musical instrument. Non-declarative memories 
are acquired by procedural learning, an explicit set of rules to complete a motor task 
or skills acquired without awareness (implicit) such as habituation, priming and 
emotional learning (Robertson & Cohen, 2006). 
", Non-Declarative 
ý' (Skill Learning) 
" Procedural (implicit/explicit) 
" Habituation (implicit) 
" Priming (Implicit) 
" Emotional Learning (implicit) 
Declarative 
(Knowledge) Tr 
" Semantic (explicit) 
" Episodic (explicit) 
Figure 1.9. Dimensions of memory. Based on Gabrieli (1998) and Stickgold and 
Walker (2005). 
Learning involves six main processes: 1) encoding (forming memory trace), 2) 
consolidation (becoming permanent, involving stabilization and enhancement or 
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improvement of a skill), 3) storage (maintenance over time), 4) retrieval (ability to 
use the memory) and 5) reconsolidation (reusing the memory and further modifying 
it) (Kandel, Kupfermann, & Iversen, 2000; Robert Stickgold & Walker, 2005; Walker 
et al., 2003a). Evidence suggests that processes 2 to 5 beyond the initial encoding of a 
memory are modulated by sleep. 
Empirical Evidence 
Experimental learning paradigms show that skills acquired during the initial learning 
phase remain stabilised for several hours, indicative of memory or skill consolidation 
over time (Brashers-Krug, Shadmehr, & Bizzi, 1996; Donchin, Sawaki, Madupu, 
Cohen, & Shadmehr, 2002; Karni & Sagi, 1993; Shadmehr & Brashers-Krug, 1997). 
Evidence suggests that the consolidation process may occur during a sleep period, 
however to a greater degree. Greater level of consolidation, demonstrated by greatest 
amount of improvement on a task, was observed post sleep compared to the same 
amount of time awake (Fischer et al., 2002; Gaab et al., 2004; Karni et al., 1994; 
Wagner et al., 2004; Wagner, Hallschmid, Verleger, & Born, 2003; Walker et al., 
2002a; Walker et al., 2003b; Walker, Liston, Hobson, & Stickgold, 2002b). 
Furthermore, a period of sleep is associated with learning complex skills, including 
fine motor dexterity (Kuriyama et al., 2004). 
Particular sleep stages are associated with consolidation of certain types of memory. 
This effect is typically identified through a correlation between proportion of a sleep 
stage and greater level of learning. REM sleep is associated with the consolidation of 
declarative memory (De Koninck, Lorrain, Christ, Proulx, & Coulombe, 1989; Gaab 
et al., 2004; Karni et at., 1994; Stickgold, Scott, Rittenhouse, & Hobson, 1999; 
Walker et al., 2002b). Both REM and slow wave sleep have been implicated in the 
consolidation of procedural or skill based memory, such as motor learning (Fischer et 
at., 2002; Smith & MacNeill, 1994; Walker et al., 2003a; Walker et al., 2002b). 
Relationships between stage two sleep and motor learning has also been observed 
(Nishida & Walker, 2007; Smith & MacNeill, 1994; Walker et al., 2002a). 
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Several studies have demonstrated that a daytime nap may also enhance memory 
consolidation (Atienza, Mednick, Cantero, Nakayama, & Stickgold, 2001; Cote, 
Milner, Baxter, Ray, & Osip, 2001; M Hayashi & Hori, 1998; Mitsuo Hayashi, Ito, & 
Hori, 1999; Hofer-Tinguely et al., 2005; Milner, Fogel, & Cote, 2006). In particular, 
it has been shown that short periods of day time sleep have enhanced motor skills 
(Backhaus & Junghanns, 2006; Mednick, Nakayama, & Stickgold, 2003; Milner et 
al., 2006; Nishida & Walker, 2007) and declarative learning (Tucker et al., 2006). 
Mechanisms Behind Sleep Dependent Consolidation 
Research has shown that sleep facilitates memory consolidation due to plasticity 
mechanisms which are triggered during sleep. "Sleep per se enables mechanisms of 
cortical plasticity [and] could be part of a more global process of memory 
consolidation [which has a] potentially crucial link in our understanding of how long- 
term memories are encoded in the brain" (Hoffman & McNaughton, 2002). 
The behavioural changes associated with sleep dependent learning, including 
enhancement and improving retention have been attributed to key cellular events 
during stage 2, SWS and REM sleep. The consistently observed relationship between 
stage two sleep and motor learning (Fogel, Smith, & Cote, 2007; Nishida & Walker, 
2007; Smith & MacNeill, 1994; Walker et at., 2002a) may be explained by the 
presence of spindles. Increased spindle density has been associated with motor 
learning (Fogel et al., 2007; Nishida & Walker, 2007). The slow oscillatory process 
of stages 3 and 4 sleep have also been implicated in brain plasticity and learning. 
Huber & Ghilardi (2004) found that slow wave activity during sleep was more 
pronounced in those same brain regions activated during motor skill learning during 
wake. It was theorised that sleep reflected local synaptic changes triggered by motor 
learning involving a specific brain region. Other studies have shown that waking 
brain activity expressed during a motor task was also replayed during REM (Maquet 
et al., 2000; Peigneux et al., 2003). 
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The evidence presented above strongly suggests that sleep may be a critical 
modulator for memory consolidation. With regard to motor learning in particular, the 
research has great implications for skill learning professions such as musicians, 
performance in sport, refining surgical skills and speech articulation (Kuriyama et al., 
2004; Walker et al., 2002a). Furthermore, several authors have concluded that sleep 
may benefit neurorehabilitation for recovering stroke patients with motor damage 
(Gomez Beldarrain, Astorgano, Gonzalez, & Garcia-Monco, 2008; Kuriyama et al., 
2004; Robertson & Cohen, 2006; Siengsukon & Boyd, 2009b; Walker et al., 2003a). 
1.3.3 Maintaining Quality of Life 
Quality of life is a term used to describe the subjective and multidimensional concept 
of physical, psychological and social wellbeing, particularly regarding vulnerable 
groups receiving medical care (Cella, 1994). Assessment of sleep is an important 
component of general medical care and quality of life (Strine & Chapman, 2005). A 
large population study of 12 million people found that those who suffered from poor 
sleep also had poorer quality of life (Strine & Chapman, 2005). Furthermore, those 
with clinical sleep disorders also report poor quality of life (Flemons & Tsai, 1997; 
Totterdell, Reynolds, Parkinson, & Briner, 1994). Such associations occur because 
poor sleep has adverse physiological effects, associated with poorer health and 
interacts with long term chronic conditions. 
Physiological Impact of Sleep Loss 
Sleep loss alters hormone and immune function which affects the body's ability to 
fight disease (Bryant, Trinder, & Curtis, 2004; Moldofsky, 1995). Sleep deprivation 
further increases vulnerability to viral and bacterial pathogens (Benca & Quintas, 
1997). It has also been shown that sleep deprivation lowers the immunity response to 
vaccinations (Spiegel, Leproult, & Van Cauter, 1999). Research has shown that sleep 
deprivation adversely impacts cardiac function by increasing in blood pressure and 
key inflammatory markers of cardiac disease (Carrington & Trinder, 2008; Meier- 
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Ewert et al., 2004). This evidence may explain why poor sleep is associated with an 
increased risk of cardiovascular disease including stroke (American Academy of 
Sleep Medicine, 1999; Ayas, Pittman, MacDonald, & White, 2003; Ayas et al., 2003; 
Bradley & Floras, 2009; Drager et al., 2009; Portela et al., 2009; Spriggs et al., 
1992b; Yaggi et al., 2005). Other studies have shown that partial sleep restriction 
severely alters metabolic processes required to synthesise carbohydrate (Spiegel et 
al., 1999). It was postulated that maintained impairment of carbohydrate synthesis as 
a result of chronic sleep loss may increase risk of diabetes, obesity and hypertension 
(Spiegel et al., 1999). 
Ill Health Risk and Development 
The incurred physiological alterations as a result of sleep loss may increase risk of 
chronic poor health and disease (Rogers, Szuba, Staab, Evans, & Dinges, 2001). Long 
term sleep disturbance presents a premorbid risk for somatic health decline (Ayas et 
al., 2003; Nijrolder et al., 2008; Wingard & Berkman, 1983). This may be due to the 
adverse effects of sleep deprivation on the immune system and ability to fight disease 
(Benca & Quintas, 1997; Bryant et al., 2004; Moldofsky, 1995). 
It is well established that sleep loss has a profound effect on psychological health 
(Ayas et al., 2003; Nijrolder et al., 2008; Wingard & Berkman, 1983). Laboratory 
based sleep deprivation studies have consistently shown decrements in mood (Dinges 
et al., 1997; Franzen, Siegle et al., 2008; Pilcher & Huffcutt, 1996). Large population 
studies revealed a strong link between sleep disturbances and poorer psychological 
health (Manocchia, Keller, & Ware, 2001; Reid et al., 2006; Strine & Chapman, 
2005). This relationship is further confirmed by evidence which suggests that 
consistently good sleep may actually prevent the development of a psychological 
illness (Ford & Kamerow, 1989; Steptoe, O'Donnell, Marmot, & Wardle, 2008). 
Poorer psychological functioning as a result of sleep loss is typically due to increased 
sleepiness and fatigue (Breslau, Roth, Rosenthal, & Andreski, 1997). Moreover, 
anxiety and depression are associated with difficulty getting to sleep and maintain 
sleep (Morin, Rodrigue, & Ivers, 2003). 
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Long Term Health Conditions 
Normal sleep patterns are commonly altered in those suffering from chronic disease. 
Illnesses such as cancer, diabetes, heart disease, arthritis, osteoporosis, lung disease, 
infections, breathing disorders, gastroesophageal reflux, chronic pain, renal disease 
are associated with sleep disturbance (Foley et al., 2004; Goldsmith & Levin, 1993; 
Kapur et al., 2002; Katz & McHorney, 1998; Parish, 2009; Pressman et al., 2000). 
Furthermore, increased prevalence of sleep problems have been observed in a range 
of neurological conditions including Parkinson's, multiple sclerosis, epilepsy, 
migraine, traumatic brain injury and stroke (Benca, Obermeyer, Thisted, & Gillin, 
1992; Pressman et al., 2000). Chronic psychiatric illness is also associated with co- 
morbid sleep disorders (Benca et al., 1992; Ohayon, 2005). Either as a result of poor 
sleep or the disease per se, daytime functioning is disrupted by the presence of 
sleepiness, fatigue and increased napping behaviour (Briones et at., 1996; Muller et 
al., 2006; Parish, 2009). Dysfunctional sleep and daytime functioning may be a result 
of the symptoms of the disease however may also arise from medication side effects 
(Legros & Bazil, 2003; Novak & Shapiro, 1997; Obermeyer & Benca, 1996) and 
change in sleeping environment (Dogan et al., 2005; Southwell & Wistow, 1995). A 
large population study revealed that patients with co-morbid sleeping problems 
utilised more health care services than those without sleep problems (Manocchia et 
al., 2001). 
Sleep has a reciprocal relationship with health. Poor sleep patterns during the course 
of illness may contribute to the worsening of symptoms and unnecessarily prolong 
the disease if left untreated (Briones et al., 1996). Furthermore, increased sleep and 
daytime functioning problems interact with treatment interventions including 
musculoskeletal rehabilitation (Hyyppä & Kronholm, 1995) and post brain injury 
neurorehabilitation (Barker-Collo et al., 2007; Morley et al., 2005; Muller et al., 
2006; Worthington & Melia, 2006). 
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The evidence presented above demonstrates that sleep is highly influential on health. 
Poor sleep is associated with the development of a range of conditions, including 
cardiovascular, as well as exacerbating symptoms present within an existing 
condition. Furthermore, prioritising healthy sleep may be of benefit for management 
and treatment of chronic conditions, including stroke. It is therefore necessary to 
specifically examine the role of sleep for stroke recovery and rehabilitation 
programmes. 
1.4 The Role of Sleep For Post Stroke Recovery and Rehabilitation 
There is strong theoretical reason to predict that sleep has a critical role for post 
stroke recovery and rehabilitation programmes for several reasons: 1) there is 
evidence to suggest that the consequences of stroke are partly modulated by sleep 
(Figure 1.5), 2) sleep supports brain plasticity, a vital process for functional recovery, 
3) sleep disturbance is associated with poorer stroke outcome, 4) poor daytime 
functioning affects rehabilitation participation which may indirectly affect treatment 
outcome. 
1.5.1 Stroke Consequences Modulated By Sleep 
The consequences of stroke are largely somatic, psychological, behavioural, cognitive 
and motor movement related. Evidence shows that sleep is a likely mediator of these 
aspects of the stroke sequelae (Figure 1.10). The modulatory processes of sleep for 
stroke symptoms may also be bidirectional, i. e. sleep may impact the consequences of 
stroke and vice versa (Figure 1.10). However, the majority of evidence that shows the 
role of sleep for these factors stems from non-stroke populations (as described in 
Section 1.3). Some studies have begun to explore this idea in stroke patient 
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populations however the evidence base is still relatively sparse and requires further 
investigation. 
-------------------------------- 
----------------- --------------- 
Critical Role of 
Sleep For Stroke 
Treatment 
Figure 1.10. The consequences of stroke are displayed. Evidence suggests that these 
same consequences are modulated by sleep as well as being influenced by poor sleep. 
Somatic 
The range of post stroke somatic complications, including seizures, infections, 
mobility deficits and pain (Langhorne et al., 2000), may further comprise sleep 
(Bassetti & Aldrich, 2001; Gamble et al., 2000; Kong et at., 2004; Krachman, 
D'Alonzo, & Criner, 1995; Widar et at., 2004). In addition, prescribed medications 
pose sedating or hypnotic side effects and also alter the sleep EEG (Bourne & Mills, 
2004; Holshoe, 2009; Lowson & Sawh, 1999; Mayers & Baldwin, 2005; Novak & 
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Shapiro, 1997; Obermeyer & Benca, 1996). Pain and cardiac complications after 
stroke are particularly relevant to sleep. 
Stroke is associated with long term pain (Gamble et al., 2000; Kong et al., 2004; 
Widar et al., 2004). Post stroke pain is associated with disturbed sleep as well as 
increased fatigue (Widar et al., 2004). Evidence further suggests that sleep 
disturbances may exacerbate acute and chronic pain in a reciprocal manner 
(Lautenbacher et al., 2006). Therefore it is important to address sleep as treating sleep 
problems may help alleviate post stroke pain (Smith & Hawthornewaite, 2003). 
Cardiac problems are a common somatic effect of stroke as well as a premorbid risk 
(American Heart Association, 2001). Poor sleep is associated with poorer cardiac 
health (American Academy of Sleep Medicine, 1999; Ayas et al., 2003). Although 
post stroke cardiac problems are typically controlled using medication, sleep loss may 
be detrimental to cardiac function after stroke. However, this notion has not yet been 
investigated. It may be important to minimise sleep loss in order to maintain cardiac 
health as post-stroke cardiac disease increases risk of further strokes (Hankey, 2003). 
This association may also occur as initial evidence suggests that sleep modulates 
blood pressure and essential protein regulation for maintaining cardiac health 
(Carrington & Trinder, 2008; Meier-Ewert et al., 2004). 
Psychological 
The debilitating effects of stroke require dramatic lifestyle alterations which pose a 
major strain on psychological adjustment (Brittain, 2002; Strine & Chapman, 2005; 
Zorowitz et al., 2005). Patients who experience poor psychological health may 
experience disturbed sleep and increased sleepiness and fatigue (Bassetti & Valko, 
2006; Leegaard, 1983; Schepers et al., 2006; Staub & Bogousslavsky, 2001). Treating 
sleep disorders may promote psychological health and well being in stroke patients. 
Although this has not been demonstrated in a stroke sample at present, there is ample 
research in non-brain injured persons which shows that sleep treatment also improves 
mental health including anxiety and depression (Menza, Marin, & Opper, 2003; 
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Thase, 2006; Uhde, Cortese, & Vedeniapin, 2009). Given that the relationship 
between sleep and psychological disturbance is reciprocal (Ellis, l-lampson, & 
Cropley, 2007; Jansson & Linton, 2006; Steptoe et al., 2008), alleviating the 
psychological stresses of patients may be of benefit to for sleep (Khan, 2004). 
Behavioural and Cognitive 
Increased sleepiness, fatigue and daytime napping are commonly experienced deficits 
of daytime functioning after stroke (Bassetti & Valko, 2006). In stroke patients, poor 
daytime functioning is associated with worse cognitive performance (Leegaard, 1983; 
Van Zandvoort et al., 1998), less active participation in neurorehabilitation (Barker- 
Collo et at., 2007; Morley et al., 2005; Muller et al., 2006; Worthington & Melia, 
2006), increased risk of accidents (Lundqvist, Alinder, & Ronnberg, 2008; Michael, 
Allen, & Macko, 2006; Sagberg, 2006) and contributes to poorer overall quality of 
life (Ingles et al., 1999; LaChapelle & Finlayson, 1998; Naess, Waje-Andreassen, 
Thomassen, Nyland, & Myhr, 2006b; Schuiling et al., 2005; Van Zandvoort et at., 
1998). Sleep is a key modulator of daytime functioning therefore improving sleep 
may help resolve daytime functioning difficulties in stroke patients (Worthington & 
Melia, 2006). Those who sleep well, however, still experience excessive daytime 
sleepiness or fatigue and may require additional forms of treatment such as stimulant 
medication (Black, Duntley, Bogan, & O'Malley, 2007; Schneerson, 2005; Bassetti, 
2005a). Furthermore, addressing depression may particularly be of benefit for 
sleepiness and fatigue. 
Increased sleepiness adversely affects cognitive performance in non-brain injured 
participants (Pilcher & Huffcutt, 1996; Samkoff & Jacques, 1991). Although 
laboratory based sleep deprivation studies have not been carried out in stroke patients 
samples, poor quality sleep and sleepiness in this cohort has known affects on 
cognitive functioning, particularly attention capacity and (Hermann et al., 2008; Van 
Zandvoort et at., 1998). Moreover, such cognitive deficits negatively impact 
rehabilitation participation and outcome (Galski et at., 1993; Sandra Zinn et al., 
2004). 
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Motor 
Motor neurorehabilitation is an essential component to stroke treatment and 
management to promote independence of patients with motor deficits (Laidler, 2000, 
p. 83). There is strong evidence that sleep may be a modulator for motor learning 
(Walker et al., 2002a; Walker, Stickgold, Alsop, Gaab, & Schlaug, 2005). This 
evidence has led several authors to postulate that sleep has a crucial role in motor 
recovery after brain damage (Gomez Beldarrain, Astorgano, Gonzalez, & Garcia- 
Monco, 2008; Kuriyama et al., 2004; Robertson & Cohen, 2006; Siengsukon & 
Boyd, 2009; Walker et al., 2003a). 
The only known research that has explored sleep and motor learning in chronic stroke 
patients is the work of Seingsukon and Boyd (Siengsukon & Boyd, 2008a, 2009a; 
Siengsukon & Boyd, 2008b). Their research involved laboratory based motor 
learning in patients and retesting one group after a period of sleep and one group after 
the same amount of time awake. Patients who slept between learning and retesting 
demonstrated greatest improvement. The authors of these studies concluded that sleep 
has important implications for motor neurorehabilitation protocols. However, this 
postulation requires further investigation. 
1.4.2 Sleep and Recovery Outcome After Stroke 
Given that sleep is related to a range of post stroke consequences, presumably poorer 
sleep is related to poorer recovery after stroke. Several studies have investigated this 
potential relationship by measuring sleep and stroke outcome in patients. Stroke 
outcome is assessed in terms of survival or general disability levels. Other studies 
have used validated tests that measure general level of functioning, including 
activities of daily living, motor ability and level of independence, such as the Barthel 
Index (Mahoney & Barthel, 1965) or Rankin Scale (Bonita & Beaglehole, 1988). 
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Stroke Outcome Studies 
Evidence shows that sleep is related to stroke outcome during the acute (<6 months) 
and chronic (> 12 months) phase of recovery. Acute patients with poor sleep quality, a 
sleep disorder or abnormal circadian rhythm were associated with increased mortality 
(Dyken, Somers, Yamada, Ren, & Zimmerman, 1996; Hachinski, Mamelak, & 
Morris, 1987) and worse recovery outcome (Claudio Bassetti, Aldrich, & Quint, 
1997; Bassetti & Aldrich, 2001; Good, Henkle, Gelber, Welsh, & Verhulst, 1996; 
Hachinski et al., 1987; Kaneko, Hajek, Zivanovic, Raboud, & Bradley, 2003b; 
Leppävuori, Pohjasvaara, Vataja, Kaste, & Erkinjuntti, 2002; Sandberg, Franklin, 
Bucht, sta, & Gustafson, 2001; Spriggs et at., 1992a; Takekawa, Miyamoto, 
Miyamoto, & Hirata, 2007). Furthermore, Hachinski et at., (1987) found that the 
relationship between sleep and recovery were independent of age and lesion location. 
A study of closed head injury patients revealed that for every unit of improvement in 
the functional independence measure, patients had a 4% decrease of risk of having 
disturbed sleep (Makley et al., 2008). Those with sleep apnoea spent longer in 
hospital after the stroke event (Kaneko et al., 2003b). Valente et al. (2002) reported 
that the presence of organised sleep patterns rather than the Glasgow Coma Scale was 
more predictive of better outcome, in terms of survival and functional recovery, in 
those with sub-acute coma after brain injury (classed as severe brain injury including 
stroke and TBI). It was concluded that sleep patterns may be a prognostic marker for 
recovery Sleep disturbance during the acute phase was also predictive of poorer long 
term outcome of stroke in the chronic phase (Good et at., 1996; Hermann et at., 2008; 
Vock et al., 2002). Chronic patients with poor sleep and daytime functioning also 
exhibited poorer recovery level (Cadilhac et al., 2005; Worthington & Melia, 2006). 
As the above studies show that sleep is related to general stroke recovery, it is 
plausible to suggest that sleep may also be specifically related to neurorehabilitation 
outcome and have implications for treatment protocols. Neurorehabilitation aims to 
facilitate recovery level after stroke and increase motor movement and control. 
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1.4.3 The Implication of Sleep For Post Stroke Neurorehabilitation Protocols 
Several authors have addressed sleep in brain injured patients, including stroke and 
TBI, and commented on the crucial implications sleep may hold for rehabilitative 
treatment (Cohen, Oksenberg, Snir, Stern, & Groswasser, 1992; Masel et al., 2001; 
Parcell, Ponsford, Rajaratnam, & Redman, 2006; Terzoudi et al., 2009; Uomoto, 
2008). However, at present, this idea remains severely under researched. Several 
studies have monitored sleep and daytime functioning behaviour during 
rehabilitation. It was found that sleep disturbance and increased daytime sleepiness 
hampered rehabilitation sessions and affected day to day functioning of patients 
(Barker-Collo et al., 2007; Morley et al., 2005; Muller et al., 2006; Worthington & 
Melia, 2006). Surprisingly, these studies did not measure rehabilitation outcome. 
Only one known study has measure sleep in a rehabilitation context and addressed 
outcome at the same time. Alessi et al. (2008) monitored a large sample of older 
patients (? 65 years) with a range of conditions (10% of which experienced stroke, the 
majority had orthopaedic problems) admitted to a post acute rehabilitation facility. 
They found that increased napping was associated with poorer rehabilitation outcome 
across all patients. However the above studies did not control for amount and type of 
rehabilitation patients received. 
Based on the evidence presented above, further research examining sleep behaviour 
in a rehabilitation context is necessary. More specifically, such research should refine 
sample selection, including the recruitment of stroke only samples, and ultilise 
carefully controlled conditions to help identify possible causal relationships and 
therapeutic interventions (Terzoudi et al., 2009). 
1.4.4 Necessity For Research 
Sleep disturbance and poor daytime functioning is highly prevalent after stroke 
however is not always recognised by medical staff or the patients themselves 
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(Bassetti & Valko, 2006; Castriotta & Lai, 2001; Castriotta et al., 2007; Makley et al., 
2008; Parcell et al., 2006; Wessendorf, Teschler, Wang, Konietzko, & Thilmann, 
2000). Although The National Stroke Association (based in USA) recently published 
patient guidelines regarding the importance of healthy sleep during recovery and 
rehabilitation (National Stroke Association, 2006), there is little applied clinical 
research in the context of sleep and stroke rehabilitation to establish a scientific link. 
The National Clinical Guidelines For Stroke (2nd Ed, 2004; UK based) does not list 
sleep disturbance treatment or management of healthy sleep within the guidelines. 
This lack of knowledge and awareness may cause unnecessary suffering of sleep 
disorders of which may be treatable. Furthermore, it is possible that the initial 
disturbance of the sleep/wake cycle by the stroke (e. g. coma) develops into a chronic 
sleep problem if left untreated. 
Based on the evidence presented in this chapter, it is hypothesised that sleep may be a 
modifiable aspect of behaviour that may benefit stroke recovery and rehabilitation, 
and benefit general well being and quality of life. Therefore maintaining healthy sleep 
after stroke might be critical. One potential avenue is devising a 24 hour approach to 
rehabilitation whereby behaviour wake and sleep are equally considered as part of the 
treatment process. 
It is essential to further investigate sleep in the context of stroke for several important 
reasons: 1) sleep disturbance is highly prevalent after stroke, 2) sleep is largely 
ignored as part of the post stroke treatment process, and 3) sleep may be a crucial 
modulator of recovery and rehabilitation outcome. Therefore a paradigm shift is 
necessary to increase awareness and improve quality of life of patients. 
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1.5 Putting Theory Into Applied Clinical Practice: Development of 
Research Aims For This Thesis 
Evidence from non-stroke populations presents a strong theoretical argument in that 
sleep may have critical role within the post stroke sequelae, including quality of life 
of patients and rehabilitative treatment. It is the prerogative of this thesis to build 
upon the limited evidence within brain injured cohorts that has suggested a 
relationship between sleep and stroke recovery and rehabilitation. In order to form a 
substantial evidence base from which further research can continue, there is a need to 
resolve the apparent limitations in previous studies, design an appropriate protocol 
that employs a highly controlled rehabilitation model. The research for this thesis was 
carried out within the framework of a motor neurorehabilitation trial, more 
specifically, Constraint Induced Movement Therapy (CIT). The CIT trial framework 
allowed the limitations from previous work to be addressed and further explore sleep 
in chronic stroke patients with residual motor deficits. Within the CIT framework, 
four individual studies were carried out to address sleep in chronic stroke patients 
with hemiparesis. 
1.5.1 Limitations In Previous Studies 
The existing literature on stroke and sleep presents several limitations which are yet 
to be addressed. Firstly, the majority of studies focus on acute stroke ranging from 
one day to six months after the event. The chronic evolution of sleep behaviour for 
long term stroke recovery remains poorly studied. Critically, time since injury is a 
modulating factor of physical and psychological recovery after stroke (Sullivan, 
2007). Stroke presents a complex multitude of consequences which develop, change 
or evolve over time, such as psychological adjustment and motor functioning 
(Dorman et al., 1991; Duncan, 1997; Horgan et al., 2009; Jorgensen et at., 1995; 
Lesniak et al., 2008; Rasquin et al., 2005). For some patients, sleep problems may 
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resolve as time since injured increases (Hermann et al., 2008; Vock et al., 2002). 
Should these factors remain uncontrolled or in an unstable state, the sample is 
vulnerable to extraneous factors on results, for example uncontrolled co-morbid 
conditions. Therefore, chronicity is an important variable that should be controlled. 
Some studies do not take time since stroke into account and recruit a broad range of 
chronicities from several weeks to years within the same sample. 
Although previous studies suggest that sleep is related to stroke recovery, the term 
'recovery' or `stroke outcome' is poorly defined in these studies. Moreover, medical 
and rehabilitative treatment may vary between patients, therefore `residual recovery' 
(independent of treatment) and `treatment induced recovery' (facilitated by treatment) 
cannot be distinguished. Furthermore, studies measuring stroke recovery utilise a 
general measure of recovery, e. g. Barthel Index. These measures may overlook 
particular deficits (Ashford, Slade, Malaprade, & Turner-Stokes, 2008; Duncan, 
1997; Lai, Studenski, Duncan, & Perera, 2002; Van Zandvoort et at., 1998) such 
feature of motor recovery including upper limb speed and quality. With regard to the 
potential role that sleep may holds for motor learning, it would be advantageous to 
incorporate measures which conceptualise the spectrum of residual motor ability, e. g. 
The Wolf Motor Function Test. 
1.5.2 Addressing Limitations in Previous Studies 
The studies carried out for this thesis aimed to address the limitations. The studies 
were designed around a highly controlled rehabilitation trial, time point of recovery 
was beyond one year and patients were carefully selected based on their physical and 
psychological adjustment. 
The Model Neurorehabilitation Context: Constraint Induction Movement Therapy 
(CIT) 
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For this thesis, research was completed within the context a CIT clinical trial. CIT is 
a form of treatment for stroke patients that specifically targets upper limb 
hemiparesis. This intervention comprises a strong motor learning component as 
patients re-learn how to use the affected upper limb through of the affected arm 
shaping combined with restriction of the non-affected arm, therefore, increasing 
affected arm use. In addition, motor learning is incorporated as part of intense 
training of the affected arm using real world based tasks (Taub et al., 1994). CIT 
sessions are disturbed equally per day across two weeks and administered in carefully 
controlled conditions. CIT is designed to capitalise on the adaptive capacity of the 
brain and promotes plasticity after brain injury. 
Evidence shows that CIT facilitates motor learning determined by behavioural 
outcome measures (Taub et al., 1993; Taub, Ramey, DeLuca, & Echols, 2004; Taub 
& Uswatte, 2003; Taub, Uswatte, & Pidikiti, 1999; van der Lee, 2003; Wolf et al., 
2006). Importantly, CIT has also facilitates neuroplastic changes within those brain 
regions required to prepare and execute movement (Kim, Park, Ko, Jang, & Lee, 
2004; Liepert, Bauder, Miltner, Taub, & Weiller, 2000). If sleep indeed facilitates 
motor learning (Kuriyama et al., 2004; Walker et al., 2002a; Walker et al., 2005), 
sleep may be a vital process in demanding learning situations such as CIT. 
CIT has shown lasting benefits beyond one year after treatment (Taub et al., 1993; 
Taub et al., 2006) however there is a need for further studies to develop advanced 
treatment protocols in order to maximise CIT success. One potential avenue is 
developing a 24 hour approach to CIT whereby improved outcome may be further 
facilitated by offline learning processes, i. e. sleep. No known studies have exclusively 
examined sleep within a motor neurorehabilitation context such as CIT, however 
several authors have stressed a need for applied clinical research of this nature 
(Hyyppä & Kronholm, 1995; Makley et al., 2008; Masel et at., 2001; Siengsukon & 
Boyd, 2009b; Terzoudi et al., 2009). Such research will have implications for 
rehabilitation protocols as promotion of healthy sleep after brain injury, i. e. a 24 hour 
approach to rehabilitation might be crucial for improving service provisions. 
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Patients 
The sampling method employed by the CIT trial utilized a highly selective 
inclusion/exclusion criteria. Firstly, patients were selected at least one year after 
stroke. This chronicity length is considered a sufficient time from which patients are 
stable with regard to their physical and psychological recovery (Dorman et al., 1991; 
Duncan et al., 1992; Horgan et al., 2009; Jorgensen et al., 1995; Lesniak et al., 2008; 
Rasquin et al., 2005). Secondly, patients with uncontrolled co-morbid conditions, 
including psychological were excluded. Finally patients were selected based on a 
narrow range of motor ability. These criteria formed a more homogenous group in 
comparison to existing studies in the sleep and stroke literature. By employing this 
selection criteria, patients are more likely to be in stable state with regard to their 
recovery. The results are then more representative of normalised stroke rather than 
the unstable trajectory of symptoms during the acute phase. 
Methods of Assessment 
The research for this thesis also aimed to address these poorly studied aspects of post 
stroke sleep behaviour in the chronic phase of injury. Firstly, both subjective and 
objective measures were used. This included a comprehensive battery of 
questionnaires and actigraphy. Actigraphy in particular has not yet been largely 
incorporated into studies regarding post stroke sleep. This method provides a 
favourable alternative to PSG, particularly when observing sleep in brain injured 
patients for several reasons: 1) there is little disruption to sleep, i. e. no electrode 
placement, 2) recordings can be completed at home, 3) recordings can continue for 
several weeks, 4) recently developed waterproof actiwatches do not need to be 
removed. Secondly, sleep was monitored over a longer period, i. e. longer than one 
week, to ensure adequate capture of normal sleep behaviour. 
Furthermore, the current research aimed to specifically measure motor recovery after 
stroke, rather than general stroke outcome as used in the majority of sleep and stroke 
studies. For example, The Wolf Motor Function Test was employed as a fine grained 
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motor assessment. This test not only scores upper limb motor ability but also 
measures reaction time in carefully controlled laboratory conditions. Furthermore, 
this test is useful for evaluating motor neurorehabilitation outcome. 
1.5.3 Thesis Aims and Manor Research Questions 
This thesis comprises four main studies presented in Chapters 3 to 6. The general 
methodological approach is described in detail in Chapter 2 and the reader is directed 
to the appropriate sections of this Chapter for specific methods regarding each study. 
The research for this thesis aimed to characterise sleep and daytime functioning 
behaviour, address the relationship between sleep and residual motor recovery, and 
the potential link between sleep and CIT outcome in a group of chronic stroke 
patients with hemiparesis. This involved the collection of habitual sleep data, long 
term subjective sleep diaries, actigraphy and high density waking EEG recordings in 
those patients volunteering for the current CIT trial. 
It is the aim of the following four studies presented in Chapters 3 to 6 to answer these 
main research questions: 
1) How does a chronic stroke population sleep and function during the day in 
comparison non-brain injured persons from a subjective point of view? 
2) How do chronic stroke patients sleep as determined by objective methods? 
3) Can chronic stroke patients accurately perceive their own sleep behaviour and 
daytime functioning levels? 
4) Is sleep and daytime functioning related to levels of residual motor recovery after 
stroke? 
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5) How does sleep and daytime functioning change during a motor 
neurorehabilitation programme and is it related to treatment outcome? 
Conclusion to Chapter 1 
" More and more people are surviving stroke and living with the consequences. 
Stroke is associated with a range of somatic, behavioural, cognitive, 
psychological and motor deficits, including poor sleep and daytime 
functioning. Current treatment provisions for patients are unsatisfactory. 
Further research is required to explore new ways to improve stroke support. 
One potential area is that of sleep. 
" Damage to mechanisms responsible for sleep and waking results in an 
instability in the sleep wake cycle, therefore it is not surprising that sleep 
problems are common after stroke . For some patients, this evolves into a 
sleep disorder. Sleep is responsible for a variety of functions including 
maintaining health, daytime functioning cognitive performance, important for 
the well being of stroke patients. Furthermore, sleep may be a critical 
modulator for motor learning with important repercussions for motor 
neurorehabilitation after stroke. 
" There is evidence to suggest that sleep is related to stroke outcome however 
this notion is poorly studied in chronic patients. Moreover, there is research 
which points towards a potential relationship between sleep and motor 
neurorehabilitation after stroke. No know study has investigated this notion, 
therefore it is the aim of the present thesis to contribute to the sleep and stroke 
literature by researching this potential link. 
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This thesis is unique in comparison to previous studies as each study emphasises 
three important factors when exploring the research aims. These factors are 
chronicity, level of recovery and a controlled setting. Moreover, this research 
specifically focused on upper limb motor ability in a group of chronic stroke patients 
with hemiparesis. No known research has examined sleep in this context. Such 
research has important implications for patients, their carers, clinicians, other 
researchers and the overall development of care systems for post stroke management. 
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CHAPTER 2 
Method Overview of All Studies 
Chapter 2 Overview 
This chapter describes the research methods used for each of the four studies carried 
out for this thesis, including the design, sample of participants, materials, procedure 
and analysis techniques. Data for all studies was collected from an opportunity 
sample of patients with chronic hemiparesis who attended screening and/or 
participated in a neurorehabilitation trial. 
Using the described methodology, the following four studies were carried out to 
investigate sleep behaviour in these patients: 1) Characterising perceived sleep and 
daytime functioning in chronic stroke patients 2) Prospective investigation of 
longitudinal sleep behaviour and correlates of residual motor recovery , 3) EEG- 
derived biomarkers for daytime sleepiness in patients with chronic stroke, and, 4) The 
role of sleep and daytime functioning in neurorehabilitation. Each of these studies are 
presented in Chapters 3 to 6 respectively. Specific design and analysis techniques for 
each study will be described within the corresponding results chapter. 
2.1 Design 
The research carried out for this thesis was designed to be fully integrated within the 
framework of a five year clinical trial entitled: "Clinical benefits and neural 
correlates of Constraint-Induced Movement Therapy (CIT). An investigation using 
behavioural outcome measures, functional magnetic resonance imaging and event 
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related brain potentials" which commenced in January 2004. The trial specifically 
investigated modified protocols of CIT in stroke patients with chronic upper limb 
hemiparesis. These modifications included reducing the traditional CIT session length 
from 6 hours of therapy per day to 1.5 and 3 hours with or without constraining the 
non-affected arm, and introducing a constraint only group with no therapy sessions. 
CIT participants were randomised into one of four groups: a) 1.5 hours of CIT with 
constraint, b) 1.5 hours of CIT without constraint, c) 3 hours with constraint and d) 3 
hours without constraint. Those patients who demonstrated high functioning upper 
limb motor ability by exceeding the maximum motor movement criteria formed 
group e) `Home CIT' group. This group did not attend laboratory CIT sessions 
however wore a constraint on the non-affected limb at home. The research design for 
this thesis was subsequently implemented within the CIT trial in October 2005. 
Ethical approval was granted in December 2006 and data collection began in January 
2007. 
Laboratory observations suggested that sleep and daytime functioning problems were 
frequent complications of stroke patients enrolled onto the CIT trial. Furthermore, the 
emerging evidence in the literature postulates that sleep may have a critical role in 
motor recovery after stroke provided good theoretical reason to research sleep in 
stroke patients. Following these notions, an investigation of sleep in patients enrolled 
onto the CIT trial was carried out. Crucial to the current research, patients involved in 
the CIT trial provided an opportunity sample for exploratory sleep and daytime 
functioning research on: 1) patients with chronic hemiparesis and 2) patients 
undergoing neurorehabilitation. 
The research methods used for the present studies were partly determined by the 
fundamental design parameters specified in the CIT protocol. The CIT trial utilises a 
randomised baseline controlled repeated measures design. The trial consists of three 
phases: baseline (2 weeks), CIT (2 weeks) and post (2 weeks). Motor ability testing 
and questionnaire based assessments were carried out at three test points: baseline 
(TI), pre-CIT (T2) and post CIT (T3). From this framework, the protocol for each of 
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the four studies was introduced which subsequently yielded four individual data sets 
within the trial presented in Chapters 3 to 6 (Figure 2.1). Control samples were 
implemented for the current study only, and not the CIT trial. The specific 
experimental design and participant grouping for each data set is described below. 
The CIT Trial Framework 
Baseline Testing (T1) Pre Testing (T2) Post Testing (T3) 
I r2 Hours -2 Weeks i2 Weeks l2 Weeks T 
SCREENING BASELINE I CIT I POST CIT 
1 Study One 11 Study Two 
EEG (T2) 
I Study Three 1 
Study Four 
II 
I Long Term Sleep Monitoring 
Figure 2.1. The CIT trial framework and the data capture sections for studies I to 4 
conducted for this thesis. Full completion of the CIT trial involved screening, three 
test points, an EEG and long term sleep monitoring during baseline, CIT and Post 
CIT phases. The same patient may appear in one of more of the four studies. 
2.1.1 Study 1 (Presented in Chapter 3): Characterising perceived sleep and 
daytime functioning in chronic stroke patients. 
Study 1 Research Aims 
Study I was a cross sectional investigation which aimed to examine post stroke sleep 
and daytime functioning in comparison to pre-morbid behaviour. The data collected 
in patients was also compared to that of healthy populations and published norms. 
The relationship between sleep, psychological functioning and perceived health of 
stroke patients was also examined. 
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Experimental Design 
A between groups design was implemented to compare habitual subjective sleep and 
daytime functioning in patients and a matched group of non-brain injured healthy 
controls. In addition, the results collated for this study was compared with data 
published in other studies using chronic stroke patients and that of other control 
groups using varying sampling methods. 
Data Collection 
Subjective habitual sleep data for this study comprised the results of a battery of 
nocturnal sleep and daytime functioning questionnaires. To further address 
psychological and health related variables upon sleep behaviour, questionnaires 
regarding psychological disturbance and perceived health were also administered. 
Sample 
Study 1 included all stroke patients invited to the laboratory to attend a screening 
session for CIT participation. This group included those who were subsequently 
invited to participate in the CIT trial, those who did not meet the CIT inclusion 
requirements and those who decided to withdraw from the CIT programme. Healthy 
non-brain injured control participants were recruited from the general population. 
They completed the same sleep questionnaires as patients. Published results for 
comparison with results of the current study were drawn from other chronic stroke 
cohorts. Published control samples used for comparison included those of good health 
and no sleep disorders, and large population studies where sleep disorders and health 
were not part of the inclusion/exclusion criteria. 
2.1.2 Study 2 (Presented in Chapter 4): Prospective investigation of longitudinal 
sleep behaviour and correlates of residual motor recovery. 
Study 2 Research Aim) 
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Following the subjective sleep data collected in Study 1, this study collected 
objective data in patients. Study 2 had three main aims. The first aim was, to assess 
the agreement between subjective sleep perception and actigraphy. Secondly, this 
study intended to describe prospective longitudinal sleep behaviour using subjective 
and objective parameters. Thirdly, this study aimed to assess the relationship between 
sleep behaviour and residual upper limb motor recovery after stroke. 
Experimental Design 
Prospective sleep data was collected over two weeks during the baseline phase for 
study 2 in stroke patients. A within groups design was implemented for these data 
whereby matched indices drawn from subjective and objective sleep reports were 
compared. Subjective parameters additionally included daytime functioning measures 
which were tested for an association with nocturnal measures. This study also 
investigated the relationship between sleep behaviour parameters and residual motor 
recovery, independent of CIT as assessed during the pre-CIT (T2) test point. 
Data Collection 
Subjective sleep monitoring data was collected using a sleep diary which comprised 
nocturnal and diurnal sleep parameters as well as daytime functioning scales. 
Objective sleep and daytime activity was measured by actigraphy. Residual motor 
functioning was assessed by a battery of upper limb ability tests. 
Sample 
The data capture for this study included all patients randomised into groups a) to e) 
recruited to undergo CIT intervention who completed a sleep diary and continued 24 
hour actigraphy monitoring for the baseline phase. This group included those that 
attended test points Ti and T2 (Figure 2.1). 
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2.1.3 Study 3 (presented in Chapter 5): EEG-derived biomarkers for daytime 
sleepiness in patients with chronic stroke 
Study 3 Research Aim 
Study 2 investigated objective sleep whereas study 3 focused on objective daytime 
functioning. The aim of this study was to use EEG as an indicator of sleepiness in 
patients and controls. The main research question was to determine if patients could 
perceive their current level of arousal as depicted in the EEG. 
Experimental Design 
An EEG protocol was carried out in stroke patients prior to the CIT trial at T2. In 
between groups comparison of the EEG data was applied to stroke patients and 
controls. A within groups comparison was also applied to examine hemispheric 
differences in the EEG. Furthermore, the EEG was used as physiological indication 
of sleepiness levels which was addressed in the context of a motor preparation and 
execution task. A within subject, repeated measures design, pre and post of the motor 
task, was implemented to assess changes in subjective sleepiness state and objective 
sleepiness as indicated by the EEG in both stroke patients and controls. Additionally, 
within groups correlation analyses were carried out to examine the relationship 
between subjective and objective sleepiness in stroke patients and controls. 
Data Collection 
Frequency composition of the EEG provided a marker of objective sleepiness and a 
sleepiness state questionnaire was employed to measure this subjectively. 
Sample 
Study 3 comprised those patients from groups a) to e) who had an EEG recording 
prior to CIT therapy and healthy non-brain injured controls, matched for age and 
gender, drawn from the general population. 
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2.1.4 Study 4 (presented in Chapter 6): The role of sleep and daytime 
functioning in neurorehabilitation 
Study 4 Research Aim 
The previous studies aimed to provide an in depth assessment of sleep and daytime 
functioning in chronic stroke patients and how this relates to psychological health, 
quality of life and residual motor recovery. The final study aimed to examine to what 
extent sleep and daytime functioning has a role in neurorehabilitation. Study 4 aimed 
to explore the role of sleep and daytime functioning in those patients undergoing CIT. 
This study focused on the effects that different sessions length of CIT had on sleep. 
Furthermore, the relationship between sleep and CIT outcome was examined. 
Experimental Design 
Twenty-four hour subjective and objective monitoring of sleep and daytime 
functioning were recorded throughout baseline, CIT and post phases for a total of six 
weeks forming a repeated measures design. The relationship between sleep, daytime 
functioning behaviour, activity and CIT outcome were examined. 
Data Collection 
Sleep and daytime functioning was measured using sleep diaries and actigraphy. CIT 
outcome was assessed by the level of change between T2 and T3 on upper limb motor 
ability tests. 
Sample 
This sample involved only those who completed the laboratory based CIT, groups a) 
to d). This particular sample was highly selective as it comprises a very specific 
cohort of ability and all participants attended CIT in a controlled setting of either 1.5 
or 3 hours of CIT per day. 
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2.2 Participants 
The thesis reports data from stroke patient and control cohorts: 1) those who have 
experienced a stroke (Stroke Patient Sample) and 2) non brain-injured matched 
controls (Control Sample). A case table for all participants involved in this thesis, 
including both stroke patients and controls, is provided in Appendix C. The selection 
criteria employed for recruitment of these two cohorts is specified below 
2.2.1 Stroke Patient Sample 
Recruitment 
The stroke patient cohort comprised an opportunity sample of community dwelling 
persons with chronic upper limb hemiparesis, recruited directly from the CIT trial. 
Advertisements for volunteers were posted in local GP practices, National Health 
Service (NHS) clinics, newspapers and relevant websites. The advert specified that 
volunteers must be between 18-75 and have experienced hemiparesis for at least a 
year as a consequence of stroke. Critically, this recruitment strategy resulted in a 
positive selection of highly motivated patients. 
Eighty-two potentially suitable participants for the CIT trial were telescreened, 61 of 
these volunteers were invited for laboratory screening (Figure 2.2). Within the study 
period, 61 participants that were screened and agreed to participate in the sleep 
related research for this thesis. Specific participant numbers for studies I to 4 
including details of exclusions, are described in the relevant result chapters. 
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n-82 
------------- r ---------- i 
Attended Screening Declined Screening Not Eligible 
n=61 n=7 n. 14 
--------------1-------------1 
II 
Eligible For CIT Trial I Declined CIT Participation I Not Eligible 
n=59 n=5 n-2 
I Attended Baseline Testing (TI) 
n=64 
--------------1 
a 
Attended Pre Testing (T2) Withdrew After TI 
n=52 n 2 
--------------------------------------t 
11 
Attended Full CIT Programme 
(1.5 Hour Group) n=21 
Attended Full CIT Programme 
(3 Hour Group) nm17 
Attended Full CIT Programme 
(Home CIT Group) n=14 
Attended Post Testing (T3) 
n=52 
Figure 2.2. This flow chart presents the number of stroke patients recruited for each 
process of the CIT trial from January 2007. 
Inclusion/Exclusion Criteria 
Volunteers of the CIT trial were subjected to strict inclusion/exclusion criteria 
outlined by the CIT protocol: 
Inclusion Criteria 
1) Hemiparesis2 >12 months after insult. 
2) Minimum of 5 degrees wrist extension and 10 degrees finger extension 
against gravity in the affected limb. 
4) Maximum of 20 degrees wrist and 10 degrees finger extension against 
gravity in the affected limb. 
2 The majority of patients experienced contralateral hemiparesis as result of unilateral stroke. Two 
patients experience bilateral strokes therefore presented both ipsilateral and contralateral hemiparesis. 
These patients were only included in Study One. 
93 
5) Generally fit to attend the study schedule. 
6) GP approval. 
Exclusion Criteria 
6) Serious co-morbid conditions. 
7) Uncontrolled psychological disturbance. 
8) Cognitive difficulties (<20 Mini Mental State Exam3, Folstein & Folstein, 
1975, described in more detail under `Materials'). 
9) Insufficient ability to understand instructions. 
10) Seizure event within the past six months. 
11) Balance difficulties. 
12) Uncorrected visual impairment. 
13) Motor Activity Log score > 2.5 on each item (described in more detail 
under `Materials'). 
2.2.2 Control Sample 
Recruitment 
All control samples used in this study comprised non-brain injured healthy 
participants drawn from the general population. Control participants were recruited 
via flyers and poster advertisements in local community services. 
Inclusion/Exclusion Criteria 
In order to gain a relatively healthy, representative sample of the general population, 
the only exclusion criteria employed was absence of brain injury, a diagnosed sleep 
disorder, excessive daytime sleepiness, participants must be in generally good health. 
Importantly, the control cohort was not selective for sleep problems. 
' Patients who experienced expressive aphasia completed the 3-step command on the MSE only. 
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2.2.3 Ethical Approval 
The CIT trial, including the EEG recordings, received ethical approval from The 
Thames Valley Multi-centre Research Ethics Committee. As the addition of sleep 
related research was implemented after the CIT trial commenced, a separate ethics 
application was submitted and approved by the Surrey Research Ethics Committee 
(NHS) specifically for sleep questionnaires (stroke patients and controls), sleep 
diaries and actigraphy data collection (stroke patients). The University of Surrey 
Research Ethics Committee approved all protocols for stroke patients and EEG 
protocols for control participants. Experimental procedures adhered to The 
Declaration of Helsinki (World Medical Association, 2000). All participants gave 
their informed consent prior to participation in this study. The ethically approved 
information sheets give to participants prior to the study and consent forms are 
provided in Appendix Al to A4. 
2.3 Measures and Assessments 
The section describes the assessments and equipment used for data collection 
employed in studies I to 4. This includes those materials used at each stage of the 
protocol including telescreening, laboratory screening, motor testing, sleep 
assessment, sleep monitoring and the EEG recording protocol. 
2.3.1 Telescreeninz (stroke patients only) 
Interested volunteers, or family members on their behalf, were asked a brief set of 
questions to avoid the inconvenience of attending laboratory screening for those 
likely to be excluded. The requested information during telescreening included: age 
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of potential volunteer, date of brain injury, current living situation, cognitive and 
language difficulties, visual impairment, secondary conditions, current rehabilitation, 
level of health care assistance required and ability to cope with a challenging 
situation. In addition, physical impairment details were asked such as: level of 
hemiparesis details including severity and ability to carry out tasks using the affected 
limb, mobility and balance control. 
2.3.2 Laboratory Screening 
The purpose of the laboratory screening assessment was to examine eligibility of 
potential CIT volunteers. This procedure also provided an opportunity to collect 
habitual sleep data on a large group of stroke patients regardless of CIT participation. 
General Screening Form 
The general screening form was designed to collate information from stroke patients 
regarding medical history, motor ability assessment, rehabilitation history and living 
situation. An example of this form is provided in Appendix Bl. 
Patients were asked to describe to the best of their knowledge, the details of their 
stroke experience including: date, circumstance, type of injury (e. g. bleed, blood 
clot), location of lesion, side of body affected by hemiparesis and possible cause of 
stroke. Should the patient have experienced multiple strokes, these details were also 
reported. Patients were asked to report the presence of secondary conditions as a 
result of the stroke, as well as current medication and levels of pain or discomfort. In 
some cases patients, nor their families, could provide all these details. GP approval 
was provided for all stroke patients recruited for the CIT trial. 
The minimal and maximum motor criterion was assessed by examining the patient's 
ability to perform the following motor tasks: lifting the wrist and returning to resting 
position, raising each digit, bending and straightening the elbow and lifting the 
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shoulder. Patients were also asked to report the degree to which spasm influences 
their affected limb use. Additionally, general use of the affected limb outside the 
laboratory was measured using a tool developed for the measurement of real world 
rehabilitation outcome, known as the Motor Activity Log (MAL; Taub et al., 1993; 
Taub et al., 1993). A detailed description of the MAL is provided in section 2.3.3. 
This assessment formed part of the exclusion criteria to excluded those patients who 
were too high functioning in terms of their real world motor activity in the home 
environment. 
Information regarding previous and current rehabilitation treatment was collected 
including type, amount and provider, e. g. UK NHS. Patients were also asked to 
describe their current goals for prospective rehabilitation and what they hope to 
achieve as a result of CIT treatment. Current living situation, marital status, previous 
and current employment position was also requested on this form. 
Cognitive Functioning and Education 
Cognitive functioning was assessed using the Mini-Mental State Exam (MMS) 
(Folstein & Folstein, 1975) which was used to indicate the presence of cognitive 
impairment. This test was implemented as part of the exclusion criteria as those with 
cognitive problems may struggle with the demands of the CIT trial. The assessment 
involved asking a series of questions to assess orientation, immediate and short-term 
memory, attention, calculation, language and spatial awareness (See Appendix B2). A 
summed score between 25 and 30 (maximum) is considered normal. Patients with 
expressive language difficulties were considered for CIT as understanding of 
instructions may remain in tact (Grodzinsky, 2000). Aphasic patients were therefore 
asked to complete the 3-step item on the MMS only. This item required patients to 
follow a 3-step command, "place the index finger of your non-affected hand on your 
nose, and then on your left ear". Failure to complete this item resulted in exclusion 
for CIT participation. This method has been used in previous studies requiring 
cognitive demand from stroke patients (Siengsukon & Boyd, 2008a, 2009a; 
Siengsukon & Boyd, 2008b). Validity and reliability of the MMS is well established 
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in population based studies (Crum, Anthony, Bassett, & Folstein, 1993) as well as 
sensitivity to moderate and severe cognitive impairment (Tombaugh & McIntyre, 
1992). It is a recommended tool for indicating cognitive status for screening 
purposes, rather than diagnosis, in those with neurological disease (Appelros, 2005; 
Dick et al., 1984). 
Patients were also asked to report their highest educational degree and to complete 
the National Adult Reading Test (NART; Nelson, 1982) to allow assessment of pre- 
morbid IQ. The NART requires participants to read aloud 50 words of irregular 
grapheme-phoneme correspondence within increasing difficulty. From the number of 
incorrect pronunciations, IQ score was estimated based on population norms. The 
NART was not applied to those with expressive aphasia. It is important to note that 
this test did not form part of the inclusion/exclusion criteria for the CIT trial. 
Sleep Questionnaires 
Sleep questionnaires were also carried out during laboratory screening. Controls also 
completed the same questionnaires. All assessments asked participants to report how 
they have felt/behaved during the past month. A description of the each questionnaire 
within sleep interview is described below: 
In House Sleep Questionnaire. The validated scales were complemented by an in 
house questionnaire to obtain further information. The in house questionnaire 
comprised a series of fixed and open ended questions regarding sleep medication 
history, caffeine, alcohol and nicotine intake, and description of any night time 
disturbances other than their own sleep, e. g. traffic noise. In order to document 
specific sleep behaviour changes as a result of stroke, an adjusted version (Version 
la; See Appendix B3) of the in house questionnaire was applied to the stroke patient 
sample only. Patients were asked to report the nature of their pre-morbid habitual 
sleep and daytime functioning behaviour. Most critically, the questionnaire asked for 
post-morbid changes during the acute (I month) and chronic phase (>1 year). The 
version for control participants (Version lb: See Appendix B4) included 
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demographical questions, such as age, gender, height, weight and highest degree, as 
they did not complete the screening protocol carried out by the patient group. 
The Pittsburg Sleep Quality Index (PSQI; Buysse et al., 1989) is a widely used 
screening tool (See Appendix B4) chosen to classify subjective levels of sleep 
quality. The PSQI contains 19 items which require a factual response, e. g. time of 
day, or a rating using four-point Likert scale ranging from 0 to 3. From these items, 
seven component scores, ranging from 0 to 3, are generated: subjective sleep quality 
(1 item), sleep latency (2 items), sleep duration (1 item), habitual sleep efficiency (3 
items), sleep disturbance (9 items), use of sleep medication (I item), and daytime 
dysfunction (2 items). The summation of all component scores, termed the PSQI 
global score (GPSQI), indicates overall level of sleep quality. GPSQI scores range 
from 0 (good sleeper) to 21 (poor sleeper) where a score >5 is applied as the cut off 
criterion to classify poor quality sleep (Buysse et at., 1989). In addition, PSQI items 
1-4 provide informative habitual sleep parameters including bed time (24 hour clock), 
get up time (24 hour clock), time in bed (mins), sleep duration (mins) and sleep onset 
latency (mins). 
The PSQI has shown high validity and reliability in a number of studies including 
healthy individuals, those with sleep disorders and elderly samples (Backhaus, 
Junghanns, Broocks, Riemann, & Hohagen, 2002; Carpenter & Andrykowski, 1998; 
Gentili, Weiner, Kuchibhatla, & Edinger, 1995). However one study reported an 
inconsistency between poor quality sleep as reported on the PSQI an objective 
measures of sleep (Buysse et al., 2008). For this reason, it must be noted that the 
PSQI is not suitable for clinical diagnosis of a sleep disorder, however is a useful 
screening tool for sleep abnormalities with potentially clinical significance (Buysse et 
al., 2008). The PSQI has also been widely used in chronically brain injured cohorts 
including stroke (Fictenberg, Putnam, Mann, Zafonte, & Millard, 2001; Mahmood, 
Rapport, Hanks, & Fictenberg, 2004; Masel et al., 2001). 
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The Sleep-50 (S50; Spoormaker, Verbeek, van den Bout, & Klip, 2005) is a 
relatively new sleep disorder screening tool. The S50 utilises DSM-IV criteria to 
screen for clinically significant sleep disorders and was incorporated in this study as 
an additional measure to assess the presence of likely sleep disorder cases. This 
questionnaire comprises 50 items from which participants rate on a four-point Likert 
scale from I (not at all) to 4 (very much), how often they experience symptoms of a 
sleep disorder (See Appendix B6). Varying numbers of items are summed for each of 
the 12 sleep disorder categories and the following cut off criteria is applied: sleep 
apnoea (> 14 on 8 items), insomnia (> 18 on 8 items), affective disorder (> 1I on items 
10,11,43 and 44 out of 4), sleep state misperception (>18 insomnia category and 
estimated amount of hours slept >4), narcolepsy (>6 on 5 items), restless legs 
syndrome/periodic leg movements (>6 on 4 items), circadian rhythm disorder (>7 on 
3 items), sleep walking (>6 on 3 items) and nightmares (>2 on item 32 and >8 on 
items 33-35). Overall, a sleep disorder is likely if participants score above the cut-off 
criteria within a category and score >14 within the `impact of sleep complaints upon 
daily functioning' category. If participants do not obtain scores above the criteria for 
any of the above sleep disorders, however a score > 14 is obtained within the `impact 
of sleep complaints upon daily functioning' category (7 items), hypersomnia is 
classified. A `factors influencing sleep' category is also included in the S50 however 
this is for reference purposes only and does not employ cut-off criterion. 
Reliability and validity of the S50 has only been tested in one study by the developers 
of the instrument (Spoormaker et al., 2005). High internal consistency and good test- 
retest reliability was found in healthy and sleep disordered samples (Spoormaker et 
al., 2005). The S50 is a recommended screening tool as it holds predictive validity for 
sleep apnea, insomnia, restless legs syndrome and periodic leg movement disorder 
and mild preliminary predictions for sleep state misinterpretation, narcolepsy, sleep 
walking and hypersomnia. It must be noted that the S50 has not yet been fully 
validated in brain injured populations. Use of this form of assessment for the current 
study provided an opportunity to test the usefulness of the S50 in stroke patients and 
matched controls. 
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The Ford Insomnia Response to Stress Test (FIRST; Drake, Richardson, & Roehrs, 
2004) is designed to measure predisposed vulnerability to insomnia precipitated by 
environmental and psychological stressors (See Appendix B7). This questionnaire 
was developed in accordance with research revealed that pre-sleep cognitive and 
physical arousal has greater impact upon those with insomnia compared to controls 
(Bonnet & Arand, 1995; Perlis, Giles, Mendelson, Bootzin, & Wyatt, 1997; Vgontzas 
et al., 2001). Therefore items within this questionnaire aimed to identify typically 
precipitating factors which influence subsequent sleep (Speilman, Caruso, & 
Glovinsky, 1987). This type of assessment was chosen for this study to distinguish 
those with sleep disturbance as a result of likely psychological origins. The FIRST 
contains nine hypothetical situations that are emotionally stressful from which 
participants rate on a four-point Likert scale, how likely their sleep may be disrupted 
should they encounter this situation. Possible ratings range from I (not likely) to 4 
(very likely). Scores for each item are summed together to give one overall score. The 
FIRST does not currently provide a cut-off criterion score. To determine high and 
low scores, a median score split has previously been used (Drake et al., 2004; Fornal- 
Pawlowska, Skalski, & Szelenberger, 2007). Initial evidence has suggested that high 
scores on the FIRST was associated with longer sleep latency and poorer sleep 
efficiency and greater hyperarousal as determined by objective methods, and poor 
mood (Fornal-Pawlowska et al., 2007). This data has highlighted that the FIRST may 
be useful for detecting persons who are vulnerable to stress related sleep disturbance. 
However, the long term reliability of this assessment in relation to chronic sleep 
problems remain unknown (Fornal-Pawlowska et al., 2007). The FIRST, like the S- 
50, is also a recently devised scale and has not yet been widely used in brain injured 
or other clinical populations. 
The Epworth Sleepiness Scale (ESS; Johns, 1991) is a widely used questionnaire 
designed to assess daytime sleep propensity. The ESS was employed to identify 
individuals with high levels of daytime sleepiness. It is important to note that the ESS 
measures habitual sleepiness rather than current state sleepiness which is typically 
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assessed by the Karolinska Sleepiness Scale (discussed in section 2.3.4). The ESS 
comprises eight hypothetical situations (See Appendix B8). Participants are asked to 
rate how likely they would fall asleep if placed in those situations during the day 
using a four-point Likert scale ranging from 0 (no chance of dozing) to 3 (high 
chance of dozing). These eight items are summed to give an overall score to indicate 
the degree of general sleep propensity during the day. Scores between 0-6 indicate 
low sleepiness, 7-9 is average and 10-24 indicate severe sleepiness with potential 
clinical implications. 
Previous studies have shown that the ESS is a valid and reliable measure of daytime 
sleepiness (Ronald D. Chervin, Aldrich, Pickett, & Christian Guilleminault, 1997; 
Johns, 1991,1992). Moreover, strong correlations with ESS and objective sleepiness 
have been demonstrated in sleep disordered and healthy participants (Johns, 1991). It 
has also been widely used in clinical samples (Kumru, Santamaria, & Belcher, 2004), 
including those with sleep disorders and daytime functioning difficulties (Violani et 
al., 2003), those with psychiatric conditions (Lundt, 2005), chronic brain injured 
patients (Bassetti & Aldrich, 1999; Cadilhac et al., 2005; Fictenberg et al., 2001; 
Masel et al., 2001; Parcell et al., 2006; Vock et al., 2002). Although the ESS provides 
important information regarding levels of daytime sleepiness, it is important to note 
that it is a subjective measure and should be used in conjunction with objective 
measures for diagnostic purposes of disorders of excessive sleepiness (Miletin & 
Hanly, 2003). 
The Fatigue Severity Scale (FSS; Krupp, LaRocca, Muir-Nash, & Steinberg, 1989) 
was used for this thesis to measure fatigue, independent to the dimension of 
sleepiness. For the purposes of this study, fatigue is defined as physical or mental 
weariness as a result of excursion. In contrast, sleepiness refers to the likelihood of 
falling asleep during the day. The FSS is one of the most commonly used 
questionnaires to measure general fatigue (Dinner, Wessely, & Brown, 2004). It is 
specifically designed to assess the degree to which post-morbid fatigue impacts daily 
life. Due to the lack of the operationalisation of fatigue between studies measuring 
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fatigue (Flossain et al., 2005), additional information was given to participants of this 
study to ensure clarification of fatigue (See Appendix B9). The FSS comprises nine 
statements relating to the impact of fatigue on daily living from which participants 
rate on a seven-point Likert scale how much they agree or disagree, from 0 (disagree) 
to 7 (agree) that the statement applies to them (See Appendix A. 7). Summed item 
scores form an overall score from which a cut off criterion of >35 indicates high 
levels of fatigue (Flachenecker et al., 2002). In addition, the mean score across all 
items can also be used where an average score >4 suggests a moderate to high impact 
of fatigue (Mathiowetz, Matuska, & Murphy, 2001). 
The FSS has been widely used in a range of clinical populations, showing high 
reliability and validity (Kleinman et al., 2000; Merkies, Schmitz, Samijn, van der 
Meche, & van Doorn, 1999; Taylor, Jason, & Torres, 2000). It has also been used in 
chronic brain injuries samples (Choi-Kwon et al., 2005; Michael et al., 2006; Naess et 
al., 2005; Schepers et al., 2006) and demonstrated high internal consistency and 
reliability within these cohorts (Valko et al., 2008). The FSS is also considered a 
useful tool for distinguishing fatigue as a result of brain injury compared to control 
participants (LaChapelle & Finlayson, 1998). 
2.3.3 CIT Test Point Assessments 
The following tests were employed to assess `residual motor recovery' (pre CIT; 
assessed during TI and T2) and `CIT induced motor recovery', otherwise known as 
`CIT outcome', (post CIT; assessed during T3) in terms of motor ability in the 
affected upper limb. In addition to the quality of life assessments were incorporated 
to assess subjective perception of health and psychological functions. All assessments 
carefully selected to be sensitive to CIT related change. 
Quality of Life Questionnaires 
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The Medical Outcome Study Short Form 36 (SF-36; Ware & Sherbourne, 1992) 
was used to assess perception of physical and mental health status. Participants were 
asked to rate the current status of their health in comparison with a year ago and the 
past 4 weeks (See Appendix 1310). Thirty-six items contribute to eight individual 
dimension scores: physical functioning, physical role limitations, bodily pain, vitality, 
social functioning, emotional role limitations, mental health and general health (See 
Appendix A. 8). Items 1,2,4a-d, 5a-c, 6-8,9a-i, 10,1la-d are scored using a five- 
point Likert scale, and items 3a-3j are scored on a three-point Likert scale. A score of 
I corresponds to poorer health on all items however a reversed Likert-scale is used 
for items 7,1,6,8,9a, 9d, 9e, 9h, 11 b and 11 d. For the purpose of this study, 
individual item scores were transformed to a scale of 0 (poor health) to 100 (good 
health) using the following algorithm: 
Transformed Score=[(Actual raw score-lowest possible raw score)]x 100 
Possible raw score range 
Transformed item values for each of the 36 items were assigned to one of the eight 
domains to which they contribute and then subsequently averaged to give a single 
score per domain. Overall physical (5 domains) and mental health (5 domains) 
dimensions can be calculated, where vitality and general heath domains contributed 
to both dimensions (Kalantar-Zadeh, Kopple, Block, & Humphreys, 2001). The 
average of all eight domains forms an overall health score. Transformed scores 
between 0-50 suggests below average and 51-100 indicates above average health. 
The SF-36 is a well known and widely used assessment for health across several 
scientific disciplines and in clinical practice. It has shown sensitivity to health 
changes in large population studies (Garratt, Ruta, Abdalla, & Russell, 1994; 
Hemingway, Stafford, Stansfeld, Shipley, & Marmot, 1997), and has high reliability 
and validity in healthy (Jenkinson, Wright, & Coulter, 1994), and clinical samples 
(Failde & Ramos, 2000; Ruta, Abdalla, Garratt, Coutts, & Russell, 1994), including 
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chronic stroke (Anderson, Laubscher, & Burns, 1996; Buck, Jacoby, Massey, & Ford, 
2000; Schuiling et al., 2005). 
The Hospital Anxiety and Depression Scale (HADS; Zigmond & Snaith, 1983). 
The HADS was developed as a screening tool to indicate possible cases of depression 
and generalized anxiety in clinical populations. It was employed in this study to 
highlight the presence of psychological disturbance, i. e. anxiety and depression, 
present in stroke patients and controls. This instrument was also used to examine the 
impact of CIT on psychological functioning. As the questionnaire refers to feelings 
experienced in the past week, it is sensitive to changing mood states rather than 
enduring traits, therefore can be re-administered over short time intervals (Snaith, 
2003). The HADS (See Appendix B 11) is a self-report questionnaire containing 14 
items contributing to two subscales, anxiety (seven items) and depression (seven 
items). Participants rate the extent to which each item is a problem using a four-point 
Liket scale, ranging from 0 to 3, where a lower score corresponds to increased 
anxiety or depression. Scores for each subscale are summed, ranging between 0 and 
21. Scores >10 are suggestive of a clinically significant condition whereas scores 
between 8-10 are considered borderline. 
It is important to note that the HADS is a screening tool and should not be used for 
diagnostic purposes (Snaith, 2003). The HADS has demonstrated high validity and 
reliability (Bjelland, Dahl, Haug, & Neckelmann, 2002; Flint & Rifat, 2002; Stafford, 
Berk, & Jackson, 2007), also in a variety of clinical populations, including chronic 
stroke (Johnston, Pollard, & Hennessey, 2000; O'Rourke, MacHale, Signorini, & 
Dennis, 1998). 
Affected Upper Limb Motor Testing 
The Wolf Motor Function Test (WMFT; Wolf, Lecraw, Barton, & Jann, 1989) was 
employed as a laboratory based motor assessment, specifically designed for CIT 
motor outcome. The test evaluates the affected upper limb in terms of reaction time 
and functional ability through a series of 13 tasks based on standardised gross and 
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dexterous motor movements (See Appendix B 12 and B 13). Such tasks include lifting 
the arm and hand onto the table, extending the elbow to a 28cm distance (with and 
without 1.35kg weight), lifting arm and hand onto a box, lifting several objects, 
turning on a light switch, placing cotton wool into a pot and lifting a basket 
containing a 1.35kg weight onto a higher table. Tasks are arranged in order of 
complexity. Time to complete each task is recorded in seconds and rated for quality 
on a 8-point functional ability scale from 0 (unable to perform task) to 7 (same as 
before stroke). In instances where the patient cannot perform a task, the task is 
aborted and a maximum reaction time of 120 seconds and functional ability score of 0 
is recorded (See Appendix B 13). 
Research has shown that the WMFT has high inter-rater reliability, internal 
consistency, test-retest reliability, construct validity, criterion validity, has preference 
over other forms of assessments and is sensitive to changes over time (Morris, 
Uswatte, Crago, Cook, & Taub, 2001; Wolf et al., 2001). This assessment has also 
shown good discrimination between high and low functioning patients (Wolf et al., 
2005). The WMFT has also been consistently used in CIT research protocols 
(Dettmers et al., 2005; Morris, Crago, DeLuca, Pidikity, & Taub, 1997; Sterr et al., 
2002b; Taub et al., 1993; Wolf et al., 2006). 
The Motor Activity Log (MAL; Taub et al., 1993) is designed to measure subjective 
affected limb use in their home environment. The MAL utilises semi-structured 
interview format to assess the amount and quality of affected limb functional use 
(with reference to pre-stroke levels) based on 12 activities of daily living, including 
eating, dressing and washing (See Appendix 1314 and B15). Amount of use scores 
range from 0 (no use of affected arm) to 5 (always use affected arm). Quality of use 
scores range from 0 (unable to complete task using affected arm) to 5 (able to use 
affected arm as well as the non-affected arm). Half points may be applied if the 
participant feels it best fits their functioning. 
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The MAL, is a reliable and valid instrument for assessing real world arm use 
(Uswatte, Taub, Morris, Vignolo, & McCulloch, 2005; van der Lee, Beckerman, 
Knol, de Vet, & Bouter, 2004). The MAI, has demonstrated particular sensitivity to 
changes post CIT intervention, and at follow-up, in both acute and in chronic stroke 
patients with various levels of motor ability (Bonifer, Anderson, & Arciniegas, 2005; 
Dettmers et al., 2005; Liepert, Bauder, Miltner et al., 2000; Miltner, Bauder, Sommer, 
Dettmers, & Taub, 1999; Stephen J. Page, Levine, Leonard, Szaflarski, & Kissela, 
2008; Rijntjes et al., 2005; Taub et al., 1993; Wolf et al., 2008). The MAL is a widely 
used assessment paired with other objective assessments of motor function in 
research and rehabilitation outcome studies (Ashford et al., 2008). 
2.3.4 Long Term Sleep Monitoring (CIT participants only) 
Sleep and daytime functioning behaviour was monitored every 24 hours for six weeks 
during the CIT trial using the following methods: 
Subjective Sleep Diary 
An in house daily sleep diary was designed to yield sleep indices typically used for 
subjective sleep assessment. The sleep diary (See Appendix B 16) contained questions 
regarding the patient's perception of the previous night's sleep including sleep quality 
and refreshment using visual analogue scales (0-100mm). The following parameters 
were also requested: bed time (24 hour clock), get up time (24 hour clock), wake time 
(24 hour clock), time in bed (mins), sleep onset latency (mins), sleep duration (mins), 
sleep efficiency4 (%) and frequency and duration (mins) of night awakenings. In 
addition, the sleep diaries incorporated daytime sleep measures including nap 
frequency and length (mins). 
4 Sleep efficiency determined by calculating the percentage of sleep duration per time in bed. This 
calculation was performed by the author of this thesis. 
107 
In addition, twice daily (morning and evening), Karolinska Sleepiness Scale (KSS) 
(Akerstedt & Gillberg, 1990) and Daily Fatigue Scale (D-FIS) (Fisk & Doble, 2002) 
were obtained. This KSS is a one-dimensional scale to assess state sleepiness at a 
particular time point rather than in general like the ESS. Current state sleepiness rated 
on a scale of I (very alert) to 9 (very sleepy). The KSS has provided good correlation 
with objective measures of alertness including EEG and vigilance tests (Kaida et al., 
2006) and sleep deprivation paradigms (Akerstedt & Gillberg, 1990; Gillberg et al., 
1994; Johannes van den Berg, Gregory Neely, Leif Nilsson, Anders Knutsson, & Ulf 
Landstrom, 2005). There is no known research which has used repeated KSS 
measures in chronically brain injured patients. The D-FIS measures the impact of 
fatigue on different areas of daytime functioning including cognitive, physical and 
psychosocial. The D-FIS is based on the Fatigue Impact Scale (FIS) (Fisk et al., 
1994) from which this modified version has been specifically created to address daily 
fatigue rather than general fatigue like the FSS used in this study. Furthermore, it has 
been used to assess changes as a result of interventions within clinical trials (Prince, 
James, Holland, & Jones, 2000). The D-FIS comprises eight fatigue related problems 
from which participants rate the extent of this problem using a scale of 0 (no 
problem) to 4 (extreme problem). The overall score comprised the sum of all eight 
items as well independent scores which distinguished mental (D-FIS Mental) and 
physical (D-FIS Physical) fatigue. The D-FIS holds good validity, is useful for long 
term assessment and is related to other general health ratings (Fisk & Doble, 2002). 
The FIS is considered an accurate and valid measure of fatigue within a brain injured 
sample in comparison to controls (Ingles et al., 1999; La Chapelle & Finlayson, 1998) 
however the use of the modified D-FIS within brain injured samples has not yet been 
examined. 
Sleep diaries are considered reliable for collecting data regarding sleep/wake patterns 
however this measure should be used with caution in participants with frequent 
fluctuations of daytime vigilance (Evans & Rogers, 1994; Rogers, Caruso, & Aldrich, 
1993). Furthermore, the use of daily diaries in clinical cohorts gives rise to some 
concerns regarding compliance as long term monitoring may result in completing 
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several days of the diary towards the end of the experiment (Stone et al., 2002). 
Although this issue cannot be avoided, all patients in the current study were asked to 
bring back the diaries prior to each study phase for inspection and reminded of the 
importance of accurate responses per day. Albeit various concerns, sleep diaries are 
useful for documenting long term sleep and daytime behaviour as well as examining 
treatment progress (Douglass, Carskadon, & Mouser, 1990). Several studies have 
successfully used the sleep diary method in brain injured cohorts (Campos et al., 
2005; Fictenberg et al., 2001; Parcell et al., 2006) which have demonstrated 
associations with objective measures (Baumann, Werth, Stocker, Ludwig, & Bassetti, 
2007). Furthermore, pairing sleep diaries with other methods such as actigraphy is 
considered accurate in providing information concerning long term sleep behaviour 
(Lockley, Skene, & Arendt, 1999; Sadeh & Acebo, 2002). 
Actigraphy 
Twenty-four hour actigraphy was used to monitor sleep/wake behaviour, for up to six 
weeks, to determine daytime napping, activity levels and nocturnal sleep indices. 
Actigraphy was recorded via a watch-like device known as an `Actiwatch Mini ®' 
(CamNtech Ltd., © 2009), worn on the non-affected wrist. The device detected all 
movement exceeding 0.05g, sampled at 32 Hz (3-11 Hz bandpass filtering) which 
stored data in 1 minute epochs. The final activity score was calculated using the 
algorithm A=0.04E-2+0.20E_, +Eo+0.20E+, +0.04E+2 (A=final activity score, 
E=epoch). The data was downloaded onto a computer and analysed using Actiwatch 
Sleep Analysis Software (version 7.22, CamNtech Ltd, © 2009). A medium 
sensitivity algorithm was set for analysis, where an activity count ? 40 defined wake, 
and the software calculated nocturnal sleep parameters using sleep or wake epoch 
detection. Diurnal sleep behaviour was measured using the nap analysis function 
whereby <10 (medium sensitivity) activity counts per minute epoch defined sleep 
within a pre-defined napping period. The Actiwatch Mini ® model is waterproof, 
therefore did not need to be removed for the duration of the study. 
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It is important to highlight here that the algorithm used in the present study was 
developed for those with normal movement and specific algorithms have not yet been 
developed for hemperetic patients. Sadeh, & Acebo (2002) advised that actigraphy 
should not be used in those with motor movement difficulties due to artefact however 
the authors did not report the degree to which increasing severity of motor handicaps 
affects actigraphy recordings. Laakso, Leinonen, Lindblom, Joutsiniemi, & Kaski 
(2004) compared actigraphy with PSG in those with a range of motor handicaps and 
concluded that the method was reliable in such a sample, apart from those with very 
severe handicaps. This is a common result found in healthy and clinical populations 
(Ancoli-Israel et al., 2003) regardless of motor ability. The actiwatches were worn on 
the non-affected wrist to reduce the possibility of movement artefact. Furthermore, 
other studies have successfully used actigraphy in acute and chronically brain injured 
populations with varying recovery levels (Baumann et al., 2007; Hermann et al., 
2008; Muller et al., 2006; Schuiling et al., 2005; Takekawa et al., 2007; Takekawa, 
Miyamoto, Miyamoto, Yokota, & Hirata, 2002) and in those undergoing 
rehabilitation (Alessi et al., 2008) which has revealed important insights with regard 
to the natural sleep-wake cycle in these patients. The validity of the actigraphy 
method is discussed in more detail within chapter 4. 
2.3.5 The EEG Protocol 
The CIT trial employed a protocol involving EEG recordings that were carried out 
during a highly controlled motor priming task. The data collected during this protocol 
was used for the current study as a physiological biomarker for daytime sleepiness. 
EEG recording equipment and a description of the motor task is provided below. 
EEG 
Qualitative EEG (qEEG) allowed for both frequency and topographical analyses of 
the resting brain state in CIT and control participants. 
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The raw data for qEEG analysis was drawn from high density waking EEG 
recordings. Sixty-four Ag/AgCl electrodes were positioned and labelled according to 
the internationally standardised 10-10 system (Chatrian, Lettich, & Nelson, 1985) 
which divides the skull into proportional distances based on four prominent 
landmarks: dent of the nose (nasion), protrusion in the back of the head (inion), and 
preauricular points directly in front of each ear (Figure 2.3). To ensure accurate 
positioning, electrodes were slotted into predefined sites using the `BrainCap', placed 
on the head. 
Figure 2.3. Electrode positions are displayed, labelled according to underlying brain 
areas: FP for frontal pole, F for frontal, P for parietal, C for central, T for temporal, 
and 0 for occipital. Sites are numerically sequenced from midline, which is set as 
zero or Z, with odd numbers on the left hemisphere alternating with even numbers on 
the right. 
Vertical (VEOG) and horizontal (HEOG) electrooculographic signals were recorded 
bipolarly using electrodes lcm above and below the left eye and from the left and 
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right outer canthi, respectively. The ground electrode was placed on the forehead in 
order to record and subsequently remove external electrical noise from the raw trace. 
Electrode impedances were kept below 5kOhm. Electrodes were recorded against an 
average reference calculated by the amplifier hardware (QuickAmp amplifier). EEG 
and EOG signals were continuously recorded in DC mode using Brain Vision 
Recorder. The data was digitally filtered using 0.5 Hz low-pass and 30Hz high pass 
phase shift-free Butterworth filter as well as a 50Hz notch filter. Recordings were 
sampled and stored at 500Hz. Raw EEG data was transferred to Brain Vision 
Analyser software for offline frequency analysis (See Section 2.5.1). All 
hard/software for EEG recordings and analyses was provided by Brain Products 
GmbH ©. Further qEEG analyses is described in more detail within Chapter 5. 
Motor Preparation Task 
The motor task aimed to elicit motor preparation and execution related activity in 
response to stimuli on a computer screen (Figure 2.4; Neurobehavioural Systems 
Presentation Software). Pre-cue (preparatory) primes consisted of two directional 
arrows and response (execution) cues of a white semi-circle displayed on a black 
background (Figure 2.4). 
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Figure 2.4. Presentation of stimuli for one trial within the motor task. One of four pre- 
cues and corresponding actual cue for each trial are presented 12 times at random per 
block. 
Font size was controlled for all stimuli (1.15° wide by 0.92° tall). Stimuli were shown 
in the centre of the screen to prevent horizontal eye movements. Participants were 
asked to respond as quickly and accurately as possible by pressing the response pad 
using the left or right index finger. Responses provided two performance measures 
including reaction time (ms) and percent correct (correct responses to the pre-cue). 
These indices are especially useful as they are known to be sensitive to sleepiness in 
sleep deprived healthy persons (Miccoli, Versace, Koterle, & Cavallero, 2008; van 
den Berg, Neely, Nilsson, Knutsson, & Landstrom, 2005), non-sleep deprived 
healthypersons (Peiris, Jones, Davidson, & Bones, 2006), those with sleep disorders 
(Edinger, Means, Carney, & Krystal, 2008; Sforza, Haba-Rubio, De Bilbao, Rochat, 
& Ibanez, 2004) and brain injured patients (Castriotta et al., 2007; Gomez-Beldarrain, 
Astorgano, Gonzalez, & Garcia-Monco, 2008). To avoid levels of motor ability 
affecting performance levels on the motor task, only responses from the non-affected 
arm were used for analyses. 
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2.4 Procedure 
2.4.1 Researcher Roles: The Clinical Neuroscience Research Team (CNRT) 
The CIT trial was carried out by CNRT, headed by Professor Annette Sterr, and 
comprised one laboratory manager, one project manager, two post-doctoral 
researchers (fMRI research only) and one PhD student (author of this thesis). The 
PhD student acted as a supportive team member by sharing several responsibilities 
within the team, including recruitment, administering CIT to patients, motor testing, 
data entry, general administration and training new staff members. The author of this 
thesis was the sole researcher for all sleep and daytime functioning questionnaires, 
sleep dairies and actigraphy collected for this thesis. The waking EEGs were recorded 
with the assistance of the laboratory manager. All data analysis, including EEG data, 
was carried out by the author of this thesis. 
2.4.2 Stroke Patients Procedure 
Telescreening 
Respondents of CIT trial advertisements were mailed a comprehensive information 
pack providing details of the trial. The information pack contained the sleep related 
research information sheet (for the current study) but did not contain the CIT trial 
information sheet as this was only presented to those who attended screening. 
Interested participants, or a close relative on their behalf, telephoned the laboratory to 
undergo the telescreening process as a brief screening procedure. Suitable participants 
for the CIT trial were then invited for laboratory screening. 
Laboratory Screening 
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During laboratory screening, suitability for the CIT trial was assessed, using the 
methods described in Section 2.3.2 of this chapter, including general screening and 
motor ability assessment, cognitive functioning and education, and then the sleep 
questionnaires. Prior to the sleep questionnaires, consent regarding sleep related 
research was taken as all potential participants were sent the information sheet 
previously. Therefore, data collected during screening could be used with the 
participant's permission regardless of participating in CIT trial. The in house sleep 
questionnaire was completed first, followed by the sleep validated scales, 
administered in the following order: PSQI, S-50, FIRST, ESS and FSS. Next, the CIT 
trial was explained to the participants and CIT trial information sheet was provided. 
Laboratory screening duration was approximately two hours. Successfully recruited 
CIT participants were provided with a study schedule to inform them in advance of 
all testing sessions and assessment phases. 
Baseline Test Point (TI) 
Firstly participants attended TI where informed consent for the CIT trial was taken. 
During TI, patients complete the motor test battery, quality of life questionnaires and 
were provided with sleep monitoring materials. 
Quality of Life Questionnaires. Participants were asked to complete the HADS and 
SF-36 in any order. All questionnaires took approximately 30 minutes to complete. 
Assistance was provided where necessary should the participants required any 
clarification regarding the questionnaires. 
Motor Movement Testing. Standardised instructions were read to the patients for all 
motor movement assessments. Firstly, the WMFT was carried out. A standardised 
map was secured to the table to enable accurate positioning of the equipment required 
for each task. Chair and table positions for each item were recorded which is then 
used as a reference for repeated test points. Prior to each task, the patient was 
instructed not to begin these tasks until the researcher says `ready, set, go'. It is at this 
point where the timer is started and the patient performed the task. All tasks were 
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videotaped and performances were re-timed and scored for functional ability. Next, 
the MAL was carried out by giving the participant two rating sheets from which to 
select their response for each activity. Ratings were recorded during the test. The total 
time for the entire motor assessment battery was approximately 60 minutes 
depending on level of motor ability. 
Sleep Monitoring. During this test point, patients were given sleep diary instructions. 
To ensure patients were clear in completing the sleep diary, they filled in an example 
page with the assistance of the researcher. Patients were also fitted with the 
actiwatches and given specific instructions to record in the sleep diary, any instances 
when the watches were removed. 
Baseline Phase (Two weeks) 
Patients completed part one of the sleep diary, relating to the previous night sleep and 
morning sleepiness/fatigue levels, 30 minutes after waking and part two, relating to 
evening sleepiness/fatigue, two hours before retiring to bed everyday for six 
consecutive weeks. Acitwatches were continuously worn for 24 hours a day. If the 
actiwatch was removed for any reason, participants were asked to report this in the 
sleep diary. No CIT was administered during the baseline phase. 
Pre CIT Test Point (T2) 
Patients returned to the laboratory, one to three days before the beginning of the CIT 
phase, to repeat the motor movement test battery and quality of life questionnaires as 
described in Tl. In addition, patients' completed the EEG protocol. The EEG was 
conducted in a recording booth (2.5 x 3.5m). Participants sat at a viewing distance of 
50cm from a 19" computer screen which presented all experimental stimuli. After 
application of electrodes (approximately 45 minutes), participants were asked to rate 
their current sleepiness level using the KSS. The a clean (no task) EEG during 
wakefulness with eyes open was recorded whilst participants focused on a solid black 
circle (8mm in diameter) against a white screen for 2 minutes. After a short break, 
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motor task instructions were provided on screen as well as clarification by the 
researcher. 
For the motor task, participants were presented with an empty white circle against a 
black screen (See Figure 2.4). Next a white pre-cue in the form of two arrows flashes 
in the centre. The pre-cue enabled participants to `prepare' their next movement in 
accordance with the direction of the pre-cue. One of four pre-cues were presented: « 
prepare left, » prepare right, <> prepare for either direction and >< don't respond. 
Next, the actual cue was presented where one half of the circle becomes white from 
which the participant has to respond with a left or right button press, or no response. 
Once the response has been registered or the time window to respond has expired, 
feedback was provided. This was followed by a grey blank screen preceding the next 
trial. 
Each pre-cue and corresponding cue were presented randomly 12 times which 
equates to 60 trials in one approximately four minute block. The response window 
was extended for those patients who had difficulty pressing the button. Cues are 
100% predictive of actual cue. Participants responded to the actual cue (circle) by 
pressing the corresponding left or right button. The ideal button press is to use the 
index finger which is achievable for control and patient responses on their non- 
affected side. Some patients were able to press the button using the index finger of 
their affected limb, however lower functioning patients may use the palm of their 
hand, or fist. For some lower functioning patients, the button required to be pressed 
by the affected hand is attached to the table to stop the button from moving. 
Firstly, a training session lasting two blocks was administered. During training 
participants were presented with a series of trials of each type in fixed order to 
familiarise themselves with the trial sequence. These training trials were repeated 
until participants gave six correct responses for each trial. Following training, 
electrodes were applied (45 minutes) and the main experimental session began 
comprising eight blocks. The motor task lasted approximately 45 minutes. Between 
117 
blocks the experiment was paused automatically and resumed by the participant when 
instructed. 
Immediately following the motor task, a second KSS measure was recorded followed 
a second two minute resting EEG, following the same procedure as prior to the motor 
task. The duration for the pre-CIT (T2) test point was approximately two hours for 
motor testing, followed by a break, and two hours to carry out the EEG protocol. The 
order of motor testing session and EEG was counterbalanced to examine time of day 
effects in the EEG. 
CIT Phase (Two weeks) 
During the treatment period CIT was administered to groups a) to d). Within CIT 
sessions, patients practiced a range of motor tasks, similar to those carried out in 
everyday life, with the affected upper limb with the supervision and encouragement 
of the therapist. Training was given on a one-to-one basis. The shaping technique is 
used to elicit the desired movement from the affected limb by gradually increasing 
task difficulty. Tasks involved upper limb movements (e. g., using a spoon uses the 
elbow, wrist, and grip) and dexterous activities (e. g., concerning individual fingers), 
which are repetitively practiced using tangible feedback on task performance from the 
therapist. For those in the constraint condition (groups a and c), the unaffected arm 
was restrained using a forearm splint, worn for a target of 90% of waking hours. 
However the constraint was removed when safety may be compromised. Participants 
were also encouraged to employ their affected arm within functional tasks at home. 
Patients attended 10 consecutive daily CIT sessions (excluding weekends) for 1.5 or 
3 hours depending on group randomisation. Patients in the home CIT group (e) did 
not attend CIT sessions, however wore the constraint and were coached at home. 
During the CIT phase, patients continued to complete the sleep diary and wore the 
actiwatches as described for the Baseline Phase. 
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POST CIT Test Point (T3) 
One to three days after the CIT phase, patients repeated the exact procedure described 
in TI. 
Post Phase (Two weeks) 
During the post phase, the patients continued the sleep diary and wore the actiwatches 
as described during for the Baseline Phase. At the end of the post phase, patients 
posted the final sleep diary and actiwatches using the pre-paid envelope provided. 
Patients were also asked to complete the debriefing interview by telephone or post at 
the end of this phase. 
2.4.3 Control Participants 
Control participants recruited to complete the habitual sleep interview and the HADS, 
did so by post or within the laboratory. Those recruited for an EEG recording 
followed the exact procedure undertaken by the stroke patients during TI. One EEG 
is recorded per control participant. 
2.5 Analyses 
This section describes the analyses theory and techniques used for QEEQ and general 
statistics throughout Studies I to 4. Specific analytical methods for the studies are 
described within the method section in each chapter. 
2.5.1 iEEG Analyses Theory 
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Frequency Analysis 
In order to perform qEEG analysis, this thesis used the Fast Fourier Transformation 
(FFT) to quantify the power within different EEG frequencies (Thakor & Tong, 
2004). FFT is an algorithm used to transform EEG data from the time-domain (wave 
form) to frequency (stationary) domain by expanding the time signal into a sum of 
infinite waves. In other words, the FFT synthesises the moving wave forms into a 
single frequency spectrum at a single point in time. The output reflects the frequency 
content of the signal which allows examination the distribution of signal power over 
frequency. FFT gives estimation of power spectral density within one block of 
stationary data (Duhamel & Vetterli, 1990). 
Frequency Analysis Data Output and Presentation 
The "Power spectrum" of a signal refers to the amplitude of the Fourier transform 
(Figure 2.5). This is typically expressed as the `power (µV2)' within a frequency bin 
(e. g. 1 Hz) or summed within a frequency band (e. g. alpha). As sampling rates, i. e. 
the amount of data points collected per second, vary per study, the power can be 
divided by the sampling rate to make the data more comparable between studies. This 
measure is termed `power density (µV2 /Hz). Frequencies are typically summed into 
four frequency bands according to the Hz range: beta (13-30Hz), alpha (8-12Hz), 
theta (7-4Hz) and delta (1-3Hz). Normal wakefulness is characterised by dominance 
of a mixture of beta and alpha although the presence of some lower frequencies may 
also be observed (Figure 2.5). Increased power in the lower frequencies (<10 Hz) 
during wakefulness is indicative of an abnormality and is commonly manifested after 
brain injury (Finnigan et al., 2007; Lukashevich et al., 1999; Sainio et al., 1983). 
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Figure 2.5. Power spectra of a waking EEG. Data from a non-brain injured participant 
drawn from Chapter Five. Although the peak within the delta band (coloured as 
orange) indicates a presence of slower waves in the EEG, this is also suggestive of 
artefact in the recording, known as spectral leakage. 
Additional analysis techniques were applied to reduced common limitations with 
respect to the resolution and leakage of noise that remains present in the EEG 
recording (Muthuswamy & Thakor, 1998). Spectral leakage (Figure 2,5) can be 
reduced by applying a tapering function known the `hanning window' (Nuwer, 
1988b) which was applied to all EEG data for this study. Application of the hanning 
window increases resolution by reducing the appearance of weak waves, i. e. those 
that are not meaningful, in the data. 
For representational details, mapping techniques were employed by expressing the 
multi-electrode output in the form a topographical EEG map (Figure 2.6). This 
method enables visualisation of the distribution varying EEG outputs including power 
within a frequency band and statistical values. Topographical maps created within 
this thesis ultilise an interpolation approach between electrodes in order to produce a 
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set of smooth gradients that are mapped over the surface of the scalp. This method 
encompasses all electrode positions and the intervening spaces between electrodes. 
Each pixel between electrodes is interpolated using an algorithm based on the 
spherical splines technique (Perrin, Pernier, Bertrand, & Echallier, 1989). 
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Figure 2.6. A topographical map of the power spectra within the beta range (13-30 
Hz) of a healthy participant focusing on a spot on a screen (no task). The red indicates 
increased power of the beta waves in the frontal areas 
2.5.2 Statistical Analyses 
All statistical analyses for this thesis were performed using Statistical Package for the 
Social Sciences, version 15.0 for Windows (SPSS Inc., Chicago, USA). The result 
sections of studies I to 4 present data in frequencies, percentages for larger samples, 
mean, median, +/-I standard deviation (+/-I SD) or (+/-1 SE) where appropriate. All 
time of day related data is presented in 24 hour clock format. Alpha (p) was set to 
p<0.05 for determining significance. The bonferroni correction was applied where 
appropriate. 
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Preliminary assumption testing was conducted to check for normality, linearity, 
univariate and multivariate outliers and homogeneity. Should any violations have 
occurred, alternative procedures were incorporated. In instances where the data were 
not normally distributed, non-parametric alternatives were applied. For the Mann- 
Whiteney U Test, the Z approximation (corrected for ties in the data) statistic will be 
reported in place of the U value as the Z-score is recommended for samples sizes 
larger than 30 (Pallent, 2005, p. 292). However, samples are lower than 30 for some 
analyses therefore the U value was reported. Abbreviations for other statistics are t 
values (t), F ratio (F), partial eta squared (nß, 2), degrees of freedom (df), unadjusted 
regression (R), R squared (R'`). 
Specifically for the highly skewed data from EEG recordings, log transformations 
were applied to enable the application of parametric statistical tests. More 
specifically, the current investigation utilised a base 10 logarithmic transformation 
(LgIO). This approach is useful as it allows more robust statistical tests to be used. 
(Thatcher et al., 2001) and has been used in previous waking EEG studies (Lockley et 
al., 2006; Viola, James, Archer, & Dijk, 2008). The raw data is presented in table 
form as this is more meaningful when comparing with findings from other studies. 
Regression analyses were only performed for larger samples where N>50 
(Tabachnick & Fidell, 2000, p. 117). For purposes of comparison with published 
work, the magnitude of difference between the results studies was examined using the 
Cohen's d statistic. The mean of one group (M1) is subtracted from another (M2) and 
divided by the standard deviation: 
d=MI - M2/SD 
The strength of the calculated effect sizes were interpreted based on the following: 
>0.20=small effect, >0.50 and <0.80=medium effect and >0.80=large effect (Cohen, 
1988). 
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Conclusion to Chapter 2 
" The overall methodology for the research carried out for this thesis was 
designed within the framework of a neurorehabilitation trail investigating the 
efficacy of CIT. 
" Four studies using chronic patients with upper limb hemiparesis were 
implemented in the current thesis research. Control participants were 
employed for Study I and 3. 
" The studies collected data on a broad range of life style factors and aspects of 
the post stroke sequelae. This included demographical information, stroke 
details, co-morbid conditions, cognitive functioning, education, health, 
psychological adjustment, sleep, daytime functioning, and motor ability. This 
information was assessed or monitored using a range of subject questionnaires 
and semistructured interviews. Additionally, objective measures were 
implemented for longitudinal sleep monitoring, daytime sleepiness and upper 
limb motor ability. 
Specific methodological details for Study I to 4 are described within the 
corresponding chapters. 
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CHAPTER 3 
Study 1: Characterising Perceived Sleep and Daytime 
Functioning in Chronic Stroke Patients 
Chapter 3 Overview 
The aim of this study was to characterise perceived sleep and levels of daytime 
functioning chronic stroke patients with residual motor deficits. Sixty-one patients 
and 61 healthy non-brain injured controls drawn from the general population 
completed a battery of in house questionnaires and validated scales. Prevalence of 
sleep difficulties, sleepiness and fatigue were compared to published data from other 
chronic stroke cohorts and non-brain injured control samples. Furthermore, the 
relationship between sleep, psychological functioning and health was examined. The 
results have important implications for gaining a greater understanding of how self 
reported sleep behaviour of stroke patients compares with non-brain injured persons 
and the impact of sleep on the quality of life of patients. 
3.1 Introduction 
Chronic health conditions, including physical and psychological, are commonly 
associated with adverse alterations in normal sleep patterns (Foley et al., 2004; Katz 
& McHorney, 1998; Manocchia et al., 2001; Ohayon, 2005; Parish, 2009). As a result 
of poor sleep or the disease per se, chronically ill patients may experience increased 
sleepiness, fatigue and frequent napping (Kapur et al., 2002; Parish, 2009). 
Furthermore, poor sleep and disrupted daytime functioning contributes to poorer 
quality of life and may inhibit recovery (Briones et al., 1996; Hyyppä & Kronholm, 
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1995; Manocchia et at., 2001). Despite this knowledge, sleep remains poorly studied 
in patients with chronic neurological conditions, more specifically stroke, associated 
with both physical and psychological consequences (Duncan et al., 1997). Although 
several studies have reported that stroke often manifests behavioural and neural 
alterations in sleep and daytime functioning, the long term evolution of perceived 
sleep and daytime functioning has not yet been characterised. 
3.1.1 Post Stroke Sleep and Daytime Functioning Alterations 
Prevalence of Nocturnal Sleep Problems 
Sleep disturbances are experienced in 20-57 % of stroke patients within the first six 
months of injury (acute), including difficulties getting to sleep, increased night 
awakenings, reduced sleep duration, reduced sleep efficiency and poor sleep/wake 
cycle based on objective reports (Bassetti & Aldrich, 1999; Bassetti & Aldrich, 2001; 
Giubilei et al., 1992; Gottselig, Bassetti, & Achermann, 2002; Hermann et al., 2008; 
Iranzo, Santamaria, Berenguer, Sanchez, & Chamorro, 2002; Müller et al., 2002; 
Santamaria et al., 2000; Siccoli & Bassetti, 2008; Takekawa et al., 2007; Takekawa et 
al., 2002; Terzoudi et al., 2009; Vock et al., 2002). These disturbances are also 
reflected subjectively (Leppävuori et al., 2002; Van Zandvoort et al., 1998) however 
less is known about perceived sleep behaviour in patients. 
Critically, prevalence of clinically diagnosed sleep disorders is high in stroke patient 
populations. Insomnia occurs in approximately 37-68% of acute patients (Leppävuori 
et al., 2002; Palomaki et al., 2003). Sleep disordered breathing is highly common 
after stroke as reported prevalence ranges from 45 to 95% (Bassetti & Aldrich, 1999; 
Good et al., 1996; Iranzo et al., 2002; Parra et al., 2000; Rola et al., 2007; Wessendorf 
et al., 2000). Fifty-five to 72% of such patients are diagnosed with sleep apnoea 
(Broadley et al., 2007; Kaneko, Hajek, Zivanovic, Raboud, & Bradley, 2003a; 
Sandberg et al., 2001). Parasomnias have also been reported in acute stroke including 
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periodic leg movements and restless leg syndromes (Lee et al., 2009; Schuiling et al., 
2005; Sechi et al., 2008) as well as frequent nightmares (Leppävuori et al., 2002). 
Few studies have addressed long term sleep behaviour in chronic stroke, i. e. at least 
12 months after injury. Of the existing small number of studies, it has been shown 
that persisting objective sleep disturbances exist in 34% of patients beyond one year 
(Schuiling et al., 2005). In addition, subjectively problematic sleep is reported in 34 
to 67% of patients (Campos et al., 2005; Masel et al., 20015; Schuiling et al., 2005; 
Sterr et al., 2008). Carer observations have also confirmed the presence of post stroke 
sleep and daytime functioning disturbance (Worthington & Melia, 20066). Palomaki 
et al. (2003) reported that at 18 months post injury, 48% of patients fulfilled DSM-IV 
criteria for insomnia. Persisting sleep breathing problems have been reported in up to 
81% of chronic stroke patients whereas 20% fulfilled diagnosis for sleep apnoea 
(Cadilhac et al., 2005). Parasomnias may also persist beyond one year in 16.9% of 
patients (Masel et al., 2001). For those studies that employed a control group, the 
reported prevalence rates of sleep disturbance were greater than in non-brain injured 
controls (Campos et al., 2005; Muller et al., 2006). 
In addition to sleep behaviour changes, alterations in sleep architecture have been 
reported. These changes are characterised by an increase or reduction of a particular 
sleep stage in comparison to a normal sleep cycle. In acute stroke, increased stage I 
(Hermann et at., 2008; Korner et at., 1986), reduced stage 2 (Bassetti & Aldrich, 
1999; Bassetti & Aldrich, 2001; Hachinski et at., 1987; Santamaria et al., 2000; 
Terzoudi et at., 2009) and reduced REM sleep (Giubilei et at., 1992; Hachinski, 
Mamelak, & Norris, 1990; Korner et at., 1986; Mohsenin & Valor, 1995; Siccoli & 
Bassetti, 2008; Vock et at., 2002) have been reported. Alterations in slow wave sleep 
are inconsistent as increased (Culebras & Miller, 1983; Santamaria et at., 2000) and 
decreased proportions of slow wave have been described (Bassetti & Aldrich, 1999; 
Bassetti & Aldrich, 2001; Mohsenin & Valor, 1995; Müller et at., 2002). Sleep 
Mixed stroke and TBI sample. 
e Mixed stroke and TBI sample. 
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abnormalities observed in the acute phase improved with no abnormal proportions of 
sleep stages observed after one year (Gottselig et at., 2002; Hachinski et al., 1987; 
Müller et at., 2002; Vock et at., 2002). In contrast, Herman et at. (2008) showed sleep 
EEG alterations remained despite improved subjective sleep. This demonstrates that 
more research is required to clarify the extent to which sleep disturbance evolves into 
a chronic problem after stroke. 
Prevalence of Daytime Functioning Problems 
While excessive sleepiness is commonly experienced during the acute phase of stroke 
(Bliwise, Rye, Dihenia, & Gurecki, 2002; Davies, Rodgers, Walshaw, James, & 
Gibson, 2003; Good et at., 1996), persisting subjective and objective sleepiness 
remains in 17 to 34% of chronic patients (Campos et at., 2005; Masel et at., 2001; 
Schuiling et al., 2005; Vock et at., 2002; Worthington & Melia, 2006). Cases of 
hypersomnia and narcolepsy are also apparent in some chronic patients (Bassetti & 
Aldrich, 1999; Masel et al., 2001). Seventy to 92% chronic stroke patients regularly 
nap to compensate for sleepiness (Campos et at., 2005; Muller et at., 2006; Schuiling 
et at., 2005). Surprisingly, none of these studies utilised a control group. Published 
norms have indicated that excessive sleepiness occurs in 19.55% in the general UK 
population (Anderson, Platten, & Horne, 2009). Therefore some sleepiness s to be 
expected irrespective of stroke, however further research is required to examine 
stroke specific changes in daytime functioning. 
Another dimension of daytime functioning, independent of sleepiness, is fatigue. 
Fatigue refers to physical or mental exhaustion as a result of exertion and is usually 
measured using subjective questionnaires. Thirty to 69% of chronic stroke patients 
complain of fatigue (Choi-Kwon et al., 2005; Ingles et al., 1999; Park et al., 2009; 
Schepers et al., 2006; Valko et al., 2008; van der Werf et al., 2001). Post stroke 
fatigue is considerably more prevalent than reported rates in controls which range 
from 12 to 36% (Ingles et al., 1999; Park et al., 2009; Valko et al., 2008; van der 
Werf et al., 2001). Furthermore, fatigue may evolve over the course of stroke 
(Schepers et al., 2006; Valko et al., 2008). It is common for patients to report that 
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fatigue is their worst symptom after suffering a stroke (Ingles et al., 1999; van der 
Werf et al., 2001). 
Mechanisms Subserving Post Stroke Sleep Alterations 
It is postulated that a stroke event is directly related to the observed changes in sleep 
behaviour due to neural damage of sleep and arousal mechanisms (Bassetti & Valko, 
2006; Evans, 2002). Some studies suggest that particular stroke topographies are 
associated with selective sleep deficits. For example, reduced sleep stages 2 and 4 has 
been attributed to supratentorial stroke (Bassetti & Aldrich, 2001). Furthermore, 
thalamic stroke is highly associated with increased sleepiness (Autret et at, 2001; 
Catsman-Berrevoets & Harskamp, 1988; Christian Guilleminault, Quera-Salva, & 
Goldberg, 1993). Although some brain mechanisms have been identified in 
modulating fatigue (Naess et al., 2005; Staub & Bogousslavsky, 2001), further 
investigation is required to establish this link. 
In contrast, there is not always a direct association between lesion location and sleep 
and daytime functioning disturbance (Autret et al., 2001; Baumann et al., 2007; Parra 
et al., 2000). Also, Choi-Kwon et al., (2005) and Ingles et al., (1999) found no 
relation between fatigue and lesion location in chronic stroke patients. This suggests 
that other non-neurological factors are likely to subserve post stroke sleep 
disturbance. For example, concomitant medications, lifestyle alterations and 
psychological consequences have been attributed to the development of sleep 
disturbance in acute patients (Bassetti, 2005b). Such relationships have not yet been 
fully addressed in the context of chronic stroke. 
3.1.2 Methodological Issues For Researching Post Stroke Sleep and Daytime 
Functioning 
Although previous studies have begun to describe sleep and daytime functioning in 
chronic stroke, several limitations arising from previous work highlights that more 
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research is required to fully address this aspect of the post stroke sequelae. It is the 
intention of the current study to resolve some of these issues. 
Conceptualising and Measuring Sleep and Daytime Functioning 
The prevalence of post stroke sleep disturbance may be subject to bias due to the 
conceptualisation of sleep problems. Some studies use strict clinical criteria as listed 
within the DSM-IV or the International Classification of Sleep Disorders whereas 
others use healthy controls as a normative comparison. It is also important to consider 
the type of assessment being used. Objective and subjective measures may not be in 
concordance or measure different aspects of sleep (Buysse et al., 2008; Masel et al., 
2001). Therefore the inferences drawn from other studies should take into account the 
inter-study variance in criteria and type of assessment. 
Another commonly occurring conceptual isation problem is the lack operational isation 
of sleepiness and fatigue. These concepts are distinct dimensions of daytime 
functioning and can be assessed independently (Hossain et al., 2005). It is possible to 
derive empirically separate sleepiness and fatigue scales from existing self report 
instruments (Bailes et al., 2006) which is necessary to explore post stroke daytime 
functioning. 
Patient Group Selection 
The majority of studies address post stroke sleep behaviour during the acute phase of 
recovery with chronicities ranging from several hours or weeks. Acute patients are 
exposed to critical factors which impose upon sleep. For example, during the first few 
months after stroke, patients are subject to changes in sleeping environment, 
biological and psychological stress, increased bed rest, medications, fever, pain and 
other complications (Bassetti and Aldrich, 2001, p. 191). Studies addressing stroke 
within 6 months are also at risk for confounds upon sleep as patients may not yet be 
discharged from the rehabilitation facility and are not yet fully adjusted to the long 
term consequences of stroke (Jorgensen et al., 1995; Sullivan, 2007). More studies 
are required to characterise sleep in patients who are in a stable state with regard to 
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their recovery, i. e. at least 12 months post stroke (Donnan et al., 1991; Duncan et al., 
1992; Horgan et al., 2009; Jorgensen et al., 1995; Kotila et al., 1984; Lesniak et al., 
2008; Rasquin et al., 2005). 
Control Group Selection 
The reported literature presents some concerns over the lack of, or choice of control 
group. The choice of control group is highly varied between studies. Some studies 
make comparisons based on published norms, whereas others choose strictly healthy 
controls. Other studies have examined alternative neurological conditions including 
transient ischemic attack (TIA) or non-brain injured persons in a hospitalised status. 
The varied choice of control group is highly influential for data interpretation. For 
example, positive selection of strictly healthy controls will contain less sleep 
disordered participants than general populations. Therefore comparing sleep 
behaviour between stroke patients and strictly healthy populations may result in an 
overestimation of post stroke sleep problems. 
3.1.3 The Rationale For Study 1 
There is a strong rationale to explore sleep behaviour in chronic stroke. Firstly, initial 
evidence suggests that post stroke sleep disturbance impacts quality of life. Secondly, 
long term outcome as well as the success of neurorehabilitation efforts is influenced 
by sleep and deficits in daytime functioning. Thirdly, post stroke sleep problems have 
been attributed to greater family burden and increased medical costs. 
Impact Sleep on Psychological Adjustment and Quality Of Life 
Quality of life construct refers to both physical and mental health, typically from the 
subjective perspective (Cella, 1994). It is well established that sleep disturbance, and 
the associated sleepiness and fatigue, contributes to poorer quality of life. This has 
been shown in healthy persons and those with chronic illness (Baldwin et al., 2001; 
Briones et al., 1996; Finn, Young, Palta, & Fryback, 1998; Flemons & Tsai, 1997; 
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Katz & McHorney, 1998; Manocchia et at., 2001; Redeker, Ruggiero, & Hedges, 
2004; Reid et al., 2006; Strine, Chapman, Balluz, Moriarty, & Mokdad, 2008; 
Totterdell et at., 1994). With regard to chronic stroke, only one study has assessed 
sleep and quality of life. Schuiling et at. (2005) investigated the relationship between 
post stroke sleep disturbance and quality of life using the SF-36. In this study, chronic 
stroke patients with sleep problems had lower quality of life compared to patients 
with no sleep problems. Although this study combined daytime functioning and 
nocturnal sleep as one variable. Specifically regarding sleepiness and fatigue, 
increased levels are associated with poorer post stroke quality of life (Ingles et at., 
1999; Naess et at., 2006b). 
Post stoke psychological conditions, including depression and anxiety, are associated 
with increased sleep disturbance, sleepiness and fatigue (Bassetti & Valko, 2006; 
Leegaard, 1983; Schepers et al., 2006; Fabienne Staub & Julien Bogousslavsky, 
2001). Few studies have examined this relationship in chronic patients, particularly 
examining both perceived sleep disturbances and daytime functioning. This is 
important to examine as psychological adjustment after stroke is an important 
contributor to quality of life after stroke (Strine & Chapman, 2005) and this is 
unlikely to stabilised until the chronic phase of stroke (Horgan et al., 2009; Kotila et 
al., 1984). 
Stroke Outcome and Rehabilitation 
Sleep problems, in addition to the physical and mental consequences of chronic 
disease, may aggravate disability and functional impairment (Parish, 2009; Stein, 
Belik, Jacobi, & Sareen, 2008). More specifically, several studies have found an 
association between sleep problems and the level of acute (Claudio Bassetti et at., 
1997; Bassetti & Aldrich, 2001; Good et al., 1996; Hachinski et al., 1987; Kaneko et 
al., 2003b; Leppävuori et al., 2002; Sandberg et al., 2001; Spriggs et al., 1992a; 
Takekawa et al., 2007) and chronic (Good et al., 1996; Hermann et al., 2008; Vock et 
al., 2002) stroke recovery outcome. Furthermore, there is evidence to suggest that 
rehabilitation participation is interrupted by sleepiness and fatigue (Barker-Collo et 
132 
al., 2007; Morley et al., 2005; Muller et al., 2006; Palomaki et al., 1999; Worthington 
& Melia, 2006). 
Medical and Family resources 
Not only is stroke a serious medical condition, it places great financial burden upon 
patients and their families as well as the healthcare system (Kapur et al., 2002). 
Moreover, high levels of sleep problems in chronically ill patients are associated with 
increased use of health care services (Manocchia et al., 2001). Treating sleep 
disorders in addition to primary chronic conditions may reduce length of stay in 
hospital therefore limit the medical burden associated with stroke (Kaneko et al., 
2003b). 
3.1.4 The Current Study 
The above studies have shown that sleep problems are especially prominent during 
the acute phase of stroke in the form of poor sleep quality or more serious sleep 
conditions including insomnia and sleep apnoea. However there are inconsistencies in 
the methodology and findings across studies. Furthermore, there is a lack of research 
considering: 1) the patients experience of post stroke sleep and daytime functioning 
disturbance and 2) the post stroke evolution of sleep disturbances in the context of 
psychological adjustment and quality of life. Moreover, patients recruited for this 
study were in the chronic state of injury, therefore more like to be in a stable state 
with regard to physical and psychological recovery. No known study has incorporated 
a battery of assessments to address subjective nocturnal sleep, addressing sleepiness 
and fatigue as separate entities, and measure psychological adjustment and quality of 
life in chronic patients compared to controls. 
Research Aims 
The aim of the current study was to characterise habitual sleep and daytime 
functioning and the potential relationship with psychological disturbance and quality 
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of life within a chronic stroke population. Crucially, the study aimed to expand the 
existing literature by providing an in depth study of perceived sleep and daytime 
functioning in patients with chronic residual motor deficits. 
Based review of the literature, the following research questions were addressed: 
1. How is sleep and daytime functioning affected after stroke in comparison to 
pre-morbid behaviour in acute and chronic patients? 
2. Is sleep and daytime functioning in chronic stroke patients different to that 
observed within healthy populations and published norms? 
3. To what degree does the stroke event per se and psychological functioning 
contribute to the manifestation of poorer sleep behaviour? 
4. Is nocturnal sleep and daytime functioning related to the perceived health of 
stroke patients? 
3.2 Method 
3.2.1 Desii! n 
A cross-sectional design was employed to address subjective sleep and daytime 
functioning in a chronic sample of patients with hemiparesis. Habitual sleep 
behaviour data was collected during the screening session for the CIT trial (Figure 
3.1). A between groups design was employed whereby stroke patients were compared 
to a group of non-brain injured healthy controls. Furthermore, data from the current 
study was compared to stroke patient and control data from published studies. A 
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within group design was applied in order to make comparisons between 
questionnaires. Stroke patients and controls were combined into one group for the 
regression analyses examining predictors of sleep behaviour. A second regression 
analyses was conducted to examine perceived health, sleep and daytime functioning 
involving stroke patients only. 
The CIT Trial Framework 
Baseline Testing (T1) Pre Testing (T2) Post Testing (T3) 
I 
r2 Hours 2 Weeks 2 Weeks 2 Weeks 
SCREENING: BASELINE 
1 Study One Study Two 
I 
it 
EEG (T2) 
j Study Three 
CIT 
Study Four 
II 
I Long Term Sleep Monitoring 
POST CIT 
Figure 3.1. Design of CIT trial, The highlighted section indicates time point from 
which data for this study was collected 
3.2.2 Participants 
Sixty-one community dwelling chronic stroke patients with residual motor deficits 
were included in the analysis for the current study. All participants fulfilled the 
inclusion/exclusion criteria as described in Section 2.2.1, Chapter 2. 
In addition, 61 non-brain injured control participants drawn from the general 
population were recruited for. Participants with clinically diagnosable sleep disorders 
were excluded, however the sample is likely to contain what would be classified as 
poor sleepers (a sampling method used by Lichstein, Taylor, Bush, Reidel, & 
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Durrence, 2004, p. 73). Furthermore, the data of the current study was compared to 
that of published subjective data from non-brain injured populations and other 
comparable samples involving chronic stroke cohorts (Clare Anderson & Horne, 
2008; Bassetti & Valko, 2006; Buysse et al., 1989; Choi-Kwon et al., 2005; Groeger 
et al., 2004; Johns, 1991; Lichstein et al., 2004; Magee, Caputi, Iverson, & Huang, 
2008; Masel et al., 2001; Monk, Buysse, Rose, Hall, & Kupfer, 2000; Motohashi et 
al., 1999; Naess et al., 2005; Park et al., 2009; Schepers et al., 2006; Siengsukon & 
Boyd, 2009a; Valko et al., 2008; Vock et al., 2002; Ziino & Ponsford, 2005). 
3.2.3 Materials 
All stroke patients completed a screening interview comprising medical history, 
motor ability, rehabilitation history, life style, cognitive functioning and education 
details. Patients also completed a battery of sleep and daytime functioning 
questionnaires including: the in house sleep questionnaire (Version Ia), The Pittsburg 
Sleep Quality Index (PSQI; Buysee et al., 1989), The Sleep 50 (S50; Spoormaker & 
van den Bout, 2005). The Ford Insomnia Response To Stress Test (FIRST; Drake et 
al., 2004), The Epworth Sleepiness Scale (ESS; Johns, 1991) and The Fatigue 
Severity Scale (FSS; Krupp et al., 1989). The cut off criterion employed within this 
study to indicate a noteworthy sleep of daytime functioning difficulty is also provided 
in Table 3.1. Presence of psychological disturbance was assessed in stroke patients 
using the Hospital Depression and Anxiety Scale (HADS; Zigmond & Snaith, 1983). 
The SF-36 was administered as a measure of perceived health. Control participants 
recruited for this study completed the in house sleep questionnaire (Version lb), 
PSQI, S50, FIRST, ESS, FSS and the HADS only. See Section 2.3.2 (Chapter 2) and 
Appendix B for a sample of all questionnaires. 
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Table 3.1. Study I questionnaires. Details include number of items, scoring range and 
cut off criteria scores above cut off criteria per questionnaire to indicate the following 
a) poor quality sleep on the PSQI, b) presence of a likely sleep disorder on the S50, c) 
vulnerability to sleep problems as a result of stress on the FIRST, d) excessive 
sleepiness on the ESS, e) high levels of fatigue on the FSS and f) clinically significant 
depression or anxiety on the HADS. 
Questionnaire 
PSQI 
S50: 
Sleep Apnea 
Insomnia 
Affective Disorder 
Sleep state misperception 
Narcolepsy 
Restless legs syndrome/periodic leg movements 
Circadian rhythm disorder 
Sleep walking 
Nightmares 
Hypersomnia 
FIRST 
ESS 
FSS 
HADS: 
Depression 
Anxiety 
SF-36 
No. of Items Score Rangy 
19 0-21 
50 - 
8 8-32 
8 6-32 
4 4-16 
8+ sleep duration - 
5 5-20 
4 4-16 
3 3-12 
3 3-12 
4 4-16 
7 7-28 
9 1-36 
8 0-24 
9 0-63 
7 0-21 
7 0.21 
36 0.100 
Cut off Criteria 
>5 
> 14 
>18 
>11 
> 18 insomnia score and >4 hours sleep duration 
>6 
>6 
>7 
>6 
>2 on 1 item 32 and >8 on items 33-35 
>14 
>median group score 
>9 
>35 (total score) or >4 mean across items 
>10 
>10 
>50 
3.3.4 Procedure 
All stroke patients completed screening and the questionnaires, during the laboratory 
screening session. HADS and SF-36 questionnaires were completed by those stroke 
patients who attended baseline testing (TI) as part of the CIT trial. These 
questionnaires were not included during screening due to increased timing constraints 
in order to accommodate the necessary assessments. Control participants completed 
the questionnaires in the laboratory or by post. 
3.3.5 Analysis 
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Statistical analysis was performed on item score, component scores, total score or 
calculated index for the PSQI (GPSQI), FIRST (FIRST Total) ESS (ESS Total), FSS 
(FSS Total), HADS (Anxiety and Depression) and SF-36 (Mental. Physical and 
Overall Health). See Section 2.3.3, Chapter 2 for a description of the calculation steps 
for questionnaire scoring. Furthermore, items I to 4 on the PSQI were used to 
provided the following habitual sleep parameters: bed time (24 hour clock), get up 
time (24 hour clock), time in bed (minutes), sleep duration (minutes), sleep onset 
latency (minutes) and sleep efficiency (% sleep duration per time in bed). The sum of 
PSQI items 5b -j was used to calculate level of sleep disturbance. Between group 
comparisons were conducted between patients, control data from participants of the 
current study and published data. Furthermore, within group analysis of nocturnal 
sleep and daytime functioning was examined. In instances where participants did not 
complete the full sleep interview and questionnaire battery, the final number of 
patients or controls was listed where appropriate. 
Due to the non-normal distribution of the data, all tests of group differences were 
calculated using Mann Whitney U Tests and tests of association used Spearman's 
Rank Correlation Coefficient. To address the magnitude of difference as well as 
statistically comparing data of the current investigation with other published data, 
effect sizes were calculated using Cohen's d (see Section 2.5.5, Chapter 2). Effect 
sizes could not be calculated for those studies which did not provide a standard 
deviation. A standard multiple regression was performed to assess the degree to 
which demographic and psychological factors contributed to sleep and daytime 
functioning difficulties. A second regression analysis was applied to stroke patients 
who completed the SF-36 to examine factors contributing to perceived health. All 
statistical tests were one tailed and the alpha value was set to p<0.05. 
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3.3 Results 
3.3.1 Demographics 
The demographics for both stroke patients and healthy controls are presented in Table 
3.2. There were marginally more male stroke patients (60%) who took part in this 
study compared to female. Gender balance was relatively similar for controls (46% 
male). Several co-morbid conditions were apparent amongst the stroke patients, most 
notably psychological and cardiac related, all of which, were medically controlled. 
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Table 3.2. Demographic data for stroke patients and controls. Values presented as 
mean (+/- 1 SD and range) or percent valid where appropriate. The remaining 41% of 
stroke patients unlisted for employment status were classified as not working. Sleep 
medication was taken by one control participant (Zipiclone taken irregularly) and one 
stroke patient (Melatonin taken every evening). For individual case information for 
all participants is provided in Appendix C. 
Demographical Variables Stroke Patients (n=61) Controls (n=61) 
Gender(M: F) 37 24 28 33 
Age (Years) 53 72 ± 12 63 (20-73) 52 13 ± 12 88 (24-72) 
BMI 24 59 !3 49 (18 20-38 30) 25 28 ±3 91 (18 00-36 90) 
NART (IQ) 115 89 ±6 94 (96-126) 
Mini Mental State Exam' 2896± 1 41 (23-30) - 
Education Level: 
School Leavers Certificate 
Further Study 
Higher Education 
Employment Status: 
Full Time 
Part Time 
Retired 
Studying 
Living Support: 
Living Alone 
Living With Family 
Chronicity (Months) 
Type of Stroke: t 
Ischemic 
Hemorrhagic 
Both 
Lesion Hemisphere 
Co-morbid Conditions: 
Psychological 
Muscular 
Neurological? 
Cardiac 
Cancer 
Diabetes 
Pain 
Dysphasia 
Medication: 
Anti-depressant 
Pain Relief 
Cardiac Control 
Anti-epileptic 
Sleep Hypnolics 
Alcohol (Units per week) 
Caffeine (Cups per day) 
Nicotine (Cigarettes Per Day) 
33 90% 27 08% 
38 98% 1458'. 
27 12°% 58 33% 
11 48% 
14 75% 
2951; b 
328% 
21 31% 
78 67% 
5974±5041 (11-252) rna 
61 76°6 wa 
2941% n! a 
882% n, /a 
30 Left 31 Right wa 
24 59% None 
491% None 
1475% None 
37 71% None 
3 27% None 
1 63% None 
163% None 
2295% None 
656% None 
164% None 
492% None 
11 48% None 
164% 1 64% 
7 89 ±9 65 (0-45) 5 83 ±6 86 (0-35) 
4.80±291 (0.12) 367±271 (0-10) 
1 11±399(0.20) 041 *168(0-10) 
(-) not required or recorded as part of this study. 
* 22.95% of the patients experienced expressive dysphasia therefore only completed the 3-step 
command on the MSE and were not included in the total mean score. These patients also did not 
complete the NART. 
t Value included only those patients who could report type of stroke. 
t Neurological conditions other than stroke. 
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There were no significant differences between the stroke patients and controls for any 
demographic variables presented in Table 3.2 apart from caffeine consumption where 
the stroke patients consumed significantly more per day compared to controls (Z= - 
2.08, p=0.0373). 
3.3.2 Sleep Behaviour Compared To Pre-Morbid Behaviour 
Acute Phase (>1 month Post Stroke) 
All patients were in hospital within the acute phase. During this time, 19% of patients 
recalled sleeping deeper compared to their pre-morbid habitual sleep behaviour. 41 % 
of patients reported disturbed sleep and 82% felt sleepy and/or fatigued. Of those who 
felt sleepy or fatigued, 70% regularly took daytime naps. Interestingly, 40.54% of 
patients felt that the hospital did not maintain a supportive environment for healthy 
sleep schedules as they were often disturbed by loud noises or awoken too early in 
the morning for rehabilitation or medication dosing during the night. Only 11% were 
prescribed sleep medication during this time despite the high levels of sleep 
disturbance. 
Chronic Phase (>1 Year Post Stroke) 
The majority of patients (85%) reported a persistent change in their nocturnal sleep 
behaviour after their stroke. Of these patients, 39% felt that this change had a 
negative impact upon their daily life. The reminder of these patients felt their sleep 
was deeper, longer and more regulated than prior to the stroke. 25% of patients 
habitually napped prior to the stroke whereas 61% now nap more frequently 
compared to before the stroke. Furthermore, 25% reported feeling persistently tired or 
fatigued. 
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3.3.3 Chronic Phase Nocturnal Sleep Questionnaires 
PSQI 
There were no significant difference between groups for GPSQI scores (Table 3.3). 
There was also little difference between the proportion of those classified as poor 
sleepers using the GPSQI cut off criteria (GPSQI>5) within the stroke group (32%) 
compared controls (38%). 
When examining PSQI individual items, significant differences emerged for several 
sleep parameters (Table 3.3). Stroke patients reported going to bed 24 minutes earlier, 
getting up 30 minutes later and spending approximately an hour longer in bed 
compared to controls. Stroke patients on average slept 36 minutes longer than 
controls although it took patients longer to fall asleep (9.28 minutes). Patient sleep 
efficiency was 3% lower for stroke patients compared to controls by near significant 
trend. Analysis of the component scores revealed a significant difference for 
Component Two (Sleep Latency) and Six (Sleep Medication). Regarding the 
component scores, stroke patients scored significantly higher for the sleep latency 
component whereas controls scored higher for sleep medication. 
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Table 3.3. PSQI parameters. Global score (GPSQI), sleep parameters and component 
scores for stroke patients (36 males, 24 female) and controls (28 male, 33 female). 
Mean (+/- 1 SD and range), Mann-Whitney U test statistic (Z) and significance value 
(p) is presented. 
PSQI Variables Stroke Patients (n=60) 
5.18 ± 3.45 (1-14) 
Controls (n=61) zp 
4.90± 3.54 (0-13) "0.51 030 GPSQI 
Habitual Sleep Parameters: 
Bed Time (24 Hour Clock) 
Get Up Time (24 Hour Clock) 
Time in Bed (mins) 
Sleep Duration (mins) 
Sleep Onset Latency (mins) 
Sleep Efficiency (%) 
Sleep Disturbancest 
PSQI Component Score: 
1 Sleep Quality 
2 Sleep Latency 
3 Sleep Duration 
4 Sleep Efficiency 
5 Sleep Disturbances 
6 Sleep Medication 
7 Daytime Dysfunction 
*Significant values 
22: 45 t 00: 57 (19: 30-02: 00) 
07: 36 t 01: 44 (03: 00-12: 50) 
541.50 t 82.81 (360-795) 
452.55 t 100.16 (180-750) 
22.62 ± 21.32 (1-90) 
83.76 t 14.77 (34.80-99.80) 
7.32 1 3.71 (0-15) 
0.70 t 0.74 (0-3) 
1.28 t 1.01 (0-3) 
0.58 t 0.87 (0-3) 
0.70: t 1.06 (0.3) 
1.20 t 0.51 (0-2) 
0.13 t 0.57 (0-3) 
0.63 t 0.74 (0-3) 
23: 09 t 00: 56 (22.00-02: 00) -2.05 0.0201* 
7: 06 t 00: 53 (05: 00-09: 00) -2.24 0.0127* 
480.00 t 54.87 (360-600) -4.39 0.0000* 
416.41 t 68.60 (190-570) -2.23 0.0123` 
13.34 t 12.56 (1-60) -2.08 0.0189* 
87.18 ± 12.01 (45.20-100) -1.34 0.09 
7.64 t 5.14 (0-25) -0.16 0.0470* 
0.82 t 0.67 (0-2) -1.22 0.11 
0.75 t 0.79 (0-3) -3.01 0.0013' 
0.61 t 0.78 (0-3) -0.48 0.32 
0.57 t 0.88 (0-3) -0.36 0.36 
1.28 ± 0.66 (0-3) -0.50 0.31 
0.25 t 0.62 (0-3) -1.62 0.0531* 
0.66: t 0.83 (0-3) -0.12 0.45 
The stroke group consisted of four cases (CPI to 4) who presented extreme scores on 
several parameters (Figure 3.2a to g). The greater spread of scores observed for bed 
time, get up time and time in bed for the stroke patients may reflect that the majority 
of the sample no longer worked therefore were not restricted to a sleep schedule 
(Figure 3.2a to c). CPI reported an extremely early bed time (19: 30), later getting up 
time (12: 30), longer sleep duration (750 minutes) and time in bed (800 minutes), 
however this patient did not report disturbed sleep (Figure 3.1 g). CP2 described an 
early get up time (3am), long sleep latency (71 minutes), very short sleep duration 
(180 minutes) and low sleep efficiency (42%), demonstrating severely poor sleep that 
was not receiving medical attention. Figure 3.2d also shows that the majority of sleep 
latency reports fall within the upper limits of box plot, i. e. more patients take longer 
to compared to controls. This effect is reflected in the significant difference observed 
for Component Two (Sleep Latency) on the PSQI between patients and controls. 
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Another two patients had severely low sleep efficiencies of 35% (CP3) and 47% 
(CP4; Figure 3.2f). Considering that healthy sleep efficiency should be at least 85% 
(Morin and Espie, 2003, p. 16) these patients are severely below a healthy level. One 
control case (C 1) had a severely low sleep efficiency (45%; Figure 3.20. 
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Figure 3.2. Box plots are displayed for PSQI habitual sleep items I to 4 for stroke 
patients and controls. Median values are demonstrated centrally in the box. The top 
and bottom values of the box represent the upper and lower interquartile range (H- 
spread) containing 50% of cases. The whiskers represent highest and lowest scores 
which lie within 1.5 times the H-spread. Values more than 1.5 times the H-spread are 
considered outliers, represented by circles. Extreme cases within the patient (CP) and 
control group (C) cases are labelled. 
S50 
The S50 scoring criteria for insomnia revealed increased presence of cases within the 
stroke group (13%) compared to controls (7%). Although the S50 detected more 
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cases of restless leg syndrome/periodic leg movement disorder in the stroke patients 
(10%) compared to controls (5%), the total score was significantly higher in control 
participants (Table 3.4). Furthermore, the control group had significantly higher 
scores for circadian rhythm disorder compared to stroke patients however no controls 
fit the criteria for this disorder. The control group also experienced significantly more 
symptoms of narcolepsy with 5% being classified as having the disorder compared to 
patients. Crucially, no control participants had been diagnosed with narcolepsy nor 
did they display any behavioural characteristics of the condition. Patients reported 
greater level of nightmares. Anecdotally, several patients reported recurring and vivid 
dreams regarding their physical disability which often awoken them during the night 
and was particularly distressing. This may reflect the high psychological impact of 
stroke. 
Table 3.4. S50 sleep disorder category scores for stroke patients (37 males, 24 
female) and (28 male, 33 female). Mean (+/- 1 SD and range), Mann-Whitney U test 
statistic (Z) between sleep disorder scores and significance value (p) are presented. 
The nightmare scoring system for the S50 only includes those who suffer nightmares, 
therefore is reported as a percentage. Presence of hypersomnia is scored as a `yes' or 
`no', therefore is also presented as a percentage. 
S50 Variables Stroke Patients %, Stroke Patients Controls (n=61) % Controls zp 
(n=61) With Disorder With Disorder 
Sleep Apnea 10.67 t 2.36 (8-18) 3.28% 10.66 12.34 (3-7) 0% -0.39 0.35 Insomnia 14.60t 5.27 (8-32) 13,11% 13.66: t 4.65 (8-26) 6.56% -0.95 0.17 
Affective Disorder 6.79 t 2.55 (4-13) 6.56% 6.44 t 2.01 (4-12) 3.28% -0.28 0.39 
Sleep State Misperception 19% - 8.2% -- 
Narcolepsy 5.33 t 1.02 (5-11) 0% 5.77 t 1.15 (3-9) 4.92% -3.25 0.0005' RLSIPLMD 4.72 t 1.53 (4.12) 9.84% 5.08 t 1.56 (4-11) 4.92% -2.01 0.0220' 
Circadian Rhythm Disorder 3.40 ± 0.82 (3-6) 0% 3.84 t 1.44 (3.9) 0% . 1.85 0.0321` 
Sleep Walking 3.09i 0.47 (3-6) 0% 3.11 t 0.78 (3.9) 1.64% -0.5 0.48 Nightmares 18.96% - 8.20% -- Hypersomnia 6.89% - 8.20% -- Influences 9.40 12 34 (6.19) - 9.26 t 1.91 (7.16) -004 0 49 
Impact 12.17 t 4.05 7-24 - 11.25 t 3.83 7.25 -1.41 0.08 
*Significant values 
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3.3.4 Dimensions of Daytime Functioning 
ESS 
In the stroke group, 28% had high levels of sleepiness as defined by ESS cut off 
criteria (>9). Marginally, more controls were classified as having high levels of 
sleepiness (31 %) compared to patients. Total EES scores for the stroke patients were 
no different from control participants which suggest that stroke patients and controls 
have similar levels of perceived overall daytime sleepiness. There were differences 
for individual item scores including the `sitting and reading' situation where controls 
felt they were more likely to doze off (Table 3.5). Furthermore, by non-significant 
trend, controls were more likely to fall asleep in a public place. 
Table 3.5. ESS item scores and total score for stroke patients (37 males, 24 female) 
and (28 male, 33 female). Mean (+/- 1 SD and range) Mann-Whitney U test statistic 
(Z) and significance value (p) are presented. 
ESS Variables 
ESS Total Score 
Sitting and Reading 
Watching TV 
Sitting inactive in a public place 
As a passenger in a carforan hourwithout a break 
Lying down to rest In the afternoon 
Sitting and talking to someone 
Sitting quietly after lunch without alcohol 
In a car, while stopped for a few minutes In traffic 
Stroke Patients (n=61) Controls (n=61) ZP 
6.20 t 4.28 (0-17) 6.62. t 4.45 (0-18) -0.48 0.32 
0.77 t 1.09 (0-3) 1.18 t 0.99 (0-3) -2.70 0.0034' 
1.21 ±1 13 (0-3) 1.34 t 1.08 (0-3) -0.76 0.22 
0.48 t 0.77 (0-3) 1.34 t 1.08 (0.3) -1.36 0.093 
0.90 ± 1.09 (0-3) 0 85 t 0.98 (0-3) -0.03 0.98 
1.72 ± 1.20 (0-3) 1,64: t 1.02 (0-3) -0.49 0.62 
0.11 t 0.37 (0-2) 0.08 t 0.28 (0-1) -0.34 0.37 
0.89 ± 1.03 (0-3) 0.77 t 0.88 (0-3) -0.37 0.36 
0.08 1 0.33 (0-2) 0.11 t 0.41 (0-2) -0.36 0.40 
*Significant values 
FSS 
There are two well used cut off criterion for classifying high levels of fatigue when 
using the FSS, either total FSS score (>35) or mean FSS (>4). According to total FSS 
score, 26% of the stroke patients reported high levels fatigue compared to 17% of 
controls, an increase of 9%. Mean score across items (>4) was similar, 25% of stroke 
patients were above the criteria compared to 16% of controls, a difference of 8%. 
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Only FSS mean score across items revealed a near significant difference between 
patients reported and controls (Table 3.6). Individual item analysis showed that 
patients reported significantly increased fatigue as a result of the following instances: 
`exercise increases fatigue', `fatigue prevents sustained physical functioning' and 
`interferes carrying out certain duties and responsibilities'. 
Table 3.6. FSS item scores and total score for stroke patients (36 males, 22 female) 
and (27 male, 31 female). Data presented as mean (+/- I SD and range), Mann- 
Whitney U test statistic (7) and significance value (p) are presented. 
FSS Variables 
FSS Total Score 
My motivation is lower when I am fatigued 
Exercise brings on my fatigue 
I am easily fatigued 
Fatigue Interferes with my physical functioning 
Fatigue causes frequent problems forme 
My fatigue prevents sustained physical 
Fatigue Interferes with carrying out certain 
Fatigue is among my three most disabling 
Fatigue interferes with my work, family or 
FSS Mean Across Items 
Stroke Patients (n=58) 
26.26 t 16.55 (3-63) 
4.23 t 2.24 (0-7) 
3.41 t 2.41 (0.7) 
2.59 t 2.36 (0-7) 
3.44 t 2.35 (0-7) 
1.78 2.13 (0-7) 
31912.45(0-7) 
3.05 2.35 (0-7) 
2.57±2.60(0-7) 
2.09. t 2.50 (0-7) 
2.98: k 1.84(0.33-7) 
Controls (n=58) ZP 
21.98t14.30(0-51) -1.24 0.11 
4.16 t 2.28 (0-7) -0.05 0.48 
2.62 t2 05(0-7) -1.65 0.0498' 
2.62 f 1.96 (0-7) -0.39 0.35 
2.93 t 2.08 (0-7) -1.09 0.14 
1.86 t 1.79 (0-6) -0.98 0.16 
2.19 t 2.01 (0-6) -2.02 0.0219' 
1.91 * 1.80 (0-5) -0.25 0.0081' 
1.78 f2 09 (0-6) -1.27 0.10 
1.84 3 1.91 (0-5) -0.18 0.43 
2.43 ± 1.59 (0-5.67) -1.29 0.099 
*Significant values (trends in bold). 
3.3.5 Comparison With Published Data 
The following analysis was carried out in order to compare results of the current 
study with results reported in other studies using the following samples: 1) stroke 
patients of varying chronicities beyond 12 months (Bassetti & Valko, 2006; Choi- 
Kwon et al., 2005; Masel et at., 2001; Motohashi et al., 1999; Naess et al., 2005; Park 
et al., 2009; Schepers et al., 2006; Siengsukon & Boyd, 2009a; Valko et al., 2008; 
Vock et at., 2002), 2) healthy samples, classified as good sleepers (Buysee et at., 
1989; Monk et at., 2000), 3) generally healthy samples (Johns, 1991; Siengsukon & 
Boyd, 2009a; Ziino & Ponsford, 2005), 4) community samples which may contain 
less healthy persons (Magee et at., 2008) and 5) large samples derived from the 
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general population (Anderson & Horne, 2008; Groeger et al., 2004; Lichstein et al., 
2004; Valko et al., 2008). Figures 3.2 to 3.5 present comparisons of mean GPSQI 
scores, time in bed, sleep duration, sleep onset latency, sleep efficiency, ESS and FSS 
scores with other published data. Effect sizes (Cohen's d) were calculated to 
determine the magnitude of difference between the current study and that of other 
studies. At present, there is currently no known published subjective sleep onset 
latency or sleep efficiency data in chronic stroke cohorts. Furthermore, the FIRST 
and S50 has not yet been used in stroke cohorts. Therefore these parameters were 
omitted from the following analyses. In instances where studies did not report the 
standard deviation, effect sizes could not be calculated. 
GPSQI Comparisons (Figure 3.3) 
There were no significant effect sizes between stroke patients of the current study in 
comparison with controls (d=0.08) and the community sample (d=0.07) as provided 
by Magee et al. (2008). When GPSQI scores of the current study were compared to 
healthy controls who were classified as good sleepers (Buysee et at., 1989), a 
significant effect size was observed (d=0.86). These results showed that stroke 
patients drawn from the current study experienced significantly more sleep problems 
compared to a healthy sample who were also healthy sleepers. However, in 
comparison to control samples who were not subjected to sleep complaints as an 
exclusion criteria, stroke patients have similar GPSQI scores. 
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GPSQI Scores Derived From The Current Study, Other Chronic 
Stroke Samples and Mixed Control Groups 
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Figure 3.3. Bar charts to display mean (+1 SD where available) GPSQI scores 
between studies. The dashed line indicates the cut off criteria for poor sleep (>5). 
Comparison of Habitual Sleep Parameters Derived From The PSQI (Figure 3.4) 
For comparisons involving time in bed, effect size could only calculated between 
stroke patients and controls of the current study. A large effect size (d=0.88) was 
observed. Upon further inspection of Figure 3.3a, it is clear that stroke patients, from 
the current study and those patients from Motohashi et al. (1999), spend longer in bed 
compared to other non-brain injured controls (Groeger et al., 2004). A medium effect 
size was found for sleep duration between stroke patients and controls of the current 
study (d=0.43). A small effect (d=0.33) was found between stroke patients of the 
current study and the general population (Groeger et al., 2000). According to Figure 
r 
_l_ 
r -T 
3.4b, stroke patients appeared to sleep marginally longer than non-brain injured 
persons. Figures 3.4c and 3.4d clearly indicated that stroke patients have longer sleep 
onset latency and lower sleep efficiency compared to all control groups, indicative of 
poorer quality sleep in patients. 
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Sleep Parameters From the Current Study (Extracted From PS01 Items) and Subjective 
Reports From Other Chronic Stroke Cohorts and Mixed Controls 
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Figure 3.4. Bar charts to display mean (+1 SD where available) time in bed and sleep 
duration between studies. 
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ESS Comparisons (Figure 3.5) 
The ESS scores derived from patients of the current study were similar, even 
compared to those patients diagnosed hypersomnia (Bassetti and Valko, 2006). The 
scores drawn from Vock et al. 's (2002) study could not be statistically compared to 
this study however, mean ESS scores differed by approximately 2 points on the scale 
which suggested the scores of this study are reasonably increased. A medium effect 
(d=0.50) was observed between the stroke patients of the current study and the 
community controls, where the controls appeared to have greater sleepiness than 
stroke patients. Interestingly, the non-brain injury community sample (Buysse et al. 
2008) had the highest ESS scores compared to all other groups. 
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Figure 3.5. Bar charts to display mean (+1 SD) ESS between studies. The dashed line 
indicates the cut of criteria (>9). 
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FSS Comparison (Figure 3.6) 
The majority of studies examining chronic stroke use the mean FSS score across 
items rather than mean total score, therefore the effect size calculations utilised the 
former method of scoring the FSS. FSS scores for controls are lower than those 
individual stroke groups, apart from Choi-Kwon (2005). Figure 3.6 shows that those 
stroke patients with the shortest chronicity (12 months) has the highest levels of 
fatigue (Schepers et al., 2006). This difference is further reflected in the very large 
effect size (d=1.18) found between these patients and those involved in the current 
study. Medium effects (d=0.69) were found between stroke patients of the current 
study and the stroke cohort with a longer chronicity of 72 months (Naess et al. 
(2005). The FSS scores of the Naess et al. (2005) study might be higher due to the 
less stringent sampling criteria. A medium effect (d0.50) was also found between 
stroke patients of the current study and those patients at 14.4 months chronicity 
(Valko et al., 2008). A small effect (d=0.37) was found between the stroke patients of 
the current study and those at 32.7 months chronicity (Park et al., 2009). These results 
suggest that fatigue levels may change over the course of stroke, however those at 
only 15 months chronicity (Choi-Kwon et al., 2005) had a lower FSS. There was a 
small effect between the stroke patients and controls derived from the current study 
(d=0.32). A small effect (d0.24) between stroke patients of the current study and 
controls reported in Zino and Ponsford (2005) was observed. 
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FSS Score Derived From the Current Study, Other Chronic 
Stroke Samples and Mixed Control Groups 
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Figure 3.6. Bar charts to display mean (+1 SD) FSS between studies. The dashed line 
indicates the cut of criteria (>4). 
3.3.6 Interaction Between Nocturnal Sleep and Daytime Functioning 
The degree to which nocturnal sleep (GPSQI) and daytime functioning (ESS and 
FSS) were associated was examined via correlation analyses. For the stroke group, 
GPSQI scores were not associated with ESS scores (r=0.10, p=0.45). Increasing 
GPSQI scores were weakly associated with higher FSS total scores (rr0.24, p0.0548) 
in stroke patients. For controls, increased GPSQI scores correlated with increased 
FSS (r=0.31, p=0.0185) but were not related to ESS score (r=0.19, p=0.14). ESS and 
FSS scores correlated (r=0.28, p=0.0358) within the stroke group however this effect 
was not observed within the control group (r=0.16, p=0.25). 
3.3.7 Psychological Disturbance, Perceived Health and Sleep 
The relationship between sleep and levels of psychological disturbance was examined 
in both stroke and control groups. The FIRST questionnaire allowed classification of 
those more vulnerable to sleep disturbance as a result of psychological stress. As only 
those patients who completed the baseline motor testing (TI) were administered the 
HADS and SF-36. Fifty-five stroke patients and 55 controls were included in 
analyses involving the HADS. Fifty-five patients completed the SF-36 whereas 
controls did not. A regression models were developed in accordance with the 
observed relationships between questionnaires to determine parameters predictive of 
a) poor sleep (GPSQI), b) sleepiness (ESS) and c) fatigue (FSS). The degree to which 
psychological disturbance, perceived health and sleep behaviour parameters interact 
was also examined in stroke patient only. A second regression model was employed 
to determine the influence sleep, daytime functioning, and psychological adjustment 
on perceived health in stroke patients only. 
Psychological Disturbance (HADS) and Sleep 
Mean anxiety was significantly increased (Z =- 4.25, p=0.0000) for the stroke group 
(5.40, SD 3.45) compared to the control group 2.60 (SD 2.23). Mean depression was 
not significantly different between stroke (5.70, SD 3.18,1-16) and controls (5.40; 
SD, 3.28; Z=-0.56, p=0.57). No participants within the control group scored above the 
criteria for anxiety where as 10% of patient were above this threshold. Even though 
uncontrolled depression was part of the exclusion criteria for this study, 12% of the 
stroke sample were above the criteria for presence of depression. 9.09% of controls 
were also above the threshold for depression. 
The median of FIRST scores was used as cut off criterion determine those more 
likely have their sleep affected by stress relative to the group in question (Drake et at., 
2004). As the median score for both stroke patients and controls was 18, scores above 
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this value were used as a cut off in each group. 58.18% of stroke patients were above 
the median compared to 49.09% of controls. Although this suggests that more 
patients reported that their sleep is affected by stress compared to controls, this was 
not reflected in item scores or total score of the FIRST (Table 3.7). Patient anxiety 
was associated with FIRST scores (rr0.35, p=0.0169) which is also indicative of 
psychological vulnerability to sleep problems. Also, higher levels of depression were 
associated with the FIRST (r=0.30, p=0.0254) in patients. 
Table 3.7. FIRST item data for stroke patients (37 males, 24 female) and (26 male, 29 
female). Mean (+/- 1 SD and range), Mann-Whitney U test statistic (Z) and 
significance value (p) is presented. Trends indicated in bold. 
FIRST Variables 
Before an important meeting the next day 
After a stressful experience during the day 
After a stressful experience in the evening 
After getting bad news during the day 
After watching a frightening movie or TV show 
After having a bad day at work 
After an argument 
Before having to speak in public 
Before going on vacation the next day 
FIRST Total Score 
Stroke Patients (n=56) 
2.1511.16(1-4) 
2.071 1.09 (1-4) 
2.161 1.13 (1-4) 
2.53 t 1.14 (1-4) 
1.361 0.82 (1-4) 
1.931 0.98 (1-4) 
2.27 (1-4) 
2.351 1.27 (1-4) 
2.001 1.09 (1-4) 
18.44 16.99 (9-36) 
Controls (n=55) Zp 
2.07 0.96 (1-4) -0.03 0.49 
2.07 ± 9,2 (1-4) -0.29 0.39 
2.27: t 0.91 (1-4) -0.82 0.21 
2.32± 1.00 (1-4) -0.96 0.17 
1.44: t 0.81 (1-4) -0.80 0.21 
1.63 ± 0.73 (1-4) -1.41 0.08 
2.21 * 0.96 (1-4) -0.14 0.45 
2.30± 1.17 (1-4) -0.08 0.47 
2.05± 1.03 (1-4) -0.41 0.34 
18.34 ± 6.23 (9-33) -0.01 0.50 
Predictors of Poor Sleep, Sleepiness and Fatigue (Stroke Patients and Controls) 
Three multiple regression models were devised to assess to what degree having a 
stroke and the associated psychological disturbance contributed to the existence of a 
sleep or daytime functioning problem. Each of the three models had a separate 
dependent variable Table 3.8: a) GPSQI, b) ESS and c) FSS. Predictor variables 
included age, group (stroke or control), depression (HADS) and anxiety (HADS). 
Due to the relationship between nocturnal sleep and daytime functioning, the GPSQI 
was included as a predictor variable in model b) and c). Although there are well 
known links between caffeine, alcohol and nicotine affects upon day time functioning 
(Roehers and Roth, 2008; Roehers and Roth, 2001), there was no correlation between 
these life style drugs with GPSQI, ESS or FSS. Furthermore, there were no gender 
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differences in sleep or psychological disturbance in both stroke and controls. 
Therefore these parameters were not included in the model. 
Table 3.8. Three regression models are presented: a) sleep quality (GPSQI) as the 
dependent variable (DV), b) sleepiness (ESS) as the DV and c) fatigue (FSS) as the 
DV. The correlations between the variables, the unstandardised regression 
coefficients (B) with +/-1 SE, and intercept, the standardised regression coefficients 
(B), R and R2. Trends are indicated in bold. Note that group is categorical (1=stroke, 
2=control). Where the p value is not reported, the degree of significant is indicated 
(*p>0.05 **p>_0.01 ***p>0.001). 
a) 
Variables GPSQI (DV) Age Group Depression Anxiety B 
Age -0.02 -0.04 0.09 -0.05 -0.00 -0.01 0.89 
Group -0.04 -0.06 - -0.43'"" -0.05 0.36 0.05 0.58 
Depression 0.34" 0.09 -0.43""" - 0.47"' 0.20 0.18 0.12 
Anxiety 0.46""" -0.05 -0.05 0.47"" - 0.41 0.38 0.0004'"" Intercept=l. 6 
Mean 5.04 52.93 1.50 3.98 5.54 R2=0.23 
SD 3.49 12.72 0.50 3.17 3.22 R=0.48" 
b) 
Variables ESS (DV) Age Group Depression Anxiety GPSQI Bp 
Age 0.19' - -0.06 0.09 -0.05 -0.02 0.06 0.19 0.0572 
Group 0.05 -0.06 - -0.43' -0.05 -0.04 1.36 0.16 0.15 
Depression 0.19* 0.09 -0.43""' - 0.47'"' 0.34" 0.35 0.25 0.0447 
Anxiety 0.06 -0.05 -0.05 0.47"' - 0.46""' -0.14 -0.10 
0.39 
GPSQI 0.12 -0.09 -0.04 0.34'" 0.46"" - 0.11 0.09 0.41 Intercept=-0.31 
Mean 6.41 52.93 1.50 3.98 5.54 5.04 R2=0.10 
SD 4.35 12.72 0.50 3.17 3.22 3.49 R=0.32 
c) 
Variables FSS (DV) Age Group Depression Anxiety GPSQI Bp 
Age 0.08 - -0.06 0.09 -0.05 -0.02 0.06 0.19 0.0572 
Group -0.14 -0.06 - -0.43"" -0.06 -0.04 1.36 0.16 0.15 
Depression 0.46"" 0.09 -0.43"" - 0.47"" 0.34"" 0.35 0.25 0.0447 
Anxiety 0.20' -0.05 -0.05 0.47'" - 0.46"' -0.14 -0.10 0.39 
GPSQI 0.30" -0.09 -0.04 0.34" 0.46""' - 0.11 0.09 0.41 
Intercept=7.74 
Mean 24.12 52.93 1.50 3.98 5.54 5.04 R2=0.25 
SD 15.55 12.72 0.50 3.17 3.22 3.49 R=0.50"" 
For sleep quality, as indicated by the GPSQI (Table 3.8a), the R for regression was 
significantly different from zero, F(4,100) = 7.53, p=0.0000). In this model, only 
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anxiety significantly contributed to the prediction of GPSQI scores. Semipartial 
correlation analyses revealed that anxiety contributed 10% to the model (sr2=0.10). 
Table 3.8b presents the regression model with sleepiness (ESS) as the DV. R for 
regression was different from zero by near-significant trend, F(5,99) = 2.10, 
p=0.0716). Only depression significantly contributed to prediction of ESS scores, 
depression, however only contributed 4% (sr2= 0.04) to the variance. Table 3.8c 
presents the regression model for fatigue (FSS) as the DV. R for regression within the 
fatigue model was significantly different from zero, F(5,97) = 6.36, p=0.0000. 
Depression significantly contributed 13% of the variance (sr`=0.13). 
Perceived Health (Stroke Patients Only) 
Overall perceived health on the SF-36 was 65.40 (SD 15.72) which is suggestive of 
above average health, although scores ranged from 30 to 91.09. Twenty four percent 
in patients reported below average health. Within the overall health dimension, mean 
mental health was 60.30 (SD 16.03) with 26% of scores falling below average. Mean 
physical health was 69.19 (SD 17.00) with 16% of scores below average. This 
indicates that despite the physical disability sustained during chronic stroke, mental 
health is rated more poorly than physical health. 
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PSOI 
SF-36 Scores For Stroke Patients With or Without Sleep Disturbance, 
Fatigue and Sleepiness 
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Figure 3.7. Bar charts to display mean (+ I SD) overall health, mental and physical 
health dimensions on the SF-36 for the following groups of patients: a) those with 
(GPSQI >5) and without sleep disturbances (GPSQI <5), b) those with high (total 
FSS >35) and low (total FSS <35) levels of fatigue and c) those with (>9) and without 
excessive sleepiness (<9). Significant differences are indicated (*p>0.05, 
***p>0.001). 
Figure 3.7a clearly demonstrates that those with greater sleep disturbance have poorer 
mental (Z=-3.28, p=0.0011), physical (Z=-3.43, p=0.0006) and overall health (Z=- 
3.21, p=0.0013) compared to those patients without these problems. Furthermore, 
those with greater fatigue (Figure 3.7b) had poorer mental (Z=-3.72, p=0.0002), 
physical (Z=-3.21, p=0.0013) and overall health (Z=-3.27, p=0.0011). Those with 
excessive sleepiness (Figure 3.7c) did not demonstrate significantly poorer mental 
(Z=-1.57, p=0.12), physical (Z=-1.17.43, p=0.24) or overall health (Z=3.21, 
p=0.0013). 
Table 3.9 presents the regression model of contributing factors, including age, 
depression (HADS), anxiety (HADS), GPSQI, ESS and FSS, to overall perceived 
health as reported on the SF-36. R for regression was significantly different from 
zero, F(6,41) = 15.56, p=0.0000). Three IVs contributed significantly to prediction of 
SF-36 scores, depression (sr2= 0.19), anxiety (sr2= 0.03) and fatigue (sr2= 0.03) 
contributing 19% and both 3% respectively. 
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Table 3.9. Standard multiple regression of contributing factors to overall perceived 
health as the dependent variable (SF-36) in stroke patients. The correlations between 
the variables, the unstandardised regression coefficients (B) with +/-1 SE, and 
intercept, the standardised regression coefficients (f3), the semipartial correlations 
(sr2), R and R2. Where the p value is not reported, the degree of significant is 
indicated (*p>0.05 **p>0.01 ***p>0.001). 
Variables SF-36 (DV) Age Depression Anxiety GPSQI ESS FSS B (SE) ßp 
Age -0.03 - -0.00 -0.23* -0.15 0.13 -0.12 -0.12 -0.09 0.30 
Depression -0.80*** -0.00 0.49*** 0.40** 0.19 -0.48** -2.68 -0.60 0.0000"' 
Anxiety -0.53*** -0.23* 0.49*** - 0.56** 0.01 -0.20 -1.15 -0.23 0.0400* 
GPSQI -0.38'* -0.15 0.40** 0.56'** - 0.06 0.25* 0.10 0.02 0.83 
ESS -0.21 -0.13 0.19 0.01 0.06 - 0.28* -0,10 -0.03 0.77 FSS -0.52*** 0.12 0.48** 0.20 0.25* 0.28* - -0.19 -0.20 0.0545 
Mean 
SD 
65.40 53.72 5.40 5.70 5.18 6.20 R2=0.70 
15.72 12.63 3.45 3.18 3.45 4.28 R=0.83"` 
Intercept=97.90 
3.4 Discussion 
3.4.1 Overall Findings 
The present study aimed to characterise sleep and daytime functioning behaviour in a 
group of chronic stroke patients with residual motor deficits. This was addressed by 
employing a battery of subjective assessments and comparing the results with those 
of healthy controls. The findings revealed that sleep and daytime functioning is 
disrupted in some patients after stroke and that control group selection is critical for 
determining prevalence of sleep problems in stroke patient groups. It was also found 
that psychological functioning has a strong influence upon sleep and daytime 
functioning in both stroke patients and controls. Furthermore, poorer sleep and 
daytime functioning was related to perception of poorer overall perceived health. 
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Perceived Sleep After Stroke 
The in house questionnaire showed that 41% of patients felt their sleep was generally 
disturbed one month after stroke compared to pre morbid sleep behaviour. 
Furthermore, post morbid sleep disturbance evolved into a chronic problem in 39% of 
patients. These results confirm previous findings where subjectively poorer sleep, as 
reported using a range of questionnaires, occurred in 34 to 67% of patients beyond 
one year (Campos et al., 2005; Masel et al., 2001; Schuiling et al., 2005; Sterr et al., 
2008). Critically, no patients for this study were receiving medical attention with 
regard to their sleep. The individual case who reported taking melatonin (a hormone 
that perpetuates sleep), did so under their own prerogative rather then that of a 
clinician. 
Stroke patients reported similar levels of sleep quality compared to controls according 
to the GPSQI scores. According to the GPSQI index, approximately a third of both 
stroke patients and controls were classified as poor sleepers. This result is 
considerably lower than the number of patients classified as poorer sleepers (67%) 
reported in Campos et al. (2005) using the same criteria. One explanation for this 
difference may be that the sample recruited for Campos et al. (2005) were not 
subjected the strict levels of exclusion criteria as employed in the current study. 
Therefore comorbidities and confounds of stroke recovery may be reflected in the 
increased sleep disturbance. PSQI results of this study were comparable with those 
findings reported by Masel et al. (2001) who found in a mixed group of stroke and 
TBI patients that 32% scored above PSQI cut off criterion. Effect size calculations 
however, revealed a significant difference in GPSQI scores between patients from 
this study and healthy controls from Buysee et al. (1989). It is important to note that 
the controls employed un Buysee et al. 's (1989) study were positively selected based 
on the absence of sleep problems. No differences were observed between stroke 
patients from this study and control samples drawn from the general population. 
Closer examination of PSQI factual sleep items that patients spent considerably 
longer in bed, had longer sleep duration, less sleep disturbance and longer sleep onset 
latency compared to controls. A similar pattern was observed when comparing stroke 
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patients data of the current study with other control groups ranging from healthy 
cohort to general population samples (Anderson & Horne, 2008; Groeger et al., 2004; 
Lichstein et al., 2004; Monk et al., 2000). 
According to S50 scoring criteria for insomnia, 13.11% of patients were likely 
insomnia cases compared to only 6.56% of controls. However this result is 
considerably lower than prevalence rates of insomnia in patients was 48% 
(Leppävuori et at., 2002). This discrepancy may have occurred due to the detailed 
clinical assessment based on DSM-IV criteria of insomnia employed by the 
Leppävuori et al. (2002) study. The S50 also revealed increased presence of the 
following sleep disorders within the control group in comparison to patients: 
narcolepsy, restless leg/periodic limb movement and circadian rhythm disorder. 
However no control participant had been diagnosed with such conditions and did not 
display behavioural characteristics of narcolepsy. These findings may have arisen due 
to different administration procedures for patients and controls. The control 
participants completed the questionnaires independently whereas the questionnaires 
were administered by a researcher for the stroke patients where there was greater 
opportunity for clarification of S50 items. 
Perceived Daytime Functioning After Stroke 
According to the in house questionnaire, 81% of patients reported high sleepiness and 
fatigue within the first month of stroke compared to before the stroke. This was 
further demonstrated by frequent napping behaviour. Poor daytime functioning was 
less prevalent one year after stroke (25%). Similar findings have also been reported in 
other studies where the prevalence of a general daytime dysfunction ranged from 17- 
34% in chronic patients (Campos et al., 2005; Masel et al., 2001; Schuiling et at., 
2005; Worthington & Melia, 2006). 
To further explore dimensions of daytime functioning, the ESS and FSS was applied 
to address sleepiness and fatigue independently. Twenty-eight percent of patients 
were excessively sleepy according to ESS criteria. Patient scores were slightly 
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increased compared to those reported in Masel et al. 's (2001) study (20.7%). Mean 
ESS score was comparable with chronic stroke patients in other studies (Bassetti and 
Valko, 2006), however was considerably higher than those patients reported in Vock 
et al. (2002). Patients' sleepiness levels were similar compared to that of controls 
employed in this study. Thirty-one percent of controls were excessively sleepy 
however this is considerably higher than that reported in the general population 
(19.55%; Anderson and Horne, 2008). Effect size calculations revealed that mean 
patient ESS scores in this study were similar to healthy controls (Johns, 1991), and in 
fact less, than those in community sample reported in (Buysee et al., 2008). Although 
patients did not report more sleepiness than controls, this finding is in contrast to 
previous literature which suggests that sleepiness is more prevalent after stroke based 
on clinical observation and objective assessments (Bassetti et al., 1996; Bassetti & 
Valko, 2006; Masel et al., 2001). 
Interestingly, half of the patient group regularly napped during the day despite just 
over a quarter reporting excessive sleepiness. Increased napping has also been 
observed in other chronic stroke patients in comparison to controls (Campos et al., 
2005; Muller et al., 2006). It is difficult to determine within this study the extent to 
which increased napping is due to the increased opportunity for a non-working 
population or the possibility that patients underestimate their sleepiness. One way of 
addressing this issue is to employ an objective measure of sleepiness. Masel et al. 
(2001) compared objective sleepiness (Multiple Sleep Latency Test; MSLT; See 
Section 1.2.3, Chapter 1) with the ESS. It was concluded that brain injured patients 
do not perceive their own sleepiness as there was a dissociation between MSLT 
results and the ESS. Other authors have also commented on the risk of under 
reporting of sleepiness in brain injured patients (Bassetti et al., 1996; Bassetti & 
Valko, 2006; Castriotta et al., 2007; Makley et al., 2008; Parcell et al., 2006). 
This study found that almost a quarter of stroke patients demonstrated high levels of 
fatigue compared to 16.39% of controls. The prevalence of fatigue in chronic stroke 
patients ranges from 30-69.5% (Choi-Kwon et al., 2005; Ingles et al., 1999; Park et 
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al., 2009; Schepers et al., 2006; Valko et at., 2008; van der Werf et al., 2001). 
Therefore, the results of this study are slightly under this range. This may be due to 
the positive selection criteria employed by the current study. Effect size calculations 
revealed significant differences between FSS scores of patients in this study and those 
of other chronic stroke samples. The high variance between scores may represent 
differences in sampling or chronicity as fatigue may evolve after stroke (Schepers et 
at., 2006; Valko et at., 2008). Schepers et al. (2006) postulated that the impact of 
fatigue becomes more relevant when stroke victims attempt to resume a normal 
lifestyle including work and social activities therefore fatigue may be increasingly 
noticeable during this time. This then suggests that patients would have higher FSS 
scores. 
A dissociation between GPSQI scores and sleepiness ratings on the ESS was 
observed as these measures did not correlate in both patients and controls. 
Furthermore, only mild associations were found between GPSQI and fatigue in both 
groups. The model of normal sleep assumes that poorer quality sleep results in 
decrements of daytime functioning in laboratory investigations (Akerstedt, Torsvall, 
& Gillberg, 1987; Franzen, Siegle et al., 2008; Marzano et al., 2007; Philip et al., 
2005; Torsvall & Akerstedt, 1987,1988; Wilhelm, Widmann, Durst, Heine, & Otto, 
2009) and in naturalistic settings (Martikainen, Hasan, Urponen, Vuori, & Partinen, 
1992; Pilcher & Huffcutt, 1996). However, subjective reports do not always follow 
this pattern, observed in non-brain injured controls (Anderson & Horne, 2008; 
Anderson et al., 2009; Buysse et al., 2008) and chronic stroke samples (Park et al., 
2009; Masel et al., 2001). Perception of sleep and daytime functioning can be 
affected by a multitude factors, including laboratory conditions and type of 
assessment (Akerstedt, Kecklund, & Axelsson, 2008; Balkin, Rupp, Picchioni, & 
Wesensten, 2008; Kosuke Kaida et al., 2007), psychological state (Anderson et al,, 
2009; Urponen, Vuori, Hasan, & Partinen, 1988), presence of a sleep disorder 
(Edinger et al., 2008) and general health status (Briones et al., 1996; Elsenbruch, 
Harnish, & Orr, 1999). Therefore increased sleepiness and fatigue is not necessarily 
due to poor sleep at night. 
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The Influence of Control Group Selection 
One of the striking findings of this study is the apparent similarity of sleep in patients 
and matched controls. As these results contradict previous literature, a secondary 
analysis was conducted to eliminate the potential influence of the chosen control 
group by examining varying types of control samples. Strong differences in GPSQI 
scores were observed when comparing stroke patient data with that of a strictly 
healthy control samples with no sleep disorders (Buysee et al., 1989). Crucially, no 
differences were found when comparing subjective data of stroke patients to controls 
drawn from general populations or community samples. This highlights the large 
impact that control sample selection can have upon the interpretation of results. 
Therefore control samples should be chosen carefully and interpreted appropriately 
Control sampling had less influence over daytime functioning differences.. Subjective 
fatigue was reported as generally higher than controls in other published studies. In 
contrast, sleepiness was generally comparable or lower than published controls. 
Overall, the results suggest that sleep problems in chronic stroke are at least as 
prevalent as found in the general population. However, the impact of poor sleep is 
likely to be more severe in patients in comparison to a healthy person. 
The Role of Psychological Disturbance For Sleep and Daytime Functioning 
The results clearly show that greater psychological disturbance (HADS anxiety and 
depression) is largely associated with poorer nocturnal sleep, including longer sleep 
latency, shorter sleep duration, reduced sleep efficiency and increased GPSQI in 
patients and controls. For daytime functioning parameters, depression was associated 
with greater fatigue in stroke patients which is in line with previous literature 
(Astrom et al., 1993a; Choi-Kwon et al., 2005; Ingles et al., 1999; Naess et al., 2005; 
Staub & Bogousslavsky, 2001). Furthermore, according to the FIRST, stroke patients 
were more vulnerable to sleeping problems as a result of stress compared to controls. 
Results of the regression models further showed that anxiety had the greatest impact 
upon GPSQI scores, independent of a stroke event. Increased depression was 
associated with both daytime functioning variables, ESS and FSS, over all other 
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predictors in the model, including having a stroke. Overall, these findings suggest 
that psychological functioning has greater influence on sleep and daytime functioning 
than stroke per se. 
The Impact of Sleep and Daytime Functioning Behaviour Upon Perceived Health 
Poor sleep and increased fatigue levels were significantly associated with poorer 
perceived health as reported on the SF-36, including mental and physical health 
dimensions. Regression analyses revealed that fatigue and psychological disturbance 
(HADS) explained the majority of the variance in perceived health, rather than 
nocturnal sleep problems. Schuiling et al. (2005) reported that sleep disturbance 
contributed to poorer health in stroke patients, however sleep disturbance and 
excessive sleepiness was characterized as a single variable. The present study 
confirms the findings of other studies which have shown fatigue is related to poorer 
quality of life after stroke (de Groot, Phillips, & Eskes, 2003). 
3.4.2 Further Theoretical Considerations 
The regression models did not fully account for the existence of sleep problems and 
daytime functioning difficulties. The literature suggests that the development of post 
stroke sleep and daytime functioning problems are likely to stem from a complex 
myriad of factors, including the direct impact of brain damage and age, as well as, the 
physical consequences, life style alterations of stroke recovery and personality factors 
which this study did not directly address. 
Recovery Factors 
The influence of brain damage per se may have differential effects upon the sleep 
regulation (Evans, 2002) and arousal centres of the brain (Bassetti & Valko, 2006; 
Cantor et al., 2008). For example, thalamic strokes are largely associated with 
excessive daytime sleepiness (Bassetti et al., 1996). Therefore varying lesion sites 
between patients may differentially influence subjective reports of sleep behaviour. 
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The physical consequences of stroke further compromise sleep (Bassetti, 2005a). The 
mobility restrictions imposed upon stroke patients suffering from hemiparesis may 
impact sleep in terms of comfort and ease of returning to bed after toileting. Post 
brain injury pain, such as neuropathic, headaches, nerve, musculoskeletal and joint 
pain (Gamble et al., 2000; Kong et al., 2004; Langhorne et al., 2000; Widar et al., 
2004), and has also been attributed to frequent sleep disturbance (Fictenberg et al., 
2001; Widar et al., 2004). Furthermore, this relationship may be reciprocal as the 
presence of sleep disturbances may to exacerbate acute and chronic pain 
(Lautenbacher et al., 2006). 
Pharmacological Agents 
Recovering patients are typically prescribed medications to control post stroke 
complications of stroke such as hypertension, pain and seizures. These medications 
may manifest sedating or hypnotic side effects that impact daytime functioning and 
also affect brain activity (Bourne & Mills, 2004; Lowson & Sawh, 1999; Novak & 
Shapiro, 1997; Obermeyer & Benca, 1996). Furthermore, antidepressants are 
commonly prescribed to stroke patients (Paolucci, 2008; Whyte & Mulsant, 2002) 
and are known to alter sleep architecture and reduce sleep efficiency (Holshoe, 2009; 
Mayers & Baldwin, 2005). 
Both patients and controls regularly consumed caffeine and alcohol which may have 
impinged on sleep and daytime functioning levels. Increased amounts of caffeine 
have known affects upon sleep including delayed sleep onset latency, reduced sleep 
length and increase amounts of stage I sleep (Roehrs & Roth, 2008). Furthermore, 
increased alcohol consumption shortens sleep latency, and has profound effects upon 
sleep continuity and architecture (Roehrs & Roth, 2001). For the current study, no 
relationships were found between any of the above lifestyle drugs and subjective 
sleep. However stroke patients consumed significantly more caffeine in compared to 
controls which may reflect increased tiredness. 
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3.4.3 Implications of The Findings 
Service Improvement 
Approximately 40% of patients felt that healthy sleep was not a priority during 
hospital stay. Patients commented on the poor sleeping environments and lack of 
specific sleep treatment. In addition, the results highlighted several severely poor 
sleepers in the stroke group, exhibiting likely clinical sleep disorders. Alarmingly, 
these patients were not receiving medical attention regarding their sleep problems. 
Untreated sleep disorders are associated with poorer vocational outcome, increased 
behavioural and cognitive problems, and greater psychological disturbance in brain 
injured patients (Burke, Shah, Schneider, Ahangar, & Aladai, 2004). Therefore sleep 
is vital to address in addition to other post stroke complications. The present study 
highlights a lack of service/neglect of major health problems in stroke. 
As psychological adjustment was largely associated with sleep and daytime 
functioning disturbances, addressing underlying psychological distress may alleviate 
sleeping difficulties and improve sleepiness and fatigue levels. Bowen, Knapp, 
Hoffman, & Lowe (2005) reported the results of a large scale audit of UK stroke 
services and only 50% of services were adequately addressing psychological health. 
The results of this chapter further highlight the need to increase access to 
psychological therapies for stroke patients as well as managing sleep. Moreover, 
improving sleep wake cycles is a possible non-pharmacological option for those with 
post stroke depression (Khan, Leung, & Jay, 2008). Furthermore, early recognition of 
sleep problems may actually act as a buffer for developing psychological illness 
(Steptoe et al., 2008). 
Increase Clinical Knowledge 
The results of this study contribute important information to clinicians by enhancing 
knowledge of post stroke sleep behaviour. At present, sleep disorders and the 
importance of healthy sleep are poorly covered in medical education (Stores, 2007) 
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and, as the results of this study suggest, are entirely lacking in stroke medicine. Post 
brain injury sleep disorders often remain unrecognised by medical staff (Richard J. 
Castriotta & Lai, 2001; Wessendorf et al., 2000), who have been known to 
overestimate the amount of sleep patients achieve (Aurell & Elmqvist, 1985). 
Improvements in post brain injury education for medical staff and the patients 
themselves is urgently required. Critically, clinicians should also promote the role of 
healthy sleep to patients and their carers (Parcell et al., 2006). In particular, patients 
should be warned of the difficulties associated with sleepiness and fatigue which 
negatively impact activities of daily living (Schepers et al., 2006) and impose safety 
risks including falls and driving (Lundqvist et al., 2008; Michael et al., 2006; 
Sagberg, 2006). 
Implications Upon Recovery and Rehabilitation 
Recent evidence suggests a potential link between sleep and stroke recovery outcome 
(Bassetti & Aldrich, 2001; Cadilhac et al., 2005; Choi-Kwon et al., 2005; Giubilei et 
al., 1992; Glader et al., 2002; Good et al., 1996; Hermann et al., 2008; Ingles et al., 
1999; Kaneko et al., 2003b; Rola et al., 2007; Sandberg et al., 2001; Vock et al., 
2002; Winward, Sackley, Metha, & Rothwell, 2009). Furthermore, several studies 
have reported that excessive sleepiness and fatigue disrupt rehabilitation sessions 
(Barker-Collo et al., 2007; Morley et al., 2005; Worthington & Melia, 2006). It is 
therefore conceivable that treating sleep disorders and alleviating daytime functioning 
problems may potentially enhance stroke recovery and the efficacy of rehabilitation 
efforts. However, further investigation is required to establish this potential link. 
These issues are addressed further in Chapters 4 and 6 of this thesis. 
3.4.4 Methodological Limitations 
Subjective Assessments 
Several authors have concluded that subjective sleep and daytime functioning reports 
in brain injured samples are subject to inaccuracies when compared to objective 
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assessments (Castriotta et at., 2007; Makley et at., 2008; Masel et at., 2001). As 
results of the current study were in contrast to some studies which show that objective 
sleep problems (Masel et al., 2001; Schuiling et at., 2005; Vock et at., 2002), and 
excessive sleepiness (Bassetti et al., 1996; Masel et at., 2001). With regard to fatigue, 
which is highly prevalent in stroke patients through self reports (Choi-Kwon et at., 
2005; Ingles et at., 1999; Park et al., 2009; Schepers et at., 2006; Valko et at., 2008; 
van der Werf et al., 2001), the results of this study suggest subjective fatigue in was 
not as high. It is possible that patient reports in this study were underestimated as 
patients are either unaware of sleep changes or influenced by experimenter bias. For 
example, recruitment of a highly motivated sample may include those more likely to 
alter their responses in order to be accepted onto the rehabilitation programme (CIT). 
Another explanation may be that the threshold for what is considered a `problem' 
changes after stroke. What is considered sleepy for someone who has had a brain 
injury may be different to a non-brain injured person. Stroke patients may accept that 
sleepiness and fatigue are normal manifestations of the stroke sequelae. For example, 
Bassetti et at. (1996) commented on the surprising lack of concern in the view of the 
patients with hypersomnia. Other subjective findings have shown no difference in 
ESS score between those with and without hypersomnia (Bassetti and Valko, 2006). 
Choice of Questionnaires 
Classification of sleep disorders as determined by the S50 should be interpreted 
carefully as additional objective measures are necessary for confirmatory diagnosis of 
a sleep disorder. For example, studies have shown that sleep apnoea is present in 20% 
of chronic stroke patients (Cadilhac et al., 2005), and sleep disordered breathing is 
present in 81% (Schuiling et al., 2005). However, the S50 scoring criteria classified 
only 3.28% of stroke patients in the current study. Furthermore, the S50 considered 
4.92% of controls as having narcolepsy although these participants had not been 
diagnosed nor displayed behavioural characteristics of the disorder, a trait that is 
largely noticeable in narcoleptic patients (Guilleminault & Fromherz, 2005, p. 550). 
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3.4.5 Future Research 
Further studies are required to characterise post stroke sleep behaviour, In particular, 
studies using alternative measures of sleep will supplement data provided by the 
current study. More specifically, it has been suggested that prospective investigations 
of sleep, e. g. using sleep diaries, are more accurate than retrospective questionnaires 
as used in the current study (Babkoff, Weller, & Lavidor, 1996). Furthermore, 
employing objective assessments of sleep behaviour will greatly build upon the 
findings presented in this chapter. Subsequent studies presented in the following 
chapters of this thesis aim to use alternative methods to further investigate sleep and 
daytime functioning in stroke patients. 
Conclusion of Study 1 
After careful consideration of the methodological influences upon interpretation of 
the data, the following main points were concluded from this study: 
" Perceived sleep problems are present in approximately 30% of chronic stroke 
patients with residual motor deficits. 
" The surprising similarity of sleep quality, sleepiness and fatigue between 
stroke patients and controls gave rise to the idea that patients may not hold 
reliable introspection of these behaviours. The results confirm previous 
findings, that subjective measures may not be accurate. 
" Subjective excessive sleepiness is present in these patients however do not 
appear affect patients any worse than non-brain injured persons from the 
general population. 
" High levels of fatigue are present in stroke patients compared to varied types 
of control samples. 
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" The selection procedure and exclusion criteria chosen for control groups is 
critical when collating incident rates of sleep problems after stroke. 
" Current service provisions to not adequately address sleep which leaves some 
patients suffering with severely disturbed sleep, and perhaps even 
undiagnosed sleep disorders. 
" Psychological adjustment is an important factor in the existence of sleep and 
daytime functioning problems. 
" Fatigue and psychological stress greatly contributed to perceived health. 
The results of the current study have implications for clinicians, patients and future 
studies with regard to subjective data collection. In particular, caution should be taken 
with regard to questionnaire choice and the control group selection. Study 4 presented 
in the following chapter aims to build on these results by using other modes of sleep 
assessment and to further examine how sleep is related to other aspects of the patients 
quality of life; specifically motor recovery. 
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CHAPTER 4 
Study 2: Prospective Investigation of Longitudinal 
Sleep Behaviour and Correlates of Residual Motor 
Recovery 
Chapter 4 Overview 
The current study comprised two main aims: a) examine the concordance between 
subjective and objective measures of sleep, b) to prospectively explore sleep and 
daytime functioning using objective and subjective measures, and c) examine the 
relationship between sleep behaviour and level of motor functioning after stroke in a 
group of 42 chronic stroke patients with chronic motor deficits. By utilising a 
prospective study design, this study monitored sleep and daytime functioning over a 
two week period. Sleep monitoring was conducted using actigraphy and sleep diaries 
which provided objective and subjective data respectively. No known study has 
measured sleep and daytime functioning using this method of assessing sleep chronic 
stroke patients. Level of motor functioning was addressed in terms of residual upper 
limb motor ability. This was measured using a test battery comprising a fine grained 
motor assessment that measure functional ability, reaction time. In addition, real word 
affected arm use was examined. This study has clinical implications for post stroke 
sleep behaviour as well as future research protocols using actigraphy and sleep diaries 
in patients. 
4.1 Introduction 
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Sleep disturbances are evident in stroke patients as detected via PSG methods of 
assessment (Bassetti, 2005b). To some extent, these disturbances are perceived by 
patients (Campos et al., 2005; Leppavuori et al., 2002; Masel et al., 20017; Schuiling 
et al., 2005) however few studies have compared both objective and subjective 
measures. Furthermore, virtually no known studies have used a combination of both 
methods in chronic stroke patients with residual motor deficits. This may partly be 
due to the inconvenience and cost of PSG paradigms. In response to these the 
methodological issues with PSG, actigraphy is a favourable mode of sleep assessment 
for vulnerable groups. 
4.1.1 Subjective and Objective Longitudinal Sleep Assessment 
Technological advancements in actigraphy equipment and software have improved 
sensitivity of this method which has great advantages for sleep research. Actigraphy 
is becoming increasingly recognised as a valid assessment of sleep in various healthy 
and clinical cohorts, including brain injury. 
Actigraphy 
Retrospective subjective assessments are a useful screening tool to characterise a 
person's perception of their own sleep and daytime functioning behaviour (Buysse et 
al., 1989; Johns, 1991,1994). However in order to fully describe how a person sleeps, 
it is useful to prospectively monitor sleep longitudinally, over several days, to 
characterise sleep more accurately (Babkoff et al., 1996). Longitudinal sleep 
monitoring is typically conducted through sleep diaries. However, perceived sleep 
estimations when benchmarked against to objective measures, give rise to an 
underestimation of night time awakenings (Fontaine, 1989; Kushida et al., 2001). 
Furthermore, some participants carrying out sleep diaries for longer periods of time 
become less motivated to complete the diaries accurately or forget to complete the 
' Mixed stroke and TBI sample. 
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diary (Stone et al., 2002). Furthermore, those with sleep disorders are often inaccurate 
in reporting their own sleep behaviour (Means et al., 2003; Variable et al., 2000). In 
order to avoid such methodological limitations, researchers often incorporate an 
objective measure of sleep. Although polysomnography (PSG) is the gold standard 
for measuring sleep, its uses in longitudinal sleep assessment are limited. As well as 
being expensive and typically limited to only several days of recording, PSG is 
intrusive upon a persons sleep due to electrode placement and unnatural sleeping 
conditions (Reynolds et al., 1992; Richards et al., 2000). Actigraphy has provided a 
favourable alternative to PSG in longitudinal sleep research as an attempt to resolve 
some of PSG limitations. 
Actigraphy is widely used in sleep research and provides a range of sleep parameters 
such as sleep duration, sleep onset latency and night awakenings as well as napping 
behaviour, daytime activity levels and circadian rhythm patterns. Actigraphic 
information is recorded via a wrist worn device similar to a watch. The device records 
the intensity and duration of activity, and stores this information in the form of an 
activity count (this process is described in more detail in Section 1.2.3, Chapter 1). 
Activity counts are subsequently converted into sleep or wake epochs using a 
threshold based algorithm8. These sleep and wake epochs are digitised for analysis 
whereby a range of sleep parameters can be extracted. Actigraphy, has a range of 
benefits; it is inexpensive, the devices can record and store data for up to three 
months, and it causes little, or no, disruption to natural sleep behaviour. The 
actigraphy method allows the longitudinal study of sleep and daytime functioning in a 
wide variety of research cohorts for up to several months and requires minimal 
supervision (Ancoli-Israel et al., 2003). 
Sleep diaries are often used in conjunction with actigraphy, either as a 
complementary measure for manual input of bed time and get up time for analysis, or 
for examination of concordance between methods. The combination of methods also 
s Algorithms vary depending on manufacturer. 
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enables detection of artefact within the actigraphy recordings, for example if the 
watch was removed for any reason, then this can be reported in the sleep diary (Avi 
Sadeh & Acebo, 2002). 
Actigraphy in Healthy Populations 
Studies have reported between 91% and 93% agreement between actigraphy and PSG 
in healthy participants for sleep variables including sleep efficiency and duration 
(Jean-Louis, Kripke, Mason, Elliott, & Youngstedt, 2001). More specifically, 
actigraphy has correctly classified sleep from wake 88-90% of the time in comparison 
to PSG (Cole et al., 1992; Sadeh et al., 1995). However, some studies have 
highlighted that actigraphy is less accurate for determining night awakenings and may 
over estimate total sleep time in comparison to PSG (Ancoli-Israel et al., 2003; 
Paquet, Kawinska, & Carrier, 2007). Improved sensitivity of actigraphy devices and 
software have greatly enhanced the calculations for sleep scoring and studies have 
shown good correlations with PSG measures in a range of populations (Littner et al., 
2003). 
Actigraphy in Populations With Sleep Disturbances and Daytime Sleepiness 
Actigraphy has been widely used in a range of sleep disordered cohorts however 
some authors emphasise the accuracy of actigraphy is reduced in these patients 
(Sadeh & Acebo, 2002). Several studies have successfully used actigraphy in 
insomnia groups, however an over estimation of sleep time is commonly observed 
(Chambers, 1994; Guilleminault et al., 1995; Hauri, 1992). However, it is important 
to note that these studies used sleep diaries as a comparison rather than PSG. Few 
studies have validated actigraphy using PSG in insomnia cohorts, however two 
studies have shown good correlation for sleep duration (Jean-Louis, Zizi, von 
Gizycki, & Hauri, 1999; Lichstein et al., 2006). Actigraphy was also sensitive to mild 
sleep disturbances in the non-sleep disordered population (Horne, Pankhurst, Reyner, 
Hume, & Diamond, 1994). 
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Actigraphy is considered less sensitive sleep disordered cohorts, other than insomnia. 
Although, Kushida et al. (2001) showed that a combination of subjective reports and 
actigraphy was able to successfully detect sleep duration and sleep efficiency in 
comparison to PSG in those with sleep disordered breathing. Furthermore, in this 
study, actigraphy was also useful for detecting night awakenings in comparison with 
PSG (Kushida et al., 2001). Some studies have also shown good correlation between 
actigraphy and PSG in those with restless leg syndrome (Collado-Seidel et al., 1999; 
Trenkwalder et al., 1995) and less success for periodic limb movement disorder 
(Gschliesser, Brandauer, Ulmer, Poewe, & Hogl, 2006; Sforza, Zamagni, Petiav, & 
Krieger, 1999). 
Daytime actigraphy is sensitive to daytime sleepiness, inferred by a reduction in 
activity counts (Bruck, Kennedy, Cooper, & Apel, 2005; Littner et al., 2003; Roehrs, 
Turner, & Roth, 2000). Actigraphy can also be used to determine daytime nap 
frequency and duration (Lockley et al., 1999). However the recordings are vulnerable 
to the possibility of falsely identify times of low activity as naps (Hauri, 1992; Paquet 
et al., 2007). Therefore, a combination of sleep diaries and actigraphy is advised to 
enable removal of artefact such as watch removal (Goldman et al., 2008; Pollak, 
Stokes, & Wagner, 1998; Sadeh & Acebo, 2002). It is important to note that 
actigraphy has also demonstrated sensitivity to napping which was not reported in 
sleep diaries (Evans & Rogers, 1994). 
Chronically III Populations (non-neurological) 
Actigraphy studies have provided crucial information regarding sleep and daytime 
functioning of chronically ill patients within hospital, institutional and home 
environments. Good concordance has been reported between actigraphy and medical 
staff observations of waking activity in hospitalised patients who were critically ill 
(Winkelman, Higgins, & Chen, 2005). The acquisition of specific sleep parameters, 
including sleep duration, in chronically ill patients has also shown good concordance 
with PSG measures (Ancoli-Israel, Clopton, Klauber, Fell, & Mason, 1997a). 
Actigraphy is further sensitive to lower levels of activity in those with chronic pain 
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(Long, Palermo, & Manees, 2008), fatigue (Friedberg & Sohl, 2009) and cancer 
patients (Minors et al., 1996; Mormont et al., 2002). 
Furthermore, studies have also examined actigraphy in the context of recovery levels 
in chronically ill patients. Improved sleep-wake cycles correlate with better quality of 
life and survival of cancer patients (Mormont et al., 2000). Normal circadian rhythm 
patterns as recorded by actigraphy correlated with better recovery after cardiac 
surgery patients (Redeker, Tamburri, & Howland, 1998). 
Actigraphy In Populations With Neurological Conditions 
Actigraphy has been useful for monitoring sleep/wake cycles in patients with 
neurological disease such as multiple sclerosis (Attarian, Brown, Duntley, Carter, & 
Cross, 2004), spinal injury (Spivak, Oksenberg, & Catz, 2007) and Alzeimer's 
disease (Ancoli-Israel et al., 2003). Actigraphy has also been applied to patients with 
acquired brain injury including stroke (Bassetti & Valko, 2006; Hermann et al., 2008; 
Masel et al., 2001; Schuiling et al., 2005) and TBI (Baumann et al., 2007; Makley et 
al., 2009). Specifically within chronic stroke, actigraphy revealed sleep disturbances 
that were confirmed by PSG (Schuiling et al., 2005). Actigraphy reports of sleep 
duration have also correlated well with subjective sleep needs in chronic stroke 
patients (Hermann et al., 2008). However, there is no known study that has addressed 
the concordance between sleep diaries and actigraphy in a brain injured cohort. 
Actigraphy has also been useful for determining daytime activity in patients in a 
group of chronic mixed stroke and traumatic brain injury (TBI) sample where naps 
correlated with less activity (Muller et al., 2006). Less activity also correlates with the 
degree of post stroke hypersomnia (Bassetti & Valko, 2006). One study used 
actigraphy to monitor ambulatory activity in a group of community dwelling stroke 
patients with chronic motor deficits (Haeuber, Shaughnessy, Forrester, Coleman, & 
Macko, 2004). It was concluded that this method was useful for quantifying daytime 
activity levels in these patients, however sleep behaviour was not addressed in this 
study. Another study used actigraphy to assess nocturnal and diurnal sleep in a group 
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of older patients with a range of rehabilitative needs including stroke, osteoporosis, 
cardiac problems and pulmonary problems (Alessi et al., 2008). The study found 
good concordance between actigraphy and staff observations of daytime sleep. A 
daily sleep diary was not completed by patients during this study however 
retrospective sleep disturbance was confirmed by actigraphy. 
Actigraphy and subjective sleep diary measures are extremely useful for 
characterising sleep and daytime behaviour in stroke patients in situations where PSG 
is not feasible. Therefore further research can explore the role of sleep in the context 
of stroke recovery. 
4.1.2 Sleep And Recovery Levels After Stroke 
Previous literature and the findings from Study 1 of this thesis have shown that sleep 
and daytime functioning is persistently disturbed in some patients after stroke 
(Cadilhac et al., 2005; Campos et at., 2005; Choi-Kwon et al., 2005; Ingles et al., 
1999; Muller et al., 2006; Park et al., 2009; Valko et al., 2008; van der Werf et al., 
2001; Vock et al., 2002). Furthermore, the findings of Study I and the results of 
Schuiling et al., (2005) revealed that poor sleep is also related to poorer perceived 
health after stroke. In addition to poor health, several studies have identified a link 
between poorer sleep and poorer recovery levels after stroke, including independence 
and ability to perform activities of daily living, often referred to as outcome. A key 
parameter in the context of sleep and stroke recovery is that of the time since injury. 
Generally, two phases have been identified: acute (<12 months) and chronic (>12 
months). The majority of studies have examined sleep and recovery within the acute 
phase, whereas follow-up investigations focusing on chronic cohorts are presently 
limited. 
Acute Outcome 
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A relationship between poor sleep and poorer stroke outcome is commonly observed 
in the acute phase of stroke (Bassetti & Aldrich, 2001; Hachinski et al., 1987; 
Leppävuori et al., 2002; Siccoli & Bassetti, 2008; Takekawa et al., 2007). In 
particular, several studies have shown that sleep disordered breathing is associated 
with poorer levels of stroke recovery (Bassetti & Aldrich, 1999; Good et al., 1996; 
Kaneko et al., 2003b; Sandberg et al., 2001; Spriggs et al., 1992a). Furthermore, 
disrupted sleep architecture has also been associated with poorer outcome after stroke 
(Bassetti & Aldrich, 2001; Giubilei et al., 1992; Hachinski et al., 1987; Valente et al., 
2002). Improvement in sleep EEG correlates with improvement of stroke recovery 
over time (Giubilei et al., 1992; Gottselig et al., 2002). The authors postulated that, 
better sleep is suggestive of good brain function, perhaps even having a supportive 
role in stroke recovery (Gottselig et al., 2002; Vock et al., 2002). 
Chronic Outcome 
The relationship between sleep and stroke recovery is less clear in the chronic phase. 
Table 4.1 presents existing studies that have examined sleep and residual recovery in 
chronic stroke patients. Although a link was observed between sleep disordered 
breathing and poorer outcome in acute stroke, this pattern has only been reported in 
one study for chronic patients (Cadilhac et al., 2005). Another study observed found 
that those patients with poor levels of functioning also had disturbed sleep 
(Worthington & Melia, 20069). The authors suggested that the observed poorer 
functioning in patients was a result of increased daytime performance deficits as a 
result of poor sleep at night. 
9 Mixed stroke and TBI sample. 
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Prospective studies have shown that good quality sleep during acute phase was 
associated with good long term outcome (Vock et al., 2002). Presence of snoring was 
related to poorer prognosis at 6 months after stroke (Spriggs et al., 1992a). Other 
studies have reported that reduced sleep efficiency, reduced total sleep time, 
increased 24 hour sleep was predictive of poorer outcome at long term follow-up. 
(Bassetti & Aldrich, 2001; Giubilei et al., 1992; Hermann et al., 2008; Vock et al., 
2002). These studies did not take into account other factors between initial sleep 
assessment and long term outcome measures which may have contributed to recovery 
outcome. Such factors may include levels of medical care and rehabilitation received 
by patients which may greatly vary between patients from acute to chronic phases of 
stroke. 
In addition to sleep difficulties, fatigue is also associated with poorer recovery levels 
in chronic phase of stroke (Glader, B. Stegmayr, & K. Asplund, 2002; Ingles et al., 
1999; Naess et al., 2005). Choi-Kwon et al. (2005) showed that chronic post stroke 
fatigue has a greater negative impact on physical functioning in comparison to 
cognitive and psychological disturbance (Choi-Kwon et al., 2005). Conversely, two 
studies found that fatigue did not correlate with specifically with physical function 
(Park et al., 2009; Schepers et al., 2006). No known studies have reported a 
correlation between increased chronic sleepiness and stroke outcome, however 
greater sleep need and increased napping was associated with poorer stroke outcome 
(Hermann et al., 2008; Muller et al., 2006). 
Sleep and fatigue may be related to post stroke recovery as evidence suggests that 
sleep is a modulator for factors that influence recovery, such as sustaining good 
daytime functioning (Bassetti & Valko, 2006; Worthington & Melia, 2006), cognitive 
performance (Decary, Rouleau, & Montplaisir, 2000; Leegaard, 1983; Van Zandvoort 
et al., 1998), maintaining good psychological health (Khan, 2004; Schuiling et al., 
2005) and generally modulating quality of life (Schuiling et al., 2005). Furthermore, 
studies show that sleep may facilitate brain plasticity (Walker & Stickgold, 2006), a 
vital process for stroke recovery (Matthews et al., 2004; Mulder & Hochstenbach, 
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2001; Platz, 2004). These findings have led some researchers to theorise that sleep 
may enhance post stroke recovery (Barker-Collo et al., 2007; Robertson & Cohen, 
2006; Siengsukon & Boyd, 2009b; Fabienne Staub & Julien Bogousslavsky, 2001; 
Walker et al., 2003a). However this notion has not yet been fully explored in chronic 
patients. 
4.1.3 Rationale For Study 2 
The evidence that shows a link between sleep and stroke recovery is encouraging 
however more research is required to address the limitations in the existing studies. 
Particular areas that require attention are chronicity, sleep assessments and outcome 
measures. 
Limitations of Previous Studies 
Existing studies typically involve patients with either a wide range of chronicity or 
recruit those still within the acute phase of recovery. Figure 4.1 presents the 
complications that arise when using such cohorts thereby increases the heterogeneous 
nature of the sample which may affect interpretation of the data. Complications of 
acute stroke are highly influential upon results of an assessment of sleep and recovery 
during this time. Such factors include change in sleep environment, biological and 
psychological stress, increased bed rest, drugs, fever, pain, cognitive deficits and poor 
psychological adjustment (Bassetti & Aldrich, 1999; Hermann et al., 2008; McDowd 
et al., 2003; Pohjasvaara et al., 2001; Sisson, 1995; Van Zandvoort et al., 1998; 
Visser-Meily et al., 2005). These factors also contribute to poorer outcomes after 
stroke (Kotila et al., 1984). There is a need for more studies to examine sleep in 
homogenous samples to minimise potential confounding factors on results (Terzoudi 
et al., 2009; Vock et al., 2002). These post stroke complications are unlikely to 
become stable until 12 months after injury (Donnan et al., 1991; Duncan et al., 1992; 
Horgan et al., 2009; Jorgensen et al., 1995; Kotila et al., 1984; Lesniak et al., 2008; 
Rasquin, Verhey, Lousberg, Winkens, & Lodder, 2002). Based on the characteristics 
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of patients during the acute phase, examining patients in the chronic phase of 
recovery enables recruitment of a more homogenous group. 
The Post Stroke Recovery Sequelae Over Time 
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Figure 4.1. Model of post stroke recovery over time. Based on the findings of 
(Donnan et al., 1991; Duncan et al., 1992; Horgan et al., 2009; Jorgensen et al., 1995; 
Kotila et al., 1984; Lesniak et al., 2008; Rasquin et al., 2002) which show that 
recovery stabilises after 12 months. 
Another prominent limitation in these studies is the substantial variation in the way 
stroke outcome or recovery is defined and measured. The reported studies use global 
assessments to measure stroke outcome such as the Barthel Index (Mahoney & 
Barthel, 1965) or Rankin Scale (Bonita & Beaglehole, 1988). These scales provide a 
measure of general recovery and are not sensitive enough to measure modest 
recovery. In particular, they are not fine grained enough to assess modest changes 
(Ashford et al., 2008; Duncan et al., 1997; Lai et at., 2002). Sensitivity of an 
instrument may be highly important when determining the relationship between sleep 
and levels of post stroke outcome. 
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Few studies have used actigraphy with acute or chronic stroke patients in terms of 
characterising post stroke sleep behaviour or how sleep relates to residual recovery 
levels. This may partly be due to the suggestion that actigraphy is vulnerable to 
artefact due to the lower levels of motor ability of brain injured patients (Laakso et 
al., 2004; Sadeh & Acebo, 2002). Careful selection of a homogenous sample that are 
recruited based on their motor ability levels, may reduce the influence of motor 
disability related artefact. For example, those with hemiparesis are only affected on 
one side of the body, therefore the actigraphy device can be worn on the non-affected 
wrist. Furthermore, sleep diaries are beneficial for addressing artifact issues of those 
with motor deficits with regard to daytime napping. 
As research indicates that sleep and post stroke recovery is related, and even postulate 
that sleep may be a mechanism to promote recovery, it is important to fully explore 
this idea as an avenue within stroke rehabilitation. Therefore it is important to firstly 
fully characterise sleep behaviour in chronic stroke patients as sleep is often disturbed 
in the chronic phase of stroke. If good sleep is related to good recovery then it is 
imperative to fully explore this notion in all stages of recovery, in particular, chronic 
stroke patients. Richter et al. (1995) reported that assessment and treatment of sleep 
disorders in patients with mild brain injury which correlated with improved clinical 
outcomes and also reduced cognitive, somatic and emotional problems associated 
with injury. Therefore, treating sleep disturbance and maintaining healthy sleep 
should be top priority in neurorehabilitative medicine. 
4.1.4 Aims and Hypotheses 
The aim of this study was to: a) investigate the agreement between subjective sleep 
perception and actigraphy, b) describe prospective longitudinal sleep behaviour using 
subjective and objective parameters, and c) assess the relationship between sleep 
behaviour and residual upper limb motor recovery after stroke. Unlike previous 
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studies which have addressed sleep, daytime functioning in terms of stroke recovery, 
this current study incorporated a motor test battery which included fine grained 
assessment of upper arm function as well as real world arm use. 
Based on review of the literature, the following research questions were formulated: 
1) How well do subjective sleep diaries and actigraphy agree in stroke patients with 
chronic residual motor deficits? 
2) Are sleep and daytime functioning disturbances present in chronic stroke patients 
as measured using subjective and objective longitudinal sleep monitoring? 
3) Are reduced overall activity levels associated with increased sleepiness and 
fatigue? 
4) Is sleep behaviour, daytime functioning, or activity levels related to residual motor 
recovery in the chronic phase after stroke? 
4.2 Methods 
4.2.1 Desian 
A prospective design was employed to monitor longitudinal sleep and daytime 
functioning behaviour for two weeks in a group of chronic stroke patients (Figure 
4.2). Subjective and objective sleep was measured using sleep diaries and actigraphy 
respectively. Residual motor recovery was assessed at baseline (Ti) and repeated at 
pre-CIT (T2). The data was subjected to a within groups design where matched sleep 
indices drawn from the sleep diary and actigraphy were compared (i. e. subjective 
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time in be compared with that same parameter recording by actigraphy). Weekday 
and weekend recordings were also compared. Furthermore, the degree of association 
between subjective sleepiness, fatigue and activity were examined. Sleep and daytime 
functioning were subsequently correlated with residual motor recovery levels. 
The CIT Trial Framework 
...................................... 
Baseline Testing (T1) Pre Testing (T2) Post Testing (T3) 
I r2 Hours n2 Weeks I2 Weeks I2 Weeks n 
SCREENING: BASELINE 
Study One 
................... I ................ 
.......... 1 
ý 
:............ .................... 
I Study Two I r ................. ... "1 
CIT POST CIT 
EEG (T2) 
j Study Three I 
Study Four 
I Long Term Sleep Monitoring 
Figure 4.2. Design of CIT trial. The highlighted section indicates time point from 
which data for this study was collected. 
4.2.2 Participants 
Forty-two community dwelling chronic stroke patients with residual motor deficits 
were recruited for the present study''. All patients fulfilled the inclusion/exclusion 
criteria as described in Section 2.2.1, Chapter 2. All patients fulfilled the motor 
criteria employed by the CIT trial. 
11A total of 54 patients were eligible for CIT (section 2.2.1, chapter 2). Ten patients were not included 
in the analysis for this study. Two patients were excluded from this study as they presented of bilateral 
strokes which resulted in hemiparesis in both upper limbs. It was felt that this may interact with 
actigraphy recordings. Two patients were non-compliant regarding sleep diary completion. The data of 
two patients was not included due to actigraphy fault. Four patients did not complete full two week 
baseline sleep monitoring. 
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4.2.3 Materials 
Subjective sleep behaviour was assessed using a pen and paper based sleep diary that 
required patients to report their perception of nocturnal sleep. The sleep diaries also 
contained twice daily Karolinska Sleepiness Scale (KSS) and Daily Fatigue Scales 
(D-FIS) to assess sleepiness and fatigue respectively during the morning and evening. 
Twenty-four hour actigraphy recordings were conducted using the `Actiwatch Mini 
®' (CamNtech Ltd., (0 2009), worn on the non-affected arm. Sleep diaries and 
actigraphy recording materials are described in more detail within Section 2.3.4, 
Chapter 2. In addition, PSQI, ESS and FSS scores were used as a measure of 
retrospective habitual sleep and daytime functioning. Residual motor recovery was 
assessed using a battery of upper limb motor ability assessments including the Wolf 
Motor Function Test (WMFT; Wolf, Lecraw, Barton, & Jann, 1989) and Motor 
Activity Log (MAL; Taub et al., 1993). These tests are all fully described Section 
2.3.3, Chapter 2. 
4.2.4 Procedure 
Patients attended the baseline test point (Ti) which comprised the first administration 
of the motor test battery. Additionally during TI, patients were fitted with the 
actiwatches, given the sleep diary and provided with instructions. Participants were 
instructed to complete the sleep diaries as accurately as possible and to report any 
instances when the actiwatches were removed to avoid miscoding of a daytime sleep 
period. Sleep diaries and actigraphy recordings were continued for two weeks 
(baseline period). At the end of the two week baseline period, the pre-CIT motor 
testing (T2) was carried out. This test point repeated the procedure carried out during 
TI. 
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4.2.5 Analysis 
Sleep diary and actigraphy data were aggregated across 10 weekdays and weekend 
days. Weekdays and weekends were analysed separately due to shifts in sleep 
schedules and behaviour observed in the general population (Groeger et al., 2004) 
and brain injured populations (Campos et al., 2005). Only weekday data was used for 
characterising sleep in these patients and for analysis in the context of motor 
recovery. Patient sleep schedules were also compared to published norms 
Sleep Diary 
The following nocturnal sleep parameters were extracted from the sleep diary: bed 
time (24 hour clock), wake time (24 hour clock)12, get up time (24 hour clock), time 
in bed (mins), sleep duration (mins), sleep onset latency (mins), sleep efficiency (%) 
and night awakenings (frequency and duration). Daytime functioning parameters 
were morning and evening KSS and D-FIS ratings as well as daytime nap reports 
including frequency and duration per day. 
Actigraphy 
Actigraphy recordings were analysed using Actiwatch Sleep Analysis Software 
(Version 7.22, CamNtech Ltd, © 2009). The following sleep parameters were 
calculated: bed Time (24 Hour Clock), wake time (24 Hour Clock)', get up time (24 
Hour Clock), time in bed (mins), sleep duration (mins), sleep onset latency (mins), 
sleep efficiency (%) and night awakenings (frequency and duration). Bed time and 
get up time were entered manually into the software (using the sleep diary for 
guidance) whereas the remaining parameters were calculated using the sleep scoring 
function within the Actiwatch Sleep Analysis Software. Sleep scoring analysis was 
set using a medium sensitivity of <40 activity counts per minute to define wake. This 
level of sensitivity has shown good correlation with PSG and actigraphy settings of 
even greater sensitivity (Kushida et al., 2001). 
12 time of final awakening. 
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Diurnal sleep behaviour was measured using the napping analysis function where a 
nap was defined as any sleep period between get up time and bed time for a minimum 
of 15 minutes. The sensitivity was set to <l0 activity counts per minute to define an 
epoch of daytime sleep. This threshold has been used previously in brain injured 
patients with chronic motor difficulties (Laakso et al., 2004). For activity analysis, 
raw data (activity count) was exported in one minute epochs between 0800 and 2200 
hours for each day. Each epoch was averaged across the weekdays recorded per phase 
(10 days), and then summed into one hour time bins. A reduction in daytime activity 
considered an indication of fatigue or sleepiness as shown previously in healthy 
(Roehrs et al., 2000) and stroke cohorts (Bassetti & Valko, 2006; Muller, Czymmek, 
Thone-Otto, & Von Cramon, 2006). 
Motor Ability Test Battery 
The WMFT provided two measures of motor ability; median reaction time13 (mins) 
and mean functional ability (score out of 7) averaged across all 15 tasks. Two 
measures of subjectively rated arm use outside of the laboratory including amount of 
use (AOU) and quality of use (QOU) were extracted from the MAL. Section 2.3.4, 
Chapter 2, provides a detailed description of scoring procedures for these tests. Due 
to the unfamiliarity of the motor test situation, residual motor ability data from T2 
was used for analysis as recommended by Whitall (2004) for a more accurate 
representation of motor ability. 
Statistical Tests 
Due to the non-normal distribution of the data, all statistical tests were carried out 
using non-parametric alternatives. Within group tests of difference were calculated 
using the Wilcoxon signed ranks test. Tests of association were calculated using 
Spearman's rank correlation coefficient. Statistical tests of difference and association 
were applied to matched indices of the sleep diary and actigraphy. This method has 
13 WMFT median reaction time is considered is more stable across repeated test sessions and less 
susceptible to outliers (Wolf et al, 1989; Morris 2001). 
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been recommended by Wicklow and Espie (2000b) as significant correlations found 
between sleep diaries and actigraphy may also significantly differ in terms of the 
mean. Activity levels were examined using a between groups analysis comparing 
those with and without fatigue or sleepiness using the Mann Whitney U test. All 
statistical tests were carried out using a one tailed analyses with an alpha level set to 
p<0.05. 
4.3 Results 
4.3.1 Demographics 
The demographics for all stroke patients are presented in Table 4.2. 
191 
Table 4.2. Data presented as mean, +/- 1 SD and range or percent valid where 
appropriate. The remaining 35.71% of stroke patients unlisted for employment status 
were classified as not working. For individual case information for all participants, 
see Appendix C. 
Demographical Variables 
Gender (M: F) 
Age (Years) 
BMI 
NART(tO) 
Mini Mental State Exam' 
GPSQI 
ESS 
FSS 
Education Level: 
School Leavers Certificate 
Further Study 
Higher Education 
Employment Status: 
Full Time 
Part Time 
Retired 
Studying 
Living Support: 
Living Alone 
Living With Family 
Chronicity (Months) 
Type of Stroke! 
Ischemic 
Hemorrhagc 
Both 
Lesion Hemisphere 
Co-morbid Conditions: 
Psycholog cal 
Muscular 
Neurologicalt 
Cardiac 
Cancer 
Diabetes 
Pain 
Dysphasia 
Medication: 
Antidepressant 
Pain Relief 
Cardiac Control 
Anti-epileptic 
Sleep Hypnotics 
Alcohol (Units per week) 
Caffeine (Cups per day) 
Nicotine (Cigarettes Per Day) 
Stroke Patients (n=42) 
24 18 
5502! 1041(2873) 
2395±_244(1820-31) 
11663±686(96-126) 
29 15 ±1 04 (26-30) 
483! 364(0-13) 
657±436(0-18) 
23 67 ± 14.67 (0-51) 
29 27% 
4146% 
29 27% 
14 29% 
16 67% 
33 33% 
0% 
1429% 
85 71% 
5793±4486(11-210) 
47 62% 
19 05% 
238% 
19 Left. 23 Right 
23 81% 
7 14% 
19 05°6 
42 86% 
238% 
2 38R. 
2 38% 
23 8% 
1429% 
238% 
476% 
1429% 
0: 6 
79±891(032) 
5.03±296(0-12) 
0 88 ±3 48 (0-20) 
(-) not required or not recorded as part of this study. 
* 23.8% of the patients experienced expressive dysphasia therefore only completed the 3-step 
command on the MSE and were not included in the total mean score. These patients also did not 
complete the NART. 
t Value included only those patients who could report type of stroke. 
$ Neurological conditions other than stroke. 
192 
4.3.2 Sleep Diary and Actigraphy Concordance 
Concordance Between Sleep Diaries and Actigraphy 
Correlations and tests of difference for matched nocturnal sleep and napping 
parameters are presented in Tables 4.3 and 4.4 for weekday and weekend day 
analyses respectively. For both weekdays and weekends, sleep diaries and actigraphy 
were in good concordance, ranging from 0.27 to 0.85, for the following parameters: 
bed time, get up time, time in bed, sleep duration, sleep onset latency and nap length. 
An exception to this pattern was observed for night awakenings. 
Significant differences between the sleep diaries and actigraphy emerged for wake 
time, time in bed, sleep duration, sleep onset latency, sleep efficiency, night 
awakenings and nap frequency during the week (Table 4.3). Significant differences in 
wake time, frequency and duration of night awakenings, and nap frequency emerged 
at weekends (Table 4.4). Apart from night awakenings, these observed differences 
also demonstrate a degree of concordance (Figure 4.3 and 4.4). This suggests that 
some patients may have been more accurate in reporting their sleep compared to 
others. Moreover, 42.86% of patients reported they did not nap on any occasion 
however actigraphy showed that this was 19.05%. A similar effect was reflected at 
weekends. This large discrepancy between the two measures of napping behaviour 
suggest that either patients do not report naps or actigraphy is miscoding quiescence 
as sleep. This finding fully mapped out observations made in the laboratory where 
some patients were clearly tired and even falling asleep during testing. 
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Table 4.3. Mean (+/-1 SD) and range across 14 weekdays for matched parameters 
drawn from the sleep diary and actigraphy recordings. Test statistics inclu de the 
Wilcoxon signed rank test (Z) and Spearman's (r). *Significant val ues. 
Weekday 
Sleep Diary Actiwatch Difference 
Mean SD Range Mean SD Range Mean z r 
Bed Time (24 Hr Clock) 22: 45 01: 15 18: 03.01: 11 23: 00 00: 52 20: 34-01: 15 00: 15 -0.12 0.68'1' 
Wake Time (24 Hr Clock) 07: 32 01: 03 05: 24-09: 48 08: 06 00: 57 05: 48-10: 41 00: 34 -0.37"' 0.45" 
Get Up Time (24 Hr Clock) 08: 08 01: 01 05: 57-10.07 08: 13 00: 57 05.49-10.41 00: 05 -1.84 0.74"' 
Time In Bed (mins) 546.07 59.75 428.33-720 555.31 57.66 427-701 9.24 -2.37"' 0.85"' 
Sleep Duration (mins) 469.05 62.4 298-591.07 460.26 45.06 371.555 -8.79 -1.68' 0.53"' 
Sleep Onset Latency (mins) 21.99 20.21 0-106 16.6 10.8 5-58 -5.39 -1.76' 0.50"' 
Sleep Efficiency (%) 86.24 7.59 69.26-97.69 83.16 582 6972-9283 -3.08 -2.52"' 0.27' 
No. of Night Awakenings (freq. ) 1.07 0.64 0-3 27.85 76 11.86-42.3 6.53 -5.65"' -0.21 
Duration of Night Awakenings (mins) 19.92 19.09 0-73.57 7079 28.55 22-133 50.87 -5.45"' 0.08 
Nap Frequency (Per Day) 0.37 0.50 0-2.43 0.63 0.69 0-2.8 0.26 -2.57"' 0.5711' 
Nap Length (mins) 16.61 24.74 0.118.57 19.55 22.96 0-8738 622 -1.29 0.66"' 
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Table 4.4. Mean (+/-I SD) and range across 4 weekend days for matched parameters 
drawn from the sleep diary and actigraphy recordings. Test statistics included the 
Wilcoxon signed ranks test (Z) and Spearman's (r). *Significant values 
Weekend 
Bed lime (24 HrClock) 
Wake lime (24 Hr Clock) 
Get Up Time (24 Hr Clock) 
Time In Bed (mins) 
Sleep Duration (mins) 
Sleep Onset Latency (mins) 
Sleep Efficiency )%) 
No. of Night Awakenings (freq. ) 
Duration of Night Awakenings (mins) 
Nap Frequency (Per Day) 
Nap Length (mins) 
Sleep Diary Actiwatch Difference 
Mean SD Range Mean SD Range Mean zr 
23: 03 01: 15 
07 37 00: 59 
08.18 00: 52 
550.35 62.98 
459.76 81.15 
24.36 24.84 
83.8 9.3 
1.01 0.73 
23.06 29.24 
0.34 0.4 
2454 34.28 
19: 26-01: 40 
05: 22.10: 10 
06: 13-11: 19 
425-690 
327.5-642 
0-111.67 
62.44-98.15 
0.3.67 
0-135 
0-1.5 
0-135 
23.13 01: 03 
08: 28 02: 08 
08: 37 02: 06 
549.23 54.02 
453.57 48.41 
19.85 1898 
82.8 6.7 
26.66 661 
65 24.24 
0.63 0.67 
23.47 29.43 
20: 39-01: 21 00.10 -0.17 0.55111 
05: 34-20.52 01: 09 -4.35"' 0.60'"' 
05: 39-20: 53 00: 19 -0.25 0.56"' 
455-700 -1.12 -0.03 0.64, - 
363-553 -6.19 -0.41 0.35- 
0-90 -4.51 -0.49 0.23' 
63.2-93.71 -1 -0.69 0.12 
11.5-37.5 5.6 -5.64"' -0.25 
24-147 41.94 -4.76"' 0.05 
0.2.5 0.29 -3.13" 0.58- 
0-123 -1.07 -0.23 0.69"' 
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Characterising Prospective Sleep and Daytime Functioning 
Sleep 
In comparison to published norms, patient sleep schedule was similar to that of the 
self reports in the general population (Monk et al., 2000). In this study bedtime and 
wake time was 23: 48 and 07: 23 respectively (Monk et al., 2000). Sleep efficiency as 
recorded by the sleep diaries, and more accurately, by actigraphy, is below the 
threshold which is considered healthy (85%; Morin and Espie, 2003, p. 16). 
Subjective and objective sleep duration was >7 hours on average per night which 
suggests patients received a sufficient amount of sleep (Carskadon & Rechtschaffen, 
2005; Van Dongen et al., 2003). However time in bed was considerably longer (>9 
hours on average per night) than the UK average of 7.5 hours (Clare Anderson & 
Horne, 2008; Groeger et al., 2004). Furthermore, increased night time awakenings, 
both frequency and duration, also contribute to poorer sleep efficiency. Night time 
awakenings appear to be increased in comparison to other actigraphy studies in 
healthy persons where number of wake bouts14 were less than 10 per night (Lockley 
et al., 1999; Paquet et al., 2007). The frequency of night awakenings in the stroke 
patients are comparable with the number of awakenings of sleep disordered patients 
who awoke 36.6 times a night (Kushida et al., 2001). Longer time in bed, in addition 
to increased night time awakenings, contribute to low sleep efficiency. 
For the majority of patients, total napping duration did not exceed 45 minutes 
however six patients reported napping longer than 45 minutes during the week, also 
confirmed by actigraphy. One patient napped on average for approximately two hours 
a day during the week and at weekends. It was indicated in the UK survey by Groeger 
et al. (2004) that non-brain injured persons do not habitually nap longer than 15 
minutes. This suggests that patients nap considerably longer than the general 
population and that this may be indicative of increased sleepiness. 
Daytime Functioning 
14 The actual number of episodes of wakefulness (> 1 minute). 
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Figure 4.5 shows that patients experienced subjective increases in sleepiness (KSS) 
and fatigue (D-FIS Overall), including mental (DFIS Mental Fatigue) and physical 
fatigue (D-FIS Physical Fatigue), in the evening compared to the morning. For 
weekday analyses, there was a significant difference for KSS scores (Z=-5.23, 
p=0.0000), overall D-FIS (Z=-2.98, p=0.0028), mental D-FIS (Z=-3.93, p=0.0000) 
and physical D-FIS (Z=-3.36, p=0.000). This effect was also present at weekends, 
increased KSS (Z=-3.09, p=0.0020), overall D-FIS (Z=-2.06, p=0.0392), mental D- 
FIS (Z=-3.07, p=0.0021) and physical D-FIS (Z=-2.56, p=0.0185). 
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Figure 4.5. Mean (+/-I SD) KSS and D-FIS scores for the morning and evening. 
Significant differences between morning and evening scores are indicated as *p<0.05, 
**p<0.01, *** p-0.001. 
Relationship Between Nocturnal Actigraphy and Daytime Functioning 
KSS scores were not associated with any sleep or napping parameters derived from 
actigraphy. Weekday morning (r=0.27, pO. 0395) and evening (r=0.35, p=0.0252) 
fatigue ratings were related to longer actigraphy sleep duration. During the weekend, 
increased evening fatigue correlated with increased actigraphy derived sleep 
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efficiency (r=0.32, p=0.0195). Increased fatigue was related to greater subjective and 
objective napping during the weekday and weekend. Greater weekday morning 
fatigue correlated with longer patient reports of napping duration (r=0.27, p=0.0393). 
Evening weekday fatigue correlated with increased objective napping frequency 
(r=0.38, p=0.0071) and duration (r=0.30, p=0.0278). For the weekend, increased 
morning overall fatigue was significantly associated with nap duration (r=0.27, 
p=0.0418). 
4.3.3 Motor Recovery Level In The Context of Sleeg 
The data obtained from the motor test battery are summarised in Table 4.5. As 
expected in a cohort of patients with upper limb hemiparesis, there are marked 
difficulties in reaction time and level of ability in task performance. 
Table 4.5. Mean (+/-1 SD and range). All values represent the score across items on 
each test battery apart from WMFT RT which is median time taken to complete a task 
(ms). 
Upper Limb Motor Ability Tests 
WMFT RT (ms) 
WMFTFA 
MAL AU 
MAL QOU 
26.27 t 39.47 (1.41-120) 
4.16 t 1.46 (1.42-6.54) 
1.20 ± 1.14 (0-3.96) 
1.12 t 0.99 (0-3.08) 
Relationship Between Motor Deficits and Sleep 
Correlations between all motor tests, nocturnal parameters as determined by 
actigraphy and subjective ratings of sleepiness and fatigue are presented in Table 4.6. 
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Table 4.6. Spearman's rank correlation coefficient of motor ability tests with sleep 
and daytime functioning. Significant values are indicated as *p<0.05, **p<0.01 and 
those in bold represent non-significant trends. The scatter plots for significant 
correlations are located in Appendix D3. 
Sleep and Daytime Functioning 
Actigraphy: 
Time in Bed (mins) 
Sleep Time (mins) 
Sleep Onset Latency (mins) 
Sleep Efficiency (%) 
No. of Night Awakenings (freq. ) 
Duration of Night Awakenings (mins) 
Nap Frequency (Per Day) 
Nap Length (rains) 
Subjective Daytime Functioning: 
AM KSS 
PM KSS 
AM D-FIS Overall Fatigue 
PM D-FIS Overall Fatigue 
AM D-FIS Mental Fatigue 
PM D-FIS Mental Fatigue 
AM Physical Fatigue 
PM Physical Fatigue 
Residual Motor Ability 
WMFTRT WMFTFA MALAU MALQOU 
0.18 -0.16 -0.33* -0.32* 
0.12 0.00 -0.25 -0.24 
0.11 -0.12 0.07 
0.05 
-0.17 0.25 0.12 0.12 
0.06 -0.11 -0.31 * -0.28* 
0.19 -0.28* -0.25 -0.24 
-0.01 0.17 0.27* 0.24 
-0.02 0.13 0.27* 0.24 
-0.31 * 0.22 0.13 0.20 
-0.00 0.07 -0.12 -0.04 
-0.31* 0.29* 0.30* 0.28* 
-0.32* 0.36" 0.27* 0.26* 
-0.17 0.15 0.03 0.03 
-0.08 0.10 -0.09 -0.07 
-0.17 0.11 0.03 0.03 
-0.15 0.08 -0.04 -0.02 
The observed increased time in bed was significantly associated with poorer scores 
on the MAL (amount and qualitiy of use ). Correlations between sleep and motor 
ability were mild ranging from 0.22 to 0.33. Systematic effects across several tests 
were found for reduced time in bed, night awakenings and better motor ability. These 
results suggest that time in bed and night time awakening parameters are mildly 
associated with poorer motor ability. Increased napping was only associated with self 
reported motor function (MAL). Other systematic effects across all tests, ranging 
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from 0.27 to 0.36, were found for increased overall fatigue (morning and evening) 
and better motor test scores. Only a small effect was found between sleepiness and 
motor ability, but this was not consistent across all tests. 
4.4 Discussion 
4.4.1 Overall Findings 
The present study aimed to prospectively examine subjective and objective sleep to 
firstly characterise sleep and daytime functioning in chronic stroke. Furthermore, this 
study aimed to examine sleep behaviour in terms of residual motor recovery. This 
was achieved by recording activity and sleep diaries over two weeks and assessing 
residual motor recovery using a comprehensive battery. Patients were relatively 
accurate in detecting their own sleep behaviour, however less accurate at determining 
daytime functioning. It was revealed that sleep and daytime functioning is highly 
disturbed in some patients. Furthermore, better daytime functioning in particular was 
related to motor ability which was contradictive to the initial assumption. 
Concordance Between Sleep Diaries and Actigraphy 
Sleep diary and actigraphy were in good agreement for the majority of parameters 
including bed time, get up time, time in bed, sleep duration, sleep onset latency and 
nap length. Therefore patients were reasonably accurate in reporting their nocturnal 
sleep behaviour however less perceptive when reporting night time awakening 
information. This effect is commonly observed in healthy (Lockley et al., 1999) those 
with a range of sleep disorders (Kushida et al., 2001; Means et al., 2003; Variable et 
al., 2000). Despite good concordance of the group, a small proportion of patients 
were largely inaccurate in self reporting. 
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A discrepancy between subjective and objective measures as 42.58% of patients 
napped according to the actigraphy however only half this amount of patients 
(19.05%) reported this in the sleep diary. A similar effect was also observed at 
weekends. Lockley et al. (1999) also found that nap frequency and duration were 
increased using actigraphy in comparison to sleep diaries, but in a healthy non-brain 
injured sample. Some authors have suggested that actigraphy has a tendency to 
miscode a period of quiescence as sleep therefore overestimate frequency of naps 
(Hauri, 1992; Paquet et at., 2007). For the present study, careful attention was paid to 
napping analysis to avoid this problem. The nap detection criteria was set to a 
minimum of 15 minutes. Therefore the likelihood of miscoded naps is reduced as 
patients are likely to move within a 15 minute period compared to a5 minute period. 
In addition, patients were asked to report if the actiwatch was removed. The detection 
of long periods of zero activity suggested that the actiwatch may have being removed. 
Where possible, patients were queried upon these findings in order to clarify if that 
period was a likely nap. Given that brain injured patients are particularly associated 
with poor perception of their sleepiness (Bassetti et at., 1996; Bassetti & Valko, 2006; 
Masel et at., 2001), it seems more plausible to assume that actigraphy is more reliable 
than sleep dairies with regard to napping. In addition, laboratory observations showed 
patients were indeed very sleepy however did not appear to acknowledge this. In this 
instance, more research is required to address daytime functioning perception in this 
cohort. 
Characterising Sleep and Daytime Functioning 
Overall, patients had healthy sleep duration (>7 hours) during the week and at 
weekends. Sleep schedules, including mean bed time, wake time and get up time 
appeared relatively normal in comparison with the general UK population (Groeger et 
at., 2004). Even though sleep duration was healthy, patients spent, on average, two 
hours longer in bed. This may explain why sleep efficiency was below the healthy 
threshold of 85% (Morin and Espie, 2003, p. 16). Fifty-five percent of chronic stroke 
patients in another study had sleep efficiencies below 80% (Schuiling et at., 2005). 
Stroke patients may stay in bed for longer due to the physical disability associated 
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with stroke and life style changes such a reduction in occupational and social activity. 
Furthermore, longer night time awakenings also contributed to the observed low sleep 
efficiency. Under normal conditions, researchers have observed less than 10 wake 
bouts in healthy non-brain injured participants using actigraphy (Lockley et al., 1999; 
Paquet et al., 2007). Patient in this study however awoke 27 to 28 times a night. This 
is also suggestive of poorer quality sleep in patients which, is fact, comparable with 
those diagnosed with a sleep disorder who awoke 36.6 times a night15 (Kushida et al., 
2001). Schuiling et al. (2005) also found that 75% of stroke patients demonstrated 
sleep fragmentation due to increased level of night awakenings. 
Forty-three percent of chronic stroke patients took naps during the week and at 
weekends. This finding is lower than those reports by Campos et al. (2005). In this 
study, 66.75% of chronic stroke patients napped during the week whereas 75% 
napped at weekends. This difference may be due to the positive selection employed 
by the current study as 39.96 % worked. Therefore these patients may have had fewer 
opportunities to nap. Interestingly, subjective reports of napping on the sleep diary for 
the present study was less than half of those patients who napped as detected by 
actigraphy. Based on the knowledge from the previous chapter which highlighted that 
patients may underestimate their sleepiness and fatigue levels, as well as the findings 
presented in other studies (Bassetti et al., 1996; Bassetti & Valko, 2006; Masel et al., 
2001), these results further show that patients underestimate napping. Furthermore, 
anecdotal evidence from the laboratory and family reports revealed that some patients 
napped regularly however the patients did not feel they had, therefore this was not 
recorded in the sleep diary. It remains unknown without the use of more objective 
measures such as MSLT or MWT tests to resolve this issue. However it is clear from 
this study that chronic stroke patients take multiple naps, which may be as long as 
two hours a day, considerably longer than napping behaviour reported in non-brain 
injured samples. A survey of 2000 UK adults showed that less than 10% of 
participants napped during the week and less that 35% napped at weekends (Groeger 
15 Using the same wake bout criteria (number of episodes of wakefulness longer than 1 minute) used in 
this study and Lockley et al, 1999). 
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et al., 2004). Furthermore, those in the general population napped, on average, for 15 
minutes (Groeger et al., 2004). 
This study also found a shift in sleep and napping behaviour at weekends in 
comparison to weekdays. During the weekend, patients had a later subjective and 
objective bed time, a behaviour trait observed in non-brain injured (Groeger et al., 
2004; Monk et at., 2000) and other stroke samples (Campos et al., 2005). An 
significant increase in duration for night awakenings may reflect alcohol consumption 
at weekends. Sleep duration also increased during the weekend which is typical of the 
general population (Groeger et al., 2004) and other stroke samples (Campos et al., 
2005). 
With regard to daytime functioning, patients reported increased sleepiness and fatigue 
during the evening compared to the morning. This follows the normal pattern the 
daily cycle of daytime functioning. As sleep need increases in conjunction with the 
homeostatic drive and circadian rhythm, feelings of sleepiness and fatigue increase 
(Borbely & Acherman, 2005). However, level of sleepiness was not related to the 
quality of sleep at night. Poorer sleep at night usually results in increased sleepiness 
and fatigue during the day, as shown under laboratory (Franzen, Siegle et al., 2008) 
and real world conditions (Drake et al., 2004; Gold et al., 1992; Harma et al., 2002; 
Papp et al., 2004; Torsvall & Akerstedt, 1987). The findings of this study, and those 
of other authors (Bassetti & Valko, 2006; Baumann et al., 2007), show that patients 
reports do not necessarily follow this model of sleep. This suggests that patients 
either experience sleepiness despite sleeping well at night or they do not report worse 
daytime functioning despite having poor quality sleep. Further research is required to 
fully address the extent to which patients can accurately report level of daytime 
functioning. 
Sleep and Motor Recovery 
This study revealed relationships between residual upper limb motor ability with 
sleep and daytime functioning. Patients with poorer motor ability tended to stay in 
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bed longer and experience longer and more frequent night awakenings. Furthermore, 
increased fatigue was associated with better motor ability across all tests. These 
findings do not agree with other studies in chronic stroke. Previous studies have 
shown that increased fatigue and sleepiness is associated with poorer functional 
recovery (Alessi et al., 2008; Choi-Kwon et al., 2005; Glader et al., 2002; Ingles et 
al., 1999; Muller et al., 2006; Naess et al., 2005; Worthington & Melia, 2006). In 
Park et al. (2009), fatigue was not related to motor function, or activity of daily living 
in chronic stroke patients whereas sleep disturbances were related to outcome. 
Schepers et al. (2006) also found that fatigue was not related to motor ability. 
However these studies measured motor ability using general assessments whereas the 
current study used a fine grained motor test and addressed real world arm use. There 
was also a mild effect of increased napping and improved subjective motor 
functioning as reported on the MAL. Therefore these results indicated that in a highly 
motivated chronic stroke sample, better upper limb motor ability is associated with 
poorer daytime functioning. Schepers et al. (2006) commented that "... in clinical 
practice, stroke patients who have made a good clinical recovery often have disabling 
fatigue problems", however this has not yet been shown scientifically. Furthermore, 
Schepers et al. (2006) direct attention to the findings of Van Zandvoort et al. (2006) 
who found that even high functioning patients still report high levels of fatigue. 
Another study revealed that patients with good physical recovery also had severe 
fatigue (Staub & Julien Bogousslavsky, 2001). One possibility for this may be that 
increased use of the upper limb requires greater efforts of patients which results in 
feelings of increased fatigue. Using a selection of patients with greater stamina, they 
may try to push themselves to perform well on motor tasks. 
4.4.2 Implications of Findings 
Prospective Sleep Monitoring 
This study showed that sleep diaries are a useful tool for monitoring sleep over time, 
however should not be used without the aid of actigraphy as some patients were 
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largely inaccurate as outlier cases were found in the concordance analyses. 
Actigraphy was also useful for monitoring sleep and daytime functioning behaviour 
in chronic stroke patients with residual motor deficits. 
Clinical Application of Results 
The results of this study have greatly contributed to the characterisation of sleep and 
daytime functioning behaviour in chronic stroke patients. The noted sleep 
disturbances should be addressed in treatment regimes and perhaps prescribed 
napping to alleviate sleepiness and fatigue. As the findings this study and the others 
revealed sleep changes in chronic stroke patients at weekends, it is important to take 
in account which days of the week are used to record sleep. Furthermore, few studies 
examining daytime functioning in stroke patients take morning and evening changes 
into account. As the results of this study have shown significant differences in 
sleepiness and fatigue between morning and evening, the timing of these assessments 
is therefore critical for interpretation. 
This study also contributes to the understanding of stroke recovery. Not only does it 
point towards a link between good quality nocturnal sleep and better motor ability, it 
highlights that those with better motor ability may be susceptible to increased fatigue. 
This shows that sleepiness and fatigue is not necessarily an indication of poorer 
recovery as other studies have shown (Choi-Kwon et al., 2005; Glader et al., 2002; 
Ingles et al., 1999; Naess et al., 2005). Moreover, these results may reflect the 
motivated personality type of patients recruited for this study. It is therefore critical to 
promote awareness of daytime functioning in stroke patients and make previsions for 
rest and promoting napping may help cope with the sleepiness and fatigue associated 
with stroke recovery. 
4.4.3 Methodological Limitations 
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Actigraphy did not appear to be affected by the level of motor deficit in these 
patients. Furthermore, patients did not report any problems with wearing the watches 
for the two week duration. Therefore, actigraphy can be a used in this sample for even 
longer periods of time to further investigate sleep within other protocols, i. e. during a 
phase where a change in sleep behaviour is expected. 
Actigraphy 
There is some concern over the use of actigraphy in clinical populations with 
fragmented sleep or in situations where the sleep cycle is challenged (Paquet et al., 
2007). Sleep duration was overestimated in those with sleep disorders using 
actigraphy in comparison to PSG (Kushida et al., 2001; Laakso et al., 2004). 
Furthermore, increased wakefulness during the night reduces the overall accuracy of 
actigraphy recordings (Hauri, 1992). As some patients within the current study 
demonstrated sleep disturbance, the validity of actigraphy recordings may have been 
affected, however this cannot be directly addressed without the use of PSG. With 
regard to the patient group in question, the benefits of actigraphy, e. g. low cost less 
disruption to sleep and ability to record longitudinal sleep, outweighed the benefits of 
PSG for this particular study. 
Due to the inconsistency between napping behaviour as recorded by actigraphy and 
KSS measures, it cannot yet be concluded if this is due to actigraphy or poor patient 
perception. Actigraphy based assessment of napping behaviour has been known to 
overestimate diurnal sleep behaviour by miscoding quiet wakefulness as sleep (P. 
Hauri, 1992). However, Roehrs et al. (2000) suggested that actigraphy is perhaps a 
more real world index of daytime sleepiness compared to MSLT methods. Previous 
studies have also indicated that stroke patients underestimate their own sleepiness 
(Bassetti et at., 1996; Bassetti & Valko, 2006; Masel et al., 2001). Further research 
using alternative objective measures of sleep is necessary to clarify this issue. 
Some authors have suggested that use of actigraphy in brain injured patients with 
physical disabilities are subject to artefact. Basetti commented that the influence of 
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fatigue and hemisparesis may contaminate actigraphy recordings (C. Bassetti et al., 
1996). Laakson et al (2004) examined the use of actigraphy in patients with varying 
motor handicaps and found actigraphy was useful in patients with mild to moderate 
disability whereas those with severe handicaps in this study, i. e. almost motionless, 
required a highly sensitive algorithm to detect sleep. The present study shows good 
overlap on actigraphy and sleep diaries which suggests that the findings of Laakson 
et at. (2004) can be extended to patients with low functioning hemiparesis. Another 
study used actigraphy to measure circadian rhythm (Takekawa et al., 2007). 
Actigraphy was considered a valid measure in this sample as this data coincided with 
other measures of circadian rhythm including body temperature. 
Possible Confounds Upon Residual Motor Ability 
Inter-patient variability is difficult to control in any study involving stroke patients. 
Motor recovery is a multi factorial process which may be influenced by factors 
beyond control of this study including, stroke pathogenesis, genetics, quality of 
medical care and rehabilitation resources as well as the patients own motivation and 
family support. However the current study used stringent selection criteria which has 
led to a homogenous group. It is also important to note that all patients received 
standard UK treatment and rehabilitation provided by the NHS whereas two patients 
received care overseas. 
4.4.4 Future Studies 
In order to ultimately characterise sleep in chronic stroke patients, it would 
additionally be useful to incorporate the gold standard measure of sleep, i. e. PSG 
recordings. However PSG is challenging in the laboratory environment for patients 
with motor deficits. Therefore the future way forward would be the use of home 
based PSG. 
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Activity was determined by actigraphy did not appear to be related to sleepiness or 
fatigue therefore alternative measures need to be employed to further examine the 
accuracy of subjective reports in these patients. Therefore using objective measures 
would be beneficial. One possible measure is employing a physiological biomarker to 
assess levels of alertness, i. e. waking EEG. 
The findings of this study revealed that sleep and daytime functioning is related to 
upper affected limb motor ability. Therefore sleep and daytime functioning may have 
a role in patients undergoing rehabilitation which specifically aims to increase motor 
movement in the affected limb, such as CIT. It may be particularly useful to 
implement actigraphy and sleep diary monitoring in those patients undergoing 
rehabilitation to examine this link. 
Conclusion to Chapter 4 
This is the first known study to prospectively measure sleep and daytime functioning 
behaviour over two weeks in a group of chronic stroke patients with residual motor 
deficits. The findings have contributed important information regarding the 
characterisation of sleep, sleepiness, fatigue and activity levels. The results have also 
suggested a relationship between sleep and daytime functioning are related to residual 
motor ability. Critically, these findings were obtained through fine grained motor 
ability assessments. 
" The majority of patients were reasonably accurate in reporting nocturnal sleep 
behaviour however were less accurate for indices pertaining to night time 
awakenings. 
" Napping reports appeared to be underestimated in patients and when 
compared to actigraphy. Furthermore, napping was unrelated to subjective 
sleepiness and daytime activity levels. 
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" According to 24 hour objective assessments, some stroke patients in this study 
presented disturbed sleep, increased napping and a significant increase in 
sleepiness and fatigue in the evening compared to morning. 
" Sleep and daytime functioning is associated with levels of residual motor 
functioning. 
" This study presented a useful protocol for monitoring longitudinal sleep 
behaviour in chronic stroke patients with residual deficits therefore was 
continued to be used for the collection of data during the neurorehabilitation 
trial reported in Chapter 6 of this thesis. 
Discussion of the current results highlighted a need for more objective measurements 
of daytime functioning in patients. Although few such measures exist for fatigue, 
several studies have indicated that waking EEG is sensitive to increasing sleepiness. 
It was therefore the prerogative of Study 3, presented in the following chapter, to 
further explore sleepiness in chronic stroke patients. 
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CHAPTER 5 
Study 3: EEG-derived biomarkers for daytime 
sleepiness in patients with chronic stroke 
Chapter 5 Overview 
The objective measure of sleep employed in Study 4 revealed that stroke patients 
were reasonably accurate in reporting their sleep. However, the study lacked an 
objective measure of daytime sleepiness and it could not be determined if patients had 
good perception of their daytime functioning. Therefore, the current study aimed to 
specifically examine post stroke objective sleepiness using EEG in the context of a 
motor priming task recorded during wakefulness in a group of 32 stroke patients and 
matched controls. In addition, patient perception of sleepiness levels was assessed 
using a subjective rating. Few studies have objectively examined post stroke 
sleepiness, and of these few, none have used EEG to measure arousal levels. This 
study will further characterise daytime functioning as part of the post stroke sequelae 
and determine the degree to which patients are able to perceive sleepiness. 
5.1 Introduction 
Brief periods of increased sleepiness is a normal response to fluctuations of the 
homeostatic drive and circadian rhythm. However sleepiness in excess is considered 
abnormal and is recognised by the International Classification of Sleep Disorders 
(ICSD-10). Furthermore, sleepiness is severely under researched in chronically ill 
populations, particularly in chronic stroke. Of the few studies available, measures of 
sleepiness are normally limited to subjective reports with little comparison to 
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objective assessments. This is surprising as excessive sleepiness is a common 
observation within the post stroke sequelae and strongly contributes to poorer quality 
of life (Schuilling et al. 2005). Moreover, it is conceivable that sleepiness hinders the 
success of rehabilitation efforts in this population and hence outcome and recovery 
(Barker-Collo et al., 2007; Morley et al., 2005; Muller et al., 2006; Worthington & 
Melia, 200616). A greater understanding of post stroke sleepiness is necessary for post 
stroke treatment and management, particularly with regard to patient well being and 
safety. 
5.1.1 Definitions of Sleepiness In Research 
Sleepiness refers to sleep propensity or a readiness to fall asleep, in opposition to 
alertness or increased arousal (Dement & Roth, 2005). Feelings of sleepiness during 
the day are typically experienced as a result of circadian timing, soporific 
environments, due to tasks (e. g. monotony) or events (after exercise), ill health and 
medication side effects (Dement & Roth, 2005; Happe, 2003). Sleepiness becomes a 
clinical syndrome when it is recurrent, intense and affects daily functioning, 
sometimes referred to as excessive daytime sleepiness (EDS). The International 
Classification of Sleep Disorders (ICSD) recognises EDS as "the inability to stay 
awake and alert during the major waking episodes of the day, resulting in unintended 
lapses into drowsiness and sleep". In instances where the sleepiness is not typically 
caused by poor sleep at night, and has another origin, it is termed `hypersomnia'. The 
ICSD specifically categorises hypersomnia due to a medical condition if the presence 
of sleepiness is not better explained by poor sleep at night, medication, mental health 
disturbance or substance abuse. Specifically regarding stroke, Bassetti and Valko 
(2006) defined post stroke hypersomnia, as "exaggerated sleep propensity with 
excessive daytime sleepiness, increase daytime napping, or prolonged nighttime sleep 
following cerebrovascular event" (p. 1). 
16 Mixed stroke and TBI sample. 
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5.1.2 Measuring Sleepiness 
Measuring Sleepiness 
Sleepiness research typically involves studying waking behaviour under experimental 
conditions where sleepiness is monitored or even induced using sleep deprivation 
paradigms. Habitual sleepiness levels in the natural environment have also been 
studied. There are four main methods used to quantify sleepiness: 1) subjective 
ratings, 2) performance decrements, 3) sleep propensity measures and 4) arousal 
decrease measures. 
Subjective assessments of sleepiness are useful as they address feelings of sleepiness 
from the participant's perspective. This is typically measured using questionnaires. 
Many studies employ validated and highly reliable questionnaires such as the 
Epworth Sleepiness Scale (ESS; Johns, 1991) and Karolinska Sleepiness Scale (KSS; 
Akerstedt & Gillberg, 1990). The ESS is a general measure of habitual sleepiness, 
sometimes referred to as `trait sleepiness'. The KSS is an immediate rating of current 
sleepiness, referred to as `state sleepiness', and is particularly useful in addressing 
sleepiness over close time points. The KSS is highly sensitive to EEG and 
behavioural variables (Gillberg et al., 1994; Kaida et al., 2006). 
Performance decrements on psychometric tests are also used as an objective measure 
of increasing sleepiness such as psychomotor vigilance, motor performance, memory, 
mental addition, logical reasoning and visual search tasks (Pilcher & Huffcutt, 1996; 
Samkoff & Jacques, 1991). Performance is usually measured in terms of reaction 
time, correct responses and lapses. It is also important to consider that length and type 
of task have deferential affects upon performance (Pilcher and Huffcutt, 1996). 
Sleep propensity tests have been devised to objectively examine sleepiness in 
laboratory conditions. The two most commonly used tests are the Multiple Sleep 
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Latency Test (MSLT; Carskadon, p962-96,1994) and the Maintenance of 
Wakefulness Test (MWT; Mitler et al., 1982). The MSLT measures how long it takes 
a person to fall asleep within 20 minutes where as the MWT examines how long a 
person can stay awake for 20 minutes. Both tests are conducted in a dark sleep 
laboratory and use polysomnographic (PSG; See Section 1.2.3, Chapter 1) signals to 
determine when stage one sleep has commenced. The shorter the sleep latency, the 
more sleepy a person is considered to be. 
Physiological arousal are used to measure sleepiness. The most commonly used 
method is electroencephalography (EEG). EEG records brain activity which is used 
to determine whether a person is awake or asleep (for further clarification of EEG 
recording please refer to Section 1.2.3, Chapter 1). Moreover, quantitative EEG 
(QEEG) analysis enables additional information regarding brain activity 
characteristics to be obtained, i. e. the frequency composition. EEG patterns in the 
normal waking adult consist primarily of beta and alpha rhythms (> 12 Hz), however 
when arousal decreases, the rhythm becomes dominated by alpha. The transition to 
increased sleepiness is associated with the presence of theta (4-7 Hz) (Finelli, 
Baumann, Borbely, & Achermann, 2000; Harris, 2005) pertaining to the onset of 
stage one sleep. Sleep deprivation studies have shown that in increase in power 
within the alpha and theta range (Cajochen, Brunner, Krauchi, Graw, & Wirz-Justice, 
1995; De Gennaro et al., 2007). In healthy participants, a significant increase alpha 
and theta in the EEG normally coincides with an increase in subjective sleepiness 
ratings (Akerstedt & Gillberg, 1990; Marzano et al., 2007; Torsvall & Akerstedt, 
1988). Although some delta, otherwise known as slow wave activity, is present in 
severely sleepy yet healthy individuals (Chapotot, Pigeau, Canini, Bourdon, & 
Buguet, 2003), increased power is considered in the absence of sleep deprivation is 
considered abnormal and is usually present after brain damage (Finnigan et al., 2004; 
Finnigan et al., 2007; Lukashevich et al., 1999; Murri et al., 1998; Sainio et al., 
1983). Other methods used to determine physiological arousal levels include heart 
rate variability, pupillary unrest index and slow eye movement detection (Franzen et 
al., 2008; Kaida et al., 2007). 
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According to Curcio, Casagrande, & Bertini (2001), the varying measures used to 
address sleepiness as discussed above, are differentially associated with sleepiness. 
Subjective rating should not be solely relied upon when examining clinical 
populations (Roth & Roehrs, 1996). Furthermore, performance measures are 
associated with lower motivation and boredom which is sometimes misinterpreted as 
sleepiness (Akerstedt et al., 2008). A combination of objective and subjective 
measures provides useful information when addressing sleepiness. 
5.1.3 Sleepiness in Chronic Stroke 
Excessive sleepiness is commonly reported after stroke in the acute phase (Bliwise et 
at., 2002; Davies et at., 2003; Good et al., 1996). For some patients, this evolves into 
a chronic problem (Bassetti et al., 1996; Campos et al., 2005; Masel et at., 2001 1'; 
Schuiling et al., 2005; Vock et at., 2002; Worthington & Melia, 2006). Brain damage 
may directly cause decreases in wake promoting neurotransmitters such as dopamine 
and serotonin, and excitatory neurons such as hypocretin (Bassetti and Valko 2006). 
Overall, post stroke sleepiness has been attributed to a myriad of causes, in addition 
to the brain damage per se (Happe, 2003) such as depression (Bassetti and Valko, 
2006), low social interaction (Campos et al., 2005), medication use (Bourne & Mills, 
2004; Lowson & Sawh, 1999; Novak & Shapiro, 1997; Obermeyer & Benca, 1996), 
poor sleep at night (Bassetti et at., 1996) and general poor health (Schuiling et at., 
2005). The results of Chapter 3 have shown that psychological factors are an 
important contributor to subjective sleepiness. Strokes of varying topographies have 
been associated with sleepiness which has been attributed to the widespread arousal 
system in the brain (Bassetti and Valko, 2006). 
" Mixed stroke and TBI. 
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The majority of studies examining sleepiness after stroke use subjective measures 
however several authors have speculated that patients may underestimate their 
sleepiness levels (Bassetti et al., 1996; Bassetti & Valko, 2006; Castriotta & Lai, 
2001; Makley et al., 2008; Masel et al., 2001). Patients may either be influenced by 
experimental biases by modifying their responses due to demand characteristics (Lied 
& Kazandjian, 1998) or they have an inability to accurately perceive how they are 
feeling (Trudel, Tryon, & Purdum, 1998). Using the MSLT, Masel et al. (2001) 
compared objective sleep propensity with subjective reports on the Epworth 
Sleepiness Scale. It was concluded that patients did not appear aware of their 
sleepiness. However this study used a mixed TBI and stroke sample which may 
differentially present differences in the manifestation of daytime sleepiness. 
Furthermore, a subjective measure of habitual sleepiness was used rather than current 
state sleepiness. Another potential issue within this study is that MSLTs require 
patients to try to fall asleep in unnatural laboratory conditions which may impact the 
sleep onset latency during the day. For example, patients may find it more natural to 
fall asleep in front on the television at home, but less likely to fall asleep in a purpose 
built sleep laboratory wearing electrodes and awareness of others monitoring them. 
Another option to measure objective sleepiness in stroke patients is to record the EEG 
during wakefulness. This method would not require patients to unnaturally force 
themselves to fall asleep or stay awake therefore enabling the capture of brain arousal 
in a normal waking state. Furthermore, patients can rate their current sleepiness levels 
subjectively whilst the recording is taking place, similarly to the studies of Akerstedt 
& Gillberg (1990), Marzano et al. (2007) and Torsvall & Akerstedt (1988), however 
without the use sleep deprivation. 
At present, waking EEGs in stroke patients are usually used it as a clinical tool to 
detect abnormality in brain function after stroke (Nuwer, 1988b). Increased delta 
activity has been associated with a poorer prognosis in acute stroke (Finnigan et al., 
2004; Lukashevich et al., 1999; Murri et al., 1998; Sainio et al., 1983). Furthermore, 
EEG abnormalities persist for months stroke (Giaquinto, Cobianchi, Macera, & 
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Nolfe, 1994; Mattia, Spanedda, Babiloni, Romigi, & Marciani, 2003; Nagata, 1989a; 
Nagata, Tagawa, Hiroi, Shishido, & Uemura, 1989b; Yokoyama et al., 1996; Yuasa, 
Maeda, Higuchi, & Motohashi, 2001) and are associated with the current levels of 
functional recovery (Yuasa et al., 2001). EEG mapping techniques (see section 2.5.1, 
chapter 2) have also shown that increased slow waves are typically most prominent 
on the same side as the lesion (ipsilateral), however some studies have shown 
abnormalities within the less affected hemisphere (contralateral), opposite to the 
lesion (Giaquinto et al., 1994; Hachinski et al., 1987; Juhasz, Kamondi, & Szirmai, 
1997; Mattia et al., 2003; Nagata, 1989a; Nagata et al., 1989b). Furthermore, greater 
symmetry between hemispheres was associated with better functional outcome 
(Giaquinto et al., 1994). 
One study acknowledges sleepiness in post stroke waking EEG however it was 
considered a confounder within the EEG rather than an effect that requires measuring 
(Finnigan, Rose, & Chalk, 2008; Finnigan et al., 2007). Another study incorporated a 
`biosocial' rhythm parameter when examining the EEG of chronic stroke patients, 
however this measure contained items relating to nocturnal sleep, social activity, 
napping behaviour and fatigue, not an independent measure of sleepiness. A 
relationship between increased alpha and better biosocial rhythms was observed 
(Yuasa et al., 2001). Critically, no study has used EEG in the context of post stroke 
sleepiness in chronic patients. 
5.1.4 The Rationale For Study 3 
More research on post stroke sleepiness is essential. It is important for the medical 
profession to identify and treat sleepiness in long term chronic illness (El-Ad & 
Korczyn, 1998). Increased sleepiness poses serious risks to a patient's safety 
(Michael, Allen & Macko, 2006) and others around them (K. Kaida et al., 2007). 
Stroke patients are more likely to have car accidents, attributed to sleepiness and 
fatigue (Lundqvist et al., 2008; Sagberg, 2006). If patients are unaware of their 
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sleepiness, as speculated by some authors (Bassetti et al., 1996; Bassetti & Valko, 
2006; Masel et al., 2001; Trudel et at., 1998), their lifestyle may not accommodate the 
possible deficits in daytime functioning and not involve precautions to minimise risk. 
Living with excessive sleepiness contributes to a poorer quality of life after stroke 
(Schuiling et al., 2005). Excessive sleepiness in patients prevents social activities 
(Campos et al., 2005) and severely impacts the ability to return to work (Murray et 
al., 2003). The cognitive problems associated with stroke have been partly attributed 
to sleepiness (Van Zandvoort et al., 1998). This may explain why rehabilitation 
sessions are also problematic for sleepier patients (Morley et al., 2005; Muller et al., 
2006; Worthington & Melia, 2006). 
5.1.5 The Current Study 
The aim of the current study was to use EEG as an objective measure of sleepiness. 
This method will not only contribute to the understanding of the level of sleepiness 
experienced by chronic stroke patients but it will also help determine if stroke 
patients are aware of arousal decrements in an experimental situation. Furthermore, 
the EEG set up employed in this study allowed the topography of frequency 
composition to be examined. 
The CIT protocol provided an opportunity for waking EEGs to be recorded in relation 
to a motor priming task. Prior to this study, laboratory observations indicated an 
increase in subjective sleepiness after the motor priming task. Therefore the recording 
of waking EEGs were subsequently introduced pre and post of the motor task as well 
as asking patients for a subjective sleepiness rating. This paradigm was also carried 
out in healthy matched controls for comparison with stroke patients. 
Research Aims 
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The aim of this part of the study within the larger framework of the thesis was to 
provide a physiological biomarker of sleepiness in chronic stroke patients. Based on 
the literature, the following research questions were formulated: 
1. What are the differences of the EEG frequency composition (<30 Hz) 
between chronic stroke patients and matched controls? 
2. To what degree is subjective sleepiness and the EEG altered after the motor 
priming task in stroke patients and controls? 
3. Is subjective sleepiness related to the EEG in stroke patients and controls? 
4. Is a larger increase in sleepiness after the task related to performance 
decrements on the motor task? 
5.2 Methods 
5.2.1 Desin 
The waking EEG paradigm for this study was carried out during the pre-CIT test 
point (T2; Figure 5.1). The EEG paradigm comprised a repeated measures design 
whereby clean EEGs (no task) were recorded before and after a motor priming task 
(Figure 5.2). Four groups completed this paradigm: 1) left stroke patients, 2) matched 
controls for left stoke patients, 3) right stroke patients, and 4) matched controls for 
right stroke patients. Pre task data was examined in order to analyse differences in the 
EEG between stroke patients and matched controls. The degree of symmetry between 
hemispheres was also addressed. Pre and post task changes in the EEG and subjective 
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sleepiness ratings were examined per group. Furthermore, the relationships between 
subjective and objective sleepiness within each group was examined. 
I 
Baseline Testing (TI) Pre Testing (T2) Post Testing (T3) 
r2 Hours 2 Weeks 2 Weeks i2 Weeks 
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Figure 5.1. Design of CIT trial, The highlighted section indicates time point from 
which data for this study was collected. 
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5 . 2.2 Participants 
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Thirty-two community dwelling chronic stroke patients attended pre-CIT testing (T2) 
prior to the CIT phase of the trial which formed an opportunity sample for data 
collection analysis for the current result chapter 18. All participants fulfilled the 
inclusion/exclusion criteria as described in Section 2.2.1 (Chapter 2). 
In addition, 32 age and gender matched non-brain injured control participants drawn 
from the general population were recruited. People with clinically significant sleep 
disorders were excluded to avoid the confounds of sleep related treatment during the 
study, however the sample is likely to contain what would be classified as poor 
sleepers (a sampling method used by Lichenstien et al. 2004, p. 73). 
5.2.3 Materials 
Waking EEGs were recorded using a 64 channel set up (Brain Products GmbH (0). 
Electrodes were applied using a cap with pre-defined sites based on the 
internationally standardised 10-10 system19. Electrode impedances were kept below 
5kOhm and were recorded against an average reference calculated by the amplifier 
hardware. EEG and EOG signals were continuously recorded in DC mode. Raw EEG 
data was analysed offline for frequency analysis (QEEG). The KSS was used as a 
subjective measure of state sleepiness (see Section 2.3.4, Chapter 2). The KSS 
requires patients to rate their current level of sleepiness ranging from I (very alert) to 
7 (very sleepy). 
18 A total of 52 patients attended T2 (pre-CIT test point; section 2.2.1, chapter 2). Twenty patients were 
not included in the analysis for this study. Two patients were excluded from this study as they 
presented of bilateral strokes. One patient could not complete then EEG due to having braided hair 
which affected electrode application. Six could not complete the full protocol due to tiredness and 
being uncomfortable. The data of nine patients was not used as the EEG contained too much artefact to 
yield at least one minute of artefact free recording. The EEGs of two patients could not be used due to 
loss of C3 or C4 channels during the experiment. 
19 Please refer to section 2.3.5 (Chapter 2) for a detailed description of EEG equipment used for EEG 
data acquisition in this chapter. 
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This study used a motor priming paradigm (Section 2.3.5, Chapter 2) which was 
designed to elicit preparation and execution of movement. The task involved the 
presentation of one of four pre-cues (left «, right », uninformative <> or no- 
response ><). Immediately following the prime, participants were presented with one 
of three response cues (left half, right half, or bottom half circle filled in white). Pre- 
cues were 100% predictive of response cue. Each pre-cue was randomised. Pre-cues 
and corresponding response cue were presented 12 times which equated to 60 trials in 
I approximately 4 minute block. The response window was 1830 to 3500 
20 milliseconds 
5.2.4 Procedure 
Both patients and controls followed the same procedure for this study. After electrode 
application, waking EEGs were recorded for two minutes pre and post of the motor 
priming task with eyes open. During the waking EEG, participants were instructed to 
focus on a black dot on the centre of the screen. Immediately preceding the waking 
EEGs, participants were asked to complete the KSS. The full EEG procedure is 
described in Section 2.4.2 (Chapter 2). 
5.2.5 Analysis 
For data acquisition, filtering and storage information, please refer to section 2.3.5 
(Chapter 2). Left and right stroke groups were analysed separately. 
QEEC Analysis 
20 Response window was extended for those patients who have difficulty using their affected within the 
set time of 4000 milliseconds. 
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EEG signals were analysed offline. The raw EEG recording from the experiment was 
approximately 45 minutes long. Pre and post clean EEG (no task) was segmented 
from the raw data for each participant. Each pre and post section was subjected to 
manual artefact inspection for the removal of eye blinks and muscle noise which 
contaminate the recording. Artefact free epochs were used for analysis. The pre and 
post segment of two minutes each were further subdivided into equally divided two 
second epochs for frequency analysis. The frequency composition was analysed using 
the Fast Fourier Transform (FFT) method (see Section 2.5.1, Chapter 2). FFT criteria 
was set to full spectrum, resolution 0.5 Hz, power density output (µV2/Hz) and the 
hanning window (10%) was applied. The FFT produced power density spectra values 
(µV2 /Hz) per two second epoch. These two second power spectra values were then 
averaged together. Averaged values were exported as text files which contained the 
power density spectra in 0.5 Hz bins ranging from 1 to 30 Hz (at a resolution of 0.5). 
From this data, continuous frequency information per 0.5 Hz was transformed into 1 
Hz bins for analysis. In addition, the values within these 1 Hz bins were further 
subdivided into discrete, non-overlapping frequency bands: delta (1-3 Hz), theta (4-7 
Hz), alpha (8-12 Hz) and beta (13-30 Hz). Due to the high variability in the EEG 
between patients, power density values were log transformed using Lg10 to normalise 
the distribution. This technique has been used in previous studies (Lockley et al., 
1999; Viola et al., 2008). 
Motor Paradigm Performance Measures 
In addition to the EEG, behavioural parameters including reaction time (ms) and 
percent of correct responses on the motor preparation task were recorded a measure 
that is sensitive to sleepiness. Reaction time (ms) was defined as time between 
response cue onset and button press. Correct response mapped on the instruction 
given by the response cue. Reaction time and percent correct as determined by the 
non affected hand was used for stroke patient responses. Reaction time and correct 
responses were averaged across blocks. 
Statistical Analysis 
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Transformed EEG data and other variables were entered into SPSS for statistical 
analysis. Statistical analyses were performed using C3 and C4. All 64 electrodes sites 
were used for topographical mapping. The p values obtained from the test of 
difference as calculated in SPSS were reimported back into Brain Vision Analyser. 
This enabled the p values to be mapped onto brain masks to demonstrate areas of 
significant changes, a technique known as probability mapping, used in previous 
studies (B6dizs, Lazar, & Rigo, 2008; Hassainia, Petit, & Montplaisir, 1994). Data 
for left and right affected patients and the corresponding matched controls were 
analysed and presented separately. For all stroke patients, the more affected 
hemisphere is referred to as the ipsilateral (same side as lesion) and the less affected 
hemisphere is termed the contralateral (opposite to the lesion). 
In order to clearly indicate differences between different conditions for EEG data in 
graphical format, it was useful to express the power density values of the stroke 
patients as a percentage of the control group, a method previously been used by 
others (James, 2008; Lockley et al., 2006; Viola et al., 2008). This was achieved by 
calculating geometric means through the following steps: 1) transforming power 
density values by log base 10 (Lg l0), 2) averaging across participants, 3) subtracting 
one condition from another, e. g. stroke patients minus controls, 4) antilogging these 
values and 5) multiplying by 100. Therefore the control condition becomes 100% and 
any increase or decrease of this baseline represents a change in the stroke patient 
group. Geometric means were calculated for visual representation of the data only. 
Geomeans calculations were also utilised for between hemisphere differences. In this 
instance, the ratios of power density between hemispheres were calculated per 
frequency bin (1-30Hz), i. e. the ipsilateral hemisphere was divided by the 
contralateral hemisphere. 
Between tests of difference for the logged power density values were calculated using 
t-tests, whereas the Mann Whitney U Test was used for between group demographic 
data which was non-normal. To analyse between hemisphere differences within 
groups, t-tests against I were conducted using the ratio data. Therefore the closer the 
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ratio value is to 1, the less difference there is between hemispheres. Correlation 
analyses was applied to address the relationship between the EEG and the KSS. 
Analyses models were applied to the whole sample to examine group and task related 
differences. A two-way analysis of variance (ANOVA) was conducted to assess 
differences in KSS scores. A two-way between groups multivariate analysis of 
variance (MANOVA) was performed to assess if there are any differences or 
interactions between group, brain hemisphere and task on the EEG. For AVONA 
analyses, the Wilk's Lambda statistic was reported. 
For EEG data, statistical tests were conducted on the power density values calculated 
for each 1 Hz bun between I and 30 Hz or for each frequency band. All EEG 
statistical analyses were performed on logged data only. Statistical tests were carried 
out using a one tailed analyses and the alpha level was set to p<0.05. The Bonferroni 
multiple comparisons correction was used for ANOVA and MANOVA results. 
5.3 Results 
5.3.1 Demographics 
Fourteen patients experienced left hemispheric stroke and 18 experienced right 
hemispheric stroke. The demographics of left and right stroke patients and the 
corresponding matched control groups are presented in Tables 5.1 and 5.2 
respectively. The majority of patients had a primary caregiver, usually a family 
member, and those who lived alone required assisted living from local services. Left 
and right patient groups were generally comparable. There were no significant 
differences between groups for age, BMI, Mini Mental State Exam, chronicity, or 
nicotine consumption between stroke patients and controls. Left stroke patients 
consumed significantly more caffeine (U=43, p=0.0106) and drank more alcohol 
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(U=56, p=0.0556) compared to controls. Right stroke patients also consumed 
significantly more alcohol than controls (U=75, p=0.0301). 
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Table 5.1. The `Left Group'. Data presented as mean, +/- 1 SD and range or percent 
valid where appropriate. The remaining 57.14% of stroke patients unlisted for 
employment status were classified as not working. Sleep medication was taken by 
one control participant (Zipiclone taken irregularly). For individual case information 
for all participants, see Appendix C. 
Demographical Variables 
Gender (M: F) 
Age (Years) 
BMI 
NART (10) 
Mint Mental State Exam' 
Education Level: 
School Leavers Cert¢ic ate 
Further Study 
Higher Education 
Employment Status: 
Full Time 
Part Time 
Rehired 
Studying 
Living Support: 
Lying Alone 
Lying With Family 
Chronicity (Months) 
Type of Stroke: t 
Ischemic 
Hemorrhagic 
Beth 
Lesion Hemisphere 
Co-morbld Conditions 
Psychdogical 
Muscular 
Neurological[ 
Cardiac 
Cancer 
Diabetes 
Pain 
Dysphasia 
Medication: 
Anti-depressant 
Pain Relief 
Cardiac Control 
Anti epileptic 
Sleep Hypnotics 
Alcohol (Units per week) 
Caffeine (Cups per day) 
Nicotine (Cigarettes Per Day) 
Left Stroke Patients Matched Controls 
(n=14) (n=14) 
86 86 
56 57 ± 11 11 (32.73) 56 36 ! 12 48 (33-72) 
23 48 t3 02 (18 20-27 30) 24 12 ±3 28 (19 20-30 80) 
11352! 803(96.126) - 
28.83±112(27-30) - 
42.87% 28 57% 
28 57% 14 29% 
28 57% 57 14% 
None 
14 29% 
28 57% 
Nme 
78 57% 
21 43% 
59 74 t 50 41 (11.252) ma 
1429% nla 
21 43% wa 
7 12% Na 
30 Left. 31 Rignt ma 
21 43% None 
None None 
714% Nme 
50 % None 
714% None 
We None 
None Ncne 
5556% No 
None None 
None None 
7 14% None 
714% None 
None 1 64% 
807! 925(0-28) 190! 331 (0 10) 
5.431 3 16(0-12) 2 34 z2 35 (0.7) 
0071027(0-1) 0 71 i261(0-10) 
(-) not required or recorded as part of this study. 
* 55.56% of the patients experienced expressive aphasia and only completed the 3-step command on 
the MSE only therefore were not included in the total mean score. These patients also did not complete 
the NART. 
fi The remainder of these values were classified as unknown. 
$ Neurological conditions other than stroke. 
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Table 5.2. The `Right Group'. Data presented as mean, +/- 1 SD and range or as 
percent valid where appropriate. The remaining 38.89% of stroke patients unlisted for 
employment status were classified as not working. Sleep medication was taken by 
one control participant (Zipiclone taken irregularly). For individual case information 
for all participants, see Appendix C. 
Demographical Variables 
Gender (M: F) 
Age (Years) 
BMI 
NART (IQ) 
MInI Mental State Exam 
Education Level: 
School Loavers Certificate 
Further Study 
Higher Education 
Employment Status: 
Full Time 
Part Time 
Retired 
Studying 
Living Support: 
Living Alone 
Living With Family 
Chronlclty (Months) 
Type of Stroke: ' 
schemic 
Hemorrhagic 
Both 
Co-morbid Conditions 
Psychological 
Muscular 
Neurologicalt 
Cardiac 
Cancer 
Diabetes 
Pain 
Dysphasia 
Medication: 
Anti-depressant 
Pain Relief 
Cardiac Control 
Anti-epileptic 
Sleep Hypnotics 
Alcohol (Units per week) 
Caffeine (Cups per day) 
Nicotine (Cigarettes Per Day) 
Right Stroke Patients Matched Controls 
(n=18) (n=18) 
108 108 
51 89 ± 12 83 (28-69) 54 44 *_ 13 71 (33-72) 
24 58 ±2 09 (2140-28 90) 24 79 *_ 3.71 (18 00-30 80) 
11588±687(100-126) 
- 
29 28 ±1 02 )26-30)" 
38 89% 28 57% 
33 33% 14 29% 
27.78% 57 14% 
1111% 
27.78% 
22 22% 
None 
83 33% 
16 67% 
65 61 1 49 40 (13-210) nla 
50 00% n/a 
11 11% n/a 
556% n! a 
44 44% None 
556% None 
33 33 % None 
55 56% None 
None None 
5 56% None 
None None 
None None 
1111% None 
None None 
556% None 
22 22% None 
None 1 64% 
9 69 ± 12 00 (1-45) 4.06 ±8 48 (0-35) 
354±207 (0-7) 334±271 (0-10) 
1 67 t5 15 (0-20) 0.56 ±2 36 (0-10) 
(-) not required or recorded as part of this study. 
* The remainder of these values were classified as unknown. 
t Neurological conditions other than stroke. 
5.3.2 The Effects of Stroke On The EEG (Pre Task Data Only) 
Between Groups Power Density of Central Electrodes Across 1-30 Hz 
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Figures 5.3a and 5.4a present the logged µV2/Hz values of the ipsilateral and 
contralateral hemisphere (either C3 or C4 channels) for the stroke patients as a 
percentage of control values (geometric mean) per 1 Hz bin. The corresponding t 
values are presented below for between group differences. 
Figures 5.3a and 5.4a show significantly increased power between 2 and 7 Hz within 
the ipsilateral hemisphere compared to controls. There is also a significant increase in 
power between 2 and 5 Hz within the contralateral hemisphere. More specifically, 
power increases observed in right affected stroke extended to 8 Hz and 9 Hz in the 
contralteral and ispilateral hemispheres respectively (Figure 5.3). 
After summing 1 Hz bins into corresponding frequency bands, it was revealed that 
patients had increased delta (left stroke patients: t(26)=2.11, p=0.0449; right patients: 
t(34)=4.12, p=0.0002) and theta (left stroke patients: t(26)=2.90, p=0.0090; right 
stroke patients:, t(34)=4.55, p=0.0000) in the ipsilateral hemisphere compared to 
controls. Increased ipsilateral alpha was found in the right stroke group (t(34)=2.43, 
p=0.0206; Figure 5.4). Furthermore, contralateral increases were observed for delta 
(t(34)=3.28, p=0.0033) and theta (1(34)=3.86, p=0.0006) in the right stroke group. 
The increases in power observed in the lower frequencies (>8 Hz) of patients are 
suggestive of high levels of sleepiness. 
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Power Density Per 1 Hz Frequency Bin For Left Stroke Patients (Pre Motor Task) 
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Figure 5.3. a) logged power density (µV2 /Hz) per 1 Hz bin, pink line=ipsilateral 
hemisphere (left, C3), blue line=contralateral hemisphere (right, C4), dashed black 
line (100%)=controls and left stroke EEG expressed as a percentage of controls. 
Figure 5.1 b) t values (df26) and corresponding one tailed p values of left stroke vs 
control. See Appendix El for the corresponding data tables. 
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Power Density Per 1 Hz Frequency Bin For Right Stroke Patients (Pre Motor Task) 
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Figure 5.4. a) logged power density (µV2 /Hz) per 1 Hz bin, pink line=ipsilateral 
hemisphere (right, C4), blue line=contralateral hemisphere (left, C3), dashed black 
line (100%)=controls and right stroke EEG expressed as a percentage of controls. 
Figure 5.1 b) t values (df34) and corresponding one tailed p values of right stroke vs 
control. See Appendix E2 for the corresponding data tables. 
Topographical Maps of Difference Between Groups 
To further examine the µV2/Hz distribution across the brain, topographical maps of 
the p values calculated for tests of difference between groups, per electrode, within 
each frequency band were computed. Figure 5.5 shows significant increases in global 
theta and alpha in the left stroke patients compared to controls. This effect is 
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particularly prominent within central and occipital areas for delta. Less affected 
occipital areas produced the least significant effects. Significant increases in beta was 
observed across the contralateral hemisphere, particularly within the frontal and right 
centro-parietal region. 
These maps show that frequencies <8 and >4 Hz are occur globally across the brain 
(Figure 5.5). The small increase in power in comparison to controls within frontal and 
right centro-parietal regions for the delta band may have occurred due to patients 
trying to remain alert whilst focusing on the dot on the screen despite feeling sleepy. 
p values 
o, Delta 
0.025 
0.06 
0.075- 
0.1 1 
Leh Stroke vs Controls 
Theta Alpha Bev 
Figure 5.5. Topographical map of p values of one tailed t test for power density 
(µV' /Hz) across all electrodes (df26) per frequency band left stroke vs controls. See 
Appendix E3 for values for each value per electrode within the map. Values between 
electrodes were interpolated using spherical splines. 
Global increases in theta and delta were observed for the right stroke patients. These 
effects were particularly prominent within the ipsilateral hemisphere (Figure 5.6). No 
significant differences across the brain were observed for the beta frequency range. 
The maps for right stroke patients suggest a different pattern to that observed in left 
patients. Right stroke patients present greater presence of slow wave activity, <4 Hz, 
during wakefulness. 
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p values Right Stroke vs Controls 
u- Delta Theta Alpha Beta 
0.070 
0.06 
0.075- 
Q., 
1 
Figure 5.6. Topographical maps of the p values calculated for tests of difference 
between µV2 /Hz of right stroke vs controls across all electrodes (df34) per frequency 
band right stroke vs controls. See Appendix E4 for values for each value per 
electrode. Values between electrodes were interpolated using spherical splines. 
Hemispheric Difference 
Figures 5.7 and 5.8 present the geometric means of one hemisphere as a percentage of 
the other for both patients and controls. For stroke patients, the ipsilateral hemisphere 
is expressed relative to the contralateral hemisphere. The closer the values are to 
100%, the less difference between hemispheres. T-tests against the baseline value of 
1 (100%) per group revealed that stroke patients showed the greatest level of 
hemispheric asymmetry. Left stroke patients showed significant increase in power 
within the affected hemisphere between 5 to 13 Hz. Right stroke patients revealed a 
significant increased in power for all frequencies <12 Hz decreased power in the 
higher frequencies for 17,18 and 24Hz. Controls did not show a systematic pattern of 
between hemispheric differences. 
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Figure 5.7. a) logged power density (µV2/Hz) per 1 Hz bin, pink line=left hemisphere 
or contralateral to stroke (C3), solid black line= control left hemisphere (C3), dashed 
black line (l00%)=ipsilateral hemisphere for left stroke or right hemisphere for 
controls (C4). Figure 5.5 b) t values (df13) and corresponding one tailed p values. See 
Appendix E5 for corresponding data table. 
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Power Density Per 1 Hz Bin For Right Stroke Patients 
and Controls (Pre Motor Task) 
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Figure 5.8. a) logged power density (µV2/Hz) per 1 Hz bin, pink line=right 
hemisphere or contralateral to stroke (C4), solid black line= control right hemisphere 
(C4), dashed black line (100%)=ispilateral hemisphere for left stroke or right 
hemisphere for controls (C3). Figure 5.6 b) t values (dfl7) and corresponding one 
tailed p values. See Appendix E5 for corresponding data table. 
5.3.3 Motor Priming Task Effects 
Performance Measures 
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Mean reaction time for the non affected arm was 546 ms (SD 107, range 362-740) 
and 612 ms (SD 306, range 291-1664) for left and right stroke patients respectively. 
Both control groups were faster than the stroke patients. The left control group mean 
reaction time was 447 ms (SD 71.81, range 333-601) and the right group mean 
reaction time was 428 ms (SD 68.51, range 326-601). Group differences in 
performance measures was statistically confirmed for right stroke patients versus 
controls (z=-2.5, p=0.0117) and left stroke patients versus controls (z=-2.62, 
p=0.0079). Percent correct responses were 99.43% (SD 0.73, range 97.9-100) for left 
and 97.2 (SD 7.34, range 68-100) for right stroke groups. The left controls were 
99.29% correct (SD 0.83, range 97.4 to 100) and the right controls were 99.34% 
correct (SD 0.75, range 96.4 to 100). These differences were not significantly 
different. Both patients and controls were similar in their level of correct responses. 
Subjective Alertness 
A two-way between groups ANOVA was performed to investigate group (stroke 
patients and controls) and task (pre and post) interactions on KSS ratings. Left and 
right stroke groups were analysed separately using the same ANOVA model. There 
were no significant effects for the group factor as patients and controls did not differ 
in subjective sleepiness ratings. A significant interaction of task was observed for 
task for the left, F(l, 52)=8.33, p=0.0056, nP2=0.14, and right group, F(1,68)=10.74, 
p=0.0017, nP2=0.14. KSS rating significantly increased by at least I point after the 
task for all groups (Table 5.3). 
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Table 5.3. KSS ratings pre and post motor task. Data reported as mean , -/+ 1 SD. t 
and p values for left stroke and control (dfl3), and right stroke and control (dfl7). 
Pre Task Post Task Mean 
KSS KSS r Difference p 
Right Stroke 3.72 ± 2.32 5.28 ± 2.02 1.56 -3.50 0.0027 Right Controls 3.05 ± 1.69 4.69 ± 2.21 1.67 -5.51 0.0000 
Left Stroke 3.43 ± 2.06 4.57 ± 2.03 1.14 -3.04 0.0095 Left Controls 2.79 ± 1.42 4.71 ± 2.33 1.93 -5.21 0.0000 
EEG 
Post task effects were observed for the higher frequencies (>8 Hz) in left affected 
stroke, demonstrated by significant increases in bilateral alpha and beta (Figure 5.9, 
Table 5.4). A similar effect was found for controls. Post task increases were found 
within the contralateral hemisphere of the right stoke patients for delta and theta 
activity. However, this effect was not observed for controls (Figure 5.10, Table 5.5). 
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Three-way between groups MANOVA was applied to investigate differences between 
µV2/Hz of frequency bands (delta, theta, alpha and beta, and a combined variable of all 
frequency bands) using three independent variables, including group (stroke patients and 
controls), hemisphere (ipsilateral and contralateral) and task (pre and post motor task). 
Left and right stroke groups were analysed separately using the same MANOVA model. 
Bonferroni adjustment was incorporated into the analyses by dividing the set alpha value 
(p) 0.05 by the amount of tests performed (3 IVs x4 DVs) therefore the new alpha value 
is 0.0042. 
A significant effect of group was observed for delta; F(l, 104)=28.22, p=0.0000, 
np2=0.21, and theta; F(l, 104)=19.02, p=0.0000, nP2=0.16, for left group. This indicated 
that patients had increased power in delta and theta bands before and after task compared 
to controls This effect was also observed for the right group (delta; F(l, 136)=40.58, 
p=0.0000, nP2=0.23, and theta; F(1,136)=36.42, p=0.0000, nP2=0.21). There was a 
noteworthy trend for an interaction of hemisphere x task for the right group for the 
combined variable of all frequency bands; F(4,133)=2.89, p=0.0246; Wilk's 
Lambda=0.92, np2=0.08. More specifically, near significant interactions of hemisphere x 
task were found for delta; F(l, 136)=5.18, p=0.0245, np2=0.04 and theta F(1,136)=5.68, 
p=0.0185, nP2=0.04. 
Relationship Between Objective and Subjective Sleepiness 
Correlation analyses revealed that patient KSS ratings were not related to the EEG for pre 
and post task data (Table 5.6, Figure 5.11 and 5.12). This suggests that patients were not 
informative of their current sleepiness state. For the right control group, increased pre 
task KSS correlated with pre task alpha (r=0.48, p=0.0106) and theta (r=0.56, p=0.0039). 
Also for controls, increased KSS correlated with post task alpha (r=0.58, p=0.0026). 
From visual inspection of the scatter plots (Figures 5.8 to 5.9), it was observed that 
increased KSS scores were mildly related to increased alpha, pre and post task, however 
this did not reach significance. These results indicate that controls could accurately 
perceive their level of sleepiness during the experiment. 
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Table 5.6. Spearman's Rho correlation coefficient for logged µV2 /Hz per frequency band 
pre and post task and KSS score. Significance indicated (*p<O. 01). 
Correlation with 
KSS 
Pre Task EEG: 
Beta 
Alpha 
Theta 
Delta 
Post Task EEG: 
Beta 
Alpha 
Theta 
Delta 
Right Stroke Right Left Stroke Left 
Control Control 
Ipsilateral Contralatral lpsilateral Contralateral 
032 0.29 0 31 0.33 0.33 0 17 
0.15 0.18 0.48' 0.10 0-40 0.41 
014 0 20 0.56' -0.29 -0.01 021 
0.16 0 04 0.30 -0 08 0.17 -0.05 
0.40 0.30 0.35 0.02 -0.12 0.36 
0.38 0.28 0.58" -0.11 0.14 0.44 
027 0.21 0.37 -0 42 -0.36 0.22 
0.22 0.23 0.11 -0.18 -0.05 -0.09 
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Scatter Plots Displaying KSS and Power Density Per Frequency Band For 
Left Affected Stroke and Controls 
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Figure 5.1 1. Scatter plots for left stroke KSS and µV2 /Hz per frequency band. la) C3= 
ipsilateral/left hemisphere and lb) C4=contralateral/right hemisphere. 2a and 2b display 
C3 and C4 sites as described for ]a and b however present post task data. Linear 
regression fit lines as indicated per group. 
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Scatter Plots Displaying KSS and Power Density Per Frequency Band For 
Right Affected Stroke and Controls 
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Figure 5.12. Scatter plots for right stroke KSS and µV`/Hz per frequency band. la) C4= 
ipsilateral/left hemisphere for control lb) C3=contralateral/right hemisphere for control. 
2a and 2b display C4 and C3 sites as described for Ia and b however present post task 
data. Linear regression fit lines as indicated per group 
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As performance decrements are associated with increased sleepiness in previous studies 
(Pitcher and Huffcutt, 1996; Samkoff and Jacques, 1991), the association between motor 
task behavioural outcomes (reaction time and percent correct) and change in KSS was 
assessed. Mean change in KSS (post minus pre) was not related to mean reaction time or 
percent correct on the motor task for the stoke patients or controls (Figure 5.13). 
Therefore, the observed increase in KSS, even though this was >1 point for both patients 
and controls, did not affect performance on the motor task (Figure 5.13). One major 
outlier within the right stroke patient group was removed for visual clarity of graphs 2a 
and 2c. This outlier was not removed for analysis. For scatter plots including outlier case 
in right stroke group, please refer to Appendix C 10. 
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Scatter Plots Of Motor Priming Task Performance and KSS For Patients and Controls 
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Figure 5.13. Mean change in KSS (post minus pre) and performance measures on the 
motor task; reaction time (RT) and percent correct (%). Linear regression fit lines as 
indicated per group. 
5.4 Discussion 
This study aimed to measure objective and subjective daytime sleepiness in stroke 
patients within the context of a motor priming paradigm. Furthermore, it was intended to 
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compare stroke patient data with a group of healthy non-brain injured matched controls. 
This was achieved by using EEG and subjective ratings on a state sleepiness 
questionnaire (KSS). According to the EEG, stroke patients appeared significantly more 
sleepy compared to controls. Engaging in the motor task increased subjective sleepiness 
of both patients and controls. The task did affect the EEG, however left stroke patients 
demonstrated increases in the higher frequencies whereas right stroke patients had 
increased lower frequencies after task. Subjective sleepiness was not related to EEG 
parameters in patients however was related in controls. This indicated that patients did 
not perceive their own sleepiness levels. 
5.4.1 Overall Findings 
Increased Objective Sleepiness In Patients 
The results of the waking EEG in the stroke patients clearly showed high levels of 
sleepiness, characterised by greater slow wave activity compared to controls, particularly 
within the ipsilateral hemisphere. A striking finding from results of the frequency 
analysis is that the high levels of power density observed (<10 Hz) in patients during 
wakefulness resembled the frequency composition of the EEG in sleep deprived non- 
brain injured participants (Cajochen et al., 1995; De Gennaro et al., 2007; Dumont, 
Macchi, Piche, & Herbert, 1997). Other studies have also found increased slow waves 
within the waking EEG in chronic stroke (Leon-Carrion, Martin-Rodriguez, Damas- 
Lopez, Barroso y Martin, & Dominguez-Morales, 2008; Yuasa et al., 2001) however this 
effect is interpreted as an indicator of brain abnormality rather than sleepiness in these 
studies (Simon P. Finnigan et al., 2007; Lukashevich et al., 1999; Nagata, 1989a; Sainio 
et al., 1983). The higher frequencies were only affected in the right stroke patients where 
a decrease in activity between 18 and 21 Hz was recorded in the affected hemisphere 
compared to controls. This result is consistent with other findings in acute stroke (Murri 
et al., 1998). 
Slow Wave Activity Distribution 
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The slowing of the EEG occurred globally across the brain. This was demonstrated for 
delta and theta bands in all patients as shown in the topographic maps. Furthermore, 
between hemispheric differences was greatest for frequencies <11 Hz. This effect has 
also been demonstrated in other studies (Giaquinto et al., 1994; Hachinski et al., 1987; 
Juhasz et al., 1997; Mattia et al., 2003; Nagata, 1989a; Nagata et al., 1989b). Increased 
slow wave activity during wakefulness and sleep over the unaffected hemisphere reflects 
global disruption of the cortext after stroke (Müller et al., 2002; Nagata, 1989a). The 
current study, in addition to others, shows that EEG alterations in both hemispheres 
during wake remain even years after insult (Seitz, Knorr, Azari, Herzog, & Freund, 
1999). 
Perception of Sleepiness 
The motor task elicited increases in sleepiness by >1 point on the KSS, average post task 
sleepiness levels reached a maximum of 5 (neither alert nor sleepy). Changes the EEG for 
both patients and controls. The EEG of the left stroke patients and controls both revealed 
increased post task alpha. In contrast, the right stroke patients experienced increases of 
slow wave activity in the contralateral hemisphere only. Right stroke patients presented a 
greater presence of slow waves (<4 Hz) pre-task which appeared to be little affected by 
task, unlike left stroke patients. In other studies, post task increases within the alpha 
range are indicative of mild subjective sleepiness whereas increased slow wave activity in 
suggestive of more severe sleepiness (Finelli et al., 2000; Harris, 2005). 
Despite task effects on the EEG, patient sleepiness ratings did not correlate with greater 
presence of slower waves or increased alpha whereas a relationship was observed for 
controls. Therefore, in contrast to controls, patients did not seem to perceive the extent of 
their own sleepiness, a similar phenomenon observed in sleep deprived healthy 
participants (Belenky et al., 2003; Van Dongen et al., 2003) and sleep disordered patients 
(Greneche et al., 2008; Sforza, Grandin, Jouny, Rochat, & Ibanez, 2002). It has been 
suggested that participants cannot reliably introspect their level of arousal when sleep 
deprived (Van Dongen et al., 2003). A crucial finding of the current study is that stroke 
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patients not only have similar EEGS to sleep deprived participants, they behave in a 
similar manner as they also cannot perceive sleepiness. 
Patients revealed an increase in beta after the task in the affected hemisphere. This effect 
was also observed in controls. This increase may be a result of the increased effort 
required to complete the task when experiencing sleepiness, known as 
`neurophysiological compensation' (Portas et al., 1998; Van Zandvoort et al., 1998). This 
can take the form of increased activity in brain regions important to the task and 
recruitment of other areas to aid the task when sleepy (Drummond & Brown, 2001; 
Portas et al., 1998; Szelenberger, Piotrowski, & Dabrowska, 2005). Neurophysiological 
compensation as a result of sleepiness has not yet been investigated in stroke patients 
however it has been suggested that as attentional capacity is limited, attentional effort 
reflects the allocation of cognitive and behavioural resources (Van Zandvoort et al., 
1998). 
In addition, the present study examined performance measures as a possible indicator of 
sleepiness. It was found that reaction time and percent correct were not related to KSS 
scores. This may be because sleepiness experienced by participants was not strong 
enough to generate show measureable performance decrements. Previous studies which 
have found performance decrements are usually under extreme sleepiness conditions, i. e. 
sleep deprivation paradigms (Akerstedt & Gillberg, 1990; Cajochen et al., 1995; De 
Gennaro et at., 2007; Marzano et al., 2007; Torsvall & Akerstedt, 1988). 
5.4.2 Mechanisms Behind Objective Sleepiness In Stroke Patients 
Objective Sleepiness 
The EEG in stroke patients is altered during wakefulness, as demonstrated in the current 
study and others (Finnigan et al., 2004; Finnigan et al., 2007; Lukashevich et al., 1999; 
Murri et al., 1998; Sainio et al., 1983). Disruption in the EEG also extends to nocturnal 
sleep (Hachinski et al., 1990; Korner et al., 1986; Yokoyama et al., 1996). The greater 
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presence of slow waves after stroke can be attributed to impact of the neural damage 
caused by stroke. This is most likely due to alterations in sleep/wake mechanisms 
implicated in control of arousal (Evans, 2002). 
Left and right stroke also presented different patterns in their EEG. More specifically, 
right stroke had greater presence of global slow wave activity which did not increase as a 
result of the task as observed in left stroke. One possible explanation for these differences 
is that left and right stroke follow different pathologies as there is evidence to suggest this 
at a behavioural and neural level (Hermann et al., 2008; Sisson, 1995,1998). Mattia et 
al., (2003) also found waking EEG differences between left and right stroke two months 
after injury. In comparison to controls, the right stroke group presented greater presence 
of delta over the affected hemisphere whereas left stroke did not. Another study has 
shown that increased delta activity occurs to a greater degree within the affected side of 
right strokes compared to left strokes (Korner et al., 1986). Therefore the sequelae of left 
and right stroke may follow independent paths. 
Subjective Sleepiness 
Poor perception of sleepiness within brain injured (including TBI) populations has been 
reported in other studies (Bassetti et al., 1996; Bassetti & Valko, 2006; Masel et al., 
2001). Other authors investigating other brain injured samples have reported similar 
findings. This disassociation may have occurred for several reasons: 1) those with severe 
injuries may underreport their symptoms due to poor introspection as a result of lack of 
awareness or cognitive deficit, 2) stroke patents have an altered threshold as to what they 
consider sleepiness or, 3) the changes in brain arousal attenuate the cognitive processes 
underlying sleepiness perception, i. e. arousal of the cortex, as evident by EEG frequency 
composition, is the cause of poor sleepiness perception. 
Some authors have suggested that lack of awareness of post brain injury symptoms are a 
result of disturbed cognitive function (Trudel et al., 1998). This may explain why patients 
did not report feeling sleepy, however those recruited for the current study did not present 
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any difficulties in all cognitive domains including memory21. Masel et al. (2001) 
objectively measured sleepiness using the MSLT technique did not correlate with ESS 
suggesting that brain injured patients did not perceived there own sleepiness. In the 
current study, laboratory observations did confirm that some patients were extremely 
sleepy, even falling asleep during the experiment, however this was not reflected in the 
KSS rating. Patients further seemed unaware of their sleepiness. Based on the evidence 
provided by the current study, it may also be that the threshold for what is considered a 
`problem' changes as what is sleepy for someone who has had a brain injury may be 
different to a non-brain injured person. If a stroke patient is sleepy all the time, they may 
interpret that as normal for them, not for a healthy person. Bassetti and Valko (2006) 
found that those with hypersomnia interpreted did not report increased sleepiness in 
comparison to those without hypersomnia. In other non-brain injured samples with 
clinical sleep disorders, even though the EEG was suggested of sleepiness, the patients 
underestimated their sleepiness levels (Greneche et al., 2008; Sforza et al., 2002). Balkin, 
Rupp, Picchioni, Wesensten (2008) found chronically sleep deprived persons in the 
general population habituate to their level of daytime functioning. This results in an 
underestimatation of sleepiness compared to those with adequate sleep. This evidence 
suggests that the disassociation between sleepiness and the EEG may be common to 
clinical patients, however healthy persons are able to accurately estimate their sleepiness 
levels. 
5.4.2 Implications of Findings 
Patients underestimation of sleepiness levels suggests that they do not view it as a 
significant problem. This may explain why sleepiness is not typically addressed in post 
stroke treatment as reported in Study One of this thesis and as commented in other 
reports (Bassetti & Valko, 2006; Castriotta & Lai, 2001; Castriotta et al., 2007; Makley et 
al., 2008; Parcell et al., 2006; Wessendorf et al., 2000). Early recognition and treatment 
of chronic sleepiness is critical due to severe safety risks if patients continue to go about 
Z' As measured by the MMS. 
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their daily activities without awareness that they are vulnerable to sleepiness. This is 
particularly relevant for those patients who drive or operate other machinery at work 
(Lukashevich et al., 1999; Sagberg, 2006). Another study showed that patients with 
disrupted daytime alertness were more susceptible to falls (Michael et al., 2006). 
Importantly, presence of subjective sleepiness, as part of a combined variable with sleep 
disturbance, is associated with poorer quality of life in this population (Schuiling et al., 
2005). Moreover, if patients do underestimate the degree to which they experience 
sleepiness, the relationship with lower quality of life may be even stronger. Sleepiness 
may be a forgotten mediator of quality of life after stroke. 
Furthermore, more research should focus on treatment options for sleepiness. As well as 
managing sleepiness as part of their lifestyle, such as taking rest and naps, 
pharmacological options may also be of benefit to sleepy patients (Schneerson, 2005; 
Thaxdon & Myers, 2002; Zafonte, Mann, & Fichtenberg, 1996). CNS active drugs which 
act upon those neurotransmitters involved in the arousal system, such as amphetamines 
and dopaminergic agents, have been used to promote wakefulness (Al-Adawi, Burke, & 
Dorvlo, 2006; Autret et al., 2001; Bassetti, 2005a; Bassetti & Valko, 2006; Roth & 
Roehrs, 1996; Schneerson, 2005). 
It is also important to highlight to clinicians and researchers the potentially differential 
pathologies between left and right stroke. As these groups responded differently to the 
motor task in terms of their EEG in this study, this suggests that it may not appropriate to 
group left and right stroke together in the same EEG analysis, a common procedure for 
smaller samples (Giaquinto et at., 1994; Yokoyama et at., 1996). 
5.4.3 Limitations of This Study 
Limitations of this study arise from the low ecological validity of the laboratory 
conditions which may not be representative of sleepiness circumstances in the real world. 
The lengthy process of electrode application followed by the motor priming task may be 
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more conductive to sleepiness due to the monotony of residing in the same seat for that 
length of time. Unfortunately, this cannot be avoided when using an EEG paradigm. 
However KSS ratings taken before the task did not suggest that patients or controls were 
highly sleepy prior to engaging in the motor priming task. 
Another limitation within this study is the potential experimental bias upon participant 
responses on the KSS. Researcher presence may momentarily alter KSS scoring, merely 
by their presence which stops feelings of sleepiness for a brief time. (Akerstedt et al., 
2008; Kosuke Kaida et al., 2007). Although there is a possibility that patients may 
monitor their response to fit what they believe the experimenter wants, patients were 
asked to answer as honestly as possible. 
5.4.4 Future Studies 
Future studies to investigate post stroke objective sleepiness could involve modifications 
of the current protocol as this particular study was limited within the constraints of the 
CIT protocol. Rather than using the motor priming task, perhaps use of validated and 
reliable psychometric tests of vigilance would provide an additional behavioural measure 
of sleepiness. Such tests could include the Psychomotor Vigilance Test (PVT) which 
primarily relies on high levels of alertness to quickly respond to stimuli (Dinges & 
Powell, 1985). In the PVT, longer reaction times are indicative of increased sleepiness. 
With regard to the potential risk of driving when sleepy, experiments could utilise driving 
simulators to examine if poor perception of sleepiness is more likely to be associated with 
dangerous driving (Groeger, 2006; Groeger & Banks, 2007). 
Other methods of measuring sleepiness such as eye movements, heart rate variability and 
pupillary unrest index (as described in (Franzen, Siegle et al., 2008; Kaida et at., 2007) 
could be introduced to support arousal levels as provided by the EEG. Furthermore, 
examining objective sleepiness in other contexts would also be useful, particularly in 
situations where patients predictable become tired such as when engaging in challenging 
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rehabilitation sessions (Barker-Collo et at., 2007; Morley et al., 2005; Muller et al., 2006; 
Worthington & Melia, 2006). 
Conclusion to Chapter 5 
It is evident that there is a physiological alteration in the EEG in chronic patients with 
may have a role in the increased sleepiness experienced in stroke patients. Critically, 
stroke patients do not perceive high levels of sleepiness which are likened to that of a 
sleep deprived person. 
The main conclusions of this study are: 
" Chronic stroke patients have a greater presence of slow waves in their waking 
EEG which indicated increased sleepiness to the level that is experienced by a 
sleep deprived person. 
" The motor priming task increased subjective sleepiness, however scores only 
increased to a mild state of sleepiness (neither alert nor sleepy), and elicited 
changes in the EEG. 
" Changes in the EEG reflected more power in the lower frequencies of right stroke 
and increased in the higher frequencies for left stroke. 
" Stroke patients did not reliability perceive their own sleepiness. 
" The increase in higher frequencies may reflect the greater effort used by these 
patients to complete the task. 
Now that it understood there are post stroke disruptions to sleep on a behavioural level as 
well as physiological daytime functioning disturbance, the impact sleep these dimensions 
have on neurorehabilitation needs to be investigated. The following Chapter presents the 
fourth and final study of this thesis which aims to examine the extent to which poor sleep 
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and day functioning deficits, as observed in the previous three studies, affect motor 
neurorehabilitation in these patients. 
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CHAPTER 6 
Study 4: The Role of Sleep and Daytime Functioning in 
Neurorehabilitation 
Chapter 4 Overview 
Studies 1,2 and 3 aimed to characterise sleep and daytime functioning in chronic stroke 
patients with residual motor deficits. Sleep disturbance and poor daytime functioning was 
clearly evident in patients. These disturbances were sever in some patients. Furthermore, 
the waking EEG of patients was abnormal, revealing similarities with the EEG of sleep 
deprived non-brain injured persons. Crucially, poorer quality sleep was associated with 
poorer motor ability. Also, those with better motor ability experienced greater fatigue. 
These findings, in addition to evidence within the literature that shows sleep may be a 
modulator for motor learning, provide strong theoretical reason to address sleep 
behaviour in a motor neurorehabilitation context. The final study for this thesis therefore 
aimed to explore sleep and daytime functioning during an upper limb motor 
neurorehabilitation programme and the potential association of sleep and rehabilitation 
outcome. No known study has systematically monitored sleep in a sample of chronic 
stroke patients with hemiparesis during CIT. The most critical aspect of this study is the 
utilisation of a homogenous group of stroke patients (n=32) who were in a chronic state 
with regard to their physical and psychological functioning. Furthermore, these patients 
were selected based on a narrow window of motor ability. The findings of this study will 
have important implications for patients undergoing neurorehabilitation treatment after 
stroke but also will inform further research of this kind. 
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6.1 Introduction 
The findings from previous studies, as well as the this thesis so far, suggest that sleep has 
a beneficial function for the following aspects of stroke recovery: 1) health and well 
being, 2) daytime functioning, 3) motor learning, and 4) neuroplasticity. Therefore there 
is strong theoretical reason to predict a relationship between sleep and post stroke 
neurorehabilitation. Previous studies have a shown a relationship between healthy sleep 
and improved recovery outcome, however no known study has examined the role of sleep 
specifically in a neurorehabilitation context for chronic upper limb hemiparesis. 
6.1.1 Theoretical Underpinnings: Somatic, Behavioural, Cognitive, and Neural 
Evidence 
Somatic Evidence: Sleep and Health 
it is now undoubted that sleep is essential for maintaining health and wellbeing in the 
general population (Groeger et at., 2004; Steptoe et al., 2008; Zeitlhofer et al., 2000). The 
nature of this relationship may also be reciprocal as symptoms of poorer health such as 
pain, muscular discomfort and psychological stress, affects quality of sleep (Kamaleri, 
Natvig, lhlebaek, Benth, & Bruusgaard, 2008). Chronically ill populations suffer high 
levels of sleep disturbance including those with primary physical, mental and 
neurological conditions (Foley et al., 2004; Katz & McHorney, 1998; Manocchia et al., 
2001; Ohayon, 2005; Parish, 2009) including stroke (Cadilhac et al., 2005; Campos et 
al., 2005; Masel et al., 200122; Muller et al., 2006; Schuiling et al., 2005; Worthington & 
Melia, 200622). In particular, chronic stroke patients with sleep disturbance experience a 
poorer quality of life compared to those with healthy sleep (Schuiling et al., 2005). 
Furthermore, Study I of this thesis showed that those who reported disturbance had 
poorer perceived health compared to those without sleep problems. This evidence 
highlights the critical role of sleep in general health and that it may be a crucial 
modulator physical and psychological wellbeing of stroke patients. Alarmingly, post 
rz Mixed stroke and TBl sample. 
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brain injury sleep problems often remain unrecognised and untreated (Castriotta & Lai, 
2001; Wessendorf et al., 2000). 
Behavioural and Cognitive Evidence: Sleep and the Maintenance of Daytime 
Functioning 
Adequate sleep is essential for minimising levels of sleepiness and fatigue as 
demonstrated in laboratory based sleep deprivation studies (Akerstedt & Gillberg, 1990; 
Franzen, Siegel, & Buysse, 2008; Ikegami et al., 2009; Marzano et al., 2007) and sleep 
disturbance experienced in the natural environment (Martikainen et al., 1992; Philip et 
al., 2005; Pilcher & Huffcutt, 1996; Torsvall & Akerstedt, 1987; Wilhelm et al., 2009). 
Sleep disordered patients frequently complain of increased daytime sleepiness (Moul et 
al., 2002; Ulfberg et al., 2007; Ulfberg, Carter, Talback, & Edling, 1996) and fatigue 
(Chervin, 2000; Hossain et al., 2005; Lichstein et al., 1997). Sleep difficulties may, in 
part, contribute to increased sleepiness and fatigue in stroke patient populations (Bassetti 
and Valko, 2006). However poorer daytime functioning may also occur despite normal 
nocturnal sleep due to damaged neural arousal mechanisms (Bassetti and Valko, 2006), 
depressed mood (Choi-Kwon et al., 2005; Ingles et al., 1999; Naess et al., 2005; Staub & 
Julien Bogousslavsky, 2001), and diminished reserves for physical (Macko et al., 2001; 
Muller et al., 2006) and mental effort (Van Zandzoort et al., 1998). Increased sleepiness 
adversely affects cognitive performance in non-brain injured participants (Dinges et al., 
1997; Durmer & Dinges, 2005; Pilcher & Huffcutt, 1996; van den Berg et al., 2005; Van 
Dongen et al., 2003) and is known to affect attention capacity of stroke patients 
(Hermann et al., 2008; Van Zandvoort et al., 1998). Moreover, cognitive deficits 
negatively impact rehabilitation participation and outcome (Galski et al., 1993; Mokler et 
al., 2000; Zinn et al., 2004). Based on this evidence, it is reasonable to assume that 
minimising sleepiness and fatigue in patients may facilitate optimum conditions when 
engaging in rehabilitation. 
Cognitive Evidence: Sleep and Learning 
There is ample evidence that demonstrates the explicit role of sleep for motor learning in 
healthy non-brain injured participants (Cohen et al., 2005; Fischer et al., 2002; Gaab et 
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at., 2004; Karni et al., 1994; Kuriyama et al., 2004; Robertson et at., 2004; Wagner et at., 
2004; Walker et al., 2002a; Walker et at., 2003b). Furthermore, daytime napping also 
enhances motor learning (Backhaus & Junghanns, 2006; Milner et al., 2006; Nishida & 
Walker, 2007). This amounting evidence has led several authors to conclude that sleep 
may have be a crucial function for post stroke motor neurorehabilitation (Gomez- 
Beldarrain et at., 2008; Kuriyama et al., 2004; Robertson & Cohen, 2006; Siengsukon & 
Boyd, 2009b; Walker et al., 2003b) however this notion has not been explored in stroke 
patients undergoing a motor neurorehabilitation programme. Firstly, it is important to 
establish if the enhancement of motor learning through sleep and napping also applies to 
patients. 
Siengsukon and Boyd are the first known research group to exclusively investigate sleep 
dependent motor learning in a group of chronic stroke patients. Their experiments utilised 
a continuous tracking task designed to generate implicit and explicit motor learning in a 
group of older (>60 years old) chronic stroke patients and non-brain injured matched 
controls (Siengsukon & Boyd, 2008a, 2009a; Siengsukon & Boyd, 2008b). Participants 
were trained and then retested for retention of motor skill learning. Patients and controls 
were assigned to one of two conditions to include a sleep period between learning and 
retesting, or a period of wakefulness. It is important to note that, unlike previous studies 
examining sleep dependent learning, this study did not incorporate a sleep deprivation 
paradigm. Participants practiced the task either in the evening (sleep group) or in the 
morning (wake group) and were retested 12 hours later. 
The overall findings of these experiments revealed that patients who slept between 
practice and retention testing demonstrated enhanced implicit and explicit learning 
compared to patients who did not sleep and the controls. This suggests that stroke 
patients do have the capacity for sleep dependent motor learning which holds clinical 
relevance for post stroke motor neurorehabilitation (Siengsukon & Boyd, 2008a, 2009a). 
In addition, a study by Gomez et al. (2008) examined sleep dependent learning in sample 
of chronic brain injured patients, four of which, had a stroke. Enhanced learning on the 
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serial reaction time task was enhanced by sleep to a greater degree in patients compared 
to controls. 
It is important to note that the above studies all examined motor learning whilst using the 
non-affected hand. It is not yet known if motor learning in the affected hand may also 
respond to sleep dependent learning in the same manner. Further investigation is required 
to establish if sleep benefits motor learning within the affected hemisphere. 
Neural Correlates of Sleep and Plasticity 
Practice induced plasticity is believed to be facilitated by processes during sleep which 
enhance motor learning (Walker & Stickgold, 2006). These processes behind sleep 
dependent plasticity may occur during stage 2 sleep as spindles are possible triggers for 
long term synaptic plasticity (Contreras, Destexhe, & Steriade, 1997; Sejnowski & 
Destexhe, 2000). Neural mechanisms within slow wave (Huber & Ghilardi, 2004) and 
REM (Maquet et al., 2000; Peigneux et al., 2003) sleep have also been implicated in 
sleep dependent plasticity. It was concluded that sleep may create a conductive 
environment for promoting neuroplasticity which serve the function of consolidating 
motor skills (Datta, 2000; Datta, Mavanji, Ulloor, & Patterson, 2004; Sejnowski & 
Destexhe, 2000; Mircea Steriade, 1999; Mircea Steriade & Timofeev, 2003; Tononi & 
Cirelli, 2003; Tononi & Cirelli, 2006). 
Neuroplasticity is an essential part of recovery after stroke. This process enables some 
functions which were lost as a result of stroke, to be restored or at least partly recovered 
(Matthews et al., 2004; Mulder & Hochstenbach, 2001; Platz, 2004). This largely 
involves regaining motor function as a result of hemiparesis. Through spontaneous 
recovery and motor neurorehabilitation, neuroplasticity mechanisms are driven in 
response to injury. Based on the evidence presented above, several authors have 
suggested that sleep may have a critical role for post stroke rehabilitation (Robertson and 
Cohen, 2006), more specifically, sleep may facilitate re-learning of lost motor skills as a 
result of hemiparesis (Gomez-Beldarrain et al., 2008; Kuriyama et at., 2004; Siengsukon 
& Boyd, 2009b; Walker et al., 2002a). This may be due to the supportive environment it 
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provides for neuroplasticity (Datta, 2000; Datta et al., 2004; Sejnowski & Destexhe, 
2000; Mircea Steriade, 1999; Mircea Steriade & Timofeev, 2003; Tononi & Cirelli, 2003; 
Tononi & Cirelli, 2006). 
Sleep and Post Stroke Recovery Outcome 
Several studies have shown a relationship between increased sleep disturbance and 
poorer recovery in both acute (Bassetti & Aldrich, 1999; Bassetti & Aldrich, 2001; Good 
et al., 1996; Hachinski et al., 1987; Kaneko et al., 2003a; Leppävuori et al., 2002; 
Sandberg et al., 2001; Siccoli & Bassetti, 2008; Takekawa et al., 2007) and chronic 
stroke samples (Bassetti & Aldrich, 2001; Giubilei et al., 1992; Hermann et al., 2008; 
Vock et al., 2002). Furthermore, the results of Study 2 of this thesis indicated that sleep 
and levels of fatigue are related to levels of residual motor recovery in the chronic stage 
of stroke. Furthermore, initial evidence shows that improvement or normalisation of the 
sleep EEG is associated with better recovery in stroke patients (Gottselig et al., 2002; 
Vock et al., 2002). 
6.1.2 Sleep and Rehabilitation Outcome 
Healthy sleep may be of benefit for offline improvements as well as increasing cognitive 
capacities for rehabilitation participation. Several studies have examined the impact of 
sleep and daytime functioning in a range of rehabilitation settings within various brain 
injured cohorts, however no known studies have examined this idea with regard to motor 
learning during a neurorehabilitation paradigm in patients with chronic hemiparesis. 
Worthington and Melia (2006) acquired sleep data from nurses and carers of a mixed 
group of chronic stroke and TBI patients admitted to a rehabilitation facility. They found 
that observable sleepiness, attributed to brain injury or sleep disturbance, which affected 
daily functional performance generally and during rehabilitation sessions. The authors 
highlighted that healthy sleep management is critical to rehabilitation success. Other 
studies have also attributed poor daytime functioning to poorer rehabilitation 
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participation and a lack of motivation in stroke patients (Barker-Collo et al., 2007; 
Morley et al., 2005; Muller et al., 2006). A study involving a large sample of older 
patients (>65 years) with a range of conditions (10% of which experienced stroke) 
admitted to a post acute rehabilitation facility reported that increased napping was 
associated with worse rehabilitation outcome (Alessi et al., 2008). This relationship was 
believed to be the result of attenuated functional gains within rehabilitation sessions due 
to decreased motivation and need to sleep. In contrast to this finding, previous studies 
have suggested that napping is beneficial for motor learning in healthy non-brain injured 
samples (Backhaus & Junghanns, 2006; Milner et al., 2006; Nishida & Walker, 2007). 
Seingsukon and Boyd (2009b) postulated that sleep could be used as a tool to capitalise 
on motor learning in between rehabilitation during the day. It may be that there is an 
optimum nap length for patients undergoing rehabilitation, however this idea has not yet 
been examined in stroke patients. 
The presented evidence suggests that sleep and daytime functioning may be modulating 
factors for motor neurorehabilitation participation and ultimately outcome. Therefore it is 
postulated that interventions to improve abnormal sleep/wake patterns during 
rehabilitation may result in better functional recovery (Alessi et al., 2008; Bassetti & 
Aldrich, 1999; Masel et al., 2001; Fabienne Staub & Julien Bogousslavsky, 2001) and 
should be considered an integral part of the rehabilitation process (Cohen et al., 1992; 
Hyyppä & Kronholm, 1995; Parcell et al., 2006; Terzoudi et al., 2009; Uomoto, 2008). 
However this idea has not been directly investigated. There a clinical demand for further 
studies regarding the role of sleep for neurorehabilitation outcome. According to 
Terzoudi et al. (2009), future studies should utilise a highly controlled rehabilitation 
setting and include homogenous samples to reduce the effects of inter patient variability 
6.1.3 The Rationale For Study 4: Clinically Application of Sleep Research Within 
CIT 
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It is the aim of this thesis to make the transition from postulations of other authors (Alessi 
et al., 2008; Bassetti & Aldrich, 1999; Masel et al., 2001; Staub & Julien Bogousslavsky, 
2001) to clinically applied research in order to ultimately investigate the role of sleep and 
daytime functioning in a highly controlled motor neurorehabilitation context. Research of 
this nature was made possible by the opportunity to research patients undergoing a form a 
neurorehabilitation known as Constraint Induced Movement Therapy (CIT). 
CIT: The Testable Model To Explore Sleep Aims Motor Neurorehabilitation 
The CIT protocol under investigation for this thesis has provided the ideal model 
situation to explore the potential link between sleep and neurorehabilitation. More 
specifically, it is the central aim of CIT to facilitate upper limb motor ability, which holds 
particular relevance for the sleep dependent motor learning theory. Motor ability is 
increased via CIT by creating the optimum environment to drive neuroplasticity 
mechanisms (Cramer & Bastings, 2000; Hamzei, Liepert, Dettmers, Weiller, & Rijntjes, 
2006). CIT creates these conditions by facilitating motor learning based the following 
principles: 1) non-use of the affected limb is partly learned, therefore may be reversed, 2) 
introducing mass practice of the affected limb and 3) incorporating a strong learning 
component to shape motor movements in correct manner. 
The `learned non-use' principle behind CIT refers to repeated failure of affected arm use 
as well as greater success with non-affected upper limb (Taub, 1980). This learning 
pattern results in reduced usage of the affected limb and reliance on the non-affected limb 
which may inhibit recovery (Kunkel et al., 1999; Morris et al., 1997; Sterr, Freivogel, & 
Schmalohr, 2002a; Taub et al., 1994; Taub et al., 1993; Taub & Wolf, 1997). Therefore, 
CIT incorporates a `forced use' aspect within the protocol involving constraint (using an 
arm splint or sling) of the non-affected limb to increase use and reverse association 
between the affected limb and failure to achieve goals. The CIT technique also employs 
an upper limb motor learning component (Taub et al., 1994) involving mass practice of 
everyday tasks under the guidance of a CIT therapist for a set amount of hours per day 
for two weeks. The therapist selects tasks that to address the motor deficits encountered 
264 
by individual. The therapist's role involves modelling motor movement, prompting, 
providing feedback and systematically increasing the difficulty level of tasks (Taub, 
2006, p. 1046). 
The other important principle behind CIT is the recognition of recovery potential. Most 
recovery occurs during the acute phase post stroke, with retainable function within a few 
weeks (Duncan et al., 1992; Jorgensen et al., 1995) which begin to plateau within 6 
months (Kwakkel, Kollen, van der Grond, & Prevo, 2003; Sullivan, 2007; Tilling et al., 
2001). Recent research has shown that the brain's ability to reorganise towards optimum 
levels has previously been underestimated (Taub, 1976; Taub, Uswatte, & Elbert, 2002) 
as neuroplastic changes may occur even years after insult (Page, Gater, & Bach, 2004). 
CIT has demonstrated high efficacy for the treatment of upper limb hemiparesis in 
matched control trials (Taub, 1999; Taub et al., 1993; Taub et al., 2004; Taub & Uswatte, 
2003; Van der Lee et al., 1999; Wolf et al., 2006) as well as within groups designs 
(Bonifer et al., 2005; Kunkel et al., 1999; Sterr et al., 2002b). The research has shown 
that CIT helps to improve the ability to use the affected arm on structured movement tests 
as well as real world arm use. Furthermore, studies using Magnetic Resonance Imaging 
(MRI) have shown new activation in motor areas as a result of CIT (Kim et al., 2004; 
Liepert, Bauder, Wolfgang et al., 2000). Follow-up investigations revealed that the 
functional gains with the affected arm are maintained beyond one year (Taub et al., 1993; 
Taub et al., 2006; Wolf et al., 2006). Moreover, the functional improvements obtained 
through the intervention enhance confidence in using the affected limb in everyday 
situations and contribute to a greater quality of life (Dettmers et al., 2005; Lin, Chang, 
Wu, & Chen, 2009). 
6.1.4 The Current Study 
The initial evidence presented above shows that sleep has implications for motor 
neurorehabilitation. However, no known study has prospectively addressed sleep in a 
265 
tightly controlled motor rehabilitation setting with particular reference to motor 
functioning in stroke patients suffering from hemiparesis. The current study was 
developed to explore under researched avenues of post stroke recovery and to ultimately 
to promote a paradigm shift in rehabilitation protocols for a 24 hour approach to 
rehabilitation. 
Research Aims 
The study aimed to investigate the relationship between sleep and motor 
neurorehabilitation outcome in a group of chronic stroke patients, based on a narrow 
range of motor ability and who are in a stable state with regard to their physical and 
psychological recovery. This will be investigated in patients undergoing CIT. The 
standard CIT protocol consists of 6 hours of training per day for two weeks, excluding 
weekends (Taub et al., 1993). The CIT trial used for this study utilises a modified CIT 
protocol whereby session length was reduced to 1.5 or 3 hours per day for two weeks. 
Modified CIT protocols have also shown high efficacy in comparison to longer treatment 
lengths (Sterr et al., 2002b). CIT was administered to patients in a highly controlled 
setting therefore all patients had similar schedules. 
Based on the literature described above, the following research questions were 
formulated: 
1) Does enduring CIT influence normal sleep or daytime functioning behaviour ? 
2) Is sleep and daytime functioning related to CIT outcome as measured by a battery of 
motor ability tests? 
6.2 Methods 
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6.2.1 Desi2n 
Longitudinal sleep assessments were carried out throughout the CIT trial for a total of six 
weeks. This period was split into three phases: baseline (BL), CIT and post equating to 
two weeks each (Figure 6.2.1). A repeated measures design was employed to compare 
results of the sleep diary and actigraphy per phase. CIT induced motor ability outcome 
was subject to a repeated measures design, comparing of motor ability scores recorded at 
pre-CIT (T2)23 with that of post-CIT (T3). 
The CIT Trial Framework 
............................................................................................................................................. Baseline Testing (T1) Pre Testing (T2) Post Testing (T3) 
I !! (2 Höurs 7: 12 Weeks 712 Weeks -1 12 Weeks ý: i1ý --I 
[SCREENINGI BASELINE I CIT 
Study One Study Two if 
EEG (T2) 
............................... 
t... Study Three 
.... 
t.... 
..... Study Four 
I Long Term Sleep Monitoring 
POST CIT 
Figure 6.1. Design of CIT trial, The highlighted section indicates time point from which 
data for this study was collected. 
6 . 2.2 Participants 
An opportunity sample of 32 community dwelling chronic stroke patients were recruited 
directly from the CIT trial24. All patients fulfilled the inclusion/exclusion criteria, as 
23 Similarly with Study 4, baseline motor testing (TI) was not used for analysis due to unfamiliarity of the 
testing situation. Therefore it is recommended that a second testing opportunity produces more reliable 
results (Whitall et al. 2006). 
24 A total of 38 patients received 1.5 or 3 hours of CIT (section 2.2.1, chapter 2). Six patients were not 
included in the analysis for this study. Two patients were non-compliant regarding sleep diary completion. 
Two patients data was not included due to actigraphy fault. Two patients did not complete the full protocol. 
267 
described in Section 2.2.1, Chapter 2, forming a highly selective homogenous group of 
low motor functioning patients. 
For the purposes of the CIT trial, all patients were randomly assigned to one of four 
groups: a) 1.5 hours of CIT with constraint (n=10), b) 1.5 hours of CIT without constraint 
(n=9), c) 3 hours with constraint (n=4) and d) 3 hours without constraint (n=9). For the 
purposes of the current study, groups a) and b) were combined to form the 1.5 hour group 
(n=19). Groups c) and d) were combined to form the 3 hour group (n=13). Overall 
compliance rates were poor for constraint use and home. In addition two patients changed 
from 3 hour groups to 1.5 hours of CIT per day. Furthermore, 3 hour sessions were 
terminated early on several occasions for patients who were too tired to continue with 
CIT. For these reasons, it was deemed appropriate to combine patient groups for analyses 
for this study. However where necessary, 1.5 and 3 hour groups were examined 
separately. 
6.2.3 Materials 
Sleep and daytime functioning was assessed via sleep diaries and 24 hour actigraphy 
throughout the baseline, CIT and post phase. The pen and paper based sleep diary 
requested patient perception of nocturnal sleep parameters. Furthermore, the sleep diaries 
also contained twice daily Karolinska Sleepiness Scale (KSS; Akerstedt & Gillberg, 
1990) and Daily Fatigue Scales (D-FIS; Fisk & Doble, 2002) to assess sleepiness and 
fatigue during the morning and evening. Actigraphy recordings were conducted using the 
`Actiwatch Mini ®' (CamNtech Ltd., (0 2009), worn on the non-affected wrist. Sleep 
diaries and actigraphy materials are described in more detail within Section 2.3.4, 
Chapter 2. CIT induced upper limb motor ability was assessed using a battery of motor 
assessments including the Wolf Motor Funtion Test (WMFT; Wolf et al., 1989) and 
Motor Activity Log (MAL; Taub et al., 1993), described in Section 2.3.3, Chapter 2. 
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6.2.4 Procedure 
All patients attended the baseline test point (T1) which comprised the first administration 
of the motor test battery (Figure 6.1). Additionally during Ti, patients were fitted with 
the actiwatches, given the sleep diary and provided with instructions. Participants were 
asked to complete the sleep diaries as accurately as possible and to report any instances 
when the actiwatches were removed to avoid miscoding of a daytime sleep period. The 
sleep diaries and actigraphy recordings were continued for a total of six weeks (baseline, 
CIT and post). The motor test battery was conducted at baseline (TI), pre-CIT (T2) and 
post-CIT (T3). 
6.2.5 Analysis 
Data drawn from the sleep diary and actiwatch were aggregated across the days recorded 
for each of the three phases. Due to differences in weekday sleep schedules to that of 
weekends as observed in Study 2, only weekday measures were used for analysis. 
Sleep Diary 
The following nocturnal sleep parameters were drawn from the sleep diary: time in bed 
(minutes), sleep duration (minutes), sleep onset latency (minutes), sleep efficiency (%) 
and night awakenings (frequency and duration). Daytime functioning parameters were 
represented by morning and evening KSS and D-FIS ratings as well as daytime nap 
reports (frequency and duration minutes). 
Actigraphy 
Actigraphy recordings were analysed using Actiwatch Sleep Analysis Software (Version 
7.22, CamNtech Ltd, © 2009) in order to calculate the following sleep parameters: time 
in bed (minutes), sleep duration (minutes), sleep onset latency (minutes), sleep efficiency 
(%) and night awakenings (frequency and duration in minutes). Bed time and get up time 
were entered manually (using the sleep diary for guidance) whereas the remaining 
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parameters were calculated using the sleep scoring function within the Actiwatch Sleep 
Analysis Software. Similarly to Study 2, sleep scoring analysis was set using a medium 
sensitivity of <40 activity counts per minute to define wake. A napping period was 
defined as any daytime sleep which occurred between get up time and bed time for a 
minimum of 15 minutes. The sensitivity was set to <10 activity counts per minute to 
define an epoch of daytime sleep. 
CIT Outcome 
The WMFT provided two measures of motor ability, median reaction time (mins) and 
mean functional ability (score out of 7) across all items. The MAL provided two 
measures of subjectively rated arm use outside of the laboratory including amount of use 
(AOU) and quality of use (QOU). See Section 2.3.4, Chapter 2, for more details. 
Statistical Analysis 
As the distribution of the data was non-normal, non-parametric alternatives were used for 
all statistical analyses. CIT outcome was calculated by subtracting post motor test scores 
(T3) from pre scores (T2). Mean CIT outcome was compared between the 1.5 and 3 hour 
using the Mann Whitney U Test. Mean sleep and daytime functioning analyses for BL, 
CIT and post phases were statistically compared using the Friedman Test. Further 
analysis between two phases (e. g. BL and CIT) utilised the Wilcoxon signed ranks test. 
Relationships between sleep, daytime functioning with CIT outcome were determined 
using Spearman's Rank Correlation Coefficient. 
6.3 Results 
6.3.1 Demographics 
The demographics for all patients is presented in Table 6.1. 
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Table 6.1. Data presented as mean (+/- 1 SD and range) or percent valid where 
appropriate. The remaining 28.12% of stroke patients unlisted for employment status 
were classified as not working. For individual case information for all participants, see 
Appendix C. 
Demographical Variables 
Gender (M: F) 
Age (Years) 
BMI 
NART (IQ) 
Mini Mental State Exam 
Education Level: 
School Leavers Certificate 
Further Study 
Higher Education 
Employment Status: 
Full Time 
Part Time 
Retired 
Studying 
Living Support: 
Living Alone 
Living With Family 
Chronicity (Months) 
Type of Stroke: ' 
Ischemic 
Hemorrhagic 
Both 
Lesion Hemisphere 
Co-morbid Conditions: 
Psychological 
Muscular 
Neurologicalt 
Cardiac 
Cancer 
Diabetes 
Pain 
Dysphasia (From Mild to Severe)' 
Medication: 
Anti-depressant 
Pain Relief 
Cardiac Control 
Anti-epileptic 
Sleep Hypnotics 
Alcohol (Units per week) 
Caffeine (Cups per day) 
Nicotine (Cigarettes Per Day) 
n=32 
1715 
5626t1057(2873) 
2384± 239(182-28.9) 
115 96 t7 63 (96-126) 
29 56 ±0 97 (26-30) 
28 13% 
50% 
21 88% 
12.5% 
1875% 
40.63% 
None 
15 59% 
84.42% 
3843±3843(11-140) 
50% 
1563% 
3 13% 
13 Left, 19 Right 
28.13% 
313% 
18 75% 
43.75% 
313% 
313% 
313% 
18 75% 
938% 
None 
313% 
15 65% 
None 
7763841(0-32) 
5.23 3 2.88 (0-12) 
099±_369(0-20) 
(-) not required or not recorded as part of this study. 
* 38.87% of the patients experienced expressive aphasia and only completed the 3-step command on the 
MSE only therefore were not included in the total mean score. These patients also did not complete the 
NART. 
t The remainder of these values were classified as unknown. 
$ Neurological conditions other than stroke. 
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6.3.2 CIT Outcome 
Figure 6.2 presents results of the motor test battery recorded pre (T2) and post (T3) CIT 
for individual treatment groups; 1.5 and 3 hours. A larger mean difference (post minus 
pre), indicates better CIT effect. Negative scores indicate faster reaction time for WMFT 
RT whereas positive scores represent greater improvement for WMFT FA and MAL. 
There were no significant differences in CIT outcome between the 1.5 and 3 hour groups. 
This suggests that 3 hours of therapy does not appear to facilitate an overall greater 
outcome compared to 1.5 hours. This further demonstrates that it was appropriate to 
combine all patients into one group for analysis. 
Motor Test Scores Pre and Post CIT 
Q Pre 
  Post 
0 
WMFT RT WMFT FA MAL AOU MAL QOU WMFT RT WMFT FA MAL AOU MAL QOU 
1.5 Hour 3 Hour 
Figure 6.2. Pre and post CIT mean scores (+/-1 SD and range) for all motor. Pre and post 
significant differences are indicated (*p<0.05). 
6.3.3 Sleep and Daytime Functioning Per Phase 
Sleep and daytime functioning were examined for the BL, CIT and post phase. Mean 
change (A) from BL to CIT, CIT to post and BL to post were also examined. 
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Nocturnal Sleep 
Figure 6.3 and 6.4 present the nocturnal parameters extracted from the sleep diary and 
actigraphy recordings per phase. A significant effect of phase was observed for subjective 
sleep duration (X2=4.98; p=0.0414). Further Wilcoxon signed-ranks test showed that this 
difference was greatest between BL and post phases where patients slept less during the 
post phase (Z=-1.70; p=0.0448). An effect was also found for actigraphy determined 
sleep duration, however this showed that patients slept less during CIT compared to BL 
(Z=-1.84; p=0.0327). This may reflect the impact of the CIT trial on sleep schedules 
where patients had less opportunity to sleep longer in order to attend morning CIT 
sessions. Actigraphy revealed lower time in bed during CIT which was significantly 
different from that of baseline (Z=-1.70; p=0.0444). This further shows that attending 
CIT affected normal sleep schedules. 
Although a difference was not observed across all phases, a closer inspection of the 
subjective reports of night awakenings revealed a significant difference between BL and 
CIT (Z=-1.70; p=0.0448). This is an indication that patients felt they slept better during 
CIT due to less night awakenings. This was also reflected in a more reliable estimate of 
night awakenings from the actigraphy recordings for night awakening frequency between 
BL and CIT (Z=-2.47; p=0.0068). In addition, a difference was observed between CIT 
and post (Z=-1.69; p=0.0462). Unlike sleep diary results, actigraphy did not reveal any 
differences for night awakening duration. 
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Figure 6.3. Mean (+/-1 SD and range) nocturnal sleep data drawn from the sleep diary per 
phase. Friedman test statistic (X2) and significance value (p) is presented (dj2). 
Significant values are indicated (*p<0.05). 
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Using actigraphy as a more accurate estimation of sleep, the results showed that despite 
the sleep changes incurred during CIT, the patient group demonstrated low sleep 
efficiency throughout all phases (Figure 6.4; >85%). This is partly due to the longer time 
in bed endured by patients. However patients also slept less than 8 hours per night, even 
during CIT. Case analysis showed that 28.13% of patients demonstrated extremely poor 
sleep during CIT (>7 hours), as low as 5.81 hours on average per night. 
Figure 6.4. Mean (+/-1 SD and range) nocturnal sleep data drawn from actigraphy 
recordings per phase. Friedman test statistic (X2) and significance value (p) is presented 
(dj2). Significant values are indicated (*p: 50.05). 
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Daytime Functioning 
Figure 6.5 presents KSS and D-FIS scores, during the morning and evening, per phase. 
Figure 6.6 displays both sleep diary and actigraphy reports of napping per phase. Both 
sleepiness and fatigue significantly increased during the evening for all phases (Figure 
6.5). There were no differences between BL, CIT and post for both sleepiness and 
fatigue. Upon closer inspection of the data, a near significant trend was revealed where 
evening KSS scores were mildly increased during CIT compared to BL (t=-1.31; 
p=0.0945). 
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Figure 6.5. Mean (+/-1 SD and range) KSS and D-FIS scores. Friedman test statistic (X2) 
and significance value (p) is presented. Significant values indicated (*p: 50.05). 
Sleep Diary Daytime Functioning Parameters Per Phase 
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OBL 
 CIT 
O Post 
Figure 6.6 shows that napping behaviour was reduced during the CIT phase. Statistical 
analyses revealed a significant difference for subjective napping between CIT and post 
(Z=-1.29; p=0.0986) and a near significant trend between BL and CIT (Z=- 
1.69p=0.0454). This effect was not observed for actigraphy results. A possible 
explanation for this discrepancy may be due to patients' perception. The structure that the 
CIT imposes on the patients' day may be associated with a sense of napping less even 
though actigraphy suggests otherwise. 
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Figure 6.6. Mean (+/-1 SD and range) daytime functioning data drawn from actigraphy 
recordings per phase. Friedman test statistic (X2) and significance value (p) is presented. 
Significant values indicated (*p50.05). 
Sleep Diary Napping Indicies Per Phase 
60 , 
Actigraphy Napping Indicles Per Phase 
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6.3.4 Sleep, Daytime Functioning and CIT Outcome 
O Bt. 
  CIT 
OPost 
Correlations were carried out to determine the level of associations between sleep, 
daytime functioning during the CIT phase and CIT outcome. Sleep parameters were 
based on actigraphy results only. 
Sleep 
The scatter plots for significant and near significant results are presented in Figure 6.7. 
Longer time in bed correlated with better MAL QOU (r0.39; p=0.0129) and by near 
significant trend with improvement on the WMFT FA (r-0.28; p=0.0578). Longer sleep 
duration was associated with increased MAL QOL (x0.30; p=0.0459). A small 
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relationship was also observed for increased MAL QOU and shorter duration of night 
awakenings (r=-0.25; p=0.0857). These results present suggestive evidence in the initial 
assumption that good sleep promotes treatment outcome. 
Figure 6.7. Significant correlations of CIT outcome and sleep as recorded by actigraphy 
recorded during the CIT phase. 
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KSS and D-FIS ratings did not correlate with any CIT outcome measure whereas a 
relationship was observed for actigraphy calculated napping (Figure 6.8). The scatter 
plots of significant and near significant trends are presented in Figure 6.8. Increased 
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MAL AOU correlated with lower napping frequency (r=-0.28; p=0.0603) and duration 
(r-=0.27; p=0.0711). Increased MAL QOU also correlated less napping frequency (x=- 
0.38; p=0.0195) and length of naps (r=-0.35; p=0.0236). These associations may be due 
to greater time spend practicing tasks and using the affected arm as much as possible at 
home. Those that nap more, may be more sleepy and therefore do not have as much 
capacity to complete motor activities outside of CIT. 
Figure 6.8. Significant correlations of CIT outcome and napping as recorded by 
actigraphy during the CIT phase. 
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6.3.5 Laboratory Observations 
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The author of this thesis and colleagues have made several observations from spending 
long periods of time with the patients involved in the current study. The most commonly 
reported observation was that poorer daytime functioning interfered with CIT sessions. 
Furthermore, sleepy or fatigued patients required more breaks within therapy sessions as 
progress could not be made without ample rest. It was common for patients to report a 
greater drive to nap, and would typically nap during their lunch break in the laboratory. 
Surprisingly, these observed naps were not always reported in the sleep diary. Caregivers 
of patients also commented on the greater drive to nap and feelings of exhaustion in 
patients as a result of CIT sessions. Several carers commented that patients would fall 
asleep in the car on the return home after treatment. In several cases, three hours of CIT 
had to be aborted early due to patients reporting being too tired to continue till the end of 
the session. For patients who drove themselves to the laboratory, it was of the opinion the 
therapists involved and the patients themselves, that naps and/or rest should be taken 
before attempting to drive home as their high sleepiness levels were considered 
detrimental to their safety. 
6.4 Discussion 
There is good theoretical reason to predict a relationship between sleep, daytime 
functioning and CIT outcome, Therefore it was the aim of the current study to investigate 
this potential link. This was achieved by monitoring sleep and daytime functioning via 
sleep diaries and actigraphy throughout a highly controlled neurorehabilitation setting 
whereby patients received two weeks of CIT. CIT outcome was determined by change in 
reaction time and ability scores on a battery of motor tests. This is the first known study 
to monitor sleep in a homogenous group of chronic stroke patients, selected based on 
their upper limb motor ability who received neurorehabilitation in a carefully controlled 
environment, 
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6.4.1 Overall Findings 
Phase Changes 
Several changes in sleep between each of the three phases of the CIT protocol were 
observed. Patients reported sleeping less during post compared to BL. Actigraphy 
determined sleep duration showed that patients slept less and spent less time in bed 
during CIT compared to BL. Patients may spend less time in bed as attending CIT added 
more structure to their day. A reduction in both perceived and actigraphy determined 
night awakenings were observed during CIT when compared to BI, and post phases. 
Even though patients slept less during this time, which was also reflected in lower sleep 
efficiency, their sleep may have been more restful and less fragmented during CIT. In 
order to truly determine the extent to which CIT affected normal sleep patterns, PSG 
recordings would be required. Furthermore, such data would enable the analysis of 
changes in sleep architecture. 
Twenty-eight percent of patients slept less that seven hours per night. Sleeping less than 
seven hours per night is associated with decrements in cognitive performance (Banks & 
Dinges, 2007; Van Dongen et al., 2003). Furthermore, it has been suggested that poor 
sleep during the night may account for poorer functioning and participation in 
rehabilitation (Worthington & Melia, 2006). Post hoc analyses revealed that patients who 
slept less that seven hours per night had lower scores on the MAL QOL and AOU (z=- 
2.04; p=0.0427 and z=-2.37; p=0.0169 respectively). This suggests that in future, efforts 
should be made to manage sleep in those patients who are vulnerable to getting less sleep. 
Self reported sleepiness and fatigue increased during the evening for BL, CIT and post 
phases. Although it was expected that patients would be sleepier and more fatigued when 
engaging in daily CIT sessions, only a near significant trend was observed for increased 
evening sleepiness. Given that patient perception of daytime functioning levels is 
unreliable, according to Study 3 and other studies (Bassetti & Aldrich, 1999; Bassetti & 
Valko, 2006; Masel et al., 2001), it may be that sleep diaries were not sensitive enough to 
detect such changes. Furthermore, laboratory observations confirmed that several patients 
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were virtually falling asleep during CIT sessions, and as a result, sessions were 
terminated early. Family and caregiver reports also supported this observation. Despite 
these anecdotal reports, patients did not accurately report their behaviour in the diaries. 
Interestingly, patients reported napping less during CIT even though observations would 
suggest they napped during the lunch break in the laboratory and again when they were at 
home. One explanation may be the structure that CIT added to their day may be 
perceived as an environment not conductive to napping therefore this would occur less. 
According to actigraphy, general napping behaviour did not change as a result of CIT. 
Therefore, it may be that patients who consistently napped, still did so during the CIT 
phase. 
CIT Outcome 
Longer time in bed and sleep duration was mildly associated with better CIT outcome. 
Furthermore, a small effect was observed for less night awakenings and better CIT 
outcome. This suggests that good sleep patterns are beneficial to CIT outcome. Perceived 
sleepiness and fatigue was not related to CIT outcome however patient daytime 
functioning reports are likely to be inaccurate. Alternative measures of daytime 
functioning would need to be employed to determine if there is a relationship between 
sleepiness and fatigue. Other studies using nursing reports have found that poorer 
daytime functioning affected rehabilitation participation (Worthington & Melia, 2006) 
and outcome (Alessi et al., 2008). 
Less napping was also associated with better CIT outcome. This may have occurred as 
extremely sleepy patients, who needed to nap more, could not attend to tasks during CIT. 
Furthermore, such patients received less CIT in instances when sessions were terminated 
earlier. It was also concluded by Alessi et al. (2008) that increased napping, as a result of 
severe sleepiness, adversely impacted rehabilitation success. However other studies have 
suggested that napping supports motor learning (Backhaus & Junghanns, 2006; Milner et 
al., 2006; Nishida & Walker, 2007), but these findings were in non-brain injured samples. 
Although this idea has not been directly tested in stroke patients, Siengsukon & Boyd 
(2009b) suggested that napping between rehabilitation sessions may have some benefit. 
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There may be an optimum nap duration for stroke patients which may be conductive for 
motor learning and allow adequate rest. 
6.4.2 Further Theoretical Considerations 
Possible Confounds 
The small effects observed for the relationship between sleep and CIT suggest that other 
factors may also contribute to the success of CIT in patients. Response to rehabilitation is 
a multi factorial process which is influenced by other long term consequences of stroke 
beyond control for this study. Such factors may include stroke pathogenesis, genetics, 
quality of medical care and as well as the patients own motivation, personality traits and 
family support (1-Ierholz & Heiss, 2000). 
Psychological Benefits of CIT and Perception of Sleepiness 
Many patients commented on the fact that they enjoyed having an activity which enabled 
them to leave the house everyday. This fits in with the findings of Campos et al. (2005) 
who showed that increased social occupation, as well as rehabilitation, has positive 
effects on the patient's sleep and mood. Improved mental health as a result of increasing 
social networks and purpose is reflected in reduced self reporting of fatigue (Glass, 
Matchar, Belyea, & Feussner, 1993). This may also explain why napping behaviour was 
perceived as occurring less during CIT as patients affect was considerable improved as 
result of achieving increased motor function during CIT. CIT has known beneficial 
effects for psychological functioning (Dettmers et at., 2005). 
6.4.3 Implications of Findings 
The effects of motor neurorehabilitation and sleep are complex. Although factors other 
than sleep may also contribute to the success of CIT treatment, the results of this study 
hold important implications for rehabilitative interventions after stroke. 
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Practical Implications For Rehabilitation 
Firstly, ensuring optimum sleep is achieved by patients may be critical to better CIT 
success. This is particularly important for patients who slept below seven hours per night 
during treatment. Better sleep has known effects for daytime functioning, general health 
and learning in stroke patients (Bassetti & Valko, 2006; Schuiling et al., 2005; 
Siengsukon & Boyd, 2009b), therefore applying sleep management may not only benefit 
CIT, but also general quality of life. Less napping was associated with better CIT 
outcome. However the literature suggests that encouraging rest and even a moderate nap 
in between rehabilitations session may benefit the latter session (Borgaro, Baker, Wethe, 
Prigatano, & Kwasnica, 2005). Siengsukon and Boyd (2008b) proposed that sleep should 
be encouraged between therapy sessions to promote offline learning. It may be that 
excessively napping during the day reflects excessive sleepiness which is associated with 
poorer participation in rehabilitation and outcome success (Barker-Collo et al., 2007; 
Morley et al., 2005; Muller et al., 2006). Napping in moderation may have benefits for 
CIT however further investigation is required to establish this idea. Furthermore, sessions 
needed to be terminated early as patients were too tired to continue, therefore adequate 
rest is crucially advised. 
Value of Clinical Observations and Case Studies 
Laboratory observations and caregiver reports proved to be a vital source of information 
to help explain results of this study. These important insights into patient behaviour 
however were not documented therefore could not be statistically examined. It would be 
advantageous for future studies to systematically record researchers and caregiver 
observations of sleep and daytime functioning in stroke patients. 
6.4.4 Limitations of the Study 
Practical Limitations 
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In order to attend CIT, patients had to alter their normal sleep schedule. Several patients 
also stayed in local accommodation, often without a carer, for the CIT phase which may 
have affected sleep. However this was beyond the control of the current study as patients 
were recruited from a various locations in the UK. 
Reliability of Patient Reports 
Results from Studies 1,2 and 3 of this thesis, in addition to other published work (Bassetti 
& Valko, 2006; Castriotta et al., 2007; Makley et al., 2008; Masel et al., 2001; Parcell et 
al., 2006), have suggested that perception of sleepiness, fatigue and napping are less 
reliable in brain injured patients. Therefore, the self reports in the current study may also 
be vulnerable to the same issue. Critically, laboratory observations and caregiver reports 
however suggested that daytime functioning was underestimated. 
Sleep and Daytime Functioning Assessment 
This study showed that sleep diaries and actigraphy only showed a mild relationship 
between sleep, daytime functioning and CIT outcome, as well as changes in sleep as a 
result of attending CIT. Despite the strong theoretical underpinnings that strongly point 
towards a link between a relationship sleep and neurorehabilitation, the results of this 
study are mixed and inconclusive at this stage. It may be that sleep diaries and actigraphy 
are not sensitive enough to pick up changes in patients sleep and daytime functioning 
whilst undergoing CIT. More sensitive measures, i. e. PSG, may not only reveal changes 
as a result of CIT, this method may also enable a closer examination of the relationship 
between sleep and CIT. Analysis of the frequency composition of the sleep EEG may 
help determine if CIT induces changes at this level and if this is associated with CIT 
outcome. This idea is postulated by several authors (Gottselig et al., 2002; Hachinski et 
al., 1990) but has not yet been investigated. 
6.4.5 Further Studies 
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More studies are clearly required to fully assess if there is a pattern between healthy sleep 
and increased rehabilitation outcome in a larger group of patients. It may be additionally 
useful to employ PSG recordings in order to examine sleep architecture as this may 
contribute important information regarding changes in the EEG as a direct result of motor 
learning during neurorehabilitation. The next avenue to explore requires protocols which 
test sleep related inventions to examine if this improves sleep and ultimately leads to 
clinically relevant gains (Alessi et al., 2008). Sleep related adaptations to rehabilitation 
protocols may also benefit outcome. For example, Seingsukon and Boyd (2008b) 
suggested that therapy may need to be conducted in the evening or late in the day in order 
to be in closer proximity with a sleeping period. The results of this study have suggested 
that optimising nap opportunities may even have some benefit for rehabilitation sessions. 
Further research is required to investigate this notion. 
Conclusion of Study 4 
This study has shown that there is a mild relationship between sleep and CIT outcome 
which fits in with the theoretical underpinnings of the research question. 
" Normal sleep schedules were altered during CIT as compared to BL and post. 
These alterations consisted of increased time in bed, shorter sleep duration and 
less night awakenings. 
" The sleep of patients may have improved during CIT as night awakenings were 
reduced in this phase. 
" Overall, the results suggested that better sleep was mildly related to greater 
improvements for CIT outcome however further research is necessary. It may be 
that sleep management is essential in order for patients to gain maximum benefit 
of CIT. 
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" Anecdotal reports of this study were consistent with reports of other therapists 
who highlight that sleepiness and fatigue impacts participation in therapy 
sessions. 
Some of the effects observed in this study fit in with the theorectical perspective which 
hold clinical implications for neurorehabilitation treatment provisions. Sleep management 
programmes that are specifically designed for stroke patients are required to facilitate 
healthy sleep and further minimise sleepiness and fatigue. Furthermore, this study has 
provided important information for future study design. It is clear that more research is 
required to fully address the relationship between sleep and CIT outcome. This idea may 
also be applied to other modes of motor neurorehabilitation as well as the CIT method. 
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CHAPTER 7: General Discussion 
7.1 Summary of The Findings 
This thesis was developed in response to a surprising lack knowledge on sleep in chronic 
stroke patients with residual motor deficits and lack of research on the role of sleep in 
recovery and neurorehabilitation outcome. Four studies were carried out using a range of 
methods to explore the idea that sleep may be a modulating factor for healthy wellbeing, 
motor recovery and neurorehabilitation success after stroke. This involved employing 
retrospective questionnaires, prospective long term sleep monitoring, 
electroencephalography (EEG) and motor ability tests within the context of a Constraint 
Induced Movement Therapy (CIT) trial. These methods captured data on nocturnal and 
diurnal sleep, daytime functioning, psychological adjustment, health related quality of 
life, residual motor functioning and neurorehabilitation outcome. The studies revealed 
that sleep is associated with the quality of life of patients as well as having implications 
for motor recovery and CIT. In addition, the results of daytime functioning assessments 
showed potential safety risks in this population. The results confirmed a proportion of 
previous literature as well as revealing several contrasts which will be discussed in this 
chapter. By and large, the results of this thesis have clinically relevant implications for 
both medical practitioners and patients. Furthermore, the main findings can be applied to 
post stroke treatment provisions thus driving forward a 24 hour approach to 
rehabilitation. 
7.1.1 Thesis Objectives 
Gap In The Literature 
The literature suggests a potentially crucial link between sleep, recovery, 
neurorehabilitation outcome and ultimately, the quality of life of stroke patients (Cadilhac 
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et at., 2005; Schuiling et at., 2005; Siengsukon & Boyd, 2009b; Worthington & Melia, 
200625). In addition to the lack of studies contributing to this link, the sparse research 
conducted poses several limitations stresses a necessity for further investigation. Sleep is 
largely ignored as part of post stroke treatment and long term care in clinical settings 
(Castriotta & Lai, 2001; Parcell et at., 2006; Wessendorf et al., 2000). The poor support 
provisions for patients may unnecessarily prolong suffering and hinder recovery 
potential. 
This thesis was developed based on five main research questions of which has not yet 
fully addressed in the literature and in clinical practice: 1) how does a chronic stroke 
population sleep and function during the day from a subjective point of view? 2) how do 
chronic stroke patients sleep as determined by objective methods? 3) can chronic stroke 
patients accurately perceive their own sleep behaviour and daytime functioning levels? 4) 
is sleep and daytime functioning related to level of residual motor recovery after stroke? 
and 5) does sleep and daytime functioning have a role in motor neurorehabilitation? 
7.1.2 The Findings 
Overall Results of Studies 1 to 4 
" Study 1 
The findings of Study I showed that 41% of patients felt their sleep was disturbed 
during the first month after stroke which evolved into a chronic problem in 39% at 
one year. The majority of patients (81%) experienced deficits in their daytime 
functioning which remained chronic in 25%. When using the cut off criterion as 
provided by the PSQI, ESS and FSS to indicate a significant difficulty, 32% of 
patients reported disturbed sleep, 28% were excessively sleepy, half of patients 
regularly napped and 25% were highly fatigued in the chronic phase of recovery. The 
PSQI further revealed that patient sleep schedules were different to that of the general 
z5 Mixed stroke and TBl sample. 
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population as they reported longer time in bed and sleep duration. A crucial finding of 
Study I was that patient sleep needs were not addressed as part of their medical care. 
Furthermore, this study highlighted that the nature of the control group was decidedly 
important for determining if the sleep behaviour manifested in stroke patients was 
different to non-brain injured persons. Sleep behaviour in patients was significantly 
different to that of healthy controls with no sleep disorders whereas in comparison to 
the general population, sleep was similar. With regard to daytime functioning, 
patients did not report greater sleepiness in comparison to a range of control groups. 
This study also showed that psychological adjustment was highly associated with 
sleep disturbance, in both stroke patients and controls. A particularly interesting 
finding of the regression analyses was that anxiety and depression was more 
predictive of sleep and daytime functioning than a stroke event per se. Fatigue and 
psychological disturbance were also more related to perceived post stroke health than 
sleep disturbance. 
" Study 2 
This study built upon the findings of study one and further confirmed that sleep was 
severely disturbed in stroke patients using actigraphy. Most notably, these 
disturbances were increased night awakenings. It was demonstrated that stroke 
patients napped longer than the general population. 
Patients' perceptions of nocturnal sleep indices, apart from night awakening 
estimations, were in good concordance with actigraphy. However, patients were not 
as accurate for daytime functioning reports. This was indicated by the observation 
that increased napping and lower levels of activity, were not related to subjective 
reports of sleepiness and fatigue. 
Study 2 also found that residual motor ability levels were poorer in those patients who 
spent longer in bed and had more night awakenings. This is inline with the 
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assumption that poorer sleep is associated with poorer recovery. However those with 
increased fatigue, had better motor ability. This might be explained by the increased 
effort executed by a group of highly motivated patients to perform motor activities. 
" Study 3 
This study revealed crucially important findings with regard to patient perception of 
sleepiness. Not only was the frequency composition of the waking EEG in patients 
significantly different from matched controls, the EEG of patients was similar to that 
of sleep deprived non-brain injured patients. This indicated that patients demonstrated 
high levels of objective sleepiness. High levels of patient sleepiness was also 
confirmed by laboratory observations. It was particularly alarming that patients did 
not appear to recognise the high presence of sleepiness. This behavioural observation 
has also been observed in sleep deprived non-brain injured persons. It appears that 
stoke patients manifest the behavioural and objective characteristics of a healthy sleep 
deprived person, despite the majority of patients slept at least 7 hours per night. This 
indicated a severe underestimation in a potentially debilitating deficit in daytime 
functioning 
. Study 4 
This study showed that participating in a highly demanding motor neurorehabilitation 
trial was reflected in self reported sleep and actigraphy. Normal time in bed and sleep 
duration was reduced when engaging in daily CIT sessions. Furthermore, patients 
appeared to sleep better during CIT as night time awakenings were reduced. As 
suggested in the literature, better sleep was associated with greater improvement in 
motor ability induced by CIT. 
The findings on napping behaviour contrasted to the literature which suggests that 
napping is beneficial for motor learning. In fact, patients that napped more frequently 
and for longer, had a poorer CIT outcome. With regard to the findings of Alessi et at. 
(2008), this result may have occurred as those who are more sleepy, do not have the 
cognitive capacity to engage well in CIT. Consistent sleepiness, and perhaps fatigue, 
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reflected in greater napping, may be associated with poorer CIT outcome. The results 
of this study highlighted a need for a better understanding of napping behaviour in a 
rehabilitation context. 
7.1.3 Findings In Comparison To Previous Literature 
The lack of existing studies that explore sleep in chronic stroke add complexity to the 
interpretation of data the current study in light of published findings. Of the sparse 
literature, varying recruitment criteria and methods employed between studies further 
contribute to the difficulty in direct comparisons. Therefore when comparing data from 
the current study with previous studies, it is important to take into account: 1) the sample 
chronicity, 2) the in/exclusion criteria and 3) the measures used, i. e. subjective or 
objective. 
General sleep disturbance prevalence rates in patients reported in Study I and 2 are 
comparable with that of other studies using chronic stroke samples without motor ability 
as part of the exclusion criteria, ranging from 31-67% (Campos et al., 2005; Masel et al., 
200126; Schuiling et al., 2005; Worthington & Melia, 2006). The prevalence rates of 
clinically relevant sleep disorders reported in this thesis are considerably lower than 
reported rates in the literature regarding insomnia (48%; Palomaki) and sleep disordered 
breathing (81%; Cadilhac et al., 2005). However the assessment of sleep disorders 
reported in thesis was based on subjective perception whereas those reported in Palmoaki 
et al. (2003) and Cadilhac et al. (2005) were based on detailed clinical assessments. With 
regard to subjective sleepiness, the results were not overly different from reports in other 
studies (Bassetti & Valko, 2006; Campos et al., 2005; Masel et al., 2001; Schuiling et al., 
2005; Worthington & Melia, 2006). The waking EEG results of Study 3 suggested that 
subjective sleepiness is underestimated. The only other known study to use objective 
measures in this cohort was a study by Masel et al. (2001). They found a dissociation 
26 Mixed stroke and TBI sample. 
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between objective, based on sleep propensity determined by EEG, and perceived 
sleepiness (Masel et al., 2001). Perceived prevalence of fatigue was reported as 5% lower 
in this study compared to rates in other chronic samples (Choi-Kwon et al., 2005; Ingles 
et al., 1999; Park et al., 2009; Valko et al., 2008; van der Werf et al., 2001; Visser-Meily 
et al., 2005). This may reflect the highly motivated nature of the particular cohort 
addressed in this thesis. 
With regard to motor recovery and neurorehabilitation, the results of this thesis present 
some complexity when comparing to previous work as no know study has specifically 
assessed upper limb motor ability only. Therefore comparisons have been made with 
studies that measure general functional outcome. In this respect, the present findings were 
in line with acute (Bassetti & Aldrich, 1999; Bassetti & Aldrich, 2001; Hachinski et al., 
1987; Leppävuori et al., 2002; Siccoli & Bassetti, 2008; Takekawa et al., 2007), chronic 
(Cadilhac et al., 2005; Worthington & Melia, 2006) and prospective (Bassetti & Aldrich, 
2001; Giubilei et al., 1992; Hermann et al., 2008; Spriggs et al., 1992a; Vock et al., 2002) 
data which suggested that poorer sleep was associated with poorer outcome. Poorer sleep 
mildly affected motor neurorehabilitation outcome which fits in with the postulations of 
Walker and Stickgold 2002a, Kuriyama et al., (2004), Siengsukon & Boyd (2009b), 
(Gomez-Beldarrain et al., 2008) and Robertson and Cohen (2006). Other studies 
examining rehabilitation patients have reported adverse effects of poorer daytime 
functioning on treatment outcome rather than sleep per se (Alessi et al., 2008; Barker- 
Collo et al., 2007; Morley et al., 2005; Worthington & Melia, 2006). The results of study 
4 showed that increased napping was associated with poorer CIT outcome. This 
observation is consistent with the findings of Alessi et at. (2008) which showed that 
greater napping behaviour was associated poorer rehabilitation participation. 
7.2 Proposed Explanations For The Findings 
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7.2.1 Disturbed Sleep and Daytime Functioning In Chronic Stroke 
The origin of sleep behaviour traits in patients recruited for the current study is yet to be 
fully determined. Several important factors for post stroke sleep have been noted in the 
literature and may explain the observations in Studies I to 4. Possible mechanisms behind 
sleep and daytime functioning alterations in patients may be neurological, somatic, 
psychological or as a result of other external attributes such as medications and lifestyle. 
Neural Mechanisms Behind Sleep Problems 
Lesion location may, in part, determine specific changes in sleep and daytime 
functioning. As populations of neurons implicated in sleep-wake cycles are widespread 
across the neural axis (Evans, 2002; Jones, 2005), various lesion locations may contribute 
to sleep problems. Lesions within the cortices (Bassetti & Aldrich, 2001; Beebe & Gozal, 
2002; Gottselig et al., 2002; Mohsenin & Valor, 1995; Muller et al., 2002; Siccoli & 
Bassetti, 2008; Vock et al., 2002) and subcortical regions including the midbrain 
(Bassetti et al., 1997; Evans, 2002) and brain stem (Blanco, Espinosa, Arpa, Barreiro, & 
Rodriguez-Albarino, 1999; Good et al., 1996; Markand & Dyken, 1976) are associated 
with sleep disturbance. Sleepiness after stroke may arise from an interruption of the 
arousal system, in particular the reticular formation (Autret et al., 2001). Subcortical 
stroke, usually involving the thalamus, is largely accompanied by poor alertness and 
hypersomnia (Bassetti et al., 1996; Catsman-Berrevoets & Harskamp, 1988; Christian 
Guilleminault et al., 1993; Hermann et al., 2008). Fatigue has also been attributed to 
neurological origins as a result of subcortical and brain stem lesions (Naess et al., 2005; 
Staub & Julien Bogousslavsky, 2001). However, the commonly observed overlap 
between post stroke fatigue and depression makes it difficult to determine the degree to 
which fatigue originates from the psychological stresses endured after stroke or as a 
result of the brain injury per se (Bassetti & Valko, 2006). After controlling for 
psychological disturbance, fatigue may occur in chronic stroke, independent of 
depression (Choi-Kwon et al., 2005; Ingles et al., 1999; Naess et al., 2005). Moreover, 
Cantor et al. (2008) found fatigue exists independent of other post stroke comorbidities. 
The authors therefore argued that fatigue can be attributed to brain damage. This 
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evidence demonstrates that fatigue has a multifactorial nature which may be caused and 
maintained by both the physiological consequences as well as part of psychological 
changes associated with stroke. 
Somatic Origins of Poor Steep 
The physical consequences of stroke, described in Section 1.1.2 (Chapter 1), further 
compromise sleep (Bassetti & Aldrich, 2001; Gamble et al., 2000; Kong et al., 2004; 
Krachman et al., 1995; Widar et al., 2004). Mobility restrictions experienced by patients 
with hemiparesis may affect manoeuvring for sleep position and ease of returning to bed 
after toileting. Several patients from the current research commonly acknowledged this 
difficulty. Pain endured after brain injury has also been attributed to increased sleep 
disturbance (Fictenberg et al., 2001; Widar et al., 2004). Furthermore, this relationship 
may be reciprocal as the presence of sleep disturbances may modulate the acute and 
chronic pain (Lautenbacher et al., 2006). 
Premorbid sleep characteristics may partly explain the prevalence of post stroke sleep 
disturbance. Risk of stroke was greater for those who slept more than eight hours a night 
and those with increased daytime sleepiness (Qureshi et at., 1997). These findings were 
independent of age, race, gender, education, smoking, BMI, serum cholesterol, systolic 
blood pressure and diabetes (Qureshi et al., 1997). A history of sleep disordered 
breathing, snoring and circadian variation in blood pressure during the night is also 
associated with increased stroke risk (Martinez-Garcia et at., 2004; Plante, 2006; Wolf, 
Lewicka, & Narkiewicz, 2007). These sleep problems may remain after a stroke event. 
Psychological Correlates of Post Stroke Sleep 
According to the results, the psychological consequences of stroke are clearly associated 
with poorer sleep and daytime functioning, which further impact perceived health. The 
direction of this relationship, however, remains unclear. Based on previous research, the 
cause and effect nature between sleep and psychological adjustment are likely to be 
reciprocal (Ellis et al., 2007; Jansson & Linton, 2006; Steptoe, O'Donnell, Marmot, & 
Wardle, 2008). Therefore psychological disturbance may not only be related to the 
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development but also the maintenance of sleep related disorders in the chronic phase of 
stroke. Fichtenberg et al. (2001) suggested that neurological factors have a primary role 
in sleep disturbance during acute TBI whereas psychological factors were greater 
contributors during the chronic phase. The results of this thesis indicate that this idea can 
be translated into stroke populations. 
The daytime functioning of patients observed for this thesis was also related to 
psychological well being. These results are in line with previous literature in chronic 
stroke samples which show that depression in particular, is associated with increased 
sleepiness and fatigue (Astrom, Adolfsson, & Asplund, 1993b; Choi-Kwon et al., 2005; 
Ingles et al., 1999; Naess et al., 2005; Staub & Bogousslavsky, 2001). Fewer studies have 
paid attention to anxiety in these patients, however Study I and the findings of McCoy 
(2006) and Sterr et al. (2008) have highlighted that post stroke anxiety contributes to 
poorer sleep. 
External Factors Affecting Sleep 
Medication use may have a role in sleep alterations after stroke as patients are often 
prescribed drugs with sedentary side effects which impact daytime functioning and also 
affect brain activity (Bourne & Mills, 2004; Lowson & Sawh, 1999; Novak & Shapiro, 
1997; Obermeyer & Benca, 1996). Approximately seven percent of patients in this study 
were on antidepressants, which is slightly lower than in the general population (Petty, 
House, Knapp, Raynor, & Zermansky, 2006). This may be due to the positive selection 
criteria employed in the current research. In the stroke population, antidepressants are 
commonly prescribed (Paolucci et al., 2001) and have well documented effects on sleep. 
Tricyclic antidepressants may improve sleep whereas others, e. g. serotonin reuptake 
inhibitors, may worsen sleep (Holshoe, 2009). More specifically, some antidepressants 
are known to alter sleep architecture and reduce sleep efficiency (Holshoe, 2009; Mayers 
& Baldwin, 2005). 
The majority of patients in the studies carried out for this thesis regularly consumed 
caffeine and a smaller proportion drank alcohol. Some patients consumed excessive 
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amounts of caffeine, up to 12 cups a per day. Alcohol reached excess, i. e. over 14 units 
for women and 21 for men (The Department of Health, UK), in only 8.06% of patients. 
Increased amounts of caffeine have known affects upon sleep including delayed sleep 
onset latency, reduced sleep length, increasing proportion of stage I and reducing REM 
sleep (Roehrs & Roth, 2008). Furthermore, increased alcohol consumption shortens sleep 
latency, and has profound effects upon sleep continuity and architecture (Rogers et at., 
2001). Nicotine also affects sleep (Zhang, Samet, Caffo, Bankman, & Punjabi, 2008; 
Zhang, Samet, Caffo, & Punjabi, 2006) however only 9.68% of patients smoked. Within 
Studies I to 4, no relationships were found between any of the above lifestyle drugs and 
subjective sleep. This indicates that caffeine and alcohol use in patients were not 
affecting sleep in patients recruited for this study. 
External life style factors, including environmental, societal and occupational, may 
contribute to poorer sleep after stroke. Non-sleep promoting cues in the home 
environment may be counteractive to sleep. Bedroom conditions negatively influence 
sleep such as light curtains, uncomfortable bed, stimulation from various electronics 
(Ellis, Hampson, & Cropley, 2002; Gellis & Lichstein, 2009). Although these behaviours 
were not measured in patients, evidence suggests that poor sleep hygiene routines is 
common in the general population and is highly associated with the existence of sleep 
disturbance (Gellis & Lichstein, 2009). Improving sleep hygiene is starting point for non- 
pharmacological sleep disorder treatments (Zafonte et al., 1996). It is difficult to isolate 
to what extent social and occupational activities contribute to sleep behaviour in a 
chronically ill population, the majority of which, does not work. Although it is evident 
that chronically ill populations, including stroke, that have a greater percentage of sleep 
per day as a result of poor health (Bassetti & Valko, 2006; Kapur et al., 2002; Parish, 
2009), low levels of social and occupational activities are possible contributors to the 
development of a weak circadian cycle and ultimately problematic sleep (Campos et al., 
2005). This may partly explain why patients' sleep schedules were different to that of the 
general population. It may be that chronically ill, non-working, populations have greater 
opportunity, as well as a need, to sleep longer and nap during the day. Interestingly in 
study 6, during CIT treatment, patients sleep schedules became more regulated. This 
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suggests that daytime activities might be beneficial to patient sleep wake-cycles as 
concluded by Campos et al. (2005). 
7.2.2 Self Perceived Sleep and Daytime Functioning 
Patient reports of sleep schedules were in agreement with objective measures whereas 
variables involving night time awakenings were least accurate. This observation is 
common in sleep research in both healthy and sleep disordered samples (Fontaine, 1989; 
Kushida et al., 2001; Lockley, Skene, & Arendt, 1999; Means et al., 2003; Vanable et al., 
2000). It is generally accepted that human perception of night awakenings are not as 
accurate as a minute to minute analysis by actigraphy or PSG, particularly detection of 
arousals during deeper stages of sleep (Kushida et al., 2001). 
The observed dissociation between sleep and daytime functioning showed that patients' 
behaviour did not follow the normal model of sleep, i. e. poorer sleep leads to decrements 
in daytime functioning (Drake et al., 2004; Franzen, et al., 2008; Gold et al., 1992; Harma 
et al., 2002; Papp et al., 2004; Pilcher & Huffcutt, 1996; Torsvall & Akerstedt, 1987). 
Some patients exhibited severely disturbed sleep however reported normal daytime 
functioning whereas others manifested sleepiness and fatigue despite sleeping well at 
night. The lack of correlation between sleep, sleepiness and fatigue suggests that patients 
did not accurately report their sleep or this sample does not follow the normal model of 
sleep. Study 3 strongly indicated that poor perception was a plausible explanation with 
regard to sleepiness. This was also considered in another study (Masel et al., 2001). 
Although further research is necessary, these results suggest that patients may find it 
easier to report factual information about sleep, e. g. bed time and sleep duration, however 
struggle with gauging levels of daytime functioning. 
Patients tended to underestimate the extent of sleepiness, this has been observed in other 
studies, either by observation or clinician or patient reports (Bassetti et at., 1996; Bassetti 
& Valko, 2006; Masel et al., 2001). It was speculated that daytime functioning data was 
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subjected to biases. Possible biases may have arisen from underreporting as a result of 
social desirability or experimenter bias (Bardwell, Ancoli-Israel, & Dimsdale, 2001; 
Mahmood et al., 2004). It is also possible that patients are generally unaware of daytime 
deficits due cognitive deficits, as a result of stroke, that may impair introspection and 
ability to rate themselves accurately (Bassetti et at., 1996; Masel et al., 2001; Trudel et 
at., 1998). According to Clinchot, Bogher, Mysiw, Fugate, & Corrigan (1998) and Beetar, 
Guilmette, & Sparadeo, (1996), those with mild brain injuries are more likely to report 
sleep disturbances compared to those with more severe injuries due to a better aptitude of 
self perception as their injury was less severe than stroke/TBI. Another possibility is that 
patients may develop a higher threshold of what they consider sleepiness after stroke. 
This idea was indicated in the results published by Bassetti and Valko (2006) who found 
that those diagnosed with hypersomnia did not rate their sleepiness levels any differently 
to those who were not diagnosed. The results of this thesis showed that even in a 
homogenous sample of stroke patients of relatively good health, difficulties in self 
perception of daytime functioning is clearly evident. As an objective measure of fatigue 
was not used for this thesis, is not yet known if patients poorly perceive this aspect of 
daytime functioning. 
7.2.3 Sleep, Daytime Functioning and Motor Ability 
Sleep 
The evidence which shows that sleep is important for maintaining health, daytime 
functioning and motor learning provided the theoretical foundation for the development 
of this thesis. Examination of the literature enabled the development of a hypothesis that 
predicted poor sleep will be associated with worse residual motor recovery after stroke. It 
was also hypothesised that poorer sleep would be associated with CIT outcome. 
However, only a mild relationship between better sleep and better motor ability was 
observed, and a relationship with therapy outcome was not observed. This result does not 
necessarily indicate that sleep is not an important factor in stroke recovery and 
neurorehabilitation success, it could be seen as part of a broad range of factors which 
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collectively contribute to motor outcome influences motor outcome. For example, the 
sample of highly motivated patients involved in Study 4 were more likely to achieve 
good therapy outcomes whether they slept well or not. Furthermore, the sample contained 
a small number of severely poor sleepers who fit the criteria for a clinical sleep disorder. 
Should the sample have involved a greater proportion of those with sleep disorders, the 
hypothesised detrimental effects of poor sleep for motor ability and CIT outcome may 
become increasingly observable. 
Although excessive napping was associated with poorer CIT outcome, the literature 
suggests that optimum level of napping may be of benefit for stroke patient (Muller et al., 
2006; Siengsukon & Boyd, 2009b). Napping may assist in alleviating sleepiness and 
fatigue acquired during the day. In addition, several studies have shown that napping also 
has a role in motor memory consolidation (Backhaus & Junghanns, 2006; Milner et al., 
2006; Nishida & Walker, 2007). It may be that napping helps patients cope with the 
demands of neurorehabilitation as well as being a process to optimise motor learning. 
Further studies are necessary to particularly address the latter. 
Fatigue: Not Necessarily A Marker of Poor Sleep 
In contrast to previous literature in healthy participants (Franzen et al., 2008; Ikegami et 
al., 2009) and stroke patients (Park et al., 2009), which showed that increased fatigue is 
related to poor sleep, this study revealed that increased subjective fatigue is not 
necessarily a marker of poor sleep. Fatigue may develop as part of the multifactorial 
consequences of stroke and may not be resolved by improving sleep-wake cycles. 
Presence of fatigue is not necessarily detrimental to motor functioning or 
neurorehabilitation outcome. In fact, patients in the current study who performed better in 
the motor ability tasks reported greater fatigue. Patients with high levels of functioning 
have also shown greater fatigue in other studies (Staub & Julien Bogousslavsky, 2001; 
Van Zandvoort et al., 1998). Furthermore, the high levels of motivation within the patient 
cohort used in this thesis are likely to comprise those who capitalise on residual motor 
ability by putting in a great amount of effort. However it is important to bear in mind that 
300 
fatigue measurements in this thesis, and other studies in the literature, rely on subjective 
reports. 
It is unlikely that the development or maintenance of sleep difficulties after stroke stem 
from one single factor. The findings of this thesis and that of other authors show that 
multifactorial nature of sleep problems after stroke consist of a complex interaction of 
neurological, somatic and environmental stressors (Bassetti, 2005a; Bassetti & Aldrich, 
2001; Gamble et al., 2000; Glader et al., 2002; Kong et al., 2004; Krachman et al., 1995; 
Leegaard, 1983; Sisson, 1998; Widar et al., 2004). These factors are necessary to 
consider when treating and researching these patients. 
7.3 Further Theoretical Considerations 
There are several issues that need to be considered when interpreting results derived from 
the current study. Firstly, the current standpoint of sleep dependent learning theory within 
the literature presents some concerns. As this theory is one of the main theoretical 
perspectives from which the current research evolved, these concerns are addressed in 
this section. Furthermore, there are particular aspects regarding patient characteristics 
which are essential when interpreting data from this thesis and when considering the 
findings in a wider context. These theoretical considerations are also important for future 
studies following on from this work. 
7.3.1 Sleep Dependent Learning Theory 
Criticisms of The Sleep Dependent Learning Theory 
The sleep dependent motor learning theory has been subject to criticism by some 
researches (Vertes, 2004). There are three main arguments that are used to support the 
idea that sleep does not have a critical role for learning: 1) experimental methodology is 
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limited, 2) consolidation occurs over time rather than sleep per se, and 3) REM 
suppression does not affect learning in psychiatric patients. 
The experimental evidence behind the sleep dependent learning theory presents several 
methodological limitations. The majority of studies within the evidence base do not 
control for stress (including animal studies) or circadian effects which may influence 
cognitive performance on the learning tasks (Vandewalle et al., 2009). The studies also 
have low ecological validity, particularly regarding laboratory based learning tasks, 
which may not be representative of learning that occurs in real life. 
It is also argued, particularly for procedural memory, that sleep merely coincides with 
memory consolidation over time, and does not facilitate learning any more so than wake. 
Walker et al. (2002a) investigated the time dependent verses sleep dependent learning 
issue. The results showed that new motor skills are considerably improved (20.5%) after 
a night's sleep compared to the same amount of time awake (3.9%). It was concluded that 
consolidation may be partly time dependent in that research suggests stabilization occurs 
during wake (Brashers-Krug et al., 1996; Muellbacher et al., 2002; Matthew P Walker et 
al., 2003b) whereas enhancement and improvement without practice occurs during sleep 
(Fischer et al., 2002; Gais & Born, 2004; Karni et al., 1994; Korman, Raz, Flash, & 
Karni, 2003; Stickgold, James, & Hobson, 2000; Walker et al., 2003a; Walker et al., 
2003b). 
Another argument against sleep dependent learning stems from research in psychiatric 
patients. Patients who take antidepressants show a reduction in REM and in some cases, 
no REM for several years (Vertes & Eastman, 2000). It appeared that lack of REM had 
little effect on memory and learning (Thompson, 1991). It is important to note that these 
studies focused on simple declarative memory tasks, rather than more complex 
procedural learning which is more likely to be affected by lack of REM sleep (Stickgold, 
Whidbee, Schirmer, Patel, & Hobson, 2000). Other studies have shown that there is a 
sudden increase in REM when the medication is ceased which may indicate a surplus 
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demand for REM after prolonged periods of REM deprivation (Landolt et al., 2001; 
Minot, Luthringer, & Macher, 1993). 
Applicability of Sleep Dependent Learning Theory To Stroke Patients 
Sleep dependent learning paradigms include the motor reaching adaptation task (Huber & 
Ghilardi, 2004), continuous tracking (Siengsukon & Boyd, 2008a, 2009a; Siengsukon & 
Boyd, 2008b), serial reaction time task (Gomez-Beldarrain et al., 2008) and sequential 
finger tapping task (Walker et at., 2002a). Not only do these tasks lack ecological 
validity, it may not be appropriate to translate the findings of these experiments to stroke 
patients. 
The work of Siengsukon and Boyd (2008a, 2008b and 2009a) are the first studies to 
address sleep dependent motor learning in chronic stroke patients. The results of these 
studies showed that patients demonstrated improvements in learning which were 
associated with a period of sleep, rather than the same amount of time awake. These 
findings provided theoretical evidence for investigating the role of sleep in motor 
neurorehabilitation as investigated Study 4. However results of Siengsukon and Boyd 
(2008a; 2008b; 2009a) presented some limitations. It is important to note that patients' 
level of learning in the non-sleep groups was tested in the evenings after the learning 
session in the morning. Patients in the sleep group were tested for learning after a nights 
sleep. It is not yet clear if patient activities between learning and testing were controlled 
in the non-sleep group. This may be an important factor as Walker et al. (2002a) found 
that participant activities between learning and testing may affect results. Furthermore, 
only habitual subjective sleep behaviour was reported, an assessment which cannot 
reliably detect if patients slept well the night before learning or testing level of learning. 
Translating Sleep Dependent Motor Learning To Motor Neurorehabilitation 
Previous research using healthy and stroke patient cohorts have related their findings to 
motor learning after brain injury (Gomez-Beldarrain et al., 2008; Kuriyama et al., 2004; 
Robertson & Cohen, 2006; Siengsukon & Boyd, 2009b; Walker et al., 2002a). With 
regard to CIT, the therapy sessions are based on real life tasks and it may not be 
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appropriate to translate findings from standardised task based motor learning in the 
laboratory to CIT. Furthermore, motor skills facilitated by CIT comprise implicit and 
explicit learning and is strongly goal orientated. This may be influenced by the 
motivation of the patient as well as the possibility of new motor skills being enhanced by 
sleep. In addition learning occurred over a two week period rather than a one off testing 
session as employed in the studies mentioned above. Further research is required to 
determine the degree to which these factors have affected motor learning after stroke. 
7.3.2 Patient Characteristics 
Patient Selection 
The positive selection of patients for the current research is an important factor for result 
interpretation. With regard to findings relating to prevalence of sleep disturbance, it is 
important to consider that the results may be underestimated. Severely sleepy or fatigued 
patients may be less likely to volunteer to participate in research. Therefore the results of 
studies reported in this thesis should be interpreted with relation to the specific patient 
sample that is researched and used with caution if translated to patients in a wider 
context. 
It is also postulated that recruitment of a fully homogenous group is not entirely possible 
amongst chronically brain injured participants (Terzoudi et al., 2009). From a neural 
perspective, the various anatomical location where strokes occur makes it difficult to 
generalize across individuals. Although patients in this study were psychologically stable, 
the dramatic impact of stroke on the individual is unlikely not to have at least some effect 
on psychological health from time to time (Langhorne et al., 2000). However some 
authors argue that despite the significant ongoing physical disability, stroke survivors 
appear to adjust well psychologically to the disease (Hackett, Duncan, Anderson, Broad, 
& Bonita, 2000). Overall, the recruitment procedures for this thesis have enabled a 
greater level of homogeny compared to other studies in the post stroke sleep literature. 
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Age 
Although age did not appear to be a contributing factor to the results of this thesis, age 
related changes in sleep, daytime functioning and memory consolidation may be 
important to consider as 16% of patients in the sample were over 65 years old. Moreover, 
in the wider context of stroke, the incidence increases with age (Hollander et al., 2003). 
Age related changes include a reduction in sleep duration, frequency night awakenings, 
early morning awakenings and alterations in circadian rhythm (Dijk, Duffy, & Czeisler, 
2000; Dijk, Duffy, Riel, Shanahan, & Czeisler, 1999; Kramer, Kerkhof, & Hofman, 
1999). Actigraphy did not reveal any age differences in patients however this may not be 
sensitive enough. Neurological alterations in sleep architecture have also been 
documented in older populations, such as reduced proportion of slow wave and REM 
sleep (Crowley, Trinder, Kim, Carrington, & Colrain, 2002; Danker-Hopfe et al., 2005; 
Dijk et al., 1999). Additional research is necessary to find out if this is also the case in 
stroke patients. 
With regard to daytime functioning, older adults report increased sleepiness, fatigue and 
napping compared to younger persons (Ancoli-Israel, Poceta, Stepnowsky, Martin, & 
Gehrman, 1997b). Furthermore, aging differences have been observed in the waking 
EEG, most notably, a reduction in theta waves (Cummings & Finnigan, 2007; Dijk et al., 
2000). Given that sleepiness and fatigue may not be accurately described by the patients 
in the current study, it cannot be determined at present if age has a role in increased 
daytime functioning problems after stroke. Some authors have suggested that illnesses 
and medication associated with increasing age better explains observed effects of age on 
sleep (Foley et al., 2004). Crowley and Colrain (2000) reported a comparison between 
healthy young and healthy older adults on sleep parameters finding no significant 
differences between the groups using subjective sleep diaries. Kramer et al., 1999 also 
found no difference in subjective ratings between young and older adults however 
objectively the older persons had a weakened circadian rhythmicity and increased night 
awakenings. Increased nocturia with age (Ali & Snape, 2004) which has an effect upon 
sleep quality and daytime functioning (Jennum, 2002). Results of the present study 
showed no effects of age upon subjective sleep or daytime functioning which has 
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previously been shown in other brain injured populations (Fictenberg et al., 2001). This 
may be because the sample within the current study is considered relatively young for a 
stroke cohort. 
Gender Differences 
It is important to recognise gender differences in sleep as the study samples were 
relatively small and contained a greater proportion of men (ranging from 47-61% across 
all studies). Although the results did not reveal any gender effects, studies have gender 
specific differences regarding sleep (Armitage & Baker, 2005; Collop, Adkins, & 
Phillips, 2004) and post stroke recovery (Saini & Shuaib, 2008). Gender differences may 
be necessary when considering sleep after stroke in a wider context then that of the 
cohort addressed in this thesis. 
The prevalence of insomnia and general sleep disturbance such as increased night 
awakenings and poor sleep quality is greater amongst women (Groeger et al., 2004; 
Reyner, Horne, & Reyner, 1995; Valipour et al., 2007). Women are known to experience 
greater levels of anxiety (Bekker & van Mens-Verhulst, 2007) compared to men which is 
attributed to the existence of increased sleep disturbance (Roth, 2007). Men are 
particularly associated with sleep related breathing disorders (Valipour et al., 2007). 
Gender differences in sleep also arise from differences in life style and health (Roth, 
2007), as well as sleep architecture (Carrier, Land, Buysse, Kupfer, & Monk, 2001; Dijk, 
Beersma, & Bloem, 1989; Goel, Kim, & Lao, 2005). It is not yet known if gender 
specific differences in sleep architecture differentially affect sleep dependent learning 
(Vassalli & Dijk, 2009). 
Gender differences are also apparent in the context of post stroke recovery. Studies show 
that women have poorer functioning, greater levels of comorbidity after stroke compared 
to men (Gargano & Reeves, 2007; Herrmann et at., 1998; Lai, Duncan, Dew, & 
Keighley, 2005; Tilling et al., 2001). This may in part be due to increased survival rates 
for women (Gresham et at., 1998) and increased levels of depression affecting their 
ability to cope with the disease (Chong, Lee, Boden-Albala, Paik, & Sacco, 2006; 
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Herrmann et al., 1998). However, several studies have found that gender was not a factor 
for rehabilitation outcome (Heinemann, Roth, Cichowski, & Betts, 1987; Henrik Stig 
Jorgensen et al., 2000) and quality of life (Kwa et al., 1996; Naess, Waje-Andreassen, 
Thomassen, Nyland, & Myhr, 2006a). 
7.4 Limitations of Thesis Research 
The research carried out for this thesis was subjected to several methodological 
limitations that are necessary to acknowledge for data interpretation and to highlight 
aspects for improvement when planning future studies. The main limitations have arisen 
from apparent constraints of the CIT trial framework and issues with the chosen 
assessments. 
7.4.1 Constraints of The CIT Trial Protocol 
As an opportunity sample was utilised for the current thesis research, the planning of the 
studies was restricted in some respects. Attending the CIT trial imposed several 
psychological, cognitive and practical demands on patients that may have affected their 
sleep which could not be controlled. 
Enduring CIT has great emotional connotations for several reasons. Firstly, patients are 
often apprehensive prior to visiting the laboratory due to the unfamiliarity of the research 
situation. Anecdotally, several patients commented on their sleep being affected prior to 
attending screening and the first CIT session as a result of increased anxiety. This 
demonstrates that stroke patients' psychological state highly impacts sleep, which was 
reflected in the results of Study 1. Conversely, observable improvement in motor ability 
over the course of CIT was usually paired with a great sense of achievement and 
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improved mood in patients. It remains unknown if short term alterations in mood affected 
sleep in these patients. Other studies have shown that after two weeks of CIT, many 
patients report improvements in their quality of life and mood (Demetters, 2005). This 
may have a beneficial effect on sleep and daytime functioning in those who experience 
psychological difficulties. This may in part explain why there was less self reported 
napping in patients during CIT. 
The CIT project also inflicted cognitive demand on patients in addition to the motor 
learning required in therapy sessions. The trial involved several appointments of which 
patients and families needed to organize themselves to attend. Patients were also required 
to read several study documents and remember to bring certain items to sessions, such as 
home CIT or sleep diaries. Completion of sleep diaries also required an additional task 
for patients on a daily basis for a total of six weeks of which some patients found 
tiresome. 
For some patients, the CIT trial imposed practical demands which almost certainly 
affected their sleep. Attending sessions involved traveling great distances everyday, of 
which contributed to patient sleepiness and fatigue. Furthermore, some patients stayed in 
alternative accommodation therefore had to adjust to a new sleeping environment. 
Therefore the observed changes during the CIT trial are vulnerable to the practicalities of 
enabling the patient to attend sessions. However it is important to note that sleep did 
become more regulated as a result of adding structure to the day. 
7.4.2 Subjective Assessments 
Sleep and Daytime Functioning Scales 
The sleep and daytime functioning scales employed in this thesis have provided useful 
information regarding post stroke sleep. However, as with any scale that measures 
constructs of behaviour, issues regarding validity and reliability should be considered 
when interpreting the data collected in the current studies. 
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The PSQI and ESS are two of the most widely used assessments of sleep quality and 
daytime sleepiness respectively. Tachibana & Taniguchi (2007) pointed out that there is a 
tendency to rely on measures due to popularity rather than reliability and validity. Buysse 
et al. (2008) carried out a study to examine the validity of the PSQI and ESS with PSG in 
187 participants. It was found that neither of these measures were related to the objective 
assessment. It was concluded that the PSQI and ESS measure different aspects of sleep to 
that of PSG, therefore it is expected they would not correlate. With regard to patients 
involved in the current research, it may be that these assessments are not sensitive to pick 
up subtle sleep abnormalities of clinical significance and should be reported as self 
perceived sleep, rather than assuming a correlations with objective measures. The Buysse 
et at. (2008) study suggested that sleep problems may not be detected subjectively which 
may explain why prevalence 31-44% of sleep problems in patients of this study was less 
than those reported in other studies using other forms of assessment. Furthermore, the 
ESS is less sensitive to those with sleep disorders due to their inability to detect their own 
sleepiness (Fong, Ho, & Wing, 2005). 
The FSS is another widely used measure to assess fatigue however there have been 
several criticisms of this scale which are relevant to the current research. The FSS asks 
participants to rate how much they agree with a list of statements that assumes they 
already have fatigue, e. g. "My motivation is lower when I have fatigue". Patients who felt 
they did not have fatigue felt that this questionnaire was not applicable to them and rated 
their response as zero for each item. A similar process occurred when completing the D- 
FIS. However, it was suspected that they may be more fatigued than a healthy person. 
Therefore, it might have been more appropriate to ask them to rate what their fatigue 
levels are like compared to premorbid levels. 
Stone et al. (2002) reported that participants may become less motivated to complete 
sleep diaries over long periods of time. This can result in participants completing several 
days' worth of the diary at the end of a study before returning them to the researcher. 
Non-compliance with regard to sleep diaries meant exclusion of two patents in Study 4 
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and 6. In addition, the content of the diary presented some limitations. Firstly, the sleep 
diaries did not track daily caffeine and alcohol use. Only a habitual measure was obtained 
during screening. This information may have been useful as whilst the majority of 
patients continued to drink their usual amount of caffeine per day, some patients 
commented on a greater need for more caffeine during CIT. Furthermore, some patients 
who attended social events and drank alcohol commented that this affected their sleep. As 
this was not systematically documented, it was not possible to include this in the 
analyses. However for future studies, it would be useful to include these measures. 
Another issue which arose from the sleep diaries was the apparent overlap between the 
first item on the D-FIS, "I feel less alert", and KSS which asked participants to rate 
alertness. This highlights the similarity in sleepiness and fatigue in the view of the scale 
developers. Furthermore, sleepiness and fatigue share conceptually share some overlap 
(Hossain et al., 2005; Mahowald & Mahowald, 2000). It may just be that the first item on 
the D-FIS represents the aspect of fatigue that extends to sleepiness. Therefore patients 
were given clarification in order to complete the sleep diaries accurately. 
Assessment of QOL 
There are some validity issues with use of the SF-36 and HADS. The SF-36 is vulnerable 
to response bias as those who score highly on this measure also score highly on Marlowe- 
Crowne Social Desirability Scale27 in a group of sleep disordered patients (Bardwell et 
al., 2001). Therefore the SF-36 may not be representative of their true behaviour 
(Bardwell et al., 2001). Moreover, the SF-36 is considered less valid when assessing 
health outcome in stroke patients due the variable ways it is administered and scored 
across studies (Hobart, Williams, Moran, & Thompson, 2002; O'Mahony, Rodgers, 
Thomson, Dobson, & James, 1998). Other authors have concluded that the SF-36 is a 
valuable measure of perceived health in stroke patients and is less susceptible to ceiling 
effects compared to other questionnaires therefore can be applied to a broad range of 
patients (Anderson et al., 1996). 
2' This scale statistically determines the degree to which a person is likely to adjust their answers in a 
socially desirable manner. 
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Subjective Upper Limb Use 
The upper limb motor test battery incorporated the MAL as a subjective assessment of 
real world arm use beyond the laboratory. Particular caution should be applied to patient 
reports of their affected arm usage. Dettmers et al. (2005) found that greatest 
improvement of arm/hand usage was reported on the MAL compared to other commonly 
used forms of assessment. It is difficult to judge whether eliciting movements due to the 
nature of an assessment would worsen performance compared to completing activities of 
daily living within the person's home. In contrast, other studies have reported that 
pessimistic patients underestimate their ability when completing the MAL (Heller et al., 
1987). The semi-structured nature of the MAL may lead to variability in the way it is 
administered and also how authors present the findings (Liepert et al., 1998; Taub et al., 
1993; Van der Lee et al., 1999). It was highlighted by Van der Lee et al. (2004) that the 
MAL has good uses within a research project, however the generalisability of the results 
are assessment not likely to extent beyond the context of which the test was used. 
However it is important to drawn on strengths of this form of assessment. In particular, 
the subjective nature of this test supplements other tests in this field which have lower 
ecological validity. Furthermore improvements on the MAL as a result of CIT have been 
shown to correlate with objective measures (Kopp et al., 1999; Levy, Nichols, 
Schmalbrock, Keller, & Chakeres, 2001; Liepert et al., 1998). 
7.4.3 Objective Assessment 
In addition to subjective scales, some limitations arose with regard to actigraphy, EEG 
and a non-subjective motor ability test (WMFT). 
Actigraphy 
Although the issue of using actigraphy in those with motor deficits was addressed in 
Chapter 4, it is necessary to further discuss this issue in more detail. The motor 
movement difficulties associated with brain damage, i. e. hemiparesis, may inflict artefact 
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within actigraphy recordings (Sadeh, & Acebo, 2002). More specifically, lower activity 
may be interpreted as sleepiness or even a period of sleep however may actually be 
related to physical limitations. The possibility of such artefact may have occurred in 
actigraphy recordings within patients used in this current research as the sensitivity 
algorithm was developed for normally moving persons. At present there is no algorithm 
specifically developed for stroke patients with upper limb hemiparesis. Therefore further 
research to develop an algorithm for this population. 
The Acitwatch © equipment and software used in the present studies (CamNtech Ltd., 
2009) could be adjusted to one of three levels of threshold sensitivity to define wake; low 
(>80 activity counts), medium (>40 activity counts) and high (? 20 activity counts). Nap 
sensitivity could be set to 10 activity counts to define sleep at a medium sensitivity and 
up to 0 for high sensitivity. After careful consideration of the available literature and the 
prospective sample being studies, a medium sensitivity was chosen for both nocturnal 
and daytime sleep. This sensitivity was chosen for several reasons: 1) patients were 
selected based on a narrow range of motor criteria, 2) patients physical ability allowed 
them to attend the CIT trial, 3) approximately 70% of patients were retired or currently 
able to work, 4) actiwatches were worn on the non-affected wrist which resembled 
normal movement, 5) varying sensitivities of actiwatches within a group of motor 
handicapped persons did not significantly impact results (Laakso et al., 2004), 6) the 
chosen senstivities were recommended by the manufacturer, and 7) sensitivities set too 
high or too low tend to over/underestimate night time awakenings (Littner et al., 2003). 
In addition, further measures were taken to correct for artefact. Sleep schedules were 
inputted manually with the guidance of the sleep diary and visual inspection of the 
actigram. For napping analyses, automatic nap detection was adjusted if the watch was 
removed for any reason. Watch removal was reported in the sleep dairies and could be 
detected visually as the actigram remained at zero for longer periods of time, as it is 
expected that some movement would occur a sleep period (Carskadon & Rechtschaffen, 
2005). These suspected periods of watch removal were also checked using the highest 
sensitivity of the nap analysis (>0 defined wake) to determine if this period was a nap. 
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Waking EEG 
Some limitations arose from the waking EEG protocol described in Chapter 5. One 
particular limitation within the protocol is the length of time between the beginning of the 
experimental paradigm and the first waking EEG recordings which was up to an hour. 
Patients remained sat in the chair during this time and often commented on the 
laboriousness of this part of the experiment which made them more tired that usual. 
Therefore subjective and objective sleepiness ratings in this study may not represent how 
the patient felt in natural conditions. With regard to EEG capture, some authors argue that 
recording with eyes closed is a better indication of sleepiness (Marzano et al., 2007). 
However other authors have found little difference between eyes open and eyes closed 
(Akerstedt & Gillberg, 1990). 
Wolf Moto Function Test (WMFT) 
The WMFT is a laboratory based test of upper limb motor ability, although tightly 
controlled in this study, is subject to limitations. The most prominent limitation is the low 
ecological validity a test of this nature as the scores may not represent what the patient 
can or can not do outside the clinic or research facility. However there are no known 
studies which have reported problems with this test regarding reliability or validity. 
However to supplement this test, the MAL was employed in order to broaden the 
assessment of upper limb motor ability from that of a structured laboratory based 
assessments to real world arm usage. 
7.5 Implications and Practical Applications of The Findings 
The results presented in this thesis have great implications the healthcare profession and 
patients by build on clinical knowledge of the post stroke sequelae. The findings are 
informative for treatment protocols, including medical, psychological and sleep. The 
results also have ramifications for neuro rehab iI itation programmes, including CIT, and 
can be translated into other rehabilitation protocols. From the current findings and those 
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provided in the literature, the development of practical solutions for promoting healthy 
sleep as well as treating sleep related difficulties in stroke patients can be established. in 
addition, these results have implications for further research. 
7.5.1 Informing The Medical Profession 
Understanding Post Stroke Sleep Behaviour 
This thesis has shown that post stroke sleep and daytime functioning are part of the 
complex and multifactorial consequences of stroke. Not only does stroke influence sleep, 
any disturbances present in patients impact quality of life, recovery and rehabilitation 
participation. It is therefore important for clinicians to have knowledge of sleep and how 
to recognise a difficulty in this respect. However, at present there is a surprising lack of 
attention paid to sleep in medical training (Wessendorf et at., 2000). Furthermore there is 
a lack of consideration of sleep when treating conditions of which sleep disturbance may 
be a secondary consequence (Chesson et at., 2000). This thesis has also shown that there 
are dimensions of daytime functioning, i. e. sleepiness and fatigue, which differentially 
affect the patient. It is known that sleepiness and fatigue are not necessarily considered as 
distinct entities in the medical profession (Hossain et al., 2005; Mahowald & Mahowald, 
2000), therefore this common misconception should be addressed as this may impact 
patient treatment (Pigeon et at., 2003). In addition to diagnosis and recognition of 
maladaptive sleep behaviour, it is also important for clinicians to understand the 
modulating properties of sleep in somatic, behavioural, cognitive and psychological 
contexts of stroke. 
Underestimation of a Chronic Problem 
This thesis particularly highlights that sleep and daytime functioning difficulties, initially 
believed to have resolved within the acute phase of injury, by both patients and their 
clinicians, may remain beyond a year after injury. It is for that reason, especially 
important to increased awareness of these continuing problems which may evolve with 
the disease. The apparent lack of medical attention paid to sleep as part of post stroke 
314 
care is alarming and requires addressing in medical education as well as raising patient 
awareness. One of the reasons that sleep is not largely addressed as part of treatment may 
be due to lack of awareness from the patient themselves of which they do not express to 
their clinician. It was postulated that patients threshold of what they consider poor levels 
of sleep quality or daytime functioning may be higher than a non-brain injured person. 
This may be due to long term adjustment to their illness. This suggests that it will be 
beneficial for patients to be educated early on during stroke treatment in recognising and 
available treatments for these problems throughout their recovery. Increased awareness 
and appropriate treatment throughout the course of stroke may hold beneficial 
implications for patient quality of life and adjustment to stroke (Ingles et al., 1999; La 
Chapelle & Finlayson, 1998; Naess et al., 2006b; Schuiling et al., 2005; Siengsukon & 
Boyd, 2009b; Van Zandvoort et al., 1998). Moreover, ensuring healthy daytime 
functioning levels have critical implications for patient safety (Hyndman & Ashburn, 
2003; Lundqvist et al., 2008; Michael et al., 2006). 
Clinical Implications For Post Stroke Treatment and Rehabilitation Protocols 
The results of Chapter 3 showed that patients felt their sleep was disrupted by the hospital 
environment within the acute phase, a common finding in clinical cohorts other than 
stroke (Dogan et al., 2005; Freedman, Gazendam, Levan, Pack, & Schwab, 2001; Gabor 
et al., 2003; Southwell & Wistow, 1995). In order to treat post stroke sleep disturbance 
and facilitate healthy sleep in acute stroke, Henmann et al. (2008) advises private rooms 
at night, with adequate noise and light reduction and also the use of sleep hyponotics 
during the night. Turkington, Bamford, Wanklyn, & Elliott, (2002) pointed out that acute 
stroke patients who were nursed in the supine position had significantly higher 
respiratory disturbance. Due to the high presence of sleep disordered breathing after 
stroke, this suggests that nursing staff should be educated with regards to optimum 
sleeping positions in hospital. The authors also advise exposure to light and increased 
mobility during the day to improve daytime functioning levels in these patients. 
The results of this thesis, in addition to findings in the literature, show that predominately 
focusing on wakefulness and ignoring sleep, may be detrimental to quality of life and 
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rehabilitation outcome to some extent, and ultimately, overall recovery after stroke. 
Therefore a `24 Hour Approach' to stroke care is a critical direction for treatment and 
rehabilitation protocols. This applies to rehabilitation within hospital stay as well 
continuation of rehabilitation sessions after the patient has been discharged. Maintenance 
of good sleep over the course of stroke should be addressed by clinicians and reiterated to 
the patients themselves. 
7.5.2 Treatment Options For Post Brain Injury Sleep Disturbance 
Several pharmacological and non-pharmacological treatments have been developed. 
More specifically, such treatment are aimed to treat insomnia, however can also be 
applied to those with only mild sleep disturbance as a way of facilitating healthy sleep 
management in brain injured populations. Syndromes such as sleep disordered breathing 
and parasomnias are more complex and require specialist treatment (Bassetti, 2005a, 
2005b). 
Several authors have outlined treatment strategies for post brain injury sleep disturbance 
(Rao & Rollings, 2002; Thaxdon & Myers, 2002; Zafonte et al., 1996). Thaxton and 
Myers (2002) described potential strategies for managing sleep disturbance after brain 
injury, including non-pharmacological options. In light of the present study, these options 
may prove beneficial to not only managing sleep after stroke, but as part of maintaining a 
healthy life style and contributing to better prognosis and rehabilitation success. By 
applying sleep management to stroke patients, improvements in sleepiness and fatigue 
may also be observed (Annoni et al., 2008; Ingles et al., 1999; Zwarts, Bleijenberg, & 
van Engelen, 2008). There are behavioural and pharmacological treatment options for 
excessive daytime sleepiness including napping, improving nocturnal sleep and use of 
stimulants (Roth & Roehrs, 1996). There are few therapy studies available for post stroke 
treatment of fatigue. The authors of one study suggest low-intensity training, cognitive 
therapy, treatment of psychological problems, use of wakefulness promoting drugs, 
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correction of risk factors and adaptation of activities may alleviate fatigue (Annoni et al., 
2008). 
Zafonte et at. (1996) introduced an outline hierarchy of approaches to addressing sleep 
disturbance for those with TBI (Figure 7.1). The hierarchy presents a stepped care model 
for addressing post brain injury sleep problems. The model will be discussed as well as 
incorporating more recent findings, including clinical trials and other therapeutic 
approaches and how this can be applied to stroke patients. 
Pharmacologic 
Intervention 
Behavioural Intervention 
Environmental Modification 
Sleep Hygiene Techniques 
Structured Evaluation 
Figure 7.1. Reproduced from Zafonte, Mann and Fichtenberg (1996) Neurorehabilitation, 
p. 192. 
Structured Evaluation 
As part of sleep treatment it is important to incorporate a comprehensive evaluation of 
sleep disturbance. Criteria of sleep disorders should be applied to the symptoms 
described by patients. The results of this thesis particularly show that patient perception 
may be different to what is reported via objective measures. Therefore the type of 
assessment is critical to determining the nature of a sleep problem in stroke patients. 
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Sleep Hygiene Techniques 
Sleep hygiene is the term used to describe the implementation or adjustment of those 
behaviours that are conductive to healthy sleep such as a regular sleep schedule, avoiding 
caffeine 4 to 6 hours before bed, scheduling exercise at least 2 hours or more before bed 
and eliminating a bedside clock (Hauri, 1992 cited in Stepanski and Wyatt, 2003; 
Thaxdon & Myers, 2002). One of the simplest strategies to apply as an early form of 
treatment for a sleep problem is to address the sleep hygiene behaviour of the patient. 
Even minor adjustments to sleep habits may facilitate a healthy sleep schedule (Stepanski 
& Wyatt, 2003). Sleep hygiene approaches overlap with other non-pharmacological 
treatments for insomnia, including environmental modification and stimulus control 
(Stepanski & Wyatt, 2003). 
Environmental Modification/ Stimulus Control 
Should improving sleep hygiene be insufficient, the next stage of the model is to 
introduce modifications to the sleeping environment to further encourage healthy sleep. 
People with sleep problems typically associate the bedroom as a stressful place where 
they cannot sleep. The aim of environmental modification, sometimes referred to as 
stimulus control, is to remove stimuli that are counteractive of sleep in the bedroom. This 
includes work related stimuli, electronic devices such as computers, visible clock and 
only using the bedroom for sleep. Removal of this stimuli aims to facilitate a stronger 
association between the bedroom and sleep. Therefore the bedroom becomes a more 
conductive environment for sleep (Ellis et al., 2002; Stepanski & Wyatt, 2003; Thaxdon 
& Myers, 2002). 
Napping behaviour requires some degree of control when managing sleep disturbance. III 
timed or excessive napping may lead to poorer quality nocturnal sleep as well as affecting 
regularity of the sleep schedule (Werth, Dijk, Achermann, & Borbely, 1996). However in 
extreme conditions, such as illness or sleep deprivation, an optimal nap holds beneficial 
properties (Takahashi, 2003). Naps help alleviate sleepiness (Rosekind et al., 1995; 
Vgontzas et al., 2007) and can be part of a health active lifestyle if structured well 
(Ceolim & Menna-Barreto, 2000). 
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Furthermore, alterations to the amount and type of light in the waking environment can 
improve daytime functioning and subsequent sleep. Approaches expose patients to 
natural light such as Chronotherapy and Bright Light Therapy (Rao & Rollings, 2002). 
The aim of this treatment is to strengthen circadian rhythm (Czeisler et al., 1989) which 
ultimately facilitates a healthy sleep-wake cycle. Bright light therapy has been useful for 
treating sleep disorders due to regulation of circadian rhythm (Czeisler et al., 1989; 
Lockley et al., 2006) as well as treating excessive daytime sleepiness (Black et al., 2007) 
and improving mood (Goel & Etwaroo, 2006). 
Cognitive and Behavioural Intervention 
A challenging yet effective behavioural intervention is sleep restriction therapy 
(Glovinsky & Speilman, 1991). This involves reducing the time that the patient is 
allowed to spend in bed to four hours for the first night and gradually increasing time in 
bed by 15 minutes per subsequent night. As patients with insomnia may find it takes them 
over an hour to fall asleep, the prescribed time in bed may only allow them a further three 
hours of sleep until they need to get up as part of the restriction therapy. This process, 
although exhausting for the patient, facilitates partial sleep deprivation thereby shortening 
sleep onset and increasing sleep maintenance after several days. The 15 minute increases 
per night gradually introduces the patient to a regular, and more efficient sleep pattern. 
This intervention has shown great success for those with insomnia (Morin et al., 2006). 
Cognitive strategies have also been applied to the treatment of insomnia and addresses 
dysfunctional beliefs about sleep which may hinder healthy sleep practice (Belanger, 
Savard, & Morin, 2006). Psychoeducation is beneficial patients to gain a better 
understanding of their sleep problem, what may have caused it and likely modulators that 
maintain it (Morin & Espie, 2003). In addition to promoting sleep awareness, cognitive 
techniques include thought stopping (Morin & Espie, 2003), changing maladaptive 
thinking whilst trying to fall asleep (Wicklow & Espie, 2000a), and more recently, 
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`mindfulness' (Ong, Shapiro, & Manber, 2008)28. Cognitive treatments for insomnia have 
benefits for improving sleep as well as having psychological benefits (Morin et al., 2003). 
Behavioural and cognitive treatments, are most successful when combined together. A 
well researched form of this combined approach is termed Cognitive Behavioural 
Therapy for Insomnia (CBTi; Morin & Espie, 2003). This is an intervention specifically 
designed to target insomnia however, can be applied to guide healthy sleep. CBTi 
systematically introduces a new skill, in the form of psychoeducation, sleep hygiene, 
relaxation, stimulus control and cognitive techniques to encourage patients to `switch 
off, into the patient's routine. CBTi has shown high efficacy (Espie, Inglis, & Harvey, 
2001). Moreover, the treatment has better long term outcome in comparison to 
pharmacological treatment and is often preferred by patients (Morin & Wooten, 1996). 
However these studies examined non-brain injured patients with insomnia. As clinical 
insomnia was not largely evident in patients of the current study, it is not yet known if 
CBTi type treatment, or elements within it, is effective in stroke cohorts. Although it may 
not be appropriate to apply some aspects of CBTi to brain injured patients, sleep 
restriction in particular, non- pharmacological treatment for sleep disturbance may be 
beneficial for stroke patients, even as part of a healthy sleep routine in those without a 
diagnosable sleep disorder. 
Pharmacologic and Medical Intervention 
Pharmacological treatments are commonly prescribed to those suffering from insomnia. 
The aim of the prescribed medications, categorised as benzodiazepines or non- 
benzodiazepine hypnotics, is to decrease sleep onset latency and maintain continuous 
sleep (Morin and Espie, 2003, p. 101-103). These medications act on the sleep receptor 
agonists in order to drive the neural mechanisms that initiate sleep (see Section 1.2.2, 
Chapter 1). However sleep medications are largely associated with a `hangover' effect 
whereby patients experience daytime sedation (Charles, Kirkham, Guyatt, & Parker, 
1987; Morin & Espie, 2003, p. 105). These effects are particularly less preferable with 
28 Mindfulness is a meditation technique used to treat anxiety and depressive disorders where a person may 
ruminate for long periods of time. It aims to teach a person to focus on the present and to gain control over 
ruminating thoughts and regulate emotion (Chambers, Gillen and Allen, 2009). 
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those with brain injury who may experience excessive daytime sleepiness (Zafonte et al., 
1996) regardless of good sleep at night. Non-benzodiazepine hypnotics are newer drugs 
that produce less side effects than traditional benzodiazepines (Ramsey & McGlohn, 
1997). Therefore this approach may be appropriate for short term alleviation of sleep 
disturbance in patients however non- pharmacological options are worthwhile for long 
term sleep management (Hajak & Rodenbeck, 1996; Morin & Wooten, 1996). 
There are also pharmacological treatments for treating excessive daytime sleepiness 
(Billiard et al., 1994) and to some extent these drugs may alleviate fatigue (Caldwell, 
2001). Brain injured patients who suffer from hypersomnia despite having healthy sleep, 
may benefit from pharmacological intervention for sleepiness and fatigue (Mitler, Erman, 
& Hajdukovic, 1993; Shneerson, 2005). Some improvements using drugs to increase 
wakefulness, such as amphetamines, modafinil, methylphenidate and dopaminergic 
agents, have shown an improvement in brain injured patients (Al-Adawi et al., 2006; 
Autret et al., 2001; Bassetti & Valko, 2006; Roth & Roehrs, 1996; Shneerson, 2005). 
Fluoxetine, a selective serotonin reuptake inhibiter used to treat depression, has been 
implemented in the treatment of post stroke fatigue (Choi-Kwon et al., 2005). It was 
found that although psychological symptoms improved, the presence of fatigue did not. 
Sleep disordered breathing is normally treated using Continuous Positive Airway 
Pressure (CPAP). CPAP acts as a pneumatic splint by preventing the upper airway 
collapsing to reduce the occurrence of apnoeas. As sleep apnoea is both a pre and co- 
morbid sleep disordered associated with stroke. Studies have shown that sleep apnoea is 
related to recovery (Bassetti, 2005b), early detection and treatment must be implicated as 
it may affect recovery and rehabilitation if left untreated (C. Bassetti & Aldrich, 1999; 
Neau, Paquereau, Meurice, Chavagnat, & Gil, 2002). CPAP treatment is well tolerated 
(Broadley et al., 2007) and has helped treat 70% of stroke patients (Wessendorf et al., 
2000). Furthermore surgery and medication are alternative treatments for post stroke 
sleep related breathing disorders (Hermann & Bassetti, 2003) however further clinical 
trials are necessary to investigate the efficacy of these methods in stroke patient. It may 
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also be critical to implement such treatment into stroke care to avoid a second stoke in 
patients with sleep disordered breathing (Bassetti, 2005b). 
Additional Treatments Applicable To Those With Sleep Disturbance 
In addition to the above treatment for sleep disturbance, further strategies regarding 
patients' lifestyle, health and psychological adjustment may also be beneficial for sleep 
and daytime functioning. Maintaining a healthy lifestyle by encouraging regular exercise, 
balanced diet and cutting down on alcohol has great benefit for sleep in brain injured 
patients (Hermann et al., 2008). It was particularly obvious in the current thesis, and in 
the literature (Rao & Rollings, 2002; Schuiling et al., 2005), that sleep problems after 
stroke are associated with psychological disturbance. Therefore attending to 
psychological needs as treating or neglecting one may impact the other (Bassetti & 
Valko, 2006; Rao & Rollings, 2002). Therefore the treatment of psychological disorders 
may help alleviate sleep and daytime functioning problems (de Groot et al., 2003). 
Treating depression using antidepressants or Cognitive Behavioural Therapy for anxiety 
or depression may also enhance daytime functioning by improving mood and alertness 
(Scheidtmann, Fries, Muller, & Koenig, 2001). 
7.5.3 Implications For Further Research 
The results and experienced gained from carrying out the research for this thesis has 
crucial implications for future research. Most notably, the findings highlight three main 
aspects of study protocols that should be taken into account when planning and 
conducting experiments within the field of post stoke sleep: sampling, operationalisation 
of behaviour and the dissociation between objective and subjective measures. 
Sampling 
Scrutiny of the literature as well as the present findings indicated that varying recruitment 
strategies of stroke patients may reveal inter group differences. For example, patients 
recruited for the current study were selected based on their chronicity and level of 
322 
physical and psychological health. Furthermore, the patients fit a narrow range of motor 
ability as part of the inclusion criteria. Few studies in the sleep field have recruited 
patients in this manner which indicates that patients in other studies are more 
heterogeneous than those in this study. Therefore the results of studies on stroke patients 
should interpreted with caution if generalised to samples outside of the recruitment 
boundaries. 
In addition to patient sampling, the results of Chapter 3 of this thesis strongly suggested 
that choice of control group has great impact on the interpretation of the data. Control 
groups selected from the general population may not appear any different from stroke 
patients in terms of subjective sleep and daytime functioning levels. Differences only 
appear when control groups are positive selected based on their health and presence of 
sleep problems. 
Operationalisation of Behaviour Capture 
This research has also shown clear operationalisation of behavioural dimensions 
measured as part of the study is critical. Other studies poorly define sleepiness and 
fatigue which suggests that their results are subject to overlap between both dimensions. 
Moreover, the definition of these concepts is not communicated to the patient which may 
contaminate their responses. It was therefore imperative that patients involved in the 
current research received clear instructions to clarify the differences between sleepiness 
and fatigue to ensure their complete the subjective indices more accurately. 
Materials 
It should also be strongly conveyed to other researchers that the combination of 
subjective and objective measures is more advantageous than such measures alone when 
exploring post stroke sleep. This allows sleep to be characterised in two different ways: 
1) how they actually behave as determined by objective measures and 2) how the patient 
perceives their sleep. Moreover, brain injured cohorts are particularly more susceptible to 
inaccurate self reports, therefore measures other than subjective may be critical to 
applying sleep disorder criteria and monitoring daytime functioning. 
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There is a lack of literature that addressed treatment and management for post stroke mild 
to server sleep disturbance. Due to this under researched area, inferences from research in 
other cohorts such as primary insomnia and sleep disordered breathing may ne applicable 
in stroke patients. Pharmacological options are effective but only for short term, therefore 
combined approaches of medication and behavioural intervention are more favourable 
than drug therapy alone (Morin & Wooten, 1996). Moreover, non-pharmacological 
interventions are as good as, or better, than pharmacological treatments and has 
preference for insomnia patients (Edinger & Wohlgemuth, 1999). Combination 
approaches are particularly useful for preventing relapse (Morin, Belanger, Bastien, & 
Vallieres, 2005). Furthermore, the side effects of sedatives, including daytime 
drowsiness, may compromise the safety of patients therefore non-pharmacological 
options should perhaps be implemented first when devising sleep treatment (Zafonte et 
al., 1996). 
7.6 Future Studies 
The findings from the present study have achieved a critical knowledge base which is 
informative for practical reasons including medical and rehabilitative interventions after 
stroke. Moreover, the findings and experience of carrying out this research has provided a 
foundation from which further research can continue and stimulate new avenues of stroke 
related sleep research. 
7.6.1 Methodological Improvements To The Current Research 
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Given that there are few studies in the literature that are similar to the studies carried out 
for the current thesis, it would be advantageous to replicate these studies, include a 
greater number of participants and incorporate additional measures. 
In particular, it would be useful to employ an objective measure of fatigue. Some 
researchers have used computer test batteries to measure fatigue (Dirnberger, Duregger, 
Trettler, Lindinger, & Lang, 2004; Philip et al., 2005). As sleepiness was underestimated 
in this Study 3, it is currently unknown if a similar effect may be observed with fatigue. 
However psychometric tests batteries design to measure fatigue may also be subject to 
overlap with sleepiness as observed with subjective measures (Bailes et al., 2006; 
Hossain et al., 2005; Mahowald & Mahowald, 2000). 
Sleep diaries used for the current study could also be improved by including daily mood 
measures to examine if fluctuations in psychological functioning affected sleep or vice 
versa. It may further be useful to monitor daily alcohol and caffeine use throughout the 
experiments. It is important to keep sleep diaries brief however as compliance may be 
affected by lengthy questionnaires per day. 
Based on the findings in the present studies and those within the literature, a measure to 
detect possible bias may highlight those patients more susceptible to underreporting of 
post traumatic symptoms (Mahmood et al., 2004). For example, the Marlowe-Crowne 
Social Desirability Scale, has been used to detect for possible bias in patients with sleep 
apnoea (Bardwell et al., 2001). Those who score higher on the scale are more susceptible 
to inaccurate responses on subjective questionnaires to due an increased desire to socially 
acceptable. 
7.6.2 Exploring Other Stroke Cohorts 
This study specifically investigated chronic patients with chronic upper limb hemiparesis. 
Further research could study sleep and daytime functioning other stroke samples 
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including acute (within 1 month), sub-acute (within 6 months) and involving those with 
greater co-morbid complications who were excluded for the research for this thesis. 
Anecdotal reports from families of the patients for the current research raised several 
issues for discussion however their responses were not systematically documented. 
Therefore, recruiting family members and primary caregivers of stroke patients would 
also be an imperative sample for future research. Other studies have used caregiver 
reports for sleep research which provided an useful perspective in addition to stroke 
patients (Alessi et al., 2008; Worthington & Melia, 2006). Moreover, a stroke suffer 
within the family has been shown to affect sleep of the primary carer within the family 
(Rittman, Hinojosa, & Findley, 2009). Consequently, it may be imperative to consider 
stroke and sleep in the wider context of the family network for the benefit of both patients 
and their families. 
7.6.3 Future Paradigms For Applied Clinical Research 
Home PSG 
While behavioural measures of sleep such as questionnaires and actigraphy give some 
insight, by far the most informative method is polysomnography. This method constitutes 
the gold standard in sleep research. Few studies have used PSG to measure sleep 
architecture chronic stroke. Furthermore, no known study has incorporated PSG in CIT to 
monitor possible affects on sleep architecture. 
PSG is typically applied in the highly controlled sleep laboratory conditions, a situation 
that is very different from the natural sleep environment and is not necessarily practical 
for studying persons with physical disabilities. Furthermore, sleep laboratory protocols 
are extremely cost intensive, applicable to a highly selective group of volunteers only, 
and available to limited number of institutions across the UK. Critically, the laboratory 
setting is rarely wheelchair adapted. Patients may further rely on mobility aids in the bed 
and bathroom in their home environment that are not available in the standardised 
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laboratory setting and hence reduce their independence in this situation. This makes sleep 
studies laboratory studies in stroke patients much more difficult and stressful for 
participating individuals. As a result there is limited knowledge on the effects of stroke 
on sleep physiology and sleep architecture. For these reasons, the development of a PSG 
study protocol for the home environment is a suitable way forward for this line of 
research. 
Neurorehabilitation Protocol Adaptations 
Further consideration towards sleep could be incorporated into rehabilitation protocols, 
applicable to acute and chronic care as well as research trials. Firstly, more studies are 
needed to test if inventions to improve sleep and daytime functioning lead to clinically 
relevant gains, including increased dependence and less care giving needs (Alessi et al., 
2008). This could be addressed as part of a randomised controlled trial, one of the 
treatment groups could participate in sleep management programme in addition to 
rehabilitation and compared to those who patients who did not have sleep management. 
The feasibility of sleep management for patients as well as rehabilitation outcome could 
be assessed to determine the subjective and objective benefits of sleep in this context. In 
addition, it was postulated by Seingsukon and Boyd (2008b) that napping between 
therapy sessions may have beneficial properties for motor memory consolidation. 
Therefore rehabilitations paradigms could incorporate a group who nap after therapy 
session and a group who does not. Comparisons of treatment outcome as well as the 
effect regular napping has on the patient who further explore this idea of Siengsukon & 
Boyd. 
The findings and experience of carrying out all four studies for this thesis have not only 
contributed to the existing literature on sleep and stroke but opened up several directions 
for future research. In particular, substantial funding opportunities would be of great 
benefit to use home PSG technology in these patients. This data would help answer the 
questions that this thesis can only speculate at present. 
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Final Conclusion 
Each study contributed its own unique findings with regard to the particular research 
questions addressed. Collectively, the findings of these studies have revealed several 
prominent patterns. The major findings of this thesis can be summarised as follows: 
" Disturbed sleep is a chronic problem in approximately one third of patients. These 
disturbances were largely associated with psychological disturbance after stroke 
and poor quality of life. 
" Daytime functioning deficits are highly prominent in patients, based on objective, 
family and observer observations, however remains unrecognised and it is 
suspected that this has not been alerted to their health practitioner. The exact 
cause of the sustaining sleep and daytime functioning difficulties remains 
unknown, however the results did suggest that psychological adjustment had a 
large impact on behaviour. It is also possible that this relationship is reciprocal 
although further research is necessary to establish the cause and effect nature of 
this association. 
" It was concluded that fatigue is highly associated with motor functioning, in terms 
of residual ability as well as neurorehabilitation outcome. It was concluded that 
the resounding fatigue was a result of increased effort employed by patients who 
tried hard to increase capacity of affected limb use. 
" As the association between sleep and CIT outcome were only mild, it cannot yet 
be concluded that better sleep results in better neurorehabilitation outcome. 
However, the results suggested that those who nap less, therefore are less sleepy, 
had a better CIT outcome. 
Overall, the results mean that sleep should not be ignored as part of stroke care and 
rehabilitation protocols throughout acute and chronic stages of recovery. To further build 
on this work, studies should utilise more sensitive measures of sleep. This will enable 
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researchers to identify if sleep changes physiologically as a result of engaging in motor 
neurorehabilitation and if there correlates associated with better outcome. 
The main clinical message of this thesis is that maintaining healthy sleep and tackling 
daytime functioning problems with prescribed medication or naps may be essential to 
maximise rehabilitation success. Furthermore, healthy sleep in the long term has benefits 
for health and wellbeing, therefore better quality of life for patients. 
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APPENDIX Al 
Information for Participation 
in Research 
Study Title: Assessment of sleeping habits during Constrained Induced Movement 
Therapy (CIT): Does sleep have a role in motor rehabilitation after stroke? 
Invitation Paragraph 
You are being invited to take part in a research study. Before you decide, it is important 
for you to understand why the research is being done and what it will involve. Please take 
time to read the following information carefully and discuss it with others if you wish. 
Ask us if there is anything that is not clear or if you would like more information. Take 
time to decide whether or not you wish to take part. Thank you for reading this. 
What is the purpose of the study? 
This purpose of this study is to monitor your sleeping habits before, during and after your 
participation in the Constraint Induced Movement Therapy trial. Recent research suggests 
that your sleeping behaviour is just as important as your waking behaviour. Your 
participation in Constraint-Induced Movement Therapy will involve learning new skills 
involved in your affected arm. Such learning must be processed in some way in order for 
it to be stored and retained in your brain. What scientists didn't know until recently is that 
many of these learning processes occur when you are sleeping. 
Why have I been chosen? 
You have been selected as you have been accepted onto the Constraint-Induced 
Movement Therapy trial. 
Do I have to take part? 
It is up to you to decide whether or not to take part. If you decide to take part you are still 
free to withdraw at any time and without giving a reason. 
What will happen to me if I take part? 
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You will be asked to complete the Pittsburgh Sleep Quality Index (PSQI), the Epworth 
Sleepiness Scale (ESS) and the Sleep-50 (S-50), the Fatigue Severity Scale (FSS) and the 
Ford Insomnia Response To Stress Test (FIRST) as a measure of your general sleep 
behaviour. These assessments will be made during your first visit to our laboratory and 
will be administered by the chief investigator of the sleep study. You will also be asked 
to complete a daily sleep diary, consisting of the Sleep Questionnaire (SQ), the 
Karolinska Sleepiness Scale (KSS) and the Daily Fatigue Scale (D-FIS) so we can 
monitor your sleep before, during and after CIT. Detailed instructions and contact details 
of the chief investigator are provided, should you have any problems. The daily sleep 
diary only takes a short moment to complete and should pose no additional cognitive load 
on those who have suffered a traumatic brain injury. 
You will also be asked to wear an `Actiwatch®' on each of your wrists. The Actiwatch® 
is a small, watch-like device which measures your activity levels during wake and sleep. 
The reason that we ask you to wear the watch on both wrists is so we can assess activity 
levels based on your affected arm as well as your unaffected arm. The Actiwatch® is 
completely waterproof and does not need to be removed for showering or taking baths. 
The Actiwatch® can be removed just like a wrist watch, however, should you wish to 
remove the Actiwatch® during the study, please contact the chief investigator first. 
You will be asked to complete the sleep diary and wear the Actiwatches® for a total of 6 
weeks. This will include a2 week baseline period prior to CIT, 2 weeks during CIT and 2 
weeks after CIT. You will be provided with a prepaid envelope to post the Actiwatch® 
back to our laboratory after the 6 weeks. 
What is the procedure that is being tested? 
We are testing whether sleep plays an important role during Constraint-Induced 
Movement Therapy. We intend to do this by assessment of sleeping habits during 
Constraint-Induced Movement Therapy. More specifically, we will also be able to look at 
different aspects of sleep, such as napping during the day. 
What are the possible disadvantages and risks of taking part? 
There is no known risk of completing the questionnaires. The questions are not of a 
sensitive nature and do not require detailed responses. 
What are the possible benefits of taking part? 
There is no known study which has investigated the role of sleep in Constraint-Induced 
Movement Therapy. Therefore this study is pioneering work as it aims to examine how 
we can improve current treatment schemes. This study will pave the way for future 
experiments that will investigate sleep and Constraint-Induced Movement Therapy in 
more detail, such as involving brain wave recordings overnight. We hope that with the 
knowledge we gain from investigative sleep, we will be able to properly advice positive 
sleep behaviour programmes to those who undergo Constraint-Induced Movement 
Therapy. 
Will my taking part in this study be kept confidential? 
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All information that is collected about you during the course of the research will be kept 
strictly confidential. Any papers that contain your personal details can only be accessed 
by the research group and will not leave the laboratory. 
Who is doing the research? 
Katherine Herron, a PhD student will be heading the project. She has been working with 
the Clinical Neuroscience Research Team (headed by Professor Annette Sterr) at the 
University of Surrey for the past 2 years. 
What will happen to the results of the research trial? 
The results will be used for a PhD thesis for a degree taken at the University of Surrey. It 
is also hoped that the results will be published in a journal. You will not be identified in 
any of these publications. 
Who has reviewed the study? 
The University of Surrey Ethics Committee 
The Surrey Research Ethics Committee 
Contact for Further Information 
Katherine Herron, Chief Investigator 
Phone: 01483 686935; e-mail: kh00002@surrey. ac. uk 
Professor Annette Sterr, Principle Supervisor 
Phone: 01483 682883, e-mail: a. sterr@surrey. ac. uk 
Jenny Sanders, Project Manager 
Phone: 01483 682877; e-mail: CIT@surrey. ac. uk 
Any complaint or concerns about any aspects of the way you have been dealt with during 
the course of the study will be addressed; please contact Katherine Herron, Chief 
Investigator on (01483) 686935. 
This copy is for you to keep. If you decide to participate, you will also be given a 
copy of the signed consent form and treatment contract to keep. 
0 Thank you for considering participation in this study! O 
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APPENDIX A2 
Information for Participation 
in Research 
Study Title: Assessment of sleeping habits during Constrained Induced Movement 
Therapy (CIT): Does sleep have a role in motor rehabilitation after stroke? 
Invitation Paragraph 
You are being invited to take part in a research study. Before you decide, it is important 
for you to understand why the research is being done and what it will involve. Please take 
time to read the following information carefully and discuss it with others if you wish. 
Ask us if there is anything that is not clear or if you would like more information. Take 
time to decide whether or not you wish to take part. Thank you for reading this. 
What is the purpose of the study? 
This purpose of this study is to collect sleep behaviour data from a non-brain injured 
population for comparison with a brain injured population. The literature suggests that 
those with brain injury experienced increased sleep disturbances compared to those who 
have not experienced brain injury. In addition, scientists have recently discovered that 
sleep may play an important role in for our learning processes. This is particularly 
important during brain injury recovery as many patients undergo intense re-learning of 
skills lost through injury. Therefore healthy sleep is important during neurorehab ilitation, 
however if sleep is likely to be disturbed in those with brain injury, we predict that this 
may affect how well they recover. We are currently assessing sleep behaviour in those 
undergoing Constraint-Induced Movement Therapy, a neurorehabilitation process 
facilitating new skills in motor movement. Your participation in this study will enable us 
to compare the prevalence of sleep disturbances in a non-brain injured population. 
Why have I been chosen? 
You have been selected as your demographic details, including age, gender and 
handedness, match another participant on the Constraint-Induced Movement Therapy 
trial. 
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Do I have to take part? 
It is up to you to decide whether or not to take part. If you decide to take part you are still 
free to withdraw at any time and without giving a reason. 
What will happen to me if I take part? 
You will be asked to complete the Pittsburgh Sleep Quality Index (PSQI), the Epworth 
Sleepiness Scale (ESS), the Sleep-50 (S-50), the Fatigue Severity Scale (FS) and the Ford 
Insomnia Response To Stress Test (FORD) as a measure of your general sleep behaviour. 
What is the procedure that is being tested? 
General sleep behaviour questionnaires and the consent form will be posted out to 
suitable non-brain injured participants. A stamped addressed envelope will be provided 
so you can post them back to us free of charge. 
What are the possible disadvantages and risks of taking part? 
There is no known risk of completing the questionnaires. The questions are not of a 
sensitive nature and do not require detailed responses. 
What are the possible benefits of taking part? 
There is no known study which has investigated the role of sleep in Constraint-Induced 
Movement Therapy. Therefore this study is pioneering work as it aims to examine how 
we can improve current treatment schemes. This study will pave the way for future 
experiments that will investigate sleep and Constraint-Induced Movement Therapy in 
more detail, such as involving brain wave recordings overnight. We hope that with the 
knowledge we gain from investigative sleep, we will be able to properly advice positive 
sleep behaviour programmes to those who undergo Constraint-Induced Movement 
Therapy. 
Will my taking part in this study be kept confidential? 
All information that is collected about you during the course of the research will be kept 
strictly confidential. Any papers that contain your personal details can only be accessed 
by the research group and will not leave the laboratory. 
Who is doing the research? 
Katherine Herron, an PhD student will be heading the project. She has been working with 
the Clinical Neuroscience Research Team (headed by Professor Annette Sterr) at the 
University of Surrey for the past 2 years. 
What will happen to the results of the research trial? 
The results will be used for a PhD thesis for a degree taken at the University of Surrey. It 
is also hoped that the results will be published in a journal. You will not be identified in 
any of these publications. 
Who has reviewed the study? 
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The University of Surrey Ethics Committee 
The South West Surrey Local Research Ethics Committee 
Contact for Further Information 
Katherine Herron, Chief Investigator 
Phone: 01483 686935; e-mail: kh00002@surrey. ac. uk 
Professor Annette Sterr, Principle Supervisor 
Phone: 01483 682883, e-mail: a. sterr@surrey. ac. uk 
Caroline Khurana, Project Manager 
Phone: 01483 682877; e-mail: CIT@surrey. ac. uk 
Any complaint or concerns about any aspects of the way you have been dealt with during 
the course of the study will be addressed; please contact Katherine Herron, Chief 
Investigator on (01483) 686935. 
This copy is for you to keep. If you decide to participate, you will also be given a 
copy of the signed consent form and treatment contract to keep. 
O Thank you for considering participation in this study! O 
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APPENDIX A3 
Participant Code: 
CONSENT FORM 
Researcher who holds scientific responsibility: 
Katherine Anne Herron 
Study Title: Assessment of sleeping habits during Constrained Induced Movement 
Therapy (CIT): Does sleep have a role in motor rehabilitation after stroke? 
Please initial box 
I. I confirm that I have read and understand the information sheet dated ....... rl 
(version ...... ) for the above study and have had the opportunity to ask 
questions. 
2.1 understand and agree to complete the questionnaires and sleep diary. C3 
3.1 agree to wear an actiwatch on each wrist for the scheduled 6 weeks. O 
4.1 understand that my participation is voluntary and that I am free to withdraw rl 
at any time, without giving any reason and without my medical care or legal 
rights being affected. 
5.1 agree to take part in the above study. 
Name of Participant Date Signature 
13 
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Researcher Date Signature 
In The Presence of (Witness) Date Signature 
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APPENDIX A4 
Participant Code: 
CONSENT FORM 
Researcher who holds scientific responsibility: 
Katherine Anne Herron 
Study Title: Assessment of sleeping habits during Constrained Induced Movement 
Therapy (CIT): Does sleep have a role in motor rehabilitation after stroke? 
Please initial box 
I. I confirm that I have read and understand the information sheet dated ....... 
(version ...... ) for the above study and have had the opportunity to ask 
questions. 
2.1 understand and agree to complete the questionnaires. 13 
3. I understand that my participation is voluntary and that I am free to withdraw 
at any time, without giving any reason and without my medical care or legal 
rights being affected. 
4.1 agree to take part in the above study. 13 
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Name of Participant Date Signature 
Researcher Date Signature 
In The Presence of (Witness) Date Signature 
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APPENDIX B: Materials Supplement for Chapter 2 
Sleep, Daytime Functioning, Quality of Life and Psycholo2ical Adjustment 
Questionnaires 
I. General Screening Form (use one from CIT trial) 
2. Mini-Mental State Exam (MMSE) 
3. In House Sleep Questionnaire Version Ia (Stroke Patients Only) 
4. In House Sleep Questionnaire Version lb (Control Participants Only) 
5. Pittsburgh Sleep Quality Index 
6. Sleep 50 
7. FIRST 
8. ESS 
9. FSS 
10. SF-36 
11. HADS 
Upper Limb Motor Movement Assessments 
12. Wolf Motor Function Test (WMFT) Standardised Instructions 
13. Wolf Motor Function Test (WMFT) Score Sheet 
14. Motor Activity Log (MAL) Standardised Instructions 
15. Motor Activity Log (MAL) Score Sheet 
Longitudinal Sleep Assessments 
16. Subjective Sleep Diary (One Day Example) 
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APPENDIX BI 
Screeniniz Evaluation Form 
Interviewer: Date: 
Name: Gender: 
Phone: Code: 
Address: DoB 
Age: 
GP Details 
Name: 
Practice 
Address 
Tel No 
Brain Injury details 
Stroke / Head Injury 
Date: Chronicity: Affected Side: 
Circumstances: 
Location: 
Pre-handedness: Left / right 
Multiple strokes: 
Minimal Motor Criterion (MMC): 
Wrist: 
Digits: 
Elbow: 
Shoulder: 
Level Overall? High Medium Low Low low 
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Spasm (Ashworth grade): 
Non-use: 
Walking aids/ balance: 
Secondary Conditions 
Cardiovasular: 
Hypertonia (medication): 
Diabetes: 
Kidney disease: 
Neurological (e. g. MS): 
Epilepsy: 
Arthritis: 
Osteoporosis: 
Depression or other emotional 
problems: 
Other head injuries: 
Surgery: 
Bladder control: 
Other: 
Any metal in body (e. g. clip, pace maker)? 
General health 
Pain: 
Medication: 
Psychosocial status: 
" Living (alone/w. partner): 
" Current employment: 
" Previous employment: 
" Education: 
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Expectancies and major goals of treatment: 
Travel needs: 
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APPENDIX B2 
Mini-Mental State Examination Test (MMSE) 
Orientation 
Day of week 
Year 
Month 
Date 
Time 
Country 
Town/City 
County 
Exact Location (University of surrey) (2points) 
Registration 
Examiner names 3 objects (apple, table, penny) 
Patient repeats the names (score one for each correct) 
Then Patient learns 3 objects (repeat until correct) 
Attention and Calculation 
"Subtract 7 from 100, then repeat subtracting 7 from the result... " 
100,93,86,79,72,65. (stop after 5) 
Or 
spell `world' backwards D, L, R, 0, W 
Score 
/10 
/3 
/5 
Recall 
Ask for 3 objects learnt earlier 
_/3 
Language 
Name a pencil and a watch _/2 Repeat (no ifs, ands, or buts) 
_/I Give a three-stage command. (Score one for each stage) 
_/3 ("Place the index finger of your right hand on your nose, and then on your left ear") 
Ask patient to read and obey a written command on a piece of paper stating: I 
"Close your eyes. " 
Ask patient to write a sentence. (Score if it is sensible and has a subject + verb) _/1 
Copying 
Ask patient to copy a pair of intersecting pentagons. _/1 
Total score: /30 
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APPENDIX B3 
In House Sleep Questionnaire (Version 1a; Stroke Patients) 
Participant Code ........................ Date................................. 
1. Are you currently taking any medication to help you sleep? (medication name, dosage, 
timing, how long it has been taken) 
................................................................................................... 
2. Have you previously taken any medication to help you sleep? 
................................................................................................... 
3. Are you currently taking any medication that has side effects which may affect your 
sleep? (medication name, dosage, timing, how long it has been taken) 
................................................................................................... 
4. Do you drink caffeinated drinks? If so, how many cups/glasses on average per day? 
................................................................................................... 
5. Do you drink alcohol? If so, how many units on average per day and per week if you 
only drink at weekends? (I unit ='/2 pint beer, small glass of wine, a single spirit) 
................................................................................................... 
6. Do you smoke? If so, how many cigarettes do you smoke per day? 
................................................................................................... 
7. Are you often disturbed during the night for reasons other than your own sleeping 
habits? For example, young children at home, partner, busy road, loud family members? 
If so how often per night? 
................................................................................................... 
8. Do you get up during the night? For example, to use the bathroom, or to have a drink? 
If so how often per night? 
................................................................................................... 
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9. Any sleep disturbances prior to brain injury? 
................................................................................................... 
10. Did you nap before brain injury? 
................................................................................................... 
11. What was your sleep like during the first month of your stroke in hospital? 
................................................................................................... 
12. What was your daytime functioning like during the first month of your stroke? 
................................................................................................... 
11. Have you noticed any major changes in your sleep behaviour since your brain injury? 
If so, can you describe these changes? 
................................................................................................... 
12. What is your sleep like now? 
................................................................................................... 
13. What is your daytime functioning like now? 
14. Do you nap regularly? 
................................................................................................... 
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APPENDIX B4 
In House Sleep Questionnaire (Version lb; Control Participants) 
Participant Code ........................ Date..................... Age............ 
Gender .............. 
Education (e. g. Degree, School Leavers Certificate) .............................. 
Weight .................................. Height.......................................... 
1. Are you currently taking any medication to help you sleep? (medication name, dosage, 
timing, how long it has been taken) 
................................................................................................... 
2. Have you previously taken any medication to help you sleep? 
................................................................................................... 
3. Are you currently taking any medication that has side effects which may affect your 
sleep? (medication name, dosage, timing, how long it has been taken) 
................................................................................................... 
4. Do you drink caffeinated drinks? If so, how many cups/glasses on average per day? 
................................................................................................... 
5. Do you drink alcohol? If so, how many units on average per day and per week if you 
only drink at weekends? (I unit ='/z pint beer, small glass of wine, a single spirit) 
................................................................................................... 
6. Do you smoke? If so, how many cigarettes do you smoke per day? 
................................................................................................... 
7. Are you often disturbed during the night for reasons other than your own sleeping 
habits? For example, young children at home, partner, busy road, loud family members? 
If so how often per night? 
................................................................................................... 
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8. Do you get up during the night? For example, to use the bathroom, or to have a drink? 
If so how often per night? 
400 
APPENDIX B5 
PITTSBURG SLEEP QUALITY INDEX (PSQI) QUESTIONNAIRE 
Volunteer code: Date: 
Instructions: The following questions relate to your usual sleep habits during the past month only. Your 
answers should indicate the most accurate reply for the majority of days and nights in the past month. 
Please answer all the questions. 
1) During the past month, when have you usually gone to bed at night? 
Usual bed time 
2) During the past month, how long (in minutes) has it usually take you to fall asleep each night? 
Number of minutes 
3) During the past month, when have you usually got up in the morning? 
Usual getting up time 
4) During the past month, how many hours of actual sleep did you get at night? (This may be different from 
the number of hours spent in bed. ) 
Hours of sleep per night 
For each of the remaining questions, check the one best response. Please answer all questions. 
5) During the past month, how often have you had trouble sleeping because you..... 
a) Cannot get to sleep within 30 minutes 
Not during the Less than Once or twice Three or more 
past month once a week a week 
b) Wake up in the middle of the night or early morning 
Not during the Less than 
past month once a week 
c) Have to get up to use the bathroom 
Not during the Less than 
past month once a week 
d) Cannot breathe comfortably 
Not during the Less than 
times a week 
Once or twice Three or more 
a week times a week 
Once or twice Three or more 
a week times a week 
Once or twice Three or more 
past month once a week a week times a week- 
e) Cough or snore loudly 
Not during the Less than Once or twice Three or more 
past month once a week a week times a week 
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I) Feel too cold 
Not during the Less than Once or twice Three or more 
past month once a week a week times a week 
g) Feel too hot 
Not during the Less than Once or twice Three or more 
past month_ once a week a week times a week 
h) Had bad dreams 
Not during the Less than Once or twice Three or more 
past month once a week a week times a week- 
i) Have pain 
Not during the Less than Once or twice Three or more 
past month once a week a week times a week- 
J) Other reason(s), please describe 
How often during the past month have you had trouble sleeping because of this? 
Not during the Less than Once or twice Three or more 
past month once a week a week times a week- 
6) During the past month, how would you rate your sleep quality overall? 
Very good 
Fairly good 
Fairly bad 
Very bad 
7) During the past month, how often have you taken medicine (prescribed or "over the counter") to help you 
sleep? 
Not during the Less than Once or twice Three or more 
past month once a week a week times a week- 
8) During the past month, how often have you had trouble staying awake while driving, eating meals, or engaging 
in social activity? 
Not during the Less than Once or twice Three or more 
past month once a week a week times a week- 
9) During the past month, how much of a problem has it been for you to show enthusiasm to get things done? 
No problem at all 
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Only a very slight problem 
Somewhat of a problem_ 
A very big problem 
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APPENDIX B6 
Sleep-50 
Participant Code .......................... Date...................................... 
Please respond to what extent a statement (item) has been applicable to you 
during the past 4 weeks. Please circle your answer accordingly: 1= not at all, 2= 
somewhat, 3= rather much and 4= very much. 
Sleep Apnea 
1. I am told that I snore. 1234 
2. I sweat during the night. 1234 
3. I am told that I hold my breath when sleeping. 1234 
4. I am told that I wake up gasping for air. 1234 
5. I wake up with a dry mouth. 1234 
6. I wake up during the night while coughing or being short of breath. 1234 
7. I wake up with a sour taste in my mouth. 1234 
8.1 wake up with a headache. 1234 
Insomnia 
9. I have difficulty in falling asleep. 1234 
10. Thoughts go through my head and keep me awake. 1234 
11. I worry and find it hard to relax. 1234 
12. I wake up during the night. 1234 
13. After waking up during the night, I fall asleep slowly. 1234 
14. I wake up early and cannot get back to sleep. 1234 
15. I sleep lightly. 1234 
16.1 sleep too little. 1234 
Narcolepsy 
17. I see dreamlike images when falling asleep or waking up. 1234 
18. I sometimes fall asleep on a social occasion. 1234 
19. I have sleep attacks during the day. 1234 
20. With intense emotions, my muscles sometimes collapse during the 
day. 1234 
21.1 sometimes cannot move when falling asleep or waking up. 1234 
Restless Legs1PLMD 
22. I am told that I kick my legs when I sleep. 1234 
23. I have cramps or pain in my legs during the night. 1234 
24. I feel little shocks in my legs during the night. 1234 
25.1 cannot keep my legs at rest when falling asleep. 1234 
Circadian Rhythm Sleep Disorder 
26. I would rather go to bed at a different time. 1234 
27. I go to bed at very different times (more than 2 hr difference). 1234 
28.1 do shift work. 1234 
Sleepwalking 
29. I sometimes walk when I am sleeping. 1234 
30. I sometimes wake up in a different place than where I fell asleep. 1234 
31.1 sometimes find evidence of having performed an action during the 
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night I do not remember. 
Nightmares 
32. I have frightening dreams (if not, go to Item 37). 1234 
33. I wake up from these dreams. 1234 
34. I remember the content of these dreams. 1234 
35. I can orientate quickly after these dreams. 1234 
36. I have physical symptoms during or after these dreams 
(e. g., movements, sweating, heart palpitations, shortness of 
breath). 1234 
Factors Influencing Sleep 
37. It is too light in my bedroom during the night. 1234 
38. It is too noisy in my bedroom during the night. 1234 
39. I drink alcoholic beverages during the evening. 1234 
40. I smoke during the evening. 1234 
41. I use other substances during the evening (e. g., sleep 
or other medication). 1234 
42. I feel sad. 1234 
43.1 have no pleasure or interest in daily occupations. 1234 
Impact of Sleep Complaints on Daily Functioning 
44. I feel tired at getting up. 1234 
45. I feel sleepy during the day and struggle to remain alert. 1234 
46. I would like to have more energy during the day. 1234 
47. I am told that I am easily irritated. 1234 
48. I have difficulty in concentrating at work or school. 1234 
49. I worry whether I sleep enough. 1234 
50. Generally, I sleep badly. 1234 
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APPENDIX B7 
Ford Insomnia Response to Stress Test 
When you experience the following situations, how likely has it been for you to have 
difficulty sleeping during the past month? Circle an answer even if you have not 
experienced these situations recently. 
* Before an important meeting the next day 
Not likely Somewhat likely Moderately likely Very Likely 
* After a stressful experience during the day 
Not likely Somewhat likely Moderately likely Very Likely 
* After a stressful experience in the evening 
Not likely Somewhat likely Moderately likely Very Likely 
* After getting bad news during the day 
Not likely Somewhat likely Moderately likely Very Likely 
* After watching a frightening movie or TV show 
Not likely Somewhat likely Moderately likely Very Likely 
* After having a bad day at work 
Not likely Somewhat likely Moderately likely Very Likely 
* After an argument 
Not likely Somewhat likely Moderately likely Very Likely 
* Before having to speak in public 
Not likely Somewhat likely Moderately likely Very Likely 
* Before going on vacation the next day 
Not likely Somewhat likely Moderately likely Very Likely 
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APPENDIX B8 
The Epworth Sleepiness Scale (ESS) 
Volunteer Code: Date: 
Instructions: How likely are you to doze off or fall asleep in the following situations, in 
contrast to feeling just tired? This refers to your usual way of life during the past month. 
Even if you have not done some of these things recently try to work out how they would 
have affected you. Use the following scale to choose the most appropriate number for 
each situation: 
0= no chance of dozing 
Sitting quietly after a luncht ht ib ngf of dozing 
2= moderate chance of dozing 
In a car, while stopped for feiiHscdýý[ng 
W. 
SITUATION 
Sitting and reading 
Sitting inactive in a public place (e. g a theatre or a 
meeting) 
As a passenger in a car for an hour without a break 
Lying down to rest in the afternoon when circumstances 
permit 
APPENDIX B9 
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The Fatigue Severity Scale 
Participant code ............................. Date................................ 
We would like to know if you are affected by fatigue during the past month. 
Please note, fatigue is defined as physical or mental weariness resulting from 
exertion NOT sleepiness (how likely you are to fall asleep). 
Please circle which response is most applicable to you to indicate whether you 
disagree or agree with the following statements about yourself. 1 indicates 
strong disagreement and 7 indicates strong agreement. If your response is 
neutral, please circle 4. 
During the past week, I have found that: Disagree " *Agree 
My motivation is lower when I am fatigued 01234567 
Exercise brings on my fatigue 01234567 
EI am easily fatigued 01234567 
Fatigue interferes with my physical functioning 01234567 
Fatigue causes frequent problems for me 01234567 
My fatigue prevents sustained physical 
Functioning 01234567 
Fatigue interferes with carrying out certain 
duties and responsibilities 01234567 
Fatigue is among my three most disabling [ymptoms 01234567 
Fatigue interferes with my work, family or 
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social life 01234567 
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APPENDIX B 10 
SF-36 Health Survey 
INSTRUCTIONS: This survey asks your views about your health. This information will help 
keep track of how you feel and how well you are able to do your usual activities. 
Please answer every question by marking the answer as indicated. If you are unsure about how to 
answer a question, please give the best answer you can. 
When complete, please return the questionnaire in the envelope provided. 
1. In general, would you say your health is: 
(circle one) 
Excelle 
nt 
Very 
good 
Good 
Fair 
Poor 
.................................................................................... 
.................................................................................... 
.................................................................................... 
.................................................................................... 
.................................................................................... 
2. Compared to one year ago, how would you rate your health in general now? 
I 
2 
3 
4 
5 
(circle one) 
Much better now than one ................................................................ 
I 
year ago 
Somewhat better than one ................................................................ 
2 
year ago 
About the same as one year ................................................................ 
3 
ago 
Somewhat worse than one ................................................................ 
4 
year ago 
Much worse now than one ................................................................ 5 
year ago 
3. The following questions are about activities you might do during a typical day. Does your 
health now limit you in these activities? If so, how much? 
(circle on 
Activities Yes, Yes, No, not 
limited a limited a limited at 
lot little all 
Vigorous activities, such as running, lifting 1 2 3 
heavy objects, participating in strenuous 
sports. 
Moderate activities, such as moving a table, 1 2 3 
pushing a vacuum cleaner, bowling or 
playing golf 
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Lifting or carrying groceries 1 2 3 
Climbing several flights of stairs 1 2 3 
Climbing one flight of stairs 1 2 3 
Bending, kneeling or stooping 1 2 3 
Walking more than a mile 1 2 3 
Walking half a mile 1 2 3 
Walking one hundred yards 1 2 3 
Bathing or dressing yourself 1 2 3 
4. During the past 4 weeks, have you had any of the following problems with your work 
or other regular daily activities as a result of your physical health? 
(circle o 
Yes No 
Cut down on the amount of time you spent on work or other activities 1 2 
Accomplished less than you would like 1 2 
Were limited in the kind of work or other activities 1 2 
Had difficulty performing the work or other activities (for example, it took 
extra effort 
1 2 
5. During the past 4 weeks, have you had any of the following problems with your work 
or other regular daily activities as a result of any emotional problems (such as feeling 
depressed or anxious)? 
(circle o 
Yes No 
Cut down on the amount of time you spent on work or other activities 1 2 
Accomplished less than you would like 1 2 
Didn't do work or other activities as carefully as usual 1 2 
6. During the past 4 weeks, to what extent has your physical health or emotional problems 
interfered with your normal social activities with family, friends, neighbours or groups? 
(circle one) 
Not at all .................................................................................... 1 
Slightly 
Moderate 
ly 
Quite a 
.................................................................................... 
.................................................................................... 
.................................................................................... 
2 
3 
4 
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bit 
Extremel 
y 
.................................................................................... 5 
7. How much bodily pain have you had during the past 4 weeks? 
(circle one) 
None .................................................................................... I 
Very .................................................................................... 2 
mild ............. Mild ...................... 3 .............................................................. 
Moderat 
.... . ............................ 4 ............................. 
e ............. 
Severe ............................................................... 5 ..................... 
Very 
severe 
8. During the past 4 weeks, how much did pain interfere with your normal work 
(including both work outside the 
home and housework)? 
(circle one) 
Not at all ......................................... ......................................... 1 
.................................................................................... 6 
A little bit .................................................................................... 2 
Moderatel 
Y 
Quite a 
bit 
Extremel 
y 
.................................................................................... 
.................................................................................... 
.................................................................................... 
3 
4 
5 
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9. These questions are about how you feel and how things have been with you during the past 
4 weeks. 
For each question please give the one answer that comes closest to the way you have been 
feeling. 
How much of the time during the past 4 weeks... 
All of the time Most A good bit Some of A little None 
of the of the time the time of the of the 
time time time 
Did you feel full of life? 1 2 3 4 5 6 
Have you been a very 1 2 3 4 5 6 
nervous person? 
Have you felt so down in 1 2 3 4 5 6 
the dumps that nothing 
could cheer you up? 
Have you felt calm and 1 2 3 4 5 6 
peaceful? 
Did you have a lot of 1 2 3 4 5 6 
energy? 
Have you felt 1 2 3 4 5 6 
downhearted and low? 
Did you feel worn out? 1 2 3 4 5 6 
Have you been a happy 1 2 3 4 5 6 
person? 
Did you feel tired? 1 2 3 4 5 6 
10. During the past 4 weeks, how much of the time has your physical health or 
emotional problems interfered with your social activities (like visiting friends, 
relatives, etc. )? 
(circle one) 
All of the time ........................................................................... 1 
Most of the time 
................... 
........................................................................... 
................... 
ý 
Some of the time ........................................................................... 3 
A little of the 4 
time 
None of the time 5 
11. How TRUE or FALSE is each of the following statements to you? 
(circle one number on each line) 
Definitely true Mostly Don't Mostly Definitely 
true know false false 
Definitely true Mostly 
true 
Don't 
know 
Mostly 
false 
Definitely 
false 
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I seem to get ill 1 2 3 4 5 
more easily than other 
people 
I am as healthy as 1 2 3 4 5 
anybody I know 
I expect my health to get 1 2 3 4 5 
worse 
My health is excellent 1 2 3 4 5 
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APPENDIX BII 
Hospital Anxiety and Depression Scale (HADS) 
Patients are asked to choose one response from the four given for each interview. 
They should give an immediate response and be dissuaded from thinking too 
long about their answers. The questions relating to anxiety are marked "A", 
and to depression "D". The score for each answer is given in the right column. 
Instruct the patient to answer how it currently describes their feelings. 
AI feel tense or 'wound up': 
Most of the time 
01.1 
A lot of the time 
From time to time, 
occasionally 
Not at all 
D :1 still enjoy the things 
I 
, used to enjoy: 
Definitely as much 
Not quite so much 1 
Only a little '2 
Hardly at all 
"'MIXAMAt'" Gä 
I get a sort of frightened 
A feeling as if something 
, awful is about to happen: 
Very definitely and quite 
badly 
Yes, but not too badly '2 
IA little, but it doesn't worry 
, me 
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Not at all 
.,, _.. ,ý_., rt'. 
I can laugh and see the 
, funny side of things: 
As much as I always could 
Not quite so much now 
, Definitely not so much now 
Not at all 
Worrying thoughts go A through my mind: 
A great deal of the time 
ýA lot of the time 
From time to time, but not 
too often 
Only occasionally 
11 ., [. 
Tý_ ._r. y r >. ý; ,. nýtI3%,,, Ynýi1", Nitr. aS°i'., 'P, d`r'".. 
DI feel cheerful: 
Not at all 
Not often 
. Sometimes 
Most of the time 
Wt 1' tA "'ýiiýýl±Yffit't@'ýýfitü2ký eý_i ä1 £S Z* 
I can sit at ease and feel A , relaxed: 
'Definitely 
1 
0 x... ý5i. ä". 54. °. 3 " #ýtiýSll6rik'ýiE4ýÖÜýti't'ý''ý+tiý', 'ýý'. Mý: ý fý äZýi!! ýF, ý'ý3ý 
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Usually 
Not Often 
, Not at all 
I feel as if I am slowed 
down: 
Nearly all the time 
Very often 
! Sometimes 
ý\1.. 4 .a . 11 ý 
INUL dL dU IV 
I get a sort of frightened 
A feeling like 'butterflies' in 
the stomach: 
Not at all 
Occasionally 
Quite Often 
Very Often 
., , 1J::: 
5ý.:. '. äsýSlý'. ' -': bYT 
D 11 have lost interest in my 
; appearance: 
Definitely 
11 don't take as much care as 
'should 
it may not take quite as much 
scare 
I take just as much care as 
! ever 
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I feel restless as I have to A be on the move: 
Very much indeed 
Quite a lot 
, 
Not very much 
Not at all 
DI 
look forward with 
enjoyment to things: 
As much as I ever did 
Rather less than I used to 1 
: Definitely less than I used to ;2 
; Hardly at all i3. 
A get sudden feelings of 
panic: 
"Very often indeed 
Quite often 
Not very often 
Not at all 
__. _ I can enjoy a good book or 
; radio or TV program: 
ýOften 
. .... ... ..... .. ; Sometimes ;1 
Not often 
', Very seldom 
ltKiýi) 
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Scoring (add the As = 
Anxiety. Add the Ds = 
Depression). The norms 
below will give you an idea 
of the level of Anxiety and 
Depression. 
0-7 = Normal 
8-10 = Borderline abnormal 
111-21 =Abnormal 
<r s 
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APPENDIX B12 
Graded WFMT Instructions 
Today we are going to take a look at how you are able to use your arm. 
Let me tell you how we are going to go about this. First, I will give you 
instructions on how to do the task, and then I will show you how to do it. 
I will describe and demonstrate each task two times. Do not practice the 
task while I'm describing and demonstrating it. However, I will be happy 
to clarify any confusing points. Then I will say "ready, set, go" and you 
will do the task. It is important that you do not start until I say "go" 
otherwise we will need to repeat the entire task. Each of the activities you 
will be asked to do should be carried out as rapidly as possible. You can 
work on each task for up to 30 seconds. We ask that you attempt each 
part of the test even if you do not think that you can do it. If you are 
unable to carry out a task then we will go onto the next one. Again, try to 
do each task as rapidly as possible. Do you have any questions? 
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APPENDIX B13 
Graded Wolf Motor Function Test 
P/Code: Date: Examiner: 
Assessment: BL PRE POST FU 
Arm Tested: Unaffected Affected 
Tasks 
1 Forearm to table (side) 
a) chair normal 
b) chair raised 
2 Forearm to box (side) 
a) full height box 
b) '/2 height box and chair 
raised 
3 Extend elbow (to side) 
a) 40 cm line 
b) 28 cm line 
4 Extend elbow with weight 
(to side) 
a) 40 cm line 
b) 28 cm line 
5 Hand to table 
a) chair normal 
b) chair raised 
6 Hand to box 
a) full height box 
b) half height box 
7 Reach and retrieve 
a) 40 cm line 
b) 28 cm line 
8 Moving foam stick 
a) supination then pronation 
b) pronation only 
Time Functional Ability Comments 
01234567 
01234567 
01234567 
01234567 
01234567 
01234567 
01234567 
01234567 
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9 Lift washcloth 
a) appropriate grasp 
b) inappropriate grasp 
Tasks 
10 Flip light switch 
a) appropriate grasp 
b) inappropriate grasp 
II Lift pen 
a) appropriate grasp 
b) inappropriate grasp 
12 Lift cotton balls 
a) appropriate grasp 
b) inappropriate grasp 
13 Lift basket 
a) full height 
b) table level height 
01234567 
Time Functional Ability Comments 
01234567 
01234567 
01234567 
01234567 
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APPENDIX B14 
MAL instructions 
The purpose of this test is to examine how much and how well you use 
your more affected arm when you are not in our laboratory. You will use 
two separate rating scales to describe how much and how well you use 
your weaker arm while you are doing specific activities. Please note that 
you can give half ratings if that best describes your performance of the 
activity in question. If for some reason you do not perform these tasks, 
we will try to determine why. We will first discuss how much you do 
each of the tasks with your weaker arm and then we will discuss how 
well you do them using your weaker arm. It is important that you realise 
that these questions are about what you actually do outside the laboratory 
and not what you think you may be able to do with your weaker arm. 
There are no right or wrong answers; simply select the ratings you 
believe best describe what you do. Do you have any questions? 
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APPENDIX B15 
Motor Activity Log V2- Score sheet 
Code: 
.............................................................................. 
Date: .............................................................................. 
Visit (e. g. BL/pre/post etc): .................................................... 
Period of time referred to: ............................................................... 
Examiner: ........................................................................ 
Task Amount 
Scale 
How well 
scale 
No Code Comments 
1) Pull back chair 
2) Take off socks or 
stockings 
3) Pick up a telephone 
receiver 
4) Carry an object in your 
hand 
5) Open a door 
6) Use a fork, knife or 
spoon to eat 
7) Close a Zipper 
8) Fasten belt or brassiere 
9) Button a shirt or 
blouse 
10) Pulling on trousers or 
underwear with both 
hands 
11) Put on socks 
12) Dry back or hair 
Codes for recording No responses 
1.1 used unaffected arm entirely 
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2. Someone else did it for me 
3.1 never do that activity because it is impossible (e. g. never wear shirt/blouse) 
4.1 did not have the opportunity to do that activity since I last answered the 
questions 
425 
APPENDIX B16 
Sleep diary, version 1, October 2006 
Baseline Day 1 PART 1 (30mins-1 Hour after waking): 
Today's Date ....................... Current Time....................... 
* How refreshed did you feel upon waking up? 
Not at all 
refreshed 
* How was the quality of your sleep last night? 
" Very 
Very Bad Very good 
* When did you go to bed last night (lights out)? ........................ hours (24 hours clock) 
* How long did it take you to fall asleep? ............... hours............... mins 
* If you woke in the night, please list the times you awoke and duration (if you woke more than 4 times, please 
add the extra details on the reverse of this page): 
Time 1 
............... 
(24 hr clock) Duration Awake............... (hh: mm) 
Reason 
.............................................. Time 2 ............... (24 hr clock) 
Duration Awake............... (hh: mm) 
Reason .............................................. Time 3 ............... (24 hr clock) Duration Awake............... (hh: mm) Reason .............................................. Time 4 ............... (24 hr clock) 
Duration Awake............... (hh: mm) 
Reason .............................................. 
* When did you finally wake up this morning (not including night awakenings mentioned above)? 
........................ 
hours (24 hours clock) 
When did you finally get up this morning? ........................ hours (24 hours clock) 
* How long did you sleep last night (time from falling asleep to waking in the morning, excluding all 
waking periods)? ............... 
hours............... mins 
* Using the scale below, please circle the number which corresponds to how sleepy you currently 
feel. 
12345678 
Very Alert Alert-normal level Neither alert nor sleepy sleepy but no effort to keep awake 
9 
Very sleepy, great 
effort to keep 
awake 
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* Please read each statement carefully with the prefix 'Because of my fatigue' and circle your 
response. 
of my fatigue.......... (although this assumes you have fatigue, if Clem oblem e Problem )lem Problem 
case circle '0' for each response. 
s alert 
reduce my workload or responsibilities 
s motivated to do anything that requires physical effort 
ouble maintaining physical effort for long periods 
lifficult to make decisions 
able to finish tasks that require thinking 
-wed down in my thinking 
limit my physical activities 
Baseline Day 1 PART 2 (1-2 Hours before bed): 
Current Time ....................... 
Sleep diary, version 1, October 2006 
* Did you take any naps today? No Q Yes Q If yes: how many naps in total......... and for how long in 
total? ............... hours............... mins 
* Using the scale below, please circle the number which corresponds to how sleepy you currently 
feel. 
12345 
Very Alert Alert-normal level Neither alert nor sleepy 
6789 
sleepy but no effort to Very sleepy, great 
keep awake effort to keep 
awake 
* Please read each statement carefully with the prefix 'Because of my fatigue' and circle your 
response. 
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of my fatigue.......... (although this assumes you have fatigue, if Clem "oblem e Problem )lem Problem 
case circle `0' for each response. 
s alert 
reduce my workload or responsibilities 
s motivated to do anything that requires physical effort 
ouble maintaining physical effort for long periods 
lifficult to make decisions 
s able to finish tasks that require thinking 
, wed down in my thinking 
limit my physical activities 
Additional Information (please report any additional information regarding your sleep last 
night and/or how you felt today): 
428 
APPENDIX C: Case Tables For All Participants 
Case Tables 
1. Stroke Patients 
2. Control Participants 
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APPENDIX C2: Control Case Table 
Control Participants Case Table 
Case table for all control participants (n=61) involved in the study. Missing data is 
indicated by a dash (-). 
Case 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
66 
57 
58 
59 
60 
61 
Age Gender BMI Education Level Medication 
35 Female 27 1 Higher Education None 
41 Male 23.5 Higher Education None 
33 Female 25.5 Higher Education None 
24 Female 20.5 Higher Education None 
34 Male 22.2 Higher Education None 
62 Male 26.6 Higher Education None 
40 Male 22 2 Higher Education None 
61 Male School Leavers Certificate None 
60 Female Higher Education None 
65 Female None 
57 Female 33.1 School Leavers Certificate None 
51 Female 28 8 Further Study None 
62 Female 204 Further Study None 
59 Female 24 4 None 
62 Male 27 None 
48 Female None 
31 Male None 
31 Female School Leavers Certificate None 
26 Female None 
32 Male None 
62 Male Higher Education None 
61 Female Higher Education None 
57 Female Higher Education None 
37 Male 36.9 Higher Education None 
38 Female 249 School Leavers Certificate None 
71 Male School Leavers Certificate None 
60 Female 22 Further Study None 
69 Female 25.8 School Leavers Certificate None 
60 Male 244 Higher Education None 
58 Male 25.2 None 
62 Female Further Study None 
60 Male 293 None 
53 Female Higher Education None 
51 Female 33.1 Higher Education None 
51 Male 234 None 
44 Female 241 Higher Education None 
58 Male 26.1 None 
58 Male 311 School Leavers Certificate None 
56 Female 204 None 
59 Male 245 None 
59 Female 24.5 School Leavers Certificate None 
33 Female 19.2 Higher Education Sleep Hypnotic" 
57 Male 23.5 Higher Education None 
38 Female 18 Higher Education None 
52 Male 28.1 Higher Education None 
58 Female 214 School Leavers Certificate None 
60 Female 21.8 School Leavers Certificate None 
38 Male 22.1 Further Study None 
63 Male 26 1 School Leavers Certificate None 
72 Male 281 Higher Education None 
70 Male 24.4 Higher Education None 
43 Male 258 School Leavers Certificate None 
38 Male 30.4 Further Study None 
40 Female 245 Higher Education None 
44 Female 24.4 Higher Education None 
45 Female 249 Higher Education None 
58 Female 20.4 Higher Education None 
62 Female 248 Higher Education None 
72 Female 30.1 Higher Education None 
69 Male 308 Further Study None 
70 Male 22.3 School Leavers Certificate None 
* Zipiclone taken irregularly 
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APPENDIX D: Supplement For Study 2 
Additional Data 
I. Scatter plots for weekday and weekend matching parameters from the sleep 
diary and actigraphy recordings. 
2. Scatter plots for weekday and weekend matching parameters from the sleep 
diary and actigraphy recordings. 
3. Scatterplots for significant correlations between sleep parameters, daytime 
functioning and residual upper limb motor ability tests. 
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Appendix E: Supplement For Study 3 
1. Data table for left stroke EEG expressed as a percentage of controls. 
2. Data table for right stroke EEG expressed as a percentage of controls. 
3. Brain map values for left stroke vs controls. 
4. Brain map values for right stroke vs controls. 
5. Hemisphere ratio values for left stroke group and controls. 
6. Hemisphere ratio values for right stroke group and controls. 
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APPENDIX El 
Data Table for Left Stroke EEG Expressed as a Percentage of 
Controls 
Pre motor task raw data for left stroke group and matched controls. Data presented as 
mean raw power density values (±1 SE) and t values (dJ26) for ispilateral (C3), 
contralateral (C4) hemispheres and right hemisphere (C4) for control. One tailed t- 
test completed on logged values of raw data. Values in bold are p_<0.05, * p<0.01, ** 
P<0.005, *** p<0.001. 
Left Stroke 
Frequency 
Bin (Hz) 
Raw Power Density 
Ivv'INZ1 
Ipsllateral Control 
Ipsllateral Hemisphere Raw Power Contralateral ipillateral vvs. 
vs. Controls Density (IJV2/Hz Hemisphere vs Controls Contralateral Hemisphere 
1 
2 
3 
4 
6 
6 
7 
9 
10 
11 
12 
13 
14 
16 
16 
17 
18 
19 
20 
21 
22 
23 
24 
26 
26 
27 
28 
29 
30 
Bete 
Alpha 
Theta 
Delta 
IYa. vuuawwrai P P 
587±179 3 1,7 1 17 046 065 447±096 
-061 054 206 006 234z049 106±010 576 0.0000' 172±028 471 0.0002" 167 011 
1693033 084±011 407 0.0004" 131±020 395 0.0006'- 1 50 016 
151z035 070±007 3.74 0.0009" 1.13±020 285 0.0086' 1 99 007 
1 53 ±0 39 0 59 ±0 06 383 0.0007" 0 93 ±0 14 292 0.0071' 2 17 0.0496 
2 60 ±1 36 0 69 ±0 09 242 0.0230' 1 17 ±0 32 1 48 0 15 3 02 0.0098' 
2243052 087±014 210 00458 140±025 093 036 281 0.0147' 
184±032 148±037 094 036 106±014 037 099 412 0.0012' 
150±025 1.82±046 045 066 102±0.16 
-101 032 337 0.0061" 132±027 264±094 
-038 071 084±012 -135 019 351 0.0038" 1.03±015 127±0.23 -020 0.84 079±0.13 -1 43 0 17 2 41 0.0317 1013021 091±021 069 049 065±0.09 -034 074 2.44 0.0296 0963013 096±028 050 064 063±012 -090 038 282 0.0146' 091±021 099±033 006 095 062±011 -105 030 190 008 091±024 111±035 -066 051 062±013 -160 012 183 009 07530.16 1.1730.36 -102 032 0.60±0.10 -187 007 167 0.12 073±017 112±034 -136 018 059±011 -200 006 127 022 0 78 ±0 19 1 15 ±0 38 -1 50 0 15 0.62 ±0.13 -2 00 0.0068' 1 42 018 065±016 094±022 
-123 023 064±016 -167 010 041 069 064±015 083±018 -119 024 0663018 -115 026 012 091 0633017 065±015 -0.54 060 063±013 -036 072 062 055 056! 015 0483009 -0.35 0.73 055±018 -026 080 074 047 054±015 040±008 040 097 053±013 068 050 020 085 
046±015 032±0.06 041 068 0.43±010 088 039 047 065 
039±012 027±0.06 066 052 033±006 101 032 064 053 
031±010 021±004 055 059 027±005 116 226 032 076 026-009 017±003 069 049 022±004 105 030 051 062 
020±007 014±003 062 054 018±004 138 018 -013 090 018±007 011±002 070 049 015±003 140 017 031 076 
017±006 010±003 091 037 013±003 117 025 051 062 
1004±220 1113±288 -0.68 050 841±169 -104 030 119 025 670±100 811±182 -014 089 437±057 -151 014 406 0,0013- 7 88 2 50 2 84 ±0 32 2 90 0.0090' 4 64± 0 76 1 87 0 08 2 62 0.0213 
9 91 ±2 45 5 47 ±1 34 2 11 0.0449 7 50 ±1 36 1 51 0 14 1 87 0 08 
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APPENDIX E2 
Data Table For Right Stroke EEG Expressed as a Percentage of 
Controls 
Pre motor task raw data for right stroke group and matched controls. Data presented 
as mean raw power density values (±I SE) and t values (dJ34) for ispilateral (C4), 
contralateral (C3) hemispheres and left hemisphere (C3) for control. One tailed t-test 
completed on logged values of raw data. Values in bold are p_<O. 05, * p<0.01, ** 
P<0.005, *** P<-0.001. 
Right Stroke 
Frequency 
&n (Hz) 
1 
2 
3 
4 
6 
6 
7 
8 
10 
it 
12 
13 
14 
16 
16 
17 
18 
19 
20 
21 
22 
23 
24 
26 
26 
27 
28 
29 
30 
Beta 
Alpha 
Theta 
Delta 
Raw Power Density Ipsilatsral Hemisphere Raw Power Contralateral Ipsllateral vs. 
_ 
VIHz) vs. Controls Density (pV'IHz) Hemisphere vs. Controls Contralateral Hemisphere 
Ipsilateral Control tp Contralateral prp 
t408±531 224to22 
841 4 48 124±017 
459±198 094±015 
317! 109 075! 008 
312! 101,064±001 
417! 129 070±008 
509±181 091±016 
569! 183 134±034 
407! 108 153±040 
253±047 222±084 
184! 036 101±019 
128! 023 076±010 
109! 018 075l014 
090! 013 070±0 12 
074! 010 076±015 
072ý011 086±017 
060±009 091±019 
055±008 092±016 
046±007 083l015 
039±005 081±016 
036! 005 067l014 
032±005 047±008 
027! 003 039l007 
023l003 030±005 
023±004 027±004 
018"003 020,003 
013±002 017±003 
011±001 013±002 
010! 001 011l002 
008±001 010±002 
746! 094 935±162 
1542/382 886±160 
1556! 509 300l033 
2708±1170 442±050 
4 09 0.0006" 8 00 ±2 37 3 07 0.0066' 2 59 0.0190 
3 84 0.0006" 381 ±1 16 3 35 0.0026" 2 66 0.0163 
3 75 0.0010' 255±086 304 0.0046" 2 75 0.0138" 
4 52 0.0001"' 1 83 ±0 37 3 57 0.0014"' 3 10 0.0066- 
462 0.000011' 169,0 33 3 93 0.0006"' 2 80 0.0123" 
4 58 0.0000"' 209- 0 43 3 85 0.000111' 2 96 0.0088" 
3 80 0.0001"' 3 55 ±0 85 3 39 0.0022" 2 17 0.0447 
3 29 0.0023" 4 27 ±1 23 2 40 0.0232 2 68 0.0158 
286 0.0072" 4 32 ±1 29 2 00 0.0476 2 18 0.0435 
164 011 273±0.71 097 034 203 006 
195 006 170±041 013 027 202 006 
1 87 007 1 30±029 1 61 012 1 30 021 
168 010 100±020 124 022 144 017 
1.18 0 25 1 02 ±0 23 1.07 029 0 95 0 36 
005 096 099±024 066 052 024 081 
. 065 053 110±034 
0 17 087 -055 057 
-1 48 0 15 1 
24 ±0 52 0 05 0 96 -2 75 0-0137- 
-209 0.0440 121±049 -040 069 2 30 
0.0344 
-241 0.0213 103±043 -065 052 -1 91 007 
246 0.0104" 090±034 -072 048 . 170 011 
226 0.0306 077±026 -056 058 1 22 024 
166 011 070±025 017 087 173 010 
-140 
017 064±023 059 056 -153 015 
-130 
020 058±0.19 1 07 029 2.20 0.0418' 
070 049 043±014 079 043 063 054 
-042 068 0.36±013 079 044 -024 081 
-070 049 029±011 065 052 -066 052 
-055 059 024±009 049 063 009 093 
-008 094 017±005 052 061 067 051 
-025 081 0.17±0.06 051 
061 043 067 
-914 037 1285±414 
028 078 -1 15 026 
2 43 0.0208' 14 32 ±3 77 1 69 010 2 45 0.0264 
4 55 0.0000' 9 16 ±1 86 3 86 0.0008" 2 79 0.0126" 
4 12 0.0002' 14 36 *_ 4 14 3 28 0.0033" 2 69 0.0168 
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APPENDIX E3 
Brain Map Values For Left Stroke vs Controls 
Delta Left Stroke Control t tost 
Mean SE Mean SE p 1D1 140 011 112 005 238 0.0286 
1-p2 1 32 0 07 1 10 0 02 2 79 0.0139 
FDL 1 36 009 1 09 002 2 86 0.0128 
A13 1170 11 0 88 0 03 2 57 0.0220 
AF4 112 007 093 003 257 0.0193 
AF 71 41 010 1 09 003 3 55 0.0030 
AF8 1 31 007 1 113 0 03 2 66 0.0132 
AFz 111 009 088 003 2 56 0.0207 
11 104 011 085 004 1.58 013 
F2 096 007 077 004 225 0.0362 
F3 1 03 Oil 0 79 004 2 12 0.0496 
F4 098 006 077 003 316 0.0049 
F5 125 011 087 003 342 0.0039 
16 113 006 091 004 321 0.0036 
F71 50 0 10 1 05 0 02 4 43 0.0006 
FB1 29 0 045 1 06 0 03 3 59 0.0014 
Fz 102 008 084 004 207 0.0486 
FC1 097 009 080 006 158 01255 
FC2 087 008 075 003 183 00817 
1-03 093 010 064 003 282 0.0123 
104 0 85 0 07 0 60 0 03 3 36 0.0039 
FC5 114 010 069 003 414 0.0009 
[CO 098 006 070 003 3 54 0.0022 
FCz 091 007 080 004 129 02102 
FT 71 39 0 09 0 98 0 03 4 37 0.0006 
FT8 118 005 098 004 3.13 0.0043 
Cl 081 006 068 004 1.77 009 
C2 084 006 067 003 280 0.0114 
C3 087 009 055 003 349 0.0028 
04 079 007 064 007 1.51 0.14 
Cl 1 03 010 058 003 4 38 0.0006 
C6 083 008 057 003 301 0.0079 
CL 089 007 080 004 117 02573 
T7 1 35 010 0 89 0 03 4 27 0.0007 
T8 104 006 085 003 293 0.0069 
CP1 090 006 078 006 150 015 
CP2 0 79 0 06 0 76 0 04 0 38 07068 
0P3 095 008 063 003 3 79 0.0014 
0P4 081 008 062 003 229 0.0364 
CP5 1 04 0 10 0 59 0 03 4 39 0.0006 
CP6 0 82 0 08 062 0 03 2.40 0.0286 
CPz 089 006 076 003 178 009 
TP7 123 010 087 006 307 0.0069 
I P8 1 02 0 07 0 84 0 03 2 38 0.0281 
P11 00 0 07 079 0 05 2 56 0.0166 
P2 0 94 0 06 082 004 1 64 0.11 
P3 1 02 0 08 0.74 0.03 3.33 0.0041 
P4 091 007 083 005 098 034 
P5 1 13 0 08 0 76 003 4.16 0.0008 
P6 096 006 084 003 1.62 0.12 
P7 118 009 086 004 337 0.0038 
P8 1 06 0.07 0 90 0.04 1 86 0 07 
Pz 099 007 082 004 221 0.0388 
P03 111 007 0 90 0 05 2 46 0.0211 
P04 102 007 093 004 119 025 
P07 1 20 0 08 0 96 0 04 2 74 0.0128 
POB 111 006 099 004 171 010 
01 1 18 0 07 1 00 0 04 2 13 0.0426 
02 1130 06 1 00 0 04 1 89 007 
Oz 116 007 098 005 212 0.0437 
FTIO 129 005 115 003 257 00162 
TP9 1 41 010 1 D6 003 3 30 0.0045 
TP10 118 006 1.04 003 213 0.0426 
POL 1 16 0 07 0 94 0 05 2 74 0.0109 
Theta 
Fpl 
Fp2 
FpZ 
AF3 
AF4 
AF7 
AF8 
AFz 
Fl 
F2 
F3 
F4 
F5 
F6 
F7 
F8 
Fz 
FC1 
FC2 
FC3 
FC4 
FC5 
FC6 
FCz 
FT 7 
FT8 
C1 
C2 
C3 
C4 
C5 
C6 
Cz 
T7 
T8 
CPI 
CP2 
CP3 
CP4 
CP5 
CP6 
CPz 
TP7 
TP8 
P1 
P2 
P3 
P4 
P5 
P6 
P7 
P8 
P2 
P03 
P04 
P07 
PO8 
01 
02 
Oz 
FT 10 
TP9 
TP10 
POz 
Left Stroke Control t test 
Mean SE Mean SE Ip 
095 008 071 004 264 0.0166 
091 008 073 003 209 0.0613 
0 90 0 09 0 69 004 224 0.0380 
083 0 08 0 59 0 05 2 50 00210 
082 0 08 0 62 004 219 0.0404 
1 03 0 07 0 75 0 04 3 36 0.0034 
0 95 0 07 077 0 03 2 32 0.0324 
081 009 061 005 1 95 0067 
080 009 062 005 177 009 
0 77 0 08 060 0 05 1 72 0.10 
081 0 08 0 59 0 04 2 32 0.0312 
077 007 057 005 228 0.0332 
0 94 0 08 0 62 0 04 3 58 0.0020 
086 0 06 0 64 0 04 2 92 0.0082 
108 008 076 0 04 379 0.0012 
095 006 075 004 275 0.0122 
0 77 0 08 063 0 06 1 48 0 15 
071 0 09 0 57 0 05 1 40 0 17 
067 007 054 005 144 016 
074 008 049 004 269 0.0144 
065 0 07 0 43 0 04 2 59 0.0170 
088 010 049 004 382 0.0014 
073 007 046 003 366 0.0018 
072 008 064 006 085 04015 
106 009 073 004 340 0.0032 
089 006 069 004 282 0.0103 
063 008 047 005 173 010 
058 007 043 005 169 010 
073 010 040 005 307 0.0064 
059 007 042 005 187 0.08 
087 011 042 004 393 0.0012 
065 008 041 004 278 0.0117 
0 66 0 08 0 55 0 05 1 20 0 24 
1 08 0 10 0 70 0 05 3 47 0.0026 
084 006 063 004 275 0.0118 
068 011 044 005 207 0.0629 
055 008 042 005 133 020 
0 80 0 13 041 0 05 2 93 0.0094 
0 58 0 08 041 0 06 1 78 0 09 
091 011 045 004 377 0.0016 
066 008 043 005 237 0.0274 
064 010 044 006 180 009 
1 08 010 0 68 0 04 3 64 0.0019 
0 83 0 07 0 62 0 04 2 52 0.0200 
078 012 047 006 2 38 0.0282 
065 009 046 005 185 008 
086 012 047 005 291 0.0099 
065 009 051 004 146 016 
0.97 Oil 0 55 0 05 3 52 0.0026 
0.74 0.08 0 55 0 05 1 94 0.067 
1.08 0.10 0 69 0 05 3 50 0.0024 
0.86 009 066 005 206 0.0626 
075 0.11 048 005 225 0.0364 
094 010 062 0 05 287 0.0097 
0 77 0 08 061 0 05 1 70 0 10 
1 05 0 09 0 77 0 05 266 0.0160 
089 0 08 0 75 0 05 1 53 0.14 
1 00 0 09 0 78 0 05 2 23 0.0378 
089 007 073 0 04 190 007 
0 92 0 08 0 72 0 04 2 14 0.0448 
1.00 0 05 087 0 04 1 93 0.07 
123 010 069 004 321 0.0062 
095 006 084 004 152 014 
086 009 001 005 2 50 0.0211 
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Alpha 
Fpt 
Fp2 
Fpz 
Al-) 
AI-4 
AF7 
AF11 
AF[ 
F1 
F2 
F3 
F4 
F`. 
ffi 
FI 
F8 
FZ 
FC1 
FC2 
FC3 
F(: 4 
Fi5 
FC6 
FC7 
FT 7 
FT8 
C1 
C2 
C3 
C4 
C5 
C6 
CZ 
Ti 
18 
CP1 
CP2 
CPT 
C P4 
CP5 
C Pti 
CPz 
TP7 
T P8 
P1 
P2 
P3 
P4 
P5 
P6 
P7 
P8 
Pz 
P03 
P04 
P07 
P08 
01 
02 
Oz 
F7f0 
TP9 
TP10 
POL 
Lett Stroke Control t test 
Mean SE Mean SE tp 
091 007 093 009 -097 034 093 005 099 009 . 139 018 
085 006 089 010 -094 035 081 007 084 010 -098 034 
085 006 087 009 -117 025 
0 99 006 1 04 0 08 -1 21 0 24 
095 005 1 02 008 -1 33 019 077 006 082 010 -116 026 071 006 078 009 -124 023 072 006 U76 009 -111 028 077 007 079 009 -089 038 075 006 079 009 -123 023 092 007 090 008 -053 060 089 005 091 009 -123 023 107 007 100 008 016 087 
0913 005 099 009 -083 041 0 70 006 0 78 010 -137 0 18 063 006 067 008 
. 090 037 0 60 006 0 64 0 08 -1 13 0 27 068 008 069 008 
-069 050 062 006 066 009 -095 0.35 089 009 079 008 012 091 
075 006 075 008 -053 060 064 004,071 009 -1 23 023 
1 14 0 09 1 00 007 0 52 0 61 
094 005 097 008 -085 040 
060 007 063 008 -077 045 053 006 060 009 
-142 017 075 008 073 011 -066 052 
058 007 077 010 -215 0.0412 
088 009 081 009 -029 078 070 006 081 009 . 164 011 061 007 065 008 -096 035 114 008 104 007 027 079 
0 96 007 0 99 0 08 -0 68 0 50 
073 0 09 0 70 011 -0 58 0 57 0 58 0 08 0 71 010 -1 85 008 0 85 0 10 077 Oil -042 0.68 064 007 082 011 
-216 00398 0 94 0 08 0 84 010 -0 31 0 76 075 007 087 009 -1 72 0.10 068 009 070 011 -1.05 030 
1 13 0 08 0 99 0 07 0 11 091 
0 96 0 06 1 00 0 07 -0 97 0 34 
088 010 079 012 -041 069 075 008 084 012 .1 47 0 15 
096 009 081 011 001 100 
0 76 0 08 0 88 0.11 -1 62 0.12 1 06 0 08 087 010 0.33 0.74 
088 007 097 010 -123 023 
1 14 0 07 0 96 0 08 0 46 0 85 
101 006 106 008 -101 032 
0 85 010 0 82 012 -0 75 0 48 108 008 094 011 008 094 
091 007 099 011 -115 026 1 16 0 06 1 01 0 09 031 0 76 
103 006 110 010 -143 016 114 007 099 008 039 070 
0 98 0 07 0 99 0 09 -096 0.35 
1 02 0 08 0 93 0 08 -0 11 0 92 
1 01 0 07 1 12 007 .1 26 0.22 
1 31 0 09 1 16 0 06 0 33 0.75 
1 10 0 07 1 15 0 07 -1 17 0 25 
1 00 0 08 0 95 012 -0 58 0 57 
Bets 
Fp1 
Fp2 
Fpz 
AF3 
AF4 
AF7 
AFB 
AFz 
F1 
F2 
F3 
F4 
F5 
F6 
F7 
F8 
FZ 
FC1 
FC2 
FC3 
FC4 
FC5 
FC6 
FCz 
FT 7 
FT8 
C1 
C2 
C3 
C4 
C5 
C6 
Cz 
T7 
T8 
CP1 
CP2 
CP3 
CP4 
CP5 
CP6 
CPz 
TP7 
T P8 
P1 
P2 
P3 
P4 
P5 
P6 
P7 
P8 
Pz 
P03 
P04 
P07 
P08 
01 
02 
Oz 
FTIO 
TP9 
TP10 
POz 
Left Stroke CoMrol t teet 
Mean SE Mean SE tp 
1.31 010 1.25 009 045 065 
1 38 010 1 38 0 10 0 03 0 98 
105 007 106 005 -009 093 100 009 103 007 -0 28 078 1 16 0 10 1 16 0 07 0 00 1 00 
1 32 010 1 47 010 -1 00 033 148 012 136 012 070 049 
080 007 093 006 . 143 016 
079 008 094 007 142 017 
083 009 095 007 . 113 027 101 009 103 007 -014 089 103 010 109 007 -049 063 126 012 125 007 011 091 
1 37 013 1 26 0 10 0 65 052 
126 010 126 008 -004 097 130 013 112 010 111 028 
072 008 091 007 1 86 007 
074 009 090 008 1 37 018 
073 009 089 007 -1 44 0 16 091 010 092 007 -011 091 084 009 091 006 067 051 
117 014 1 00 0 07 1 07 0 29 
1.06 0.11 096 007 078 044 
070 009 092 007 -189 007 1.29 015 1.14 007 0 95 035 
118 010 114 008 030 077 
067 009 085 007 -149 015 067 009 083 007 -144 016 085 011 089 007 -033 074 082 009 094 008 -104 0.31 
103 U13 097 007 036 072 
096 009 091 007 -016 088 071 011 091 008 149 015 
127 009 127 011 001 099 
126 008 114 008 107 029 
065 009 083 006 -1.58 013 064 008 083 007 180 008 
080 010 090 006 -085 040 080 009 094 007 -124 023 
089 010 096 006 -057 057 095 010 097 007 -020 084 069 010 084 007 -1 20 024 1 04 0 08 1.17 0 07 -1 21 024 113 010 110 007 025 080 
071 008 086 006 -153 0.14 072 007 087 006 -166 011 078 008 091 006 -130 0.20 079 007 094 006 
-169 010 088 007 098 006 -1.15 026 091 006 102 006 -124 023 102 007 110 006 . 095 035 1 06 0 08 1 13 0 07 . 060 0 55 072 008 086 006 -148 015 089 006 101 006 
. 141 017 087 006 1.02 006 -1.78 009 1.05 006 1.15 006 -121 024 105 006 118 008 -137 018 103 007 112 006 100 033 
100 006 107 006 -078 045 097 007 102 005 064 053 
1.18 008 123 009 -038 0.71 124 009 136 007 099 033 
1 20 0 08 1 26 0 05 -0 68 0 50 085 006 097 006 -147 015 
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APPENDIX E4 
Brain Map Values For Right Stroke vs Controls 
Delta 
Fpl 
Fp2 
Fpz 
AF3 
AF4 
AF7 
AF8 
AFz 
F1 
F2 
F3 
F4 
F5 
F6 
F7 
F8 
Fz 
FC1 
FC2 
FC3 
FC4 
FC5 
FC6 
FCz 
FT 7 
FT8 
C1 
C2 
C3 
C4 
C5 
C6 
Cz 
T7 
T8 
CP1 
CP2 
CP3 
CP4 
CP5 
CP6 
CPz 
T P7 
T P8 
P1 
P2 
P3 
P4 
P5 
P6 
P7 
P8 
Pz 
PO3 
P04 
PO7 
PO8 
01 
02 
Oz 
FT 10 
T P9 
TP10 
POz 
Right Stroke Control t test 
Mean SE Mean SE rp 
1 51 all 1.14 0 05 3 03 0.0068 
1 64 013 1 16 0 04 3 52 0.0022 
1 55 012 1 13 0 04 3 33 0.0033 
1 28 0 11 0 94 0 04 2 94 0.0076 
140 014 099 004 282 0.0104 
1 50 010 1.12 0.04 3 52 0.0019 
1 64 012 1 25 0 06 2 84 0.0089 
1 33 0 12 0 94 0 05 2 95 0.0074 
1 18 010 089 005 2 58 0.0164 
1.16 012 087 006 2 13 0.0428 
116 009 084 005 295 0.0066 
1 24 012 085 005 3.00 0.0066 
139 014 093 004 306 0.0061 
1 34 0 11 0 99 0 05 2 85 0.0090 
1 42 009 109 004 327 0.0034 
1 48 all 1 10 0 04 3.31 0.0032 
1 19 0 11 090 0 05 2 30 0.0305 
102 009 081 006 190 007 
107 010 078 004 259 0.0164 
1 06 0 08 0 69 0 04 4 03 0.0004 
108 010 066 004 385 0.0008 
1 13 0 09 075 0 04 3 74 0.0010 
118 011 075 004 370 0.0012 
105 010 084 004 204 0.0623 
1 34 0 09 1 02 0 04 3 26 0.0036 
1 44 012 1 02 0 04 3 28 0.0036 
0 97 0 08 0 70 0 04 3 03 0.0066 
108 010 070 003 358 0.0018 
095 010 061 004 328 0.0033 
1.12 012 069 006 332 00028 
102 010 066 005 324 0.0034 
118 012 064 005 431 0.0003 
1 04 0 09 0 80 0 04 2 43 0.0232 
1 26 010 0 92 0 03 3 13 0.0061 
1 39 013 0 90 0 05 3 36 0.0028 
1 03 0 11 0 80 0 05 1 94 0.0643 
1 08 all 0 79 0 04 2 48 0.0214 
097 010 069 004 250 0.0198 
118 013 069 004 361 0.0017 
104 010 069 005 313 0.0047 
1 25 013 067 004 4 34 0.0003 
1 04 009 061 0 05 2 24 0.0340 
1 20 010 0 92 0 06 2 43 0.0224 
137 013 087 004 369 0.0016 
1.04 009 0.85 0 05 1 86 0 07 
1 15 011 085 0 04 2 57 0.0174 
1 04 010 082 0 05 2 00 006 
1 26 all 087 0 05 3 17 0.0043 
1 08 010 082 0 04 2 42 0.0236 
1 28 012 089 0 04 3 11 0.0062 
1 16 010 0 92 005 2 21 0.0366 
1 36 012 0 94 0 05 3 27 0.0035 
1 14 0 09 0.88 0 04 2.84 0.0142 
116 009 096 005 198 006 
1 28 all 0 96 0 05 2 68 0.0136 
1 23 008 1 00 005 2 36 0.0262 
1 38 all 102 0 05 3 02 0.0061 
1 24 0 08 1 05 0 06 2 00 0.0539 
1 33 0 09 1 02 0 05 2 85 0.0085 
1 26 0 08 1 00 0 05 2 67 0.0126 
165 014 1.17 003 344 00027 
136 009 109 004 257 0.0171 
154 013 107 003 350 0.0023 
1 24 0 09 0 96 0 05 2 60 0.0152 
Theta 
Fpl 
Fp2 
Fpz 
AF3 
AF4 
AF7 
AF8 
AFz 
Fl 
F2 
F3 
F4 
F5 
F6 
F7 
F8 
Fz 
FC1 
FC2 
FC3 
FC4 
FC5 
FC6 
FCz 
FT7 
FT8 
C1 
C2 
C3 
C4 
C5 
C6 
Cz 
T7 
T8 
CP1 
CP2 
CP3 
CP4 
CP5 
CP6 
CPz 
TP7 
TP8 
P1 
P2 
P3 
P4 
P5 
P6 
P7 
P8 
Pz 
P03 
P04 
P07 
P08 
01 
02 
Oz 
FT 10 
TP9 
TP10 
POz 
Right Stroke Control t test 
Mean SE Mean SE tp 
1 19 0 09 0 76 0 04 
-049 0.0002 1 26 0 10 077 0 04 071 0.0001 
1.21 0 10 074 004 098 0.0001 
1 07 0 09 065 0 05 0 59 0.0002 
114 010 067 004 -003 0.0001 1 19 0 08 079 0 04 029 0.0001 
127 008 083 004 131 0.0000 
112 010 067 005 -086 0.0003 
101 009 065 005 -135 0.0014 
1 04 010 065 005 -121 0.0013 099 008 062 005 094 0.0004 
1 07 010 062 004 . 021 0.0002 1 12 009 067 005 009 0.0001 
112 009 067 004 069 0.0000 
114 007 080 004 025 0.0004 
1 20 008 077 004 0 18 0.0000 
104 009 067 005 -146 0.0016 090 008 058 005 178 0.0035 
095 009 056 005 -126 0.0010 087 008 051 005 -044 0.0004 094 009 047 005 031 0.0000 
0.93 008 052 005 069 0.0001 
099 0 09 049 0 04 1 14 0.0000 
0 95 0 09 0 66 0 05 -2 08 0.0086 
108 007 075 004 048 0.0006 
1 15 0 09 071 0 04 1 10 0.0001 
078 008 047 005 -038 0.0023 088 010 045 005 038 0.0004 
082 009 043 005 134 0.0006 
096 010 046 005 171 00002 
086 008 047 005 202 0.0002 
101 010 046 005 113 0.0000 
086 008 054 005 -139 0.0026 107 009 073 005 274 0.0022 
118 011 066 005 210 0.0001 
079 008 045 005 073 0.0008 
091 010 044 005 102 0.0002 
084 009 045 005 197 0.0006 
1 02 011 040 006 196 0.0001 
092 009 051 005 225 0.0002 
109 012 047 005 186 0.0003 
0 84 008 046 005 009 0.0006 
1 08 0 10 072 0 04 2 71 0.0016 
1 25 0 12 065 0 04 1 68 0.0000 
081 0 08 01.0 00 1 09 0.0006 
097 010 049 005 150 0.0001 
090 0 09 053 0 04 1 71 0.0004 
1 07 0 10 0 54 0 04 1 66 0.0000 
0 99 0 09 059 0 04 1 50 0.0003 
116 011 059 005 159 0.0000 
110 009 072 004 127 0.0006 
1 31 012 068 005 123 0.0000 
092 008 051 005 107 0.0002 
104 008 066 005 136 0.0002 
113 010 064 005 131 0.0001 
1 15 0 08 0 79 0 05 073 0.0004 
1 32 0 11 0 76 0 05 0 83 0.0000 
114 007 080 004 044 0.0002 
122 009 074 004 029 0.0000 
113 008 074 004 009 0.0001 
134 011 087 004 092 00003 
125 008 089 004 179 0.0006 
145 012 083 004 111 0.0000 
1 04 008 064 005 103 0.0001 
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Alpha 
Fp1 
Fp2 
Fpz 
AF3 
AF4 
AF7 
AF8 
AFz 
F1 
F2 
F3 
F4 
F5 
F6 
F7 
F8 
Fz 
FC1 
FC2 
FC3 
FC4 
FC5 
FC6 
FCz 
FT7 
FT8 
C1 
C2 
C3 
C4 
C5 
C6 
Cz 
T7 
T8 
CP1 
CP2 
CP3 
CP4 
CP5 
CP6 
CPz 
TP7 
TP8 
P1 
P2 
P3 
P4 
p5 
P6 
P7 
P8 
Pz 
P03 
P04 
P07 
P08 
01 
02 
Oz 
FTIO 
T P9 
TP10 
POz 
Left Stroke Control tteat 
Mean SE Mean SE rp 
1 16 0 09 0 90 0 08 3 63 0.0009 
1 16 0 08 095 007 3 44 0.0016 
112 009 086 008 377 0.0006 
106 009 081 008 358 0.0011 
107 009 084 007 352 0.0013 
1 22 0 07 1 00 0 07 3 67 0.0008 
1.22 0 07 099 0 07 3 66 0.0008 
1 04 010 0 79 0 08 3 36 0.0020 
0 96 0 10 0 75 0 08 3 04 0.0046 
0 98 010 0 73 008 3 40 0.0017 
102 009 075 008 364 0.0009 
1 05 010 0 77 0 08 3 80 0.0006 
1 18 0 07 0 87 007 453 0.0001 
1 13 0 09 0 88 0 07 3 72 0.0007 
1 22 0 07 0 96 0 07 3 88 0.0006 
1 22 008 094 007 394 0.0004 
097 010 075 008 316 0.0033 
085 010 064 007 321 0.0029 
090 009 0 62 0 08 3 97 0.0004 
090 0 09 005 007 3 74 0.0007 
095 009 064 008 431 0.0001 
1 07 0 07 075 007 4 70 0.0000 
107 008 072 007 499 0.0000 
088 009 068 008 322 0.0028 
122 007 096 007 386 0.0006 
1 21 0 09 0 92 0 07 3 88 0.0006 
077 009 059 007 287 0.0069 
087 009 057 007 393 0.0004 
092 011 069 008 311 0.0038 
1 00 0 10 0 72 008 3 68 00008 
1 05 009 077 0 07 3 63 0.0009 
1 05 010 0 74 0 07 4 11 0.0002 
081 008 059 008 326 0.0026 
1 25 0 08 1 01 006 3 32 0.0021 
1.22 0 10 0 94 0 07 3 67 0.0008 
088 010 066 009 316 0.0033 
100 010 066 008 423 0.0002 
101 011 076 009 330 0.0023 
1 12 Oil 0 77 0 09 4 27 0.0001 
1.12 0.11 081 0 08 3 71 0.0007 
1 15 011 0 80 0 07 4 33 0.0001 
090 009 065 009 341 0,0017 
128 010 097 006 368 0.0008 
127 011 095 007 401 0.0003 
1.05 010 079 010 336 0.0019 
114 011 080 009 393 0.0004 
112 011 082 009 364 0.0009 
122 011 085 009 461 0.0001 
122 011 088 008 400 0.0003 
129 011 093 008 449 0.0001 
130 011 097 007 401 0.0003 
1 35 Oll 1 02 0 07 4 18 0.0002 
1 08 010 0 79 010 3 43 0.0016 
1 29 011 097 010 355 0.0012 
1 31 0 10 097 010 4 23 0.0002 
1 39 010 1 02 0 08 4 13 0.0002 
1.43 0 10 1 07 0 09 4 50 0.0001 
1 35 0 10 1 00 0 09 4 07 0.0003 
1 35 0.10 0 97 0 09 4 52 0.0001 
1 26 0 10 093 0 08 4 14 0.0002 
135 010 1 06 006 3 52 00013 
1 41 009 1 11 006 389 0.0004 
1 44 0 11 1 07 006 4 36 0.0001 
1 25 010 094 010 3 55 0.0011 
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Beta 
Fpi 
Fp2 
Fpz 
AF3 
AF4 
AF7 
AF8 
AFz 
Fl 
F2 
F3 
F4 
F5 
F6 
F7 
FB 
Fz 
FC1 
FC2 
FG3 
FC4 
FC5 
FC6 
FCz 
FT7 
FT8 
Cl 
C2 
C3 
C4 
C5 
Cd 
Cz 
T7 
T8 
CP1 
CP2 
CP3 
CP4 
CP5 
CP6 
C Pz 
TP7 
T P8 
P1 
P2 
P3 
P4 
P5 
P6 
P7 
P8 
Pz 
P03 
P04 
P07 
P08 
01 
02 
Oz 
FTfO 
TP9 
TP10 
POz 
Left Stroke Control t test 
Mean SE Mean SE ro 
1 23 0 10 1 18 0 09 0 37 0 71 
118 009 131 009 -109 028 095 007 101 006 . 065 052 099 008 098 007 010 092 
097 007 108 007 -108 029 136 009 144 009 
-063 054 1 32 Oil 1 36 010 0 26 080 
080 006 088 006 -088 039 081 007 088 007 076 045 
079 007 089 006 -102 031 103 009 097 006 052 061 
0 96 0 08 1 02 0 07 -0 56 0 58 126 009 119 008 062 054 
118 009 122 009 -035 073 1 20 0 07 1 22 0 07 -0 20 084 122 009 110 008 099 033 
076 007 086 007 -101 032 077 007 084 007 -065 052 0 76 0 07 0 82 007 -0 68 0 50 093 007 088 007 050 062 
085 007 086 006 
-012 091 113 008 094 007 185 007 
108 008 091 006 1 79 008 
074 006 085 007 . 117 025 120 007 108 008 118 025 
127 008 110 008 1 55 013 
076 007 081 007 -053 060 
070 006 079 007 
-090 038 092 009 089 006 028 078 
081 006 091 007 .1 09 0.28 
100 007 093 007 066 051 
099 007 092 007 012 041 
076 006 081 008 052 061 
118 006 127 009 -076 045 121 008 108 007 123 023 
077 006 079 006 -024 081 070 007 078 007 -079 043 092 008 089 006 027 079 
078 007 089 007 109 028 
098 007 092 006 064 053 
087 007 090 007 -035 073 075 006 076 008 
-013 090 111 006 110 006 01`ý 088 
110 009 103 006 067 051 
081 006 083 007 
. 025 081 076 007 081 007 -054 059 089 006 089 006 003 098 
079 008 088 006 -090 038 098 006 096 006 0 18 086 
088 008 097 007 -080 043 1 09 0 05 1 09 0 06 . 006 0 96 104 008 106 007 022 083 
078 006 080 007 
. 016 087 098 006 100 007 
-017 087 089 007 096 007 066 052 
112 005 114 007 -021 084 
106 007 111 008 -048 064 110 005 110 006 003 097 
103 007 101 007 024 081 
101 006 098 006 039 070 
137 009 121 009 130 0.20 
131 008 125 007 053 060 
131 008 118 005 131 020 
092 006 092 007 -003 098 
APPENDIX E5 
Hemisphere ratio values for left stroke group and controls 
One tailed t test against I for between hemisphere ratios (C3/C4) of left stroke group 
and controls. Values in bold are p<0.05, * p<0.01, ** p<_0.005, *** p<0.001 
Frequency 
Bin (Hz) 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
Beta 
Alpha 
Theta 
Delta 
Left Stroke Controls 
tptp 
2 06 0.0495 0.52 0.61 
1 67 0.0098* -0.16 0.88 
1 50 0.0147* -0.03 0.98 
1 99 0.0012"' 0.43 0.67 
2 17 0.0051'" 0.53 0.60 
3 02 0.0038" 0.15 0.88 
2 81 0.0317 -0.72 0.48 
4.12 0.0296 -0.79 0.45 3.37 0.0145' -2.91 0.0122' 
3.51 0.08 -1.23 0.24 
2.41 0 09 -2.23 0.0442 
2 44 0.12 -3.49 0.0040" 
2.82 0.22 -1.84 0.09 
1.90 0.18 -1.14 0.27 
1.83 0.69 -1.13 0.28 
1 67 091 -0.60 0 56 
1.27 0.55 1.04 0.32 
1 42 0.47 0 03 0.98 
0.41 0.85 1.07 0.30 
0.12 0.65 0.63 0 54 
0 62 0.53 1 44 0.17 
0.74 0.76 0.41 0.69 
0.20 0.62 0.67 0.52 
0.47 0.90 0.87 0.40 
0.64 0.76 1.00 0 33 
0.32 0.62 1.99 0.07 
0.51 0.25 -1.93 0.08 
-0.13 0.0013 -0.10 0 92 
0.31 0.0213 0.16 0.88 
0.51 0.08 -0.19 0.85 
1.19 0.0495 0.52 0.61 
4.06 0.0098 -0.16 0.88 
2.62 0.0147 -0.03 0.98 
1.87 0.0012 0.43 0.67 
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APPENDIX E6 
Hemisphere Ratio Values for Right Stroke Group and Controls 
One tailed t test against I for between hemisphere ratios (C4/C3) of right stroke 
group and controls. Values in bold are p<0.05, * p<0.01, ** p<0.005, *** p<0.001. 
Frequency 
Bin (Hz) 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
Beta 
Alpha 
Theta 
Delta 
Right Stroke Controls 
rprp 
2 59 0.0190' 1.56 0.14 
2.66 0.0163* 1.15 0.27 
2.75 0.0138" 0.94 0.36 
3.10 0.0066" 1.12 0.28 
2.80 0.0123" 1.80 0.09 
2 96 0.0088"" 0.70 0 49 
2.17 0.0447 1.21 0.24 
2 68 0.0158 0.89 0.39 
2.18 0.0435 1.28 0.22 
2.03 0.0579 1.28 0.22 
2.02 0.0597 2.18 0.0439 
1,30 0.21 0.96 0.3523 
1.44 0.17 2.06 0.06 
0.95 0.36 2.03 0.06 
424 0.81 2.13 0.0477 
-0 55 0.59 1 72 010 
-2.75 0.0137" 1.79 0.09 
-2.30 0.0344 0.97 0.34 
-1.91 0.07 1.09 0.29 
-1.70 0.11 1.17 0.26 
-1.22 0.24 -0.58 0.57 
-1.73 0.10 0.43 0.67 
-1.53 0.15 -0.05 0.96 
-2.20 0.0416 0.08 0.94 
-0.63 0.54 -0.68 0.51 
-0.24 0.81 0.06 0.95 
-0.66 0.52 0.51 0.61 
0.09 0.93 -0.15 0.88 
0.67 0.51 -0.04 0.97 
0.43 0.67 -0.08 0.94 
-1.15 0.26 1.36 0.19 
2.45 0.0254 1.42 0.17 
2.79 0.0125" 1.33 0.20 
2.69 0.0166 1.47 0.16 
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Appendix F: List of Abbreviations 
Fatigue Impact Scale (FIS) 
Oxford I landicap Scale (OHS) 
Tinetti Test (TT) 
Basic Activities of Daily Living (BADL) 
Modified Rankin Scale (MRS) 
Motricity Index (Ml) 
Scandinavian Stroke Scale (SSS) 
Stroke Severity Scale (SSVS) 
Multidirnentional Health Locus of Control Scale (MHLC) 
Geriatric Depression Scale (GDS) 
Beck Depresion Inventory (BDI) 
Activities of Daily Living (ADLs) 
Apathy Evaluation Scale (AES) 
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